<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://www.nal.usda.gov/exhibits/speccoll/items/browse?advanced%5B0%5D%5Belement_id%5D=49&amp;advanced%5B0%5D%5Btype%5D=is+exactly&amp;advanced%5B0%5D%5Bterms%5D=pesticide+testing&amp;output=omeka-xml" accessDate="2026-09-12T23:10:38+00:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>15</perPage>
      <totalResults>11</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="2316" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15828">
              <text>049</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15829">
              <text>1263</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15833">
              <text>Series III Subseries II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15825">
                <text>Goring, C. A. I.</text>
              </elementText>
              <elementText elementTextId="15826">
                <text>J. W. Hamaker</text>
              </elementText>
              <elementText elementTextId="15827">
                <text>D. A. Laskowski</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="15830">
                <text>Chemicals, Human Health and the Environment: A Collection of Dow Scientific Papers, Volume 1</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15831">
                <text>April 9 1973</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15832">
                <text>A Proposed Approach to PR 70-15 Guidelines</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15834">
                <text>EPA</text>
              </elementText>
              <elementText elementTextId="15835">
                <text>pesticide testing</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2299" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15662">
              <text>048</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15663">
              <text>1246</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15667">
              <text>Series III Subseries II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="15664">
                <text>Bulletin of the World Health Organization</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15665">
                <text>1962</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15666">
                <text>Measurement of the Exposure of Workers to Pesticides</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15668">
                <text>industrial exposure</text>
              </elementText>
              <elementText elementTextId="15669">
                <text>pesticide testing</text>
              </elementText>
              <elementText elementTextId="15670">
                <text>study protocol</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2248" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15114">
              <text>048</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15115">
              <text>1195</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15119">
              <text>Series III Subseries I</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="15116">
                <text>Food and Cosmetics Toxicology</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15117">
                <text>1971</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15118">
                <text>Reduction of Pesticide Residues in Human Adipose Tissue with Diphenylhydantoin</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15120">
                <text>adipose tissue testing</text>
              </elementText>
              <elementText elementTextId="15121">
                <text>human testing</text>
              </elementText>
              <elementText elementTextId="15122">
                <text>pesticide testing</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2239" public="1" featured="0">
    <fileContainer>
      <file fileId="1294">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/d84c18225cc860ed084c3c1c298f0c95.pdf</src>
        <authentication>2624455df9ce42ce184cefedb29a7862</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63243">
                    <text>Item ID Number

°1186

Author

Adamovic, V. M.

Corporate Author
Lower

Level Phenomena of DDT Cumulation in Female
Abdominal Fatty Tissue

JOIirnal/BOOk Title

Year

Arhiv za

Higijenu Rada

1973

Month/Day
Color
Number of Images

n

4

Alvin L. Young filed this item under the category
"DDT/Human Toxicology and Environmental Fate"

Wednesday, April 11, 2001

Page 1186 of 1242

�hig. rada. 24 (1973) 303.

LOWER LEVEL PHENOMENA
O F JJDJ C U M U L A T I O N I N F E M A L E
ABDOMINAL FATTY T I S S U E f

^-V. M. A n fl M n v i ^ and B o R K A S O K I d
Institute for Health Protection of Serbia, and Department for Sanitary
Chemistry, Beograd
The authors found a significantly higher level of DDT storage
in the fatty tissue samples of men than in women (mean pp'DDE
was 12.8 ppm and 10.2 ppm respectively). By comparing the excretion of organochlorine insecticides in the milk of breast-feeding
mothers with their total daily DDT intake by food, they registered
considerably greater quantities of pp'DDE eliminated than ingested. By excluding the nondietetic DDT intake the authors explain
this phenomenon by hormonal factors i. e. by increased mobilization of the stored DDT metabolites during the lactation period.
The lower DDT storage found in women may also reduce the mean
residue values related to the general population.
Irrespective of its restricted use the presence of DDT in the human
environment will continue for some time yet to influence to a very great
extent man's existence and of course, his health. The conclusions arrived
at meetings of experts (1) show that DDT will continue to be used for
controlfing the vectors of certain diseases and even in the control of
various agricultural pests. Taking into account the persistence of these
compounds on one side and the quantities that have been used so far
and that will be used in the future on the other, it is not hard to conclude that man's contact with DDT remains inevitable, whatever guarantees may be prescribed.
Past investigations of the toxioological, cancerogenic, mutagenic and
other properties of DDT have yielded so many data that it may well be
claimed that DDT is the most widely checked compound to date (2, 3).
Even so, present knowledge does not offer a realistic idea of its effect
upon man. Very little is known about the daily effect of small quantities
"Of DDT on the general population, except that it is stored in the adipose
'tissue (4) and that it is thus present in all organs of vital importance.
These effects can be evaluated by periodical determinations of the concentration of stored DDT and its degraded products in the human adipose tissue and blood or serum, and correlated with the data on the

�304

V. M. AlMMOVld, BORKA SOKI(5

daily intake of DDT with food. Some authors have found the concentration of stored DDT to be on a steady downward line and it is considered that the measures undertaken will further diminish its excretion (2).
Among numerous data of this kind there are some which suggest the
existence of a significantly higher level of DDT, especially of pp'DDE,
in males than in females. We found the same in 1967/68 after having investigated 100 samples of adipose tissue from the inhabitants of Belgrade and Serbia proper (5): the mean value of the total DDT depot was
10.2 ppm in women as compared to 12.8 ppm in men, the total mean
value for the general population amounting to 11.5 ppm.
This difference of about 2—2.5 mg/kg of adipose tissue is to be found
in papers published before (6) and after (7, 8) our report, although there
have been papers (9) in which no difference was found. The existence of
a difference has been explained in several ways, one being the relative
complexity of female hormonal interrelationships which could conceivably result in an increased microsomal enzyme activity and a subsequent
body burden reduction. This may also be interpreted in part by a differing female pattern of fat deposition and the likelihood of males having
greater environmental exposure to pesticides. However, in the course
of our examinations of the factors contributing to increased concentrations of organochlorine insecticides in infants (10) we found some interesting data which might help to explain this phenomenon too.
Namely, in investigating the daily intake of organochlorine insecticides by infants we also determined the entire daily intake of these insecticides with food by breast-feeding mothers and the daily excretion
with milk. We found a significant disproportion between the total daily
intake of DDT and its excretion as illustrated in Table 1.
From the above data the following may be concluded:
a) breast-feeding mothers excreted considerably greater quantities of
pp'DDE with milk than they took in with food;
b) the disproportion was far greater in mothers of twins (A and B)
than in mothers of a single child (persons C);
c) similar occurrences were not found in the case of other organochlorine insecticides, although we found (5) that the levels of stored
djeldrin likewise differed according to sex, which was not suggested by
other authors.
Since the experiment was carried out under controlled conditions and
since the factor of non-dietetic DDT intake could be ignored on this
occasion, obviously a powerful mobilization of the stored pp'DDE and
other DDT derivatives takes place during the lactation period i, e., the
surplus of DDE excffeted with milk becomes more apparent. Knowing
that the »good old practice* of breast-feeding is still maintained in some
parts of the world, that in some regions this lactation .period lasts up to
six — nine months, that a balance in subsequent storage of DDT is not

�LOWER LEVEL

PHENOMENA OF DDT

CUMULATION

305

Table 1
Total daily excretion of organochlorine insecticides in human milk compared
to their total daily intake with food (expressed in y/day person)
O

Person

Mean
quantity
of milk
ml/day

ffi
«

£
G,

CJ

ffl
«

W
Q
O

I

&lt;

Kj
O

&amp;

a

H
Q
Q

a

H
Q
Q

«

01

a.
o

5H
oQ
HQ

.s
•a

S

A

1.590

8

22

828

16

154

9

1.078

9

B

1.249

3

14

745

14

179

9

1.033

3

C

527

1

4

67

3

25

2

105

&lt;1

9

317

65

20

112

59

266

9

Total daily intake
with food (2.660 g)

The result represents the mean value for the observed period of seven consecutive days.
A and B are mothers breast-feeding twins
C are mothers with one child.
attained at once and that such cases figure among the examined subjects from the general population, we may assume that such samples
can significantly contribute to a decrease of the mean value for one group
of examined subjects and thereby explain the phenomenon of reduced
storage of DDT in women. This should be borne in mind when assessing the results of epidemiological studies of OC insecticide exposure.
References
1. Deichmann, W. B,: Arch. Toxikol., 29 (1972) 1.
2. Report of the Secretary's Commission on Pesticides and Their Relationship to Environmental Health. U.S. Dept. of Health, Education and Welfare, 1969.
3. Kagan, Yu. S., Pudel-Ossipova, S. I., Khaikina, B, J., Kuzminskaya, U. A.,
Kouton, S. D.: Res. Rev., 27 (1969) 43.
4. Howell, D. E.: Proc. Okla. Acad. Sci., 29 (1948) 31.
5. Adamovit, V. M., Hus, M.t Sindjic, M., Dukid, V.; Hrana i ishrana, 11 (1970)
6. Zavon, M. R., Hine, H. C., Parker, E. D.: J.A.M.A., 193 (1965) 181.
7. Watson, M., Benson, W. W., Gabica, J.: Pestic. Monit. J.( 4 (1970) 47.
8. Wyltie, /., Gabica, J., Benson, W. W.: Pestic. Monit. J., 6 (1972) 84.
9. FiSerova-Bergerova, V,, Radomski, J. £., Davtes, J. E., Davies, J. H.: Ind.
Med. Surg., 36 (1967) 65.
10. Adamovic, V. M., Soktt, B., Petrovic, O.: Ernahrungsforschung, 16 (1971)
579.

�306

V. M. ADAMOVIC, BORKA SOKI&lt;;

SaZetak
POJAVA MANJE KUMULACIJE DDT-ja U ABDOMINALNOM
MASNOM TKIVU 2ENA
Autori su naSli znacajno viSu razinu pdlaganja DDT-ja u masnom tkivu muSkaraca nego onorn u zena (srcdnja vrijednost pp'DDE iznosila je 12.8 ppm za
muSkarce odnosno 10.2 ppm za zenc). Usppredujuci izlucivanje organoklornih
insckticida u mlijeku zcna-dojilja s kolicinom DDT-ja uncsenog hranom, izmjerili su znatno viSe eliminiranih rezidua no 5to bi odgovaraio ingestiji insekticida. Isklju£ivSi drugi put apsorpcijc izuzev hranom, autori tumafie tu
pojavu hormonskim ciniocima, tj. povecanom mobilizacijom deponiranih metabolita DDT-ja za vrijcine laktacijskpg razdoblja. Smanjeno odlaganje DDT-ja
u zena bit cc da utje(?.e i na srednje vrijcdnosti deponiranih metabolita za
cjelokupnu populaciju nckog podrucja.
Odjel sanitarne kernije,
Zavod za zaStitu zdravlja Srbije,
Beogmd

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15017">
              <text>047</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15018">
              <text>1186</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="15022">
              <text>Series III Subseries I</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15014">
                <text>Adamovic, V. M.</text>
              </elementText>
              <elementText elementTextId="15015">
                <text>Sokic</text>
              </elementText>
              <elementText elementTextId="15016">
                <text>Borka</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="15019">
                <text>Arhiv za Higijenu Rada</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15020">
                <text>1973</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15021">
                <text>Lower Level Phenomena of DDT Cumulation in Female Abdominal Fatty Tissue</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="15023">
                <text>human testing</text>
              </elementText>
              <elementText elementTextId="15024">
                <text>pesticide testing</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="2073" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13299">
              <text>043</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13300">
              <text>1020</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="13304">
              <text>Series III Subseries I</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13296">
                <text>Rivers, Jerry B.</text>
              </elementText>
              <elementText elementTextId="13297">
                <text>William L. Yauger, Jr.</text>
              </elementText>
              <elementText elementTextId="13298">
                <text>Howard W. Klemmer</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="13301">
                <text>Journal of Chromatography</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13302">
                <text>1970</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13303">
                <text>Simultaneous Gas Chromatographic Determination of 2, 4 -D and Dicamba in Human Blood and Urine</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="13305">
                <text>pesticide properties</text>
              </elementText>
              <elementText elementTextId="13306">
                <text>pesticide testing</text>
              </elementText>
              <elementText elementTextId="13307">
                <text>human exposure</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="1">
        <name>ao_seriesIII</name>
      </tag>
    </tagContainer>
  </item>
  <item itemId="1411" public="1" featured="0">
    <fileContainer>
      <file fileId="1227">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/c8d45f6a1ae447cf1ee7f5cc9b3b5c30.pdf</src>
        <authentication>09987213933822e963f6186b366cb26c</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63176">
                    <text>°0309

Item ID Number
Author
CorpOratB Author

Office of the Federal Register

ROpOPt/ArtMO TitlO

pro

JOUmal/BOOk Title

Federal Register

Year

1978

Month/Day

Ju| 31

Color

Posed Tolerances for the Pesticide Chemical
Malathion

v

n

Number of linages

2

DeSOrlOtOU NOtBS

Found in a file labeled: "Correspondence Relating to
the First Use of Military Aircraft for the Dessimination of
Insecticides"

Monday, January 22, 2001

Page 309 of 341

�'

Dated: July 24,1978.
DOUGLAS D. CAMPT,
Acting Director,
Registration Division.
Statutory Authority: Section 408(e) at the
Federal Food, Drug, and Cosmetic Act [21
U.8.C. 348a&lt;e)3.

It is proponed that part 180, Subpart
c, § 180.208 be revised in Its entirety by
editorially revising the section into an
alphabetized columnar listing and by
alphabetically inserting the toleraice
of 0.5 ppm on satflower seed, as follows:
§ 180.298 Methidnthion; tolerances for residues.

Tolerances are established tor residues of the insecticide methidathton
(0,0-dimethyl phosphorodithioate, Sfnt&amp;r with 4-(mercaptomethyl)"2-methoxy-AM,3,4-thiadla!solin-8"On8&gt; in or
on the following raw agricultural commodities:
Commodity:
Alfalfa
AHalft, lw

..„.,...

OiOVCf, ,.,.„.,.,„„.,.,.,

»ll,t.4...(.

Ctovor, hay
Cottonseed............ ,„
Qrapoftuit
,.,...„.

8
8

.-..«....HIM...

,.„

8

6
.3
3

„...

Onm, hay ...„,»
Feaehca........

... . 3

09
.08

PotfttOGJI,.,....,...,..,.,....,..,,...,,.,.,. .......... ,„ ....... .„, '

Sorghum, f
Braghum, forage.-..
Sorghum. fi's.in ...........,
Sunflower seeds .......... ,.

,2

t
8

3
.0

CPR Doc. 7S-.31016 Plied 7-3ft-78; 8:« am]
[$560.01]
[40 Cft Pert 180]

^/

EW 7E1881/P81; FBL S34-4]
PtO»» TOLiRAKCi COS THI PESTICIDE
CHIMSCAl MALATHiOM
Tolorcncos
few f *tij;!rf« Chamktib in or on Sow Ayrktil-

AGENCY: Office of Pesticide Programs, Environmental
Protection
Agency (EPA).
ACTION: Proposed rule.
SUMMARY: This notice proposes that
the insecticide nmlathion be weed on
wild rice. The proposal was submitted
by the Interregional Research Project
No. 4. This amendment to the regulations would establish a maximum permissible level for residues of malathion on wild rice.
,
DATE: Comsiersts must be received by
August 30, 1OT8.

1 Comma
ister Section, Techr
..***• Division (WH-569), Off/estlcide Programs, EPA, Room ,:01, East Tower,
401 M Street SW., Washington, D.C.
20460.
POP, FURTHER INFORMATION
CONTACT;
Mrs. Patricia Critchlow, Registration
Division (WH-567), Office of Pesticide Programs, EPA, 202-756-2516.
SUPPLEMENTARY INFORMATION
Dr. C.C. Compton, Coordinator, Interregional Research Project No. 4 (IR4), New Jersey State Agricultural Experiment Station, P.O. Box 231,
Rutgers University, New Brunswick,
N.J. 08903, on behalf of the IR-4
Technical Committee and the Agricultural Experiment Station of Minnesota has submitted a pesticide petition
(PP 7E1881) to the EPA. This petition
request that the Administrator propose that 40 CPR 180.111 be amended
by the establishment of a tolerance
for residues of the insecticide malathion (0,0-dimethyl dithlophosphate of
dlethyl mercaptoaucciiiate) in or on
the raw agricultural commodity wild
rice at 8 parts per million (ppm).
The data submitted in the petition
and other relevant material have been
evaluated. The toxicological data considered in support of the proposed tolerance ^Included two 2-year rat feeding
studies, 'one with a no-observableeffect level (NOEL) of 100 ppm; the
other showing chollnesterase-lnhibition at 100 ppm but no systemic effects at 1,000 ppm; a one-generation
rat reproduction study in which reproductive effects were observed at 4.000
ppm, the only level tested; a negative
neurotoxicity study; a negative single
dose (900 milligrams (mgVkilogram
(kg) of body weight (bw)) Intraperitoneal teratology study in rats; rat and
mouse oral lethal dose (LDW) tests;
two negative mutagenicity tests using
microbial assay systems; and a 47-day
human feeding study with an NOEL at
0.2 mg/kg bw/day. Based on this last
study and using a safety factor of 10,
the acceptable daily intake (ADI) is
0.03 rag/kg bw/day. The maximum
permissible intake for a 80-kg man la
1.2 mg/day.
Tolerances have previously been established for residues of malathion on
a variety of raw agricultural commodities at levels ranging from 135 ppm to
0.1 ppm. Food additive tolerances have
also been established for malathion residues on raisins at 12 ppm and in safflower oil at 0.6 ppm. Peed additive tolerances have been established for malathion residues in dehydrated citrus
pulp at 50 ppm and in nonmedicatedi
cattle feed concentrate blocks at 10
ppm.
On a theoretical besis, the total
maximal residue contribution (TMRC)

of thoe« tolerances, exceeds the ADI;
however, total diet surveys show that
Over a 4-year period the actual exposure to malathion, was not more than
0.00013 mg/kg bw/day, which is less
than 1 percent of the ADI. The increment of human exposure due to the
tolerance on wild rice would be negligible, and thus, the increment In risk, if
any, is acceptable. The metabolism of
malathion is adequately understood,
and an adequate analytical method
(gas chromatography using a flame
photometric detector) is available for
enforcement purposes. The following
studies are currently lacking: oncogenicity studies in two mammalian species
using currently acceptable protocols, a
multlgeneration reproduction study,
and a teratology (oral) study. However, it has been determined that the
proposed tolerance can be established
because: (1) Tolerances currently exist
for malathion on a majority of food
and feed items in the United States
and (2) the use of malathion on wild
rice would not significantly Increase
human exposure to malathion residues. There Is no reasonable expectation of residues In eggs, meat, milk, or
poultry as delineated in 40 CFR
180.6(a)(3&gt;.
The pesticide is considered useful
for the purpose for which a tolerance
is sought, and it is concluded that the
tolerance of 8 ppm established by
amending 40 CFR 180.111 will protect
the' public health. It is proposed,
therefore, that the tolerance be established as set forth below.
Any person who has registered, or
submitted an application for the registration of a pesticide under the Federal Insecticide, Fungicide, and Rodenticide Act which contains any of the ingredients listed herein may request,
within 30 days after publication of this
proposal in the FEDERAL REGISTER, that
this rulemaklng proposal be referred
to an advisory committee in accordance with section 408(e) of the Federal
Food, Drug, and Cosmetic Act.
Interested persons are invited to
submit written comments on the proposed regulation. The comments must
bear a notation indicating both the
subject and the petition/document
control number, "PP7E1881/P81." All
written comments filed in response to
this notice of proposed rulemaklng
will be available for public inspection
in the Office of the Federal Register
Section from 8:30 a.m. to 4 p.m.
Monday through Friday.
STATUTORY AUTHORITY: Section 408(e) of
the Federal Food, Drug, and Cosmetic Act
(21 U.S.C. 346*(e».

FE0etAl HE©OTfft, VOL 43, NO. 147-~MON0AY, JULY 31,

�33265

PROPOSE RULES
Dated: July 24,1978.
DOUGLAS D. CAMPT,

Acting Director
Registration Division,
It is proposed that part 180, subpart
C, § 180.111 be amended by alphabetically inserting the tolerance of 8 ppm
on wild rice In the table to read as follows:
Section 180.111 Malathion; tolerances for residues.
Commodity:

Port* per
million

Rice, wild....

IFR Doc. 78-21016 Filed 7-28 78; 8:45 am]
[4110-84]
DEPARTMENT OF HEALTH,
EDUCATION, AND WELFARE
Public Health Service
[42 CFK Part 23]
NATIONAL HEALTH SERVICE CORPS
Subpart A—Assignment of National Health
Ssrvice Corp* Personnel

AGENCY: Public Health Service,
HEW.
ACTION: Notice of proposed rulemaking.
SUMMARY: These proposed regulations prescribe the requirements for
the assignment of National Health
Service Corps personnel under Section
333 of the Public Health Service Act
(42 U.S.C. 254f) to public or nonprofit
private entities to provide health services in or to a health manpower
shortage area designated under Section 332 of the Public Health Service
Act.
DATE: Comments must be received
August 30, 1978.
ADDRESSES: Written comments,
preferably in triplicate, should be addressed to the Director, Division of
Policy Development, Bureau of Community Health Services, Health Services Administration, room 6-17, 5600
Fishers Lane, Rockville, Md. 20857. All
comments received will be available
for public inspection and copying at
the above address, weekdays (Federal
holidays excepted) between the hours
of 8:30 a.m. and 5 p.m.
FOR FURTHER
CONTACT:

INFORMATION

Fitzhugh S. M. Mullan, M.D., Director, National Health Service Corps,
Bureau of Community Health Ser-

vices, Room 6-05, Parklawn Building, 5600 Fishers Lane, Rockville,
Md. 20857, 301-443-4434.
SUPPLEMENTARY INFORMATION:
On October 12,1976, a new section 333
was added to the Public Health Service Act (42 U.S.C. 254f) by Pub. L. 04484, the Health Professions Educational Assistance Act of 1976. This section
allows the Secretary to assign, pursuant to regulations, members of the National Health Service Corps to public
and nonprofit entitles to provide
health services In or to a health manpower shortage area.
Based upon the enactment of this
new section 333, the Assistant Secretary for Health, Department of
Health, Education, and Welfare, proposes to revoke the existing part 23,
subpart A, and add a new Subpart A
entitled "Assignment of National
Health Service Corps Personnel."
A notice of intent to issue regulations for this program was published
in the FEDERAL REGISTER on May 20,
1977 (42 FR 25992). Interested persons
were invited to comment on the issues
raised and several comments were received.
The regulations establish the conditions applicable to the assignment of
National Health Service Corps personnel to a public or nonprofit private
entity to provide health services in or
to a health manpower shortage area.
In the interest of streamlining regulations and reducing regulatory burden,
minute program particulars have not
been set forth In the regulations. For
this reason, most of the comments received on the notice of Intent were not
pertinent to the development of these
regulations, but will be considered by
the Department in developing program policies.
Following Is a brief summary of the
major features of the proposed regulations:
(1) In approving applications for assignment, section 23.5(b) provides that
if two eligible entities, one located In
the health shortage area and one not
located in the area but having a demonstrated Interest in It, submit applications for assignment of National
Health Service Corps personnel to provide health services to the area, spe-..
clal consideration will be given to the
entity located In such health manpower shortage area. This special consideration was adopted in response to the
several public comments received suggesting that such a consideration
would promote greater community involvement between the approved
entity and the individuals receiving
health services.
(2) Section 333(c) of the Public
Health Service Act requires that the
Secretary take into consideration four
factors in assigning National Health
Service Corps personnel to entities

v/ith approved applications. The four
factors are (i) Need of the health manpower shortage area, (ii) Use of physician assistants, nurse practitioners, or
expanded function dental auxiliaries,
(ill) Willingness of the individuals
within the health manpower shortage
area to assist and cooperate with the
National Health Service Corps and (iv)
Comments of professional societies
serving the health manpower shortage
area. In implementing this statutory
requirement, the regulations provide
that the Secretary will utilize a
weighted-value system in which
weights will be assigned to the four
statutory factors, with the greatest
weight being assigned to the first
factor listed above and weights being
assigned to the remaining factors in
descending order. Based on this approach, approved applications will be
assigned to priority categories. Personnel assignments will then be made to
entitles In accordance with these priority categories to the extent possible
consistent with the statutory mandate
that in assigning personnel to provide
health services to a health manpower
shortage area, the Secretary shall seek
to assign to an area personnel with
those characteristics which will increase the probability of their remainIng to serve the area upon completion
of the assignment period.
(3) The proposed regulations require
that individuals receiving services
from assigned National Health Service
Corps personnel be charged on a fecfor-scrvlce or other basis at a rate to
be approved by the Secretary. Fees are
to be based upon the cost of delivering
services and on fees charged for similar services by similarly situated practitioners and facilities. The proposed
regulations further provide that no individual will be denied health services
based upon his inability to pay for
such services. With respect to this inability to pay, §23.9 of the proposed
regulations states that those individuals with annual incomes at or below
the "CSA Income Poverty Guidelines"
(45 CFR 1060.2) may receive services
at a reduced charge. Individuals who
have annual incomes above the "CSA
Income Poverty Guidelines" but
which do not exceed 200 percent of
such CSA levels will also receive
health services at reduced charge.
Charges will be made, however, for
services to Individuals to the extent
that payment will be made by a third
party which is authorized or under
legal obligation to pay such charges.
(4) The statute requires In section
334(a)(3) that the National Health
Service Corps site repay the Federal
Government for the costs involved in
providing assigned National Health
Services Corps personnel. The statute
also provides that repayment may,
under certain specific circumstances,

FEDERAL REGISTER, VOL. 43, NO. 147—MONDAY, JULY 31, 1978

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="6536">
              <text>020</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="6538">
              <text>0309</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="6542">
              <text>Series II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6537">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Office of the Federal Register</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="6539">
                <text>Federal Register</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6540">
                <text>July 31 1978</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6541">
                <text>Proposed Tolerances for the Pesticide Chemical Malathion</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6543">
                <text>pesticide testing</text>
              </elementText>
              <elementText elementTextId="6544">
                <text>pesticide properties</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="1410" public="1" featured="0">
    <fileContainer>
      <file fileId="1226">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/61abe0a593ddec01560c1d1658a4d339.pdf</src>
        <authentication>b2cdea012ae9de4b978e37bf74848498</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63175">
                    <text>°0308

Item ID Number
Author
Corporate Author

Office of the Federal Register

Report/Article TitlB Proposed Tolerances for the Pesticide Chemical
Malathion; Proposed Tolerances for the Pesticide
Chemical 5-ethoxy-3-trichloro-methyl-1,2,4-thiadiazole

JOUmal/BOOk Title

Federal Register

Year

1978

Month/Day

March e

Color

n

Number of Images

4

DeSOrlptOU Notes

Found in a file labeled: "Correspondence Relating to
the First Use of Military Aircraft for the Dessimination of
Insecticides"

Monday, January 22, 2001

Page 308 of 341

�PROPOSED RULES

land submitted to the Regional Administrator a proposed revision of the
Maryland State Implementation Plan
for the attainment and maintenance
of national ambient air quality standards (NAAQS). The proposed revision
was defined in an Order issued by the
Maryland Secretary of the Department of Health and Mental Hygiene
on July 8,1975. The proposal consisted
Of a request to grant an exception to
the Westvaco Corp., Luke, Md., from
Maryland's sulfur-in-fuel regulation
(10.03.36.04B) which requires the use
of fuel containing 1% orless sulfur by
weight. The purpose of this request
for an exception was to allow the
Westvaco Corp., to burn coal with a
higher sulfur content. At the same
time the Westvaco Corp., would be allowed to emit up to 58 tons/day of
sulfur dioxide (SO,) from all fuel
burning equipment. The State of
Maryland justified this request with
the following:
1. Westvaco desires to remain on
coal firing, but lias been unable to
secure an adequate supply of 1 percent
sulfur coal.
~
2. Desulfurization alternatives were
not yet available to the company.
3. Such an exception would not
cause violation of federal or state standards in the vicinity of the plant.
The State of Maryland submitted
proof that a public hearing with adequate public notice was held on May
26, 1975, pursuant to 40 CPR Part 51,
Requirements for Preparation, Adoption, and Submittal of State Implementation Plans.
The State of Maryland, on behalf of
the Westvaco Corp., submitted a modeling analysis intended to demonstrate
that the exception requested would
not result in violations of NAAQS for
S0». Upon review of the analysis, EPA
determined that it was incorrect in a
number of respects and underpredipts
the impact of SO, emissions. Therefore EPA concluded that the analysis
did not provide a demonstration that
air quality standards would be attained or maintained if the exception
were to be approved as a SIP revision.
Subsequent meetings were held with
the State of Maryland and Westvaco
in attempts to resolve differences between the company's modeling approach in support of the request for
exception and that which EPA believes to be appropriate. Although
some minor differences were resolved,
EPA maintained that, overall, the
modeling analysis did not demonstrate
that the SO, limitations specified in
the exception request will not violate
the NAAQS for SO,. Accordingly, EPA
informed the State of Maryland, in a
:letter dated February 28, 1977, that
the exception request was uhapprovable as a revision of the Maryland SIP.
On November 18, 1977, the State of
Maryland submitted to the Regional

Administrator an Amendment to the
aforementioned Secretarial Order.
This submittal alters the originally
proposed revision of the SIP in that
the Westvaco Corp. would be limited
to 49 tons/day of SO, instead of 58
tons/day. Also, under the terms of the
Amendment, the Westvaco Corp. consents to its installing two meteorological stations and additional SO, monitors. The stated purposes of the additional equipment is to provide information regarding air quality levels and
to verify the adequacy of the 49 ton/
day emission limitation as determined
by the Company's modeling analysis,
or to establish with any new data, a
different emission limitation. After
evaluating the revised submittal, EPA
maintains that the modeling analysis,
including the most current revision
dated June 14, 1977, does not demonstrate that the 49 ton/day SO, limitation will not violate NAAQS for SO,.
This determination is not altered by
an evaluation of information contained in a February 2, 1978 report
forwarded directly to EPA by Westvaco. Thus the agency believes that
the revised request for an exception
on behalf of the Westvacp Corporation is also unapprovable as a revision
of the Maryland SIP.
The State of Maryland submitted
proof that a public hearing on the
Amendment to the Secretarial Order
of July 8, 1975 was held on October 7,
1977, after adequate public notice,
pursuant to 40 CPR Part 51, Requirements for Preparation, Adoption and
Submittal of State Implementation
Plans.
This notice is to advise the public of
receipt of Maryland's request for an
exception, and to request public comment on it. Only comments received
before April 5,1978, will be considered.
The Administrator's decision to approve or disapprove this proposed revision will be based on whether it meets
the requirements of Section 110 of the
Clean Air Act and EPA regulations in
40 CPR Part 51.
Copies of the proposed revision, together with supporting documentation
and correspondence, are available for
public Inspection during normal business hours at the offices of:

tion Agency, Region III, Curtis Building,
Sixth and Walnut Streets, Philadelphia,
Pa. 19106, ATTN: AHOOGMD.
(42 U.S.C. 7401 et seq.)
Dated: February 27,1978.
JACK J. SCHRAMM,
Regional Administrator.
IFR Doc. 78-5707 Piled 3-3-78; 8:45 am]
[1505-01]
[40 CFR Part 141]
[PRL 851-5]
INTERIM PRIMARY DRINKING WATER
REGULATIONS
. Control of Organic Chemical
Contaminants in Drinking Water

Correction
In FR Doc. 78-3414 appearing at
page 5756 in the issue for Thursday,
February 9,1978, on page 5777, second
column, (c) of § 141.12 should read as
follows:
(c) Total trihalomethanes
[the sum of the concentrations of bromodichloromethane,
dibromochloromethane, tribromomethane
(bromoform) and trichloromethane (chloroform)]." ....0.10 mg/1
[6560-01]
[40 CFR Part 180]
[PRL 863-4; PP 7E2001/P64]
PESTICIDE PROGRAMS
TOLERANCES
AND
EXEMPTIONS
FROM TOLERANCES FOR PESTICIDE
CHEMICALS IN OR ON RAW AGRICULTURAL COMMODITIES
Proposed Tolerances for The Pesticide
Chemical Matothion

AGENCY: Office of Pesticide Programs, Environmental Protection
Agency (EPA).
U.S. Environmental Protection Agency, ACTION: Proposed rule.
Region III, Air Programs Branch, Curtis
Building, Sixth and Walnut Streets, Phila- SUMMARY: This notice proposes that
delphia, Pa. 19106, ATTN: Mr. Harold the insecticide malathion be used on
Frankford (3AK11).
birdsfopt, trefoil. The proposal was
Maryland State Bureau of Air Quality and submitted by the interregional ReNoise Control, 201 West Preston Street, search Project No. 4. This amendment
Baltimore, Md. 21201, ATTN: Mr. George to the regulations would establish a
Perreri.
Public Information Reference Unit, U.S. En- maximum permissible level for resivironmental Protection Agency, 401 M dues of malathion on birdsfoot trefoil.
Street SW., Washington, D.C. 20460.
DATE: Comments must be received on
All comments should be addressed or before April 5,1978.
to:
ADDRESS COMMENTS TO: Federal
Mr. Howard R. Helm (3AH10). Chief, Air Register Section, Technical Services
Planning Branch, Environmental Protec- Division (WH-569), Office of Pesticide

FEDERAL REGISTER, VOL 43, NO. 44-ttONDAY, MARCH 6, 1*78

�9164

PROPOSEP RULES

Programs, EPA, Room 401, East
Tower, 401 M Street SW7, Washington,
D.C. 20460.
FOR FURTHER INFORMATION
CONTACT:
Mrs. Patricia Critchlpw, Registration
Division (WH-561?), Office of Pesticide Programs, EPA, 202-755-2516.
SUPPLEMENTARY INFORMATION:
Dr. C. C. Compton, Interregional Research Project No. 4, New Jersey State
Agricultural Experiment Station, P.O.
Box 231, Rutgers University, New
Brunswick, N.J. 08903, on behalf of
the IR-4 Technical Committee and
the Agricultural Experiment Station
of New York has submitted a pesticide
petition (PP 7E2001) to the EPA. This
petition requests that the Administrator propose that 40 CFR 180.111 be
amended by the establishment of a
tolerance for residues of the insecticide malathion (O.O-dimethyl dithiophosphate of diethyl mercaptosucclnate) in or on the raw agricultural commodity birdsfoot trefoil at 135 parts
per million (ppm).
The data submitted in the petition
and all other relevant material have
been evaluated. The pesticide is considered useful for the purpose for
which the tolerance is sought, and it is
concluded that the tolerance of 135
ppm established by amending 40 CFR
180.111 will protect the public health.
The toxicologlcal data considered in
support of the proposed tolerance Included rat and mouse oral acute toxicity determinations, recombinant assay
and reversion assay mutagenicity studies, a delayed neurotoxocicity study, a
single-dose intraperitoneal teratology
study, a one-generation reproduction
study, two 2-year rat-feeding studies,
and a 47-day human-feeding study.
Since birdsfoot trefoil is not a human
food but a substitute forage crop for
alfalfa on which a tolerance is already
established and since tolerances are
also established in meat, milk, and
meat byproducts, the Toxicology
Branch concludes that there will be no
increase in residues contributed to the
human diet resulting from the proposed use. Oncogenic studies in two
species, a multigeneration reproduction study, and a teratology (feeling)
study, are lacking.
An adequate analytical method (gas
chromatography using electron capture detection) is available for enforcement purposes, and the nature of the
residues is adequately delineated. Tolerances have previously been established (40 CFR 180.111) for residues of
malathion on a variety of raw agricultural commodities ranging from 135
ppm to 0.1 ppm.
There is no reasonable expectation
of residues in eggs and poultry from
the proposed use. The established tolerances for residues in meat arid milk
are adequate to cover secondary resi-

dues resulting from the proposed use
as delineated in 40 CFR 180.6(a)(2).
It is proposed, therefore, that the
tolerance be established as set forth
_,

, - . i ' -

'Any person who has registered, or
submitted an application for the registration of a pesticide under the Federal Insecticide, Fungicide, and Rodenticide Act which contains any of the in-'
gradients listed herein may request, on
or before April 5, 1978, that this rulemaking proposal be referred to an adTisory committee in accordance with
section 408(e) of the Federal Food,
are invited to
submit written comments on the proposed regulation. The comments must
bear a notation indicating both the
subject and the petition/document
control number, "PP7E2001/P64". All
written comments filed in response to
this notice of proposed rulemaking
will be available for public inspection
in the office of the Federal Register
from 8:30 a.m. to 4 p.m. Monday .
*i- _.._i. 1-u.ij,...
... •
through Friday.
Dated: February 27, 1978.

It is proposed that Part 180, Subpart
C, sectiQn 180.111 be revised in its entirety by editorially reformatting the
section into an alphabetized columnar
listing and alphabetically inserting the
new tolerance of 135 ppm on birdsfoot
as lOllUWS..
as follows

^ i

.

§180.111 Malathion; tolerances ffor residues,

Tolerances are established for residues of the insecticide malathion
(0,0-dimethyl dithiophosphate of
diethyl mercaptosuccinate) in or on
the following raw agricultural commodities:
Commodity
Alfalfa (PRE-H)..............................
Almond hulls (PRE-H) ............. „
Almonds (PRE- and POST-H).......
Apples (PRE-H)
Apricots (PRE-H)
Asparagus (PRE-H)........
Avocadoes (PRE-H)
Barley, grain (PRE- and POST-H)
Beans (PRE-H)
Beets (including tops) (PRE-H)
Be^ts, sugar, roots (PRE-H)
Beets, sugar, tops (PRE-H)
Birdsfoot trefoil, forage (PRE-H)......
Birdsfoot trefoil, hay (PRE-H)
Blackberries (PRE-H)
Blueberries (PRE-H)
Boysenberrles (PRE-H)..................
Broccoli (PRE-H)
Brussels sprouts (PRE-H) .....
Cabbage (PRE-H).....................................
Carrots (PRE-H)...................................
Cattle, fat (PRE-S)
Cattle, meat1 (PRE-S) ......... ..&gt;........
Cauliflower (PRE-H)........,.„„..„„..,.........
Celery (PRE-H)......

136
8
8

cowpea, nay (PRE-H&gt;
cranberries (PRE-H)

135
135
a

corn, fresh (including sweet
K+CWHRHPRE-H)..............................
*"• ****? &lt;P°T-H).......................«••»-

Dandelions (PRE-H)
Dates &lt;PRE-H&gt;
Dewberries (PRE-H)
Eggplants (PRE-H)

8

°l
a

Figs (PRE-H)

1

Goats, mbyp- ( p R E . . .
Goats, meatorapes (PRE-H)
ora^ (PRE-H) ..
Grass, hay (PRE-H) ....................................

P&amp;rts psf
million
135
50
8
8
8
8
8
8
8
8
1
8
135
135
8
8
8
8
8
8
8
4
4
8
8

4

.......

Limes (PRE-H) ................................... ...-.
Loganberries (PRE-H) _ ..............................

Lupine, hay (PRE-H).................. ................
Lupine, seed (PRE-H) .................................
Lupine, straw (PRE-H) ..."........ ....................

Macadamla nuts (PRE-H).........................
Mangos (PRE-H)..................„...„„......,.......,

Melons (PRE-H) ...........................................

cows).,

(from application to dairy

etarineRE-H)
.,
oats, grain (PRE- an'd"p'osT-H")'"""!""»]
okra (PRE-H) .............................. .........,. .....

Onions (Including green onions) (PREH) ...... * ................... .. ....... ........ ......... *............
Oranges (PRE-H) .................................. .. .....
Papayas (PRE-H) .........................................
Parsley (PRE-H) ................................. .„„..,.
Parsnips (PRE-H)................................. .......
Passion fruit (PRB-H) ................................
Peaches (PRE-H) .........................................
Peanut, forage (PRE-H) ....................... ......
Peanut, hay (PRE-H).............'.............— ...
Peanuts (PRE- and POST-H) ...................
Pears (PRE-H).................................„ ...........
Peas (PRE-H).............................. .................
Peayine, hay (PRE-H) .................................
Peavlnes (PRE-H)................................. .......
Pecans (PRE-H) ...........................................
Peppermint (PRE-H) „.... ............................
Peppers (PRE-H)........................................
Pineapples (PRE-H)..............................„.,.
Plums (PRE-H) ......................................... ...
Potatoes (PRE-H).....................................-.
Poultry, fat (PRE-S) .................................
Poultry, mbyp1 (PRE-S).............. ...............
Poultry, meat- (PRE-S) ..............................
Prunes (PRE-H) ...........................................
Pumpkins (PRE-H).....................................
Quinces (PRE-H) ............ ., ...........................
Radishes (PRE-H) ........,»,wv...........„,„...„

FEDERAL REGISTER, VOL. 43, NO. 44—MONDAY, MARCH «, 1978

S
a
135
135
4
i

Lentils (PRE-H)
Lespedeza, nay (PRE-H)

MUt fat

4
4

!
4

Hogs, mbyp -(PRE-S)

Kale (PRE-H)
Kohlrabi (PRE-H)
Kumquats (PRE-H)
Leeks (PRE-H);.,.
Lemons (PivE-H)

*

8
g
a

Horses, mbyp '(PRE-S)

STATUTORY AUTHORITY: Sec. 408(e), Federal
Pood, Drug, and Cosmetic Act (21 U.S.C.
345a(e)&gt;.

»...,•

CoUards (PBE-H) .................................... .....
Corn, forage (PBE-H) .................................

Horses, meat* (FRE-S)

Registration Division,

o „«.....

8
i

cherries (PEEchestnuts (PRE-H)

4

8

8
8
8
8

8

135

8
8
8

135
8
135

1
8
8

o.s

I
I
&amp;
8
8
8

1
8
8
8,

8 j
135 j
135 •
8)

8 j
8 j
8 (
8 j
8'
8
8
8

8
8
4
4
4
8
8
8
8

�9165

PROPOSED RULES
-•-.

Partsper
Commodity
million
Raspberries (PR£-H)
8
n
Bice, grain (PRE- and POST-H)
t
Rutabagas (PRE-H)
„
„.
8
Rye, grain (PRE- arid POST-H)
8
Safflowcr, seed (PRE-H)
O.Z
Salsify (including tops) (PRE-H)
8
Shallots (PRE-H)
,
' 8
:
Sheep, fat (PRE-S)
4
Sheep, mbyp &gt; (PRE-S)
4
Sheep, meat' &lt;PRE-S)
4.
Sorghum, forage (PRE-H)
" 8
Sorghum, grain (PRE-and POST-H j.—
' 8
Soybeans (dry and succulent) (PRE-H)...
. 8
Soybeans, forage (PRE-H)
135
Soybeans, hay (PRE-H)...
135
Spearmint &lt;PRE-H)
™
8
Spinach (PRE-H)
8
Squafh, summer and winter (PRE-H)....
8
Strawberries (PRE-H)
8
Sweet potatoes (PRE-H)
1
Swiss chard (PRE-H)
8
Tangerines (PRE-H)
8
:
Tomatoes (PRE-H)
8
Turnips (Including tops) &lt;PRE-H)
8
Vetch, hay (PRE-H)
135
Vetch, seed (PRE-H)
„
8
Vetch, straw (PRE-H)
i
135
Walnuts (PRE-H)
8
Watercress (PRE-H)
—
8
Wheat, grain &lt;PRE- and POST-JO
8
•The tolerance level shall not be exceeded in any
cut of meat or in any meat byproduct from cattle,
goats, hogs, horses, poultry, or sheep. '
IFB Doc. 78-5716 Piled 3-3-78; 8:45 am]

SUPPLEMENTARY INFORMATION:
The California State Dept. of Food
and Agriculture, Agricultural Chemicals and Feed, 1220 N Street, Sacramento, Calif. 95814, has submitted a
pesticide petition (PP 6E1747) to the
EPA. The petition requests that the
Administrator propose that 40 CFR
Part 180 be amended by the establishment of a tolerance for combined residues of the fungicide 5-ethoxy-3-trichloromethyl-l,2,4-thiadiazole and its
monoacid metabolite 3-carboxy-5ethoxy-l,2,4-thiadazole in or on the
raw agricultural commodity avocados
at 0.15 part per million (ppm).
The data submitted in the petition
and other relevant material have been
evaluated. The pesticide is considered
useful for the purpose for which the
tolerance is sought. The toxicology
data considered in support of the proposed 0.15 ppm tolerance were a twoyear rat and dog-feeding study with
no-effect levels (_NEL) of 80j&gt;pni based
on systemic effects in the rat study
and 100 ppm based on the dog study, a
three-generation rat reproduction
study with an NEL of 80 ppm, and an
oral lethal dose (LDSO) study in rats.
[6560-01]
There is no reasonable expectation
of residues in eggs, meat, milk, or
C40 CFR Parti 80]
poultry as delineated in 40 CFR
[PRL 863-5; PP 6E1747/P62]
180.6(a)&lt;3). The nature of the residue
is adequately understood, and adeTOLERANCES
AND ' EXEMPTIONS
quate analytical methods (electron
FROM TOLERANCES FOR PESTICIDE
capture gas-liquid chromatography
CHEMICALS IN OR ON RAW AGttland liquid chromatography using a UV
. detector) are available for enforceCULTURAL COMMODITIES
ment purposes. An interim tolerance
Proposed Tolerances for the Pesticide
has previously been established (40
CFR 180.319) for residues of the subClieinical5ieTli«xy=3=fncril9roject fungicide on cottonseed at 0.3
m*thyl-l,2,4-th1adiazo1e
ppm.
AGENCY: Office of Pesticide ProA second oncogeniclty study and a
grams, Environmental Protection teratogenicity study are lacking. HowAgency (EPA).
ever, based on: (1) The above information considered by the Agency; (2) the
ACTION: Proposed rule.
fact that there is no expectation of reSUMMARY: This notice proposes that sidues on avocados; and (3) the insiga tolerance be established for residues nificance of avocados in the diet, it is
of the fungicide 5-ethpxy-3-trichloro- concluded that the tolerance of 0.15
methyl-l,2,4-thiadiazole. The proposal ppm established by amending 40 CFR
was submitted by the California State Part 180 would protect the public
Dept. of Pood and Agriculture. This health. Should any
amendment will establish a maximum op to show adverseinformation develeffects from the
permissible level for residues of the fungicide on man or the environment,
&gt; subject fungicide on avocados.
the petitioner has agreed not to conDATE: Comments must be received on test a revocation of the tolerance by
or before April 5,1978.
this Agency. It is proposed, therefore,
ADDRESS COMMENTS TO: Federal that the tolerance be established as
Register Section, Technical Services set forth below.
Division (WH—569), Office of PestiAny person who has registered, or
cide Programs, EPA, Rm. 401, East submitted an application for the regisTower, 401 M Street SW., Washington, tration of a pesticide under the Federal Insecticide, Fungicide, and Rodenti-"
D.C. 20460.
FOR FURTHER INFORMATION cide Act which contains any of the ingredients
CONTACT:
.
. t or before listed herein may request, on
April 5, 1978 that this ruleMrs. Patricia Critchlow. Registration making proposal be referred to an adDivision (WH-567), Office of Pesti- visory committee in accordance with,
cide Programs, Environmental Pro- section 408(e) of the Federal Food,
tection Agency, 202-755-2516. ' - Drug, and Cosmetic Act.

Interested persons are invited to
submit written comments on the proposed regulation. The comments must
bear a notation indicating both the
subject and the petition/document
control number, "PP6E1747/P62". All
written comments filed in response to
this notice of proposed rulemaking
will be available for public inspection
in the Office of the Federal Register
from 8:30 a.m. to 4 p.m., Monday
through Friday.
Dated: February 27,1978.
DOUGLAS D. CAMPT,
Acting Director,
Registration Division.
(Sec. 408(e), Federal Pood, Drug, and Cosmetic Act &lt;21 U.S.C. 34«a(e)&gt;.)

It is proposed that Part 180, Subpart
C, be amended by adding the new
§ 180.370 to read as follows:
§ 180.370 5-Ethoxy-3-trichlorometli}l-l,2,4tbiadiazole; tolerances for residues.

Tolerances are established for combined residues of the fungicide 5ethoxy - 3 - trichloromethyl - 1,2.4"thiadiazole and its monoacid metabolite 3-carboxy-5-ethoxy-l,2,4-thiadiazole in or on the following raw agricultural commodities:
Commodity:

Paris per
million
Avocados ,
,..,„
0.15
IFR Doc. 78-5717 FJled £ 3-78; 8:45 *m]

[4910-14]
DEPARTMENT OF TRANSPORTATION
Coast Guard
[46 CFR Part 4]
[COD 77-036]
VESSEL REPORTING REQUIREMENTS

AGENCY: Coast Guard, DOT.
ACTION: Proposed rule.
SUMMARY: The Coast Guard is considering amending the Marine Investigation regulations in order to eliminate dual reporting requirements imposed upon certain vessels. Vessels
that do not hold a Certificate of Inspection and that are either numbered
under the provisions of the Federal
Boat Safety Act of 1971, or used by
their operators for recreational purposes are presently subject to dual reporting requirements for accidents or
casualties. This proposed amendment
will eliminate the undue burden currently imposed upon the .owners of
these vessels.
DATES: Comments must be received
on or before April 23,1978.
ADDRESSES: Comments should be
submitted to Commandant (G-CMC/

FEDERAL REGISTER, VOL 43, NO. 44—MONDAY, MARCH 6, 1978

�9166

PROPOSED RULES

81) (COD 77-036), U.S. Coast Guard,
Washington, D.C. 20590. Comments
will be available for examination at
the Marine Safety Council (G-CMC/
81), Room 8117, Department of Transportation, Nassif Building, 400 Seventh Street SW., Washington, D.C.
20590.
' . ' . / .
FOR FURTHER INFORMATION
CONTACT:
Captain George K. Greiner, Marine
Safety Council (G-CMC/81), Room
8117, Department of Transportation,
Nassif Building, 400 Seventh Street
SW., Washington, D.C. 20590, 202426-1477.
SUPPLEMENTARY INFORMATION:
Interested persons are invited to participate in this proposed 'rulemaking
by submitting written views, data, or
arguments. Each comment should include the name and address of the
person submitting the comment, reference this notice (CGD 77-036), identify the specific section of the proposal
to which each comment applies, and
give the reasons for each comment. All
comments received before the expiration of the comment period will be
considered before final action is taken
on this proposal. No public hearing is
planned but one may be held at a time
and place to be set in a later notice in
the FEDERAL REGISTER if requested in
writing by an interested person raising
a genuine issue and desiring to comment orally at a public hearing.
DRAFTING INFORMATION
The principal persons involved in
drafting this proposal are: Lieutenant
Anthony Regalbuto, Project Manager,
Office of Merchant Marine Safety,
and Edward J. Gill, Jr., Project Attorney, Office of the Chief Counsel.
DISCUSSION OF THE PROPOSED
REGULATIONS
An operator of a vessel that does not
hold a^ Certificate of Inspection and
that is either numbered under the provisions of the Federal Boat Safety Act
of 1971, or used by the operator for
recreational purposes, is required by
33 CFR 173.55 to submit Coast Guard
Form CG-3865, Boating Accident
Report, or an equivalent form prescribed by state authorities whenever
the vessel or equipment is involved in
any occurrence specified in 33 CFR
173.55. If such a vessel is involved in a
casualty which meets the reporting
criteria in 46 CFR 4.05-1, then the operator is also required to submit Coast
Guard Form CG-2692, Report of
Vessel Casualty or Accident and Coast
Guard Form CG-924E, Report'of Personal Injury. The reporting criteria
for 46 CFR 4.05-1 and 33 CFR 173.55
overlap whenever a vessel or its equipment is involved in a casualty or accident where there is loss of life, injury
causing any persons to remain inca-

pacitated for a period in excess of 72
hours, or actual physical damage to
property in excess of $1,500.00
In consideration of the foregoing, it
is proposed that part 4 of Title 46 of
the Code of Federal Regulations be
amended by adding a new §4.01-3 to
read as follows:
.
§ 4.01-3 Reporting exclusion.

Vessels subject to 33 CFR 173.51 are
excluded from the requirements of
Subpart 4.05.
(Sec. 10, 18 Stat. 128, as amended (33 U.S.C.
361); R.S. 4462, as amended (46 U.S.C. 416);
Sec. 17, 54 Stat. 166, as amended (46 U.S.C.
S26p); Sec. 6(b)(l), 80 Stat. 937 (49 U.S.C.
1655(b)(l); 49 CFR 1.46(b».)
NOTE.—The Coast Guard has determined
that this document does not contain a
major proposal requiring preparation of an
Economic Impact Statement under Executive Order 11821, as amended, and OMB Circular A-107.
i

Dated: March 1,1978.
O. W. SlLER,

Admiral, U.S. Coast Guard,
Commandant
IFR Doc. 78-5799 Piled 3-3-78; 8:45 am]
[4910-22]
Federal Highway Administration
[49 CFR Part 393]
[BMCS Docket No. MC-82; Notice No; 78-5]
PARTS AND ACCESSORIES
NECESSARY FOR SAFE OPERATIONS
Proposed Rulemaking

AGENCY: Federal Highway Administration, DOT.
ACTION: Notice of Proposed Rulemaking.
SUMMARY: There is concern that the
Federal Motor Carrier Safety Regulations (FMCSR) which are applicable
to users of commercial vehicles in interstate and foreign commerce, and
the Federal Motor Vehicle Safety
Standards which are applicable to
manufacturers of new motor vehicles
and new vehicle equipment do not conform in certain instances resulting in
the appearance of inconsistency. This
document proposes changes to the
Federal Motor Carrier Safety Regulations to coordinate the FMCSR and
the FMVSS, and also to resolve the inconsistencies in the regulations.
DATES: Comments' must, be received
on or before August 3,1978.
ADDRESSES: BMCS Docket Number
MC-82, Bureau of Motor Carrier
Safety, Federal Highway Administration, Room 3402, 400 Seventh Street
SW., Washington, D.C. 20590.

All comments and suggestions received will be available for examination at the above address between 7:45
a.m. and 4:15 p.m. .e.s.t., Monday
through Friday.

FOR FURTHER
CONTACT:

INFORMATION

Mr. D. W. Morrison, Chief, Vehicle
Requirements Branch, Bureau of
Motor Carrier Safety, 202-426-1700;
or Mrs. K. S. Markman. Attorney,
Office of the Chief Counsel, 202426-0786, Federal Highway Administration, 400 Seventh Street SW.,
Washington, D.C. 20590. Office
hours are from 7:45 a.m. to 4:15 p.m.
e.s.t., Monday through Friday.
SUPPLEMENTARY INFORMATION:
The Federal Motor Carrier Safety
Regulations apply to users of commercial vehicles in interstate or foreign
commerce, while the Federal Motor
Vehicle Safety Standards apply to
manufacturers of new vehicles and vehicle equipment. Concern has been expressed that the two sets of regulations do not conform in certain instances, resulting in the appearance of
inconsistency.
The principal reasons for the issuance of this notice are to coordinate
the FMCSR and the FMVSS and to
resolve inconsistencies in the requirements where they may exist. In instances in which _the two sets of regulations, FMCSR and FMVSS, are not
complementary, confusion could arise
among commercial vehicle owners, operators, and manufacturers as to
which set of regulations should be adhered to. The possibility exists that a
vehicle may be manufactured in accordance with FMVSS requirements but
once that same vehicle is put in operation, it may be in violation of a particular FMCSR. In order to eliminate
possible discrepancies, it is recommended that 49 CFR 393.45, 393.46,
393.60 and 393.80 be amended. In
§ 393.45(a)(6), the proposed change is
the inclusion of FMVSS 106 as a requirement for commercial vehicles in
use. In § 393.46, the addition of a new
paragraph, §393.46(e), is proposed.
The new paragraph, (e), would require
compliance with FMVSS 106 where
applicable for vehicles manufactured
on and after April 1, 1979. In § 393.60,
the proposed change would amend
§393.60(a) by deleting the American
Safety Standard Code year of "1964"
and substituting in its place "1966"
and supplements through March 1969.
Changing the Safety Code reference
date in the subject FMCSR would
bring BMCS requirements into line
with those of NHTSA. Presently, the
FMCSR, following 1964 Safety Code
guidelines, requires fewer samples of
glass to" be used in vehicles' windows
be subjected to the prescribed tests.
The newer guidelines, on which the
NHTSA regulations are based, include

FEDERAL REGISTER, VOL. 43, NO. 44—MONDAY, MARCH 6, 1978

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="6527">
              <text>020</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="6529">
              <text>0308</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="6533">
              <text>Series II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6528">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Office of the Federal Register</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="48">
            <name>Source</name>
            <description>A related resource from which the described resource is derived</description>
            <elementTextContainer>
              <elementText elementTextId="6530">
                <text>Federal Register</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6531">
                <text>March 6 1978</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6532">
                <text>Proposed Tolerances for the Pesticide Chemical Malathion; Proposed Tolerances for the Pesticide Chemical 5-ethoxy-3-trichloro-methyl-1,2,4-thiadiazole</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="6534">
                <text>pesticide testing</text>
              </elementText>
              <elementText elementTextId="6535">
                <text>pesticide properties</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="1334" public="1" featured="0">
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5936">
              <text>018</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5938">
              <text>0199</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5941">
              <text>Series II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5937">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;United States Air Force Academy, Colorado</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5939">
                <text>1971</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5940">
                <text>Faculty Publications, 1971: Papers, Books, Chapters, Reports, and Talks by Members of the Faculty and Research Staff</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5942">
                <text>pesticide testing</text>
              </elementText>
              <elementText elementTextId="5943">
                <text>Eglin AFB</text>
              </elementText>
              <elementText elementTextId="5944">
                <text>ecological fate</text>
              </elementText>
              <elementText elementTextId="5945">
                <text>bibliography</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="1310" public="1" featured="0">
    <fileContainer>
      <file fileId="1150">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/a43524e853447ff25b9c6cdce1df9cc7.pdf</src>
        <authentication>eac9e207abbff5e41591d8b44990dc3b</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63099">
                    <text>00172
Author
CorporatG Author

Kotchmar, George S,, Jr.
Flame, Incendiary, and Explosives Division, Air Force
Armament Laboratory, Eglin AFB, Florida
Metabolism of High Concentrations of the Organophosphorus Insecticide
Phorate Applied Foliariy to Selected Plant Species

Journal/Book Title
Year
MOIltll/Day

Color

February
n

54
Project No. 5066

Friday, January 05, 2001

Page 172 of 194

�AFATL-TR-71-22
THE METABOLISM
OF HIGH CONCENTRATIONS
OF THE O R G A N O P H O S P H O R U S INSECTICIDE
PHORATE APPLIED FOLIARLY
TO SELECTED PLANT SPECIES

PYROTECHNICS BRANCH
FLAME INCENDIARY, AND EXPLOSIVES DIVISION

TECHNICAL

REPORT AFATL-TR-71-22

F E B R U A R Y 1971

Approved for public release; distribution unlimited,

AIR FORCE ARMAMENT LABORATORY
AIR FOtCE SYSTIMS COMMAND • UNITED STATES AIM FORCE

EGLIN AIR FORCE BASE, FLORIDA

�The Metabolism
of High Concentrations
of the Organophosphorus Insecticide
Phorate Applied Foliarly
to Selected Plant Species

George S. K o t c h m a r , Jr., Capt, U S A F
Billy C. W o l v e r t o r t
E l i z a b e t h I. Soothe
Sandra M. L e f s t a d

Approved for public release; distribution unlimited,

�FOREWORD

The active Air Force project directly related to the information
discussed in this report is Exploratory Development Project 5066. Requests
for further detailed information or any comments on this report may be
referred to Air Force Armament Laboratory (DLI), Eglin Air Force Base,
Florida 32542.
Statistical analyses were performed by Booz-Allen Applied Research.
The use of trade names is for identification purposes only and does
not constitute endorsement by the United States Air Force.
This report has been reviewed and is approved.

r ^ ^ { t^ —~z—/- te
FRANKIN C. p M E S w i o n e l , USAF
KLI
Chief, Flame, Incendiary and
Explosives Division

�ABSTRACT

Gas chromatographic and enzymatic analyses (cholinesterase-inhibition
SthSr«re used to monitor the metabolism of the organophosphorus
insect dde 0,0-diethyl S-[(ethylthio)methyl] phosphorod thioate (Pforate)
Ippfied fofiarly to three economically important plants (Homestead tomato,
Siley sorg m" and Honey sorghum). The resulting data provided guide ines
in predicting toxicity and persistence of metabo ite residues £r high

^binr^r^ei^i^

Ice d'on ass plates located adjacent to treated Plants, indicated the
formation of toxic phorate metabolites was without the influence of
biological substrates within the plants. There were no statisticaljy
s gnificant differences with respect to the rate of increase of cholinesterl e- n ibition percentage values between the sorghum and glass plates,
the rate of formation of anticholinesterase oxidized metabolites was
predominantly through chemical oxidation on the leaf surface and not by
K enzymecatalysis, or at least, the oxidation occurred at_such a
ratfas tfmask the enzyme catalysis. The large droplet size in the
application^ phorate resulted in higher toxic residue values, especially
on the surface of the plant, than would normally be expected.

Approved for public release; distribution unlimited.

m
(The reverse of this page is blank)

��TABLE OF CONTENTS

Section

I
II

Title

Page

INTRODUCTION

1

EXPERIMENTAL PROCEDURES

4

MATERIALS AND METHODS

4

STATISTICAL ANALYSES

9

III

RESULTS AND DISCUSSION

12

IV

SUMMARY AND CONCLUSIONS

40

REFERENCES

43

�LIST OF FIGURES
Figure
1

Title

Page

Plant Metabolism Pathway of Phorate (Based on Reference
5)

2

Horse Serum Cholinesterase Inhibition Versus Concentration
of 0,0-Diethyl S-[Ethylsulfinyl)methyl] Phosphorothiolate..

8

3

Cholinesterase Inhibition of Homestead Tomato.....

13

4

Cholinesterase Inhibition of Wiley Sorghum

14

5

Cholinesterase Inhibition of Honev Sorqhum (Phorate Applied
in May)
15

6

Comparison of Percent Cholinesterase Inhibition for Three
Varieties of Plants.

17

7

Percent Cholinesterase Inhibition, Homestead Tomato

19

8

Effects of Passage of Time upon Percent Cholinesterase
Inhibition, Homestead Tomato

20

2

9

Percent Cholinesterase Inhibition, Wiley Sorghum

10

Percent Cholinesterase Inhibition, Honey Sorghum..

11

Percent Chlinesterase Inhibition, Wiley and Honey Sorghum.. 23

12

Effects of Passage of Time Upon Percent Cholinesterase
Inhibition, Wiley Sorghum(March) and Honey Sorghum(April).. 24

13

Percent Cholinesterase Inhibition, Wiley and Honey
Sorghum (May)

26

Effects of Passage of Time Upon Percent Cholinesterase
Inhibition, Wiley and Honey Sorghum (May)

27

14

21
22

15

Percent Cholinesterase Inhibition, Glass Plates

16

Comparison of Percentage Cholinesterase Inhibition for
Glass Plates and Wiley Sorghum

33

Comparison of Percentage Cholinesterase Inhibition for
Gl ass PI ates and Honey Sorghum

34

17

VI

32

�LIST OF TABLES
Table
I

II
III

Title

Page

Plant Parameters Employed With High Concentrations of
Phorate.

5

Efficiency of Extraction Technique for Phorate With Tomato
and Sorghum
6
Measurement Days by Species and Experiment.

10

IV

Gas Chromatographic Analysis for Phorate From Tomato
and Sorghum.

,,.

V

Average Percent Cholinesterase Inhibition, Homestead
Tomato

12

VI
VII
VIII
IX

Average Percent Cholinesterase Inhibition, Wiley
Sorghum (March) and Honey Sorghum (April).
Average Percent Cholinesterase Inhibition, Wiley
and Honey Sorghum (May).
Gas Chromatographic Analysis for Phorate from Glass
Plates and Sorghum.

"
?R

^

*'

Persistence of Phorate Oxygen Analog Sulfoxide Equivalent

in Sorghum.

™

vii
(The reverse of this page is blank)

��SECTION I
INTRODUCTION

The research reported in this study constitutes part of a program to
elucidate toxicological and ecological hazards associated with repetitive
aerial applications and spills of organophosphorus insecticides. Toxicological hazards may exist in plant foliage even after environmental
persistence studies determine the absence or safe level of the parent
insecticide. These hazards result from the conversion of the parent
insecticide to toxic oxidized metabolites. The rate of this conversion
determines the nature and magnitude of the toxic residues in the plant
tissues.
The use of organophosphorus insecticides is increasing because of their
wide spectrum of effectiveness (comparable to the chlorinated hydrocarbons)
and their short residual action in water, soils, and plants. Any accident
involving ultra-low-volume formulations of insecticides could result in
a per-unit-area concentration that would be detrimental to agronomic plants
because of unacceptable residue levels. For this reason, data relating
the tolerance of agronomic plants to repetitive aerial applications of
ultra-low-volume formulations of organophosphorus insecticides are of
interest to military pest control programs.
Guidelines were desired for predicting toxicity and persistence of
metabolite residues in plants after application of high concentrations of
the insecticide. Insecticides in or under considerations for the Air Force
inventory include malathion (dithiophosphoric derivative), naled (phosphoric
acid derivative), fenthion (thiophosphoric acid derivative with sulfide
linkage), and Dursban^(thiophosphoric acid derivative).
Phorate, 0,0-diethyl S-[(ethylthio) methyl] phosphorodithioate, was the
insecticide selected because it is a model compound containing oxidation
sites analogous to those found in sulfur-containing organophosphorus
insecticides. Its toxicity, expressed as an oral 105^ value,
is more tnan 100 times as great as the most toxic insecticide presently
used by the militaryO). Thus, persistence data on toxic metabloties
of phorate should provide a model system of maximum toxic residues on
foliage wnich should be unapproachable for insecticides presently used
by the military wnen applied at the same concentration. Furthermore,
previous studies^' ^» "&gt; ^J have elucidated the plant metabolism
pathway (Figure 1) of the insecticide along with solvent-partitioning
functions of phorate and its metabolites(2, 4).
Conclusive research data are not available concerning insecticide
pnytotoxicity; however, it is known tnat plant species exhibit a wide
range of tolerance to applications of organophosphorus insecticides ^»'t.

1

�(CH3CH20)PSCH2SCH2CH3

S

0

(CH3CH20)2PSCH2SCH2CH3

0
^^
II
I
*r
(CH3CH20)2PSCH2SCH2CH3

N.
0 0
X
11
*
(CH3CH20)2PSCH2SCH2CH3

(CH3CH20)2PSCH2SCH2CH3

Figure 1.

Plant Metabolism Pathway of Phorate
(Based on Reference 5}

The basis for this phytotoxic resistance or susceptibility is not clear.
The experimental procedure used in this study allowed an investigation
into the role performed by individual plant chemistries in metabolizing
organophosphorus insecticides.
Studies of the morphological effects caused by highly concentrated
foliar applications of mevinphos and methyl demeton on selected plant
species indicated that, in general, brpadleaf plants were more susceptible
to the insecticides than were grasses^ 7 /. Severe morphological injuries
were observed on soybean, cotton, and tomato plants one day after foliar
treatment, w h i l e seven days were required before comparable injuries were
noted on corn and sorghum. Coleman and Dean^°' found that resistance of
sorghum to methyl parathion was genetically controlled in their studies
with a resistant and a susceptible variety, Wiley and Honey, respectively.
Thus, differential phytotoxicity to organophosphorus insecticides can be
expected between plant species as well as w i t h i n a given species. Differences do occur in the rates of metabolism of insecticides in different
plant species. A study^) of the plant metabolism of Di-Syston® (dithioSystoxdD) and phorate indicated that the rates of a reaction may vary
slightly from one plant species to another and according to the stage of
growth, but the data obtained may be used as a guide to the relative
proportions of the metabolites present at intervals after application. In

�another study w y the effects of temperature and plant species upon the
rates of metabolism of systemically applied Di-Syston®were considered,
and s i m i l a r results were obtained. Phorate differs from Di-Syston® due
to the presence of an ethylene rather than a methylene group in its side
chain. Thus, this study attempted to relate the metabolism of the insecticide to phytotoxic damage among plant species and within a plant species.
Oxidation can increase both the water solubility and the anticholinesterase activity of organophosphorus insecticides^"'. The logical
approach for monitoring anticholinesterase compounds (toxic phosphorus
esters) formed during the metabolism of phorate was a cholinesterasei n h i b i t i o n method. Phorate alone is too weak an inhibitor to be detected
in micro amounts, but when applied to plants, it is very rapidly converted
to potent anticholinesterase agents. The final unhydrolyzed metabolite
(phorate oxygen analog sulfone) in the oxidation series (Figure 1) is
the most active i n h i b i t o r ' ^ ' . The 150 value (molarity of i n h i b i t o r which
results in 50 percent of the activity of the control) of phorate is
approximately 250 times that of the phorate oxygen analog s u l f o n e ' ^ ) .
One day after the application of phorate to corn, the residue of phorate
sulfoxide, which has an 159 value approximately 1/100 that of phorate,
was more than three times that of phorate^.

�SECTION II
EXPERIMENTAL PROCEDURES
1. MATERIALS AND METHODS
a. Apparatus. A Son/all Omni-mixer^ was used for macerating plants.
A gas chromotograph equipped with a flame photometric phosphorus detector
and a digital integrator was employed in the phorate analyses. A
recording pH stat was used to determine cholinesterase activity.
b. Reagents and Solvents. Standards, supplied by the American
Cyanamid Company, were technical grade phorate (Thimet® ) of 90-percent
purity, analytical grade phorate of 97.8-percent purity, and 94-percent
phorate oxygen analog sulfoxide containing 6-percent phorated oxygen
analog sulfone.
Reagents were anhydrous sodium sulfate, certified A . C . S . ;
acetylcholine perchlorate (a "rare and fine" chemical from K and K
Laboratories, Inc.); sterile filtered horse serum (Colorado Serum Co.);
sodium chloride (crystals), analytical reagent grade; sodium chloride
(granular), U.S.P. grade; sodium hydroxide pellets, analytical reagent
grade; and potassium hydrogen phthalate, certified A.C.S. acidimetric
standard.
Solvents were certified A.C.S, acetone, certified A.C.S. hexanes,
and vegetable oil.
c. Plant Parameters. The representative broadleaf plant selected
was Lycopersicon esculenturn mill, var. Homestead 24 (tomato), and the
grasses were Sorghum vulgare Pers. var. Wiley (sorghum), and Sorghum
vulgare Pers. var. Honey (sorghum). The two varieties of sorghum were
selected to represent a variety (Wiley) that was resistant to an organophosphorus insecticide and one (Honey) that was susceptible. The plants
were grown in a clear glass greenhouse with a minimum night temperature
of 60° to 65°F and a maximum day temperature of 95° to 100°F. Seeds were
planted in a soil consisting of a 7:3:1 mixture of sandy loam, peatmoss,
and perlite with four pounds of dolomitic limestone and one pound of
superphosphate added per cubic yard of soil. The pH of the soil was 6.5.
Each tomato plant was transplanted to an individual four-inch plastic pot
at the age of four weeks. The sorghum experimental unit consisted of 10
plants per four-inch plastic pot. A 15-15-15 liquid fertilizer was applied
bi-weekly.
A 2 percent or 1 percent solution of phorate (0.2 milliliter or 0.1
milliliter of technical grade phorate dissolved in 10 mi Hi liters of
vegetable oil medium) was applied foliarly as 0.01 milliliter droplets
with microsyringe to the tomato and sorghum at the concentrations shown
in Table I. This procedure allowed a uniform and exact application to all

�TABLE I. PLANT PARAMETERS EMPLOYED WITH HIGH CONCENTRATIONS OF PHORATE

Species

Age, Weeks

Homestead Tomato

Date of
Application
8 August1969
19 November 1969

Phorate, Concentration,
pprrr

lb/Ab

19,839
16,630

2.19
1.84

Wiley Sorghum

4
3

2 March 1970
20 May 1970

8,753
(c)

1.26
(c)

Honey Sorghum

4
3

8 April 1970
20 May 1970

8,461
(d)

1.22
(d)

Concentration of phorate solution based on gas chromatographic analysis
with analytical grade phorate.
"Concentration applied to plant based on leaf area (pounds of active
ingredient per acre).
c
Same concentration applied as 2 March 1970, but no gas chromatographic
analysis.
"Same concentration applied as 8 April 1970, but no gas chromatographic
analysis.
the plants. The levels of phorate applied were adjusted to the maximum amount
that would result in minimal visible damage. To insure similarity in
plant size at each application, the phorate was applied after three to
six weeks of initial plant growth. The varying lengths of time between
planting and insecticide application were to compensate for seasonal
variation in plant growth. Table I shows the age of the plants with the
date of application of phorate. During the March (Wiley sorghum) and April
(Honey sorghum) portions of the experiment, the phorate in the vegetable
oil medium was applied to glass plates located adjacent to the treated
and control plants.
d. Extraction Technique. The plants to be sampled were severed at
soil level, sectioned, and rinsed in a 400-milliliter beaker containing
25 mi 11 iliters of hexanes and 25 mi Hi liters of acetone in distilled
water (60 percent by volume) to remove any residues remaining on the
plant surface. The solvent mixture, followed with the plant material,
was poured into a cup for the Sorvall Omni-mixer®. The beaker was rinsed
with 5 mi 11iliters of hexanes and then by 5 mi 11iliters of acetone in
distilled water (60 percent by volume). After the plant material was
thoroughly macerated, the macerate was filtered through three layers of
5

�cheesecloth into a separatory funnel. The cup which had contained the
macerate was rinsed with 10 milliliters of hexanes and then by 10 millilitars
of acetone in distilled water (60 percent by volume). The rinsings were
added to the separatory funnel followed by 15 milliliters of a saturated
sodium chloride solution which aided in separating the organic and aqueous
phases.
Acetone was removed from the aqueous layer by use of a rotary evaporator attached to a water aspirator. Complete removal of the acetone
was essential because of its ability to inhibit cholinesterase. The
aqueous layer was filtered (to remove minute pieces of plant material)
through Whatman No. 2 paper into a 50-mi Hi liter volumetric flask and
brought to volume with distilled water. The organic phase was placed over
10 grams of anhydrous sodium sulfate, filtered into a 50-mi11iliter
volumetric flask, and brought to volume with hexanes. If the samples
could not be analyzed immediately, they were stored at 5°C.
The aqueous layer was analyzed for cholinesterase-inhibiting metabolites and breakdown products. Gas chromatographic analysis of the
organic phase for phorate allowed monitoring of the rapidity of breakdown and oxidation. The efficiency of the extraction technique, based
on the recovery of phorate in the organic phase, is shown in Table II.
TABLE II.

EFFICIENCY OF EXTRACTION TECHNIQUE FOR PHORATE WITH TOMATO
AND SORGHUM

Species

Date of
Experiment

Homestead Tomato

August
November

Wiley Sorghum

March

Honey Sorghum

Apri 1

Efficiency of Extraction, Percent
Controls3 Insecticide-Treated Plants^
3
3

66.2
87.7

32.4
63.2

63.3)
[ Qla ss
75.9) pla tesc

46.7

51 .7

^Concentration of phorate applied to plant placed through extraction scheme.
b
Phorate-treated plants from day 0 placed through extraction scheme.
c
Glass surface residues from day 0 placed through extraction scheme.
e. Cholinesterase-Inhibition Method. The advantages of using
cholinesterase-inhibition methods for determining organophosphorus residues
are that (a) the sensitivity is far greater than for chemical methods and
(b) the method is particularly suitable when the insecticide undergoes
6

�changes in the plant to produce metabolites with a high inhibitory
activity(10,11}_ One of the disadvantages is the lack of specificity
or inability to distinguish among different types of cholinesterase
inhibitors found within the plant.
The persistency of toxic metabolites and breakdown products in the
respective plant species was monitored using an automated pH stat method(12)
to determine cholinesterase activity. The cholinesterase inhibition for
each species and glass plate sample was measured immediately after the
application of the insecticide and on various succeeding days for one
month. Control plants were treated with only the corresponding amounts of
vegetable oil and were similarly measured. The experiment was repeated
for each species.
The cholinesterase activity of the prepared water sample was
recorded with a recording pH stat. A sample (0.2 milliliter tomato or
0.4 milliliter sorghum sample) was placed in a microbeaker containing
5 milliliters of a 0.154-molar saline solution (9.000 grams of analytical
reagent grade sodium chloride in 1000 mi Hi liters distilled water) and
0.5 milliliter horse serum. The microbeaker solution was heated to
37.5°C and adjusted to pH 8.0 prior to addition of 0.3 milliliter of the
cholinesterase enzyme substrate, 0.110-molar acetylcholine perch!orate
(0.675 grams crystalline substrate in 10 milliliters distilled water).
The titrant, 0.0100N sodium hydroxide.was standardized with 0.0100N
potassium acid phthalate (0.20423 grams acid in 1000 milliliters
distilled water).
Normal-activity curves (no samples added) and control-activity
curves (aqueous samples from control plants) were obtained prior to
measuring cholinesterase activity for the aqueous samples from phoratetreated plants. Cholinesterase inhibition of the phorate metabolites and
breakdown products was expressed as a percentage value obtained from a
ratio of cholinesterase activity (expressed in units of micromoles of
acetylcholine hydrolyzed per minute per milliliter of horse serum) of
the samples from the phorate-treated plants to samples from the control
plants. A second percentage of cholinesterase inhibition was calculated
using the normal activity value as the base.
f. Calibration Curve. To equate the percentage of cholinesterase
inhibition to the concentration of the metabolite extract, a log-linear
plot was made of the phorate oxygen analog sulfoxide equivalent, in
parts per million (ppm) of 0,0-diethyl S-[(ethylsulfinyl) methyl]
phosphorothiolate, versus the percentage of cholinesterase inhibition.
Figure 2 contains the calibration curve based on 0.4 milliliter samples of
the standard parts-per-million solutions of the phorate oxygen analog
sulfoxide. Sample sizes of 0.2 milliliter gave cholinesterase inhibition
percentages that were approximately half the values shown in Figure 2.

�109

a

76
5

4
uu
Ci
I—I
X
o
u.

2-

co
.9-

uu

1

!?•
.6.5.4-

.3.2-

JO-

20

Figure 2.

30

50

60

HORSE SERUM CHOIIMESTERASE INHIBITION (PERCENT)
Horse Serum Cholinesterase Inhibition Versus Concentration of
0,0»Diethyl S-[(Ethylsulfinyl)methyl] Phosphorothiolate

�g. Gas Chromatographic Analysis. Gas chromatography was used to
detect unaltered phorate in the organic phase from the plant extracts.
A gas chromatograph equipped with a flame photometric phosphorus detector
was employed. A six foot by one-fourth inch stainless steel column
containing Chromport X X X , 80/90 mesh, coated with 3 percent SE-30, and
conditioned for 24 hours at 220°C, was used for the phorate analysis of
the August tomato extracts. A retention time of 105 seconds was recorded
with the inlet temperature set at 250°C, the column-oven temperature at
200°C, and the detector temperature at 235°C. Gas flow rates in cubic
centimeters per minute were nitrogen 80, hydrogen 150, air 20, and oxygen
20.
A six foot by one-fourth inch glass column containing Chromosorb id ,
80/90 mesh, coated with 3 percent QV-1 and conditioned for 24 hours at
210°C was used for the phorate analysis of the November tomato extracts,
March Wiley sorghum extracts, April Honey sorghum extracts, and glass
plates. A retention time of 130 seconds was recorded with the inlet
temperature set at 245°C, the column-oven temperature at 190°C, and the
detector temperature at 185°C.
Injection sample sizes 1 for August tomato extracts were 5 microliters,
and all others were 2.7 microliters. Concentrations of phorate present
in the August analysis were determined by integration of peak area by a
digital integrator. Concentrations of all other analyses were determined
by peak height. All determinations were expressed in parts per million
based on standard curves.
2.

STATISTICAL ANALYSES.

Before any of the data were analyzed, all of the cholinesterase inhibition percentages were transformed using the arc sine formula:
8 = 2 arcsin P
where 6 is the new variable to be analyzed
and P is the percent of cholinesterase inhibition divided by 100.
Tnis transformation minimized and stabilized the variation of the
data and created the homogeneity of variance that was essential to the
use of the analysis of variance technique, and the other statistical
procedures used for the analysis of these experiments. The results were
stated in percentage notations for presentation throughout the report.
It was not possiole to analyze all of the cholinesterase inhibition
percentages on an experiment-wide basis because the measurements of the
three experimental species were taken on various and differing days

�during the month following application of the insecticide. To make comparisons that were valid and meaningful, it was necessary to select those
days on which all species under consideration were measured. Table III
shows the days of measurement for each species. During the first week
TABLE III. HEASUREMENT DAYS BY SPECIES AND EXPERIMENT

Days After
Application

0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
25
26
27

Homestead Tomato
August November

X
X
X
X
X
X

Wiley Sorghum
March May

Honey Sorghum
April May

X
X
X

X
X
X

X

X

X

X

X
X

X

X

X
X

X
X

X

X

X
X

X
X

X

X

X
X

X
X

X
X

X

X
X

X
X

X

X

X
X

X

X

X

X

X

X

X
X
X
X

X

X

X
X

X

X

X

X

X
X

X
X
X
X

following application of the insecticide, only those measurements that
were made on the same day were compared; during the next three weeks,
measurements that were made on contiguous days were also included in the
comparison.

10

�Only one measurement of cholinesterase inhibition was made on each of
the days for the Homestead tomato experiments and for the March and April
Wiley and Honey sorghum experiments. It was not possible, therefore, to
test for significance of the interaction between seasonal effects and the
number of days following application. Since this interaction would have
been used to test the seasonal and time-passage effects individually, an
unduly large interaction would have masked significance of the main effects,
Paired t-tests with the same or contiguous days' results were used to
circumvent this possibility. When nonsignificance of the paired values
was determined, an analysis-of-variance technique was used to test for
significance of the passage of time upon the cholinesterase-inhibition
percentage. In those cases in which these results were significant,
Duncan's new multiple range test was used to identify where the differences
did, in fact, exist. In the absence of significance, means were computed,
and the effects of the passage of time upon the cholinesterase inhibition
were studied. Two replicates of measurements were made for the May Wiley
and Honey sorghum plants, and it was, therefore, possible to use the
analysis of variance technique when only these data were involved in
comparisons.
Initially, all testing was conducted at the 95-percent probability
level (significant). When this proved significant, subsequent testing
was conducted at the 99-percent probability level (highly significant).

11

�SECTION

III

RESULTS AND DISCUSSION

Ultra-low-volume formulations of insecticides used by the military
involve the aerial application of a low-volume concentrate (0.75 to 10
ounces per acre, undiluted). Phorate is applied with normal formulations
at rates of 0.5 to 3 pounds of active ingredient per acre. Table I
presents the application rates within this range. However, the defined,
directed application of phorate to the leaf surface without spraying
resulted in a maximum interface between insecticide droplet (10 microliters)
and leaf area. This large droplet size represented the application of
high concentrations of phorate; the droplet contained more phorate (0.25
milligram) and is larger than that ordinarily found following routine
application of insecticides. The optimum3 diameter for insecticide spray
droplets is in the range of 20 microns'' '.
The percentages representing the efficiency of the extraction technique
employed (Table II) are minimum values because of the volatility of
phorate. Phorate is lost from the soil by volatilization and about 25
percent of the loss occurs in the first hour after treatment^'^/. Similar
results would be expected on the leaf surface, therefore, the length of
time between treatment and initial extraction of the plant would result
in a value of phorate present that is slightly less than that which was
applied. The time before initial extraction was approximately the same
in all cases; however, the extraction of the August tomato after application of phorate during the late morning heat probably accounts to some
degree for the lower value in extraction efficiency. Phorate was applied
to the other plants in the early morning.
A comparison of the percentage of cholinesterase inhibition obtained
using the normal-activity value and the percentage obtained using the
control-activity value as a base is shown in Figures 3 and 4 for Homestead
tomatoes and for Wiley sorghum for each of the two applications of
insecticide. A comparison for Honey sorghum is shown in Figure 5 for
the May application; however, the April control plants were not usable due
to contamination. The results of paired t-tests in analyzing the differences between percentages for each species allowed the use of all the
cholinesterase-inhibition percentages based on the normal activity value.
Cholinesterase-inhibition values obtained showed no correlation with
plant weight.
A comparison of the percentages of cholinesterase inhibition during
the month following application of the insecticide for each of the three
plants, using the analysis of variance technique, indicated that the
average for the Homestead tomato was significantly lower than those for

12

�/D
fe
CJ

50 -

uj

ex.
O
t~~t
K
h~,

—
UJ
-J
&lt;

nr
.?
j
(

fc

to o

t~t GO

2:. uj
t ^ —c
&gt; ---*

rf
t,^

»/

'• .• " «

•

'

lc

b

UJ CO

'-=C CJ
fti K
UJ •&lt;
r™"- ••——

•

0
U

o^

UJ

-5

• CONTROL

25

§

O NORMAL
1
I
I

§
o
1
0

I

1

1

1

1

1

1

2

4

6

S

10

12

14

U

U

20

22

1

1

24

26

21

TIME FROM APPLICATION WS)

a.

_

Phorate Applied in August

75

iUj

|

— 50

C±-

8

r^

0

ft

S^ A«s
UJ
UJ S

oo t-i

S^
uu o

0

8

•

&gt;-~&lt; UJ

m

°

8

8

0

8

—

h- Oi

c/) -&lt;

UJ •—•

3:
o

j.

-25

• CONTROL

1
0.

I

I

I

I

1

1

1

2

4

6

6

10

12

14

U

O NORMAL
I
1
1
18

20

22

1

I

24

26

TIME FROM APPLICATION [VMS]
b. Phorate Applied _in November

Figure 3. Cholinesterase Inhibition of Homestead Tomato
13

2B

�/p

s-

§ •

A

UJ
CJ

c*

50

UJ

O UJ

»—1 —1

-

»

§

•

8

»

o

8

25

e

CO V)
^—

1 1 1

?5 t—&lt;
CO
UJ

5ur§
5t

CO CJ

tf &lt;c

UJ —

n
U

to
UJ
t—1
—1

• CONTROL

-5 —
O NORMAL

o
CJ

1

1

1

1

1

1

f

I

6

-25

i

1

1

1

1

«
/O
12 14 16 H 20
TIME FROM APPLICATION (PAKS)

22

24

26

28

1
26

21

a. Phorate Applied in March

/5

* 8i
|

0-

O UJ
t—t —J

\~ •&lt;

50

8
•
8

* ' o •

881$
8

» 8

UJ

o
e*
UJ

25

t-i CJ
CO CO

b-&lt; 1—t
UJ
W "&lt;t
UJ •—

1-

UJ
t—&lt;

—1

o

5 —

'.r

• CONTROL

-5(

3:
o

O NORMAL

i

^c

0

i

2

4

i
6

1
B

1
10

1
12

1
14

1
16

1
U

1
20

1
22

1
24

TIME FROM APPLICATION

b. Phorate Applied in May
Figure 4. Cholinesterase Inhibition of Wiley Sorghum
14

�72

!s
UJ

75

^*

o

CM
UJ
(X
"~"

50

—

25

i ii
o

S 8 *
•
^k

^k

^

^fc.

- 8

O
t—1 —

PQ •&lt;

8

8

•t
^2

"»
8
^h

t—t CJ
(-1 UJ

UJ *-&lt;
C/) C/)

5

-

So
UJ CM

UJ
t—t
—4
O
-C

o

0

_

1

* CONTROL
O WORMAL

I

1

1

i

I

t

I

i

I

i

t

i

I

g

10

12

J4

76

JS

20

22

24

26

28

TIME FROM APPLICATIOW (PA^S)

Figure 5. Cholinesterase Inhibition of Honey Sorghum (Phorate Applied in May)

15

�the two varieties of sorghum. Figure 6 shows the inhibition percentage
values for each of the three plants; the lower level for the tomato
plants is evident. Therefore, for statistical purposes, data from the
tomato plant experiments were analyzed independent of the sorghum data.
Gas chromatographic analysis of the hexanes phase after extraction from
tomato and sorghum indicated less than one ppm phorate present by the sixth
day (Table IV). A determination of residues of-phorate and five of its netab-

TABLE IV. GAS CHROMATOGRAPHIC ANALYSIS FOR PHORATE FROM TOMATO AND SORGHUM

Day

Tomato
August November

Concentration of Phorate, ppm
Sorq lum
March (Wiley) April (Honey)

0

128

42

16

18

1

140

34

9-12

9

28

6-7

5-6

9

&lt;3

1

2
3

23

4

&lt;1

5

4

6

1

&lt;1

elites from various parts of corn plants (treated with one pound of the.insecticide per acre) indicated that phorate was essentially gone in 14 days(4).
During this determination, phorate was recovered from fortified samples with
96 percent efficiency using a Soxhlet apparatus in an eight-hour extraction
technique. The higher values of phorate in the August tomato samples, as
compared to the November samples, were due to the concentration of the sample
to 10 milliliters instead of the 50-milliliter final volume of all other
samples. Small differences in the data are probably due to the slight variations in extraction efficiencies for each plant. The disappearance of phorate
proceeds at approximately the same rate in each plant variety.

16

�75

A

D

A

A

9

50

—

O
9

•

o

A

D

nc
'--'

O

g

«-&lt; o
_ =5 °°

0

•

*

A
|

&gt; •

UjS
C/) CO
UJ CM

^

A

H

*

•

o

00 —

D

A

UJ
(X

*vl S UJ

Q

A

UJ

PuJ
t—&lt; —J
CO •&lt;

n

A

1
P

*

(*

^9

r

5

0

o

o

—1
o

o

0 -

HOMESTEAD TOMATO

,
0

1
2

i

1
4

i

|
6

i

1
8

O.VO I/EMBER

WILE/ SORGHUM

I3

•AUGUST
* MARCH

^ MA/

HO/JE/ SORGHUM
i
1 i
1
i
10
12

• APRIL
1
i
1
14
16

D MA/
t
1
20

i

1
IS

i

TIME FROM APPLICATIO/V (3A/S)

Figure 6. Comparison of Percent Cholinesterase Inhibition
for Three Varieties of Plants

1
22

i

|
24

I
2&lt;

�The results of a cholinesterase-inhibition analysis for the Homestead
tomato plants for all of the days measured for the August and November
applications of insecticide are shown in Figure 7. An analysis of
comparable daily measurements in August and November indicated no significant differences between the two application dates or by the number of
days after application. The average percentages of cholinesterase inhibition for the days used in the comparison are given in Table V and Figure 8
and are not significantly different at the 95 percent probability level.
TABLE V.

AVERAGE PERCENT CHOLINESTERASE INHIBITION, HOMESTEAD TOMATO

Days After Application

Cholinesterase Inhibition, Percent

21,22

27.1

6

24.4

12,13

23.9

4

21.4

9,10

15.9

1

12.4

0

11.3

Figures 9 and 10 show the percentages of cholinesterase inhibition
for Wiley and Honey sorghum, respectively. Analyses of the possible
daily comparisons for each variety indicated significant differences
between the March and May data for the Wiley sorghum and highly significant differences between the April and May data for the Honey sorghum.
Similar analyses of those cholinesterase-inhibition percentages which
were obtained on the same or contiguous days for Wiley sorghum in March
and Honey sorghum in April indicated no significant differences between
the two varieties for those two months (Figure 11). An analysis of the
differences in cholinesterase-inhibition percentages with respect to the
number of days after application of phorate to sorghum during March and
April indicated highly significant differences. Table VI shows average
daily percentages. In Figure 12, the average values with associated
letters are shown graphically. The cholinesterase-inhibition percentage
peak was reached by the ninth day following application of phorate, and an

18

�14J

C_&gt;

{*
U-i

o

« I4J

CO O
*-» CO

U3 2 UU

UJ •&lt;
CO

UJ

o
o

AUGUST APPLICATIOM
WOI/&amp;MBER APPLICATION

70

72

74

16

18

TIME FROM APPLICATION (VAVS)
Figure 7. Percent Cholinesterase Inhibition, Homestead Tomato

O

�75

UJ
UJ
PL.

\~ UJ
CO
t—
t\3

25

UJ

O

)—&lt;
UJ CO
•&lt;C C_&gt;

UJ •&lt;

UJ

a:
«—&lt;
—i
o

»

-5
10

n

TIME FROM APPLICATION

Figure 8.

H

14

(VMS)

20

Effects of Passage of Time Upon Percent Cholinesterase
Inhibition, Homestead Tomato

24

26

�uj
UJ

h- UJ

t~&gt; —J

CQ •
&lt;
t~&lt; O
UJ

V)

uj
»oo

O

UJ

MARCH APPLICATION •
APPLICATIOW

JO
72
H
16
TIME FROM APPLICATION (VAVS]
Figure 9, Percent Cholinesterase Inhibition, Wiley Sorqhum

O

�fe
UJ

o
Be:
UJ
R-

CQ

™ UJ2

APRIL APPLICATIOW
MAV APPLICATION

Figure 10.

O

TIME FROM APPLICATION {DAYS}
Percent Cholinesterase I n h i b i t i o n , Honey Sorghum

�95

WILEV SORGHUM
MARCH APPLICATION
HOWE/ SORGHUM
APRIL APPLICATION O

-25
10

72

14

U

TIME FROM APPLICATION (PA/S)
Figure 11. Percent Cholinesterase Inhibition, Wiley and Honey Sorghum

�Cxi
UJ
R-

1- UJ

1-1 •—I
CO •&lt;
l-« CJ

K CJ
UJ C*
V- &lt;

TIME FROM APPLICATION
Figure 12. Effects of Passage of Time Upon Percent Cholinesterase
Inhibition, Wiley Sorghum (March) and Honey Sorghum (April)

�average peak level of 63.9 percent Inhibition was maintained until the
eighteenth to twenty-first day, when it began decreasing. By the twentythird to twenty-fifth day it had decreased to 31.5 percent.
TABLE VI.

Days
After
Application

AVERAGE PERCENT CHOLINESTERASE INHIBITION, WILEY SORGHUM
(MARCH) AND HONEY SORGHUM (APRIL)

Cholinesterase
Inhibition ,
Percent

Remarks (Common letter
indicates no significant
difference at 99-percent
Probability Level)

11

67.9

a

16,18

62.5

ab

9

61.1

ab

14

51.0

be

4

49.1

be

7

49.0

be

21,20

42.1

c

25,23

31.5

d

2

18.5

e

0

10.2

e

1

9.8

e

Figure 13 shows the percentages of cholinesterase inhibition for
Wiley and Honey sorghum on various days during May. The analysis
indicated highly significant differences only with respect to the
number of days after application; neither the species of sorghum nor
the species/day interaction yielded results which indicated any significant effect. The average percentages for the various days after application are shown in Table VII. All averages that are not significantly
different at the 99 percent probability level have a common letter.
In Figure 14, the average values with associated letters are shown
graphically. May Wiley and Honey sorghum plants reached a peak percentage

25

�o
H- Uj
CQ &lt;

5: &lt;s&gt;

2:
t-t UU
li? Lu a:
Ol
l-t

UU

o

WILE/ SORGHUM
O WNEV SORGHUM

n

u

TIME FROM APPLICATION

Figure 13. Percent Cholinesterase Inhibition, Wiley and Honey
Sorghum (May)

�UJ
(X

o
l— ul
t-i ~j
B3 •
&lt;
»—* O

r\&gt;

i60
&gt;-' ty
uj Si
UU Oi

h- •&lt;
o
o

-5

1 I

I

1

I

1 1

1 1

1

1 1

n

1

1

1

1

n

1

1

1 i

20

1

1

1

1
24

TIME FROM APPLICATION (PAW)

Figure 14. Effects of Passage of Time Upon Percent Cholinesterase
Inhibition, Wiley and Honey Sorghum (May)

1

1
26

1

�of cholinesterase inhibition by the fourth day and maintained an average
peak level of 64.5 percent for the remainder of the month.
TABLE VII. AVERAGE PERCENT CHOLINESTERASE INHIBITION, WILEY AND HONEY
SORGHUM (MAY)

Days
After
Application

Cholinesterase
Inhibition,
Percent

Remarks (Common letter
indicates no significant
difference at 99-percent
Probability Level )

14

68.8

a

12

68.7

a

8

65.2

a

7

65.1

a

19

64.5

a

4

64.0

a

5

63.1

a

16

60.6

a

21

60.4

a

2

28.9

b

0

-1.5

c

With no significant differences existing between the two varieties of
sorghum in May or during continuous experiments in March and April, it
appeared that the metabolism of high concentrations of phorate proceeded
at the same rate in each variety; however, distinct visible differences
occurred between the two plant varieties.
Despite slight initial visible damage, both sorghum and tomato
recovered from insecticide damage within 30 days of treatment. The
preliminary data did show, however, that neither variety of sorghum
recovered from insecticide damage when exposed to the same concentration
of phorate as was used on the tomato plants. This is indicative of the
28

�effects of a high concentration of phorate due to the large droplet size,
since any visible damage at the rates used in this experiment would not
be expected. With the tomato, minor c u r l i n g of the leaves was observed
and many plants had a loss of apical dominance indicating that possibly,
at the concentrations of phorate used, there was a change in the auxin
content or hormonal distribution w i t h i n the plant. The first injury
symptoms for both sorghum varieties were characterized by a localized
bleaching of the blade pigments ( i . e . , chlorophyll) to a yellow-green
coloration with a s l i g h t l y flaccid condition. These necrotic blotches
were more distinct with Honey sorghum as they acquired a red-brown
coloration. This characteristic color difference was apparent in the
aqueous samples, as Honey samples were much darker than those of Wiley.
The flaccid condition was more evident with Honey sorghum. The more
v i s i b l e damage to sorghum compared to tomato in preliminary experiments,
with both exposed to the same concentration of phorate, may appear to
contradict the research reported in Reference 7. However, that report
notes that (a) conclusions regarding the possible effects of organophosphorus insecticides, except mevinphos and methyl demeton, could not be
made since the experiment was a fixed-effects model and not a random
selection of possible organophosphorus insecticides; and (b) differences
in plant response (susceptibility or resistance) could be accounted for
by a postulation that differences may be related to leaf area interception
of the insecticide.
The reason for existing differences between March/April and May
sorghum can only be postulated. Peak percentages of cholinesterase i n h i bition by the fourth day (64.5 percent) in May versus the n i n t h day
(63.9 percent) in March/April indicate a more rapid oxidation of phorate
to anticholinesterase metabolites. A s i g n i f i c a n t factor may be the
relatively higher mean temperatures in May. In an evaluation of the
effects of environmental temperature on Di-Syston©systemically applied
to cotton leaves, the oxidation of the s u l f i d e , Di-Syston®, to the
sulfoxide occurred so rapidly at temperatures above 70°F that only traces
could be detected, even at intervals as short as one hour after treatment'**)
The major^component in the leaves during the one-week experiment was the
Di-Syston®sulfoxide. The rate of disappearance of sulfoxide was increased
approximately 1.86 times for each 10°C rise in temperature (energy of
activation of 10 kcal/mole). The i n i t i a l oxidation of phorate in cotton
leaves was less rapid than the oxidation of Di-Syston®with traces of
phorate found up to three days, although these never.exceeded 5 percent
of the total radioactivity in the labeled experiment'^). It was also
noted^ that the rate of oxidation of the sulfoxides in the oxidation
series (Figure 1) was measurably slower for phorate than for Di-Syston®
The sum of the rate constants for the disappearance of phorate sulfoxide
due to oxidation is h a l f that of Di-Syston®sulfoxide. This indicates
that phorate sulfoxide was probably the major metabolite during the first
two weeks of this investigation. Also, when a l f a l f a seed was treated with
29

�treated with phorate or Di-Systorr% the effectiveness for aphid control
varied by as much as several weeks depending on the rate of plant grow
The rate of metabolism is slower in cooler weather, and the slower the
plant growth, the longer the persistence of toxic residues.
Tomato behaved similarly to the May sorghum. Tomato maintained a mean
percentage value of 19.5 throughout the experiment; sorghum maintained
a constant mean value throughout the month after, the third day.
Thus, the results indicated that the metabolism of high concentrations
of phorate proceeded at approximately the same rate in each species and
between plant varieties. These results were not in complete harmony with
those from earlier experiments. In previous metabolism studies of phorate
and Di-Syston®on various plants such as cotton, alfalfa, lemon, and bean,
it was found that the rates of reaction may be expected to vary slightly
among pjant species and according to the stage of growth^). Later,,
studies\°' specifically oriented toward the metabolism of Di-Syston^in a *
variety of plant species, indicated that at 70°F, the metabolism of Di-Syston
sulfoxide and hydrolytic decomposition of the toxic products occurred two
to three times faster in tomato leaves than in cotton leaves.
Differences in results and insecticide application parameters indicated
the experimental data resulted from the chemical nature of phorate on
the plant surface without the influence of biological substrates. Application methods^ 5 &gt; included topical application of 5 to 25 microliters of
insecticide to the base of a young plant or placement of isolated leaves
in a water dispersion (0.1 percent solution) of the insecticide to permit
the study of the rates of metabolism uncomplicated by the continual
accumulation of translocated material. The method of application used in
this work was foliar with a definite quantity of phorate aoplied as larae
droplets to each intact plant.
An earlier study' '^/ with Systox^(similar to phorate in structure)
showed that the chemical nature of the surface washes from fruit treated
with thiono- and thiolo-isomers changed rapidly upon exposure to light
and air. Exposure of the isomers to light and air under controlled conditions on glass plates, uncomplicated by biological substrates, resulted
in a surprisingly rapid conversion of the Systox®isomers into compounds
which appeared to be chromatographically similar to those found within
the plant tissues. Another study'''' showed that the action of air and
sunlight on surface residues of Systox®isomers has a rapid effect and
appears to promote their oxidation in the same sequence as found in vitro
with hydrogen peroxide and in plant tissues. Thin films of phorate
exposed to ultraviolet light or sunlight and air gave similar
results^» ^8, 19, 20) ^ Exposure to sunlight on paper, glass, and leaf
surfaces indicated that the initial stable residues of phorate may not be
the original compound or its simple oxidation products; prolonged exposure
resulted in the formation of more polar compounds^' 0 '. Results of ultra-

30

�violet irradiation of phorate on the surface of a liquid suggested that
the oxidation products are the sulfoxide and sulfone of the parent
compound, with the sulfone showing greater persistency and the s p]foxide
being in greater quantity during the early stages of irradiation''^» ^0).
To substantiate the concept that the experimental results in these
investigations were without the influence of biological substrates within
the plants, the same concentrations of phorate were applied to glass
plates as were applied to the treated plants. The glass plates were
located on the greenhouse bench adjacent to the control and treated plants.
This was done with Wiley and Honey sorghum, in March and April, respectively,
Table VIII shows a comparison of the gas chromatographic data for the
plants and glass plates. Within 48 hours, phorate could no longer be
detected on the glass plates; the same rapid disappearance was noted with
the plants—approximately one ppm detected after 96 hours.

TABLE VIII. GAS CHROMATOGRAPHIC ANALYSIS FOR PHORATE FROM GLASS PLATES
AND SORGHUM

Day

Phorate Concentration, ppm
March
Aoril
Wiley Sorghum
Glass Plates
Honey Sorghum Glass Plates

0

16

22

18

26

1

9-12

5-6

9

5

2

6-7

5-6

4

&lt;3

1
&lt;1

6

The cholinesterase-inhibition percentages obtained from the glass
plates for the March and April experiments (Figure 15) were compared with
the values obtained for the treated plants (Figure 11). The plots are
very similar, with the glass plate cholinesterase-inhibition values being
significantly higher on all days considered. However, most noteworthy
is that the data through the twentieth day following application exhibited
logarithmically linear trends (99 percent probability level) with no
quadratic tendencies for both the sorghum and glass plates in March and
April. The best-fitting straight lines have been plotted (Figures 16 and
17), and the equations for each of the lines are:
31

�99. Sr

hUJ
O

R3 •&lt;

UJ

(A)

ro

CO
UJ

CJ

I

UJ

o
CJ

25

O

*
Figure 15.

n

APRIL APPLICATION

u

TIME FROM APPLICATION (PAKS)
Percent Cholinesterase Inhibition. Glass Plates

�99.5

UJ
CJ

c*:

o •—
l~&gt; UJ
co

to
t"-t

3=

&lt;Z

50

*—»
UJ

CJ

SORGHUM, MARCH APPLICATION
O GLASS PLATES, MARCH APPLICATION

2

7
TIME FROM APPLICATION (PAVS)
(LOGARITHMIC SCALE)

Figure 16. Comparison of Percentage Cholinesterase Inhibition for
Glass Plates and Wiley Sorghum

I
24

29

�99.5

UJ
UJ
UJ
_J

t—1

I—

•&lt;
uj

II
UJ

kV)
UJ

o

• HONEV SORGHUM, APRIL APPLICATION
OGLASS PLATES, APRIL APPLICATION

I

I

I

I

4
7
3
TIME FROM APPLICATION (VMS)

(LOGARITHMIC SCALE)

Figure 17. Comparison of Percentage Cholinesterase Inhibition
for Glass Plates and Honey Sorghum

79

24

29

�Wiley sorghum, March

Y = 0.597 + 0.484 log (X + 1)

Glass plate, March

Y = 0.922 + 0.626 log (X + 1)

Honey sorghum, April

Y = 0.489 + 0.480 log (X + 1)

Glass plate, April

Y = 0.917 + 0.621 log (X + 1)

where Y is the arc sine transformation of the percent cholinesterase
inhibition
and X is the number of days after the application of phorate in vegetable
oil.
An analysis of comparison of the linear plots gave significant results.
The percentage of cholinesterase inhibition increased at the same rate
for both varieties of sorghum. The percentages of cholinesterase inhibition for Wiley and Honey sorghum increased at the same rate as did
those for the glass plates. The percent of variation explained by the
linear trend is as follows:

Wiley Sorghum

78.6

Glass Plate, March

89.3

Honey Sorghum

88.2

Glass Plate, April

92.4

The rate of formation of cholinesterase-inhibiting compounds appeared
the same between the glass plates and sorghum plants. It appeared that,
at least at high concentrations of phorate, formation of anticholinesterase
oxidized metabolites was predominantly through a chemical oxidation on the
leaf surface, and not plant enzyme catalysis. This took place at least
at such a rate as to mask enzyme catalysis. With low concentrations of
phorate within sorghum blades, methods similar to those described in
References 5 and 8 could distinguish any difference in the rates of
metabolism between the two varieties of sorghum.
The higher cholinesterase inhibition values for the glass plates,
(Figure 15) in comparison with the sorghum (Figure 11), can be attributed
to the higher extraction efficiency with the glass plates. However, the
phorate plant residue analysis by gas chromatography indicated the presence
of phorate 48 hours after it could no longer be detected in samples from

35

�the glass plates. Although the cholinesterase-inhibition analysis Indicates
the same rapid oxidation of phorate on leaf and glass plate, phorate could
be present witnin certain portions of the leaf, e.g., within stomatal pores,
and hence, within a potentially low-oxygen environment. This could explain
the gas chromatographic data. An examination of roots resulted in no
detectable cholinesterase inhibitors. Metabolism studies with lemon leaves
showed the presence of large amounts of intact Di-Syston® accompanied by
very slow conversion to other oxidative products(8). This suggested that
the oil-soluble esters were being protected from aqueous hydrolysis by the
oil content of the leaves. This was confirmed bv a radioautograph which
showed nearly all of the radioactivity from P^2 Di-Syston® translocated
into a lemon leaf is confined to the oil glands. A similar radioautograph
of Systox®-thiol-isomer translocated into lemon leaves showed that, most of
the radioactivity was located in the aqueous tissues of the plants^''.
These differences were correlated with the relative water solubilities of
the compounds, i.e., Di-Syston® 66 ppm and Systox®thipl-isonner 3900 ppm.
The water solubility of phorate was recorded as 85
With the rate of formation of cholinesterase inhibitors the same en
glass plates and sorghum leaf surfaces, the lower cholinesterase-inhibition
percentage values for tomato (Figure 6) are difficult to explain. The
values are lower than expected with tomato having received a concentration
of phorate double that received by sorghum. Since the gas chromatographic
data for tomato and sorghum agree, the distinct differences in cholinesteraseinhibition percentage values could have resulted from poorer efficiency in
recovering oxidized metabolites from tomato compared to sorghum. The
similarities in graphic plots for May sorghum (Figure 14) and tomato (Figure
8) would support this rationale.
Evaluation of the cholinesterase-inhibition percentage values with
the calibration curve resulted in values relating the concentration of
toxic residues present in and on the plant foliage. Fourteen days after
application of phorate to Honey sorghum in April, sample preparation of a
foliar rinse of the surface of the plant accounted for approximately 50
percent of the total cholinesterase inhibition of the plant. A lack of
detection of phorate within seven days indicated that residues of the
oxidized metabolites in sorghum occurred to a very large degree via
oxidation of phorate on the leaf surface, absorption within the leaf, and
possible translocation within the plant. This is not in agreement with
the previous studies presented in References 5 and 9. Other researchers have
postulated(S) that the relative rates of absorption and translocation of
phorate and Di-Syston® increased as the experiment proceeded because of the
formation of more water-soluble oxidative metabolites in the subcuticular
layers of olant tissue around the region of application. In Reference 9,
the postulation is that the parent compounds were fairly persistent on the
surface of the leaves but were metabolized rapidly once they had penetrated.

�These variations can be explained by the differences in application method
and in insecticide concentration: i.e., a 5 microliter topical application
to the base of the stem of a cotton plant versus a 0.2 milliliter application of a 2 percent solution of phorate in vegetable oil to the blades of
sorghum.
It must be remembered that as the toxic metabolites are forming, they
are concurrently being hydrolyzed to nontoxic phosphoric or thiophosphoric
acids. Though the oxygen-analogs of phorate can inhibit cholinesterase
activity more than their thionpohosphate precursors, they appear to have
a higher degree of instability'^' ^'• The phosphorus is considerably more
electrophilic in the P=0 compounds, thus weakening the P-S ester bond and
facilitating hydrolysis and accelerating phosphorylation of the enzyme'^).
Consequently, the presence of relatively large amounts of a highly oxidized
metabolite in a plant would result in higher cholinesterase inhibition and
higher apparent residue values than would an equivalent amount of a metabolite with less cholinesterase activity in another plant. The higher
cholinesterase-inhibition values mean the presence of metabolites which
are easily hydrolyzed, resulting in an overall faster rate of metabolic
detoxification.
The concentrations of phorate metabolites in tomato and sorghum were
expressed in parts per million (ppn.) as phorate oxygen analog sulfoxide
equivalent via a cholinesterase-inhibition method of analysis. The calibration curve for the residue method is given in Figure 2. It is independent of plant material analyzed and of the sample preparation technique.
It reflects none of the losses that may occur in the various steps of
sample preparation. A sample calculation follows the formula:
.v = parts per million of phorate oxygen analog sulfoxide equivalent
in sample analyzed.
Where w is the phorate oxygen analog sulfoxide equivalent obtained in the
analyses, micrograms.
v is the aqueous extract in the determination, mi Hi liters.
V is the total solvent in sample extraction, milliliters.
W is the sample extracted, grams (fresh weight).
The toxic residues present in tomato foliage were based .on the average
weight of tomato plants initially after application of phorate (six weeks)
and at the conclusion of the experiment (nine weeks), 6 grams and 28 grams,
respectively. Thus, residues in the tomato foliage ranged from 1.1 to 5.3
ppm phorate oxygen analog sulfoxide equivalent.

37

�Residue persistence in sorghum (Table X) was higher. The May sorghum
had concentrations with a range of 0 to 20.2 ppm. The average residue value
after the second day was 17.9 ppm. The March/April sorghum had concentrations with a range of 2.4 to 18.5 ppm. The fourfold increase in residues
by the ninth day is comparable to that found by Bowman and Casida'^' in
considering the persistence of phorate-P 2 and its metabolites in vegetable
crops. The total anticholinesterase activity of greenhouse pea plants,
sprayed with phorate at one pound per acre, increased for about the firslv
four days and then declined, but inhibitors persisted for 20 to 30
^ '
Foliage application of 0,0-diethyl S-[(isopropylthio) methyl] phosphorodithioate to pea plants resulted in the appearance of anticholinesterase
metabolites within one day and persistence of such metabolites in high
concentration for at least nine days with detectable amounts present for
21 days^'. The results of this investigation were comparable: the main
difference was higher residue levels.
In crops treated with phorate., the ultimate toxic residues are present
in a fractional part per million'". When applied to corn at a rate of one
pound per acre, phorate was essentially gone in 14 days, while very low
levels of its sulfoxide and sulfone (0.1 ppm or less) persisted through the
28-day experimental interval. At harvest time, the plant was essentially
4
free of insecticide, less than 0.01
'
The concentration of phorate metabolite residues present, though high,
would probably be at a safe level by harvest time. The ultimate toxic
metabolites present in harvest time residues are dependent upon both the
interval between application and harvest and the method of application.
Older plants having phorate applied at high rates would definitely have to
be monitored for toxic residues.
The lower residue values for tomato foliage are due in part to a
larger daily plant weight—approximately threefold that of sorghum. The
result could be a more rapid metabolism and hydrolysis and provides another
possibility for the cholinesterase-inhibition percentage values being lower
for tomato than for sorghum.
Generally, oxidation. in plants never increases the toxicity of an
application significantly^"'. However, the large residue values obtained
in this study indicate that the toxicity is increased considerably on the
surface of the plant when high concentrations are involved. A number of
researchers, in speculating upon potential residue problems after various
methods of treatment with systemic insecticides, have concluded that persistence curves should be 8
established on different crops grow under different
environmental conditions' '. Military application of insecticides at normal
rates results in residues which can be monitored with guidance from available
literature. Residue breakdown of these organophosphorus insecticides is
usually rapid with no persistency problems. However, the result of repetitive

38

�aerial application or spillage of insecticides in cropland areas may
result in concentrations higher than usual. This study indicates exposure
studies of the respective insecticides on glass plates alone under different
environmental conditions would serve as a guide in predicting residues from
high concentrations of insecticides.
TABLE IX.

PERSISTENCE OF PHORATE OXYGEN ANALOG SULFOXIDE EQUIVALENT IN
SORGHUM

Time From Application,
Day

0
1
2
4
5
7
8
9
11
12
14
16
18
19
20
21
23
25
a

Concentration, ppm
March /April 3
2.4-5.3
2.4-5.3
2.4-5.3
10.3-14.5
10.3-14.5

Mayu

0
8.3
17.1
19.7
18.7
18.5

12.6-18.5
16.0-18.5
10.3-14.5
12.6-18.5
12.6-18.5

16.6
20.2
18.0
15.3

10.3-11.9
10.3-11.9
6.9-7.9
6.9-7.9

17.0

Concentration range is the result of considering the standard deviation
for the average plant weight for the entire experimental period in May;
this is due to the lack of plant weight values for March/April. Results
are averages of two samples, three replications each.

3

Results are averages of four samples, three replications each.

39

�SECTION IV
SUMMARY AND CONCLUSIONS

Data on the metabolism of foliar applications of high concentrations
of the organophosphorus insecticide phorate on Homestead tomato and Wiley
and Honey sorghum are reported. The investigation of phorate metabolism,
monitored by gas chromatographic and enzymatic analysis, produced the
following results:
1. The cholinesterase activity values obtained showed no correlation
with plant weight.
2. The disappearance of phorate appeared to proceed at the same rate
in each plant species and variety; phorate disappeared more quickly from
glass plates than from March/April sorghum under the same experimental
parameters.
3. No significant differences were apparent between the two varieties
of sorghum in May or during continuous experiments in March and April.
It appeared that the formation of anticholinesterase metabolites, after
high foliar applications of phorate, proceeded at the same rate in each
variety although distinct visible differences occurred between the Wiley
and Honey sorghum.
4. The peak percentages of cholinesterase inhibition from sorghum
samples by the fourth day in May versus the ninth day in March/April
indicated more rapid oxidation of phorate to anticholinesterase metabolites
at higher temperatures.
5. The phorate metabolism in tomato was similar to metabolism in the
May sorghum; however, actual comparison of percentage values of cholinesterase inhibition during the month for each of the three plants indicated
that the average for the Homestead tomato was significantly lower than
those for the two varieties of sorghum.
6. The percentage values of cholinesterase inhibition for the Wiley
and Honey sorghum increased at the same rate as for the glass plates,
indicating that the rate of formation of anticholinesterase-oxidized
metabolites was predominantly through chemical oxidation on the leaf
surface and not by plant enzyme catalysis; this surface oxidation took
place at least at such a rate as to mask enzyme catalysis.
7. The larger droplet size in application technique resulted in
higher toxic-residue values for phorate metabolites, especially on the
surface of the plant, than would normally be expected.

40

�This study was initiated to find a basis for predicting toxicity and
persistence of metabolite residues in plants after application of high
concentrations of sulfur-containing oraanophosphorus insecticides during
military spray operations. The results indicate that exposure studies of
high concentrations of insecticides on glass plates alone, under different
environmental conditions, would serve as a guide in predicting residues
from repetitive aerial application or spillage of insecticides used by
the military in cropland areas. Such studies with a controlled environment
would yield toxic-residue-persistence data under various conditions for
high concentrations of insecticides.

41
(The reverse of this page is blank)

��REFERENCES

1.

Thomson, W.T. Agricultural Chemicals, Book I. Insecticides,
Acaricides, and Ovicides. Thomson Publications, Davis,
California, 1967.

2.

Bowman, J.S. and J.E. Casida. Metabolism of the Systemic
Insecticide 0,0-Diethyl S-Ethylthiomethyl Phosphorodithioate
(Thimet) in Plants. J. Agr. Food Chem. 5: 192-197, 1957.

3.

Bowman, J.S. and J.E. Casida. Further Studies on the Metabolism
of Thimet by Plants, Insects, and Hammals. J. Econ. Entomol.
51:838-843, 1958.

4.

Bowman, M.C., M. Beroza, and J.A. Harding. Determination of Phorate
and Five of Its Metabolites in Corn. J. Agr. Food Chem.
17:138-142, 1969.

5.

Metcalf, R.I., T.R. Fukuto, and R.B. March. Plant Metabolism of
Dithio-Systox and Thimet. J. Econ. Entomol. 50:338-345, 1957.

6.

Coleman, O.H. and J.L. Dean. Inheritance of Resistance to Methyl
Parathion in Sorgo. Crop Sci. 4:371-372, 1964.

7.

Wolverton, B.C., W.J. Wallace, A.L. Young, and D.D. Harrison.
Studies on the Systemic Uptake of Toxic Phosphorus Esters by Plants.
Morphological Effects of Foliar Applications of the Organophosphate
Insecticides Mevinphos and Methyl Demeton on Selected Plant Species.
Air Force Armament Laboratory Technical Report AFATL-TR-69-116,
Eg!in Air Force Base, Florida, September, 1969.

8.

Metcalf, R.L., H.T. Reynolds, M. Winton, and T.R. Fukuto.
Effects of Temperature and Plant Species upon the Rates of Metabolism
of Systemically Applied Di-Syston. J. Econ. Entomol. 52:435-439,
1959.

9.

Heath, D.F. Metabolism in Plants and Soils. Jm Organophosphorus
Poisons, Anticholinesterases and Related Compounds edited by
D.F. Heath. Pergamon Press, Mew York, 1961.

10. Archer, T.E. Enzymatic Methods. Jm Analytical Methods for
Pesticides, Plant Growth Regulators, and Food Additives, Volume I
edited by G. Zweig. Academic Press, New York, 1963.
11. Sutherland, G.L., P.A. Giang, and T.E. Archer. Thimet. I_n
Analytical Methods for Pesticides, Plant Growth Regulators, and
Food Additives , Volume II edited by G. Zweig. Academic Press,
New York, 1964.
43

�12. Nabb, D.P. and Florence Whitfield. Determination of Cholinesterase
by an Automated pH Stat Method. Arch. Environ. Health. 15:147-154,
1967.
13. Himel, C.M. The Optimum Size for Insecticide Spray Droplets.
J. Econ. Entomol. 62:919-925, 1969.
14. Young, A.L. and B.C. Wolverton. Military Herbicides and Insecticides. Air Force Armament Laboratory Technical Note
AFATL-TN-70-1, Eglin Air Force Base, Florida, January, 1970.
15. Reynolds, H.T., T.R. Fukuto, R.L. Metcalf, and R.B. March.
Seed Treatment of Field Crops with Systemic Insecticides.
J. Econ. Entomol. 50:527-539, 1957.
16. Metcalf, R.L., R.B. March, T.R. Fukuto, and M.G. Maxon. The
Nature and Significance of Systox Residues in Plant Materials.
J. Econ. Entomol. 48:364-369, 1955.
17. Fukuto, T.R., R.L. Metcalf, R.B. March, and M.G. Maxon. Chemical
Behavior of Systox in Biological Systems. J. Econ. Entomol.
48:347-354, 1955.
18. Cook, J.W. and R. Ottes. Note on the Conversion of Some
Organophosphate Pesticides to Less Polar Compounds by Ultraviolet
Light. J. Assoc. Offie . Agr. Chemists. 42:211-212, 1959.
19. Mitchell, T.H., J.H. Ruzicka, J. Thomson, and B.B. Wheals.
The Chromatographic Determination of Organophosphorus Pesticides.
Part III. The Effect of Irradiation on the Parent Compounds.
J. Chromatog. 32:17-23, 1968.
20. Ruzicka, J.H., J. Thomson, and B.B. Wheals. The Gas Chromatographic
Examination of Organophosphorus Pesticides and Their Oxidation
Products. J. Chromatog. 30:92-99, 1967.
21. Metcalf, R.L., R.B. March, T.R. Fukuto, and M.G. Maxon. The
Behavior of Systox-isomers in Bean and Citrus Plants. J. Econ.
Entomol. 47:1045-1055, 1954.

44

�DISTRIBUTION LIST
AFSC (DLSW)
(SDWM)
(SGP)
ARPA (TECH INFO)
DDR&amp;E (CHEM TECH)
(TECH LIB)
SAAMA (SFQT)

2
3
3
1
1
5
5

AIR UNIVERSITY LIB
HQ DA OACSFOR (FOR CM SR)
OPERATIONS RSCH GRP
EDGEWOOD ARSENAL
(SMUEA-TD-S)
(SMUEA-RPRE (2))
(SMUEA-CC)
(SMUEA-QS)
(SMUEA-CCCR)
(SMUEA-TSTI-L)
(SMUEA-D)
(SMUEA-TS-CF)

1
1
1
1
2
1
1
1
1
1
1

(WPNS DEV &amp; ENGR LABS)
ENGR R&amp;D LABS (TECH DOC CTR)
ABERDEEN PRV GD (TECH LIB)
DESERET TEST CENTER (TECH LIB)
CBR AGENCY (CSGSB-ST)
USA CHEMICAL SCHOOL (AJMCL-A)
NAV AIR SYS COMD (AIR-532G)
USN WEAPONS LAB

2
2
1
4
1
1
2
2

USN RESEARCH LAB (CODE 6140)
4525 FTR WPN UG (FWOA)
6570TH AMRL (HEF)
DDC
12AF (DMEME)
DL
DLIP
SSLT
TAWC (DOD)
(DIM)
SOC (DFS)
HQ USAF (AFRDPA)
TAC (DOO-S)
SOF-DOR
319SOS-DM
TAWC-CB
USAFETAC
USAF ENVIRONMENTAL HEALTH LAB
(Kelly AFB TX)

1
1
1
12
1
1
50
2
1
1
1
2
2
2
2
1
1
1

45

�DISTRIBUTION LIST (Concluded)
USAF ENVIRONMENTAL HEALTH LAB
(McClellan AFB CA)

1

USAFEL
AFWL (DEE)
USAFA (DFLS)
DUGWAY PROVING GROUND (TECH LIB)
ONR (CODE 440)
HQ USACDC (NBC BRANCH)
ASD (ENYS)
DLOS
CDCLNO

1
2
2
1
1
1
1
1
2

46

�UNCLASSIFIED
Security Classification
DOCUMENT CONTROL DATA - R &amp; D
(Security classification of title, body of abstract and indexing annotation must be entered when the overall report is
ORIGINATING A C T I V I T Y (Corporate author)

Flame, Incendiary, and Explosives Division
Air Force Armament Laboratory
Eqlin Air Force Base, Florida
3

classified)

. REPORT SECURITY CLASSIFICATION

UNCLASSIFIED
26. GROUP*

REPORT TITL.E

THE METABOLISM OF HIGH CONCENTRATIONS OF THE ORGANOPHOSPHORUS INSECTICIDE
PHORATE APPLIED FOLIARLY TO SELECTED PLANT SPECIES
D E S C R I P T I V E NOTES (Type- ot report and inclusive dates)

Final Report (May - December 1970)
5 AUTHORCSI (First name, middle initial, Imxt name)

George S. Kotchmar, Jr., Capt, USAF3 Billy C. Wolverton, Elizabeth.E. Boothe,
Sandra M. Lefstad
6

REPORT D A T E

7«. T O T A L NO. OF PAGES

February 1971
8«- C O N T R A C T OR G R A N T NO.

&amp;. PROJECT NO.

5066

53

\7t. NO. OF REFS

1

21

9a. ORIGINATOR*^ REPORT NJUMBERfSt

AFATL-TR-71-22
9b. OTHER REPORT NO (si (Any other numbers that may oe assigned
this report)

C.

d.

1O. DISTRIBUTION S T A T E M E N T

Approved for public release; distribution unlimited.

M- S U P P L E M E N T A R Y NOTES

Available in DDC

12- SPONSORING M I L I T A R Y A C T I V I T Y

Air Force Armament Lauoratory
Air Force Systers Command
Eglin Air Force Base, Florida 32542

ABSTRACT

Gas chromatographic and enzymatic analyses (cholinesterase-inhibition method)
were used to monitor the metabolism of the organophosphorus insecticide 0,0diethyl S-[(ethylthio)methyl] phosphorodithioate (phorate) applied foliarly
to three economically important plants (Homestead tomato, Wiley sorghum, and
Honey sorghum). The resulting data provided guidelines in predicting toxicity
and persistence of metabolite residues for high concentrations of insecticides
employed by the military. An attempt was also made to relate the metabolism
of the insecticide to phytotoxic damage among and within plant species. The
data indicated that no plant-variety-dependent distinction exists in the
formation of toxic phorate metabolites as shown by in vitro anticholinesterase
activity recorded over a four-week period. Further investigation, with the
same high concentrations of phorate placed on glass plates located adjacent
to treated plants, indicated the formation of toxic phorate metabolites was
without the influence of biological substrates within the plants. There were
no statistically significant differences with respect to the rate of increase
of cholinesterase-inhibition percentage values between the sorghum and glass
plates; the rate of formation of anticholinesterase oxidized metabolites was
predominantly through chemical oxidation on the leaf surface and not by
plant enzyme catalysis, or at least, the oxidation occurred at such a rate
as to mask the enzyme catalysis. The large droplet size in the application
of phorate resulted in higher toxic residue values, especially on the surface
of the plant, than would normally be expected^

DD

FORM
1 NOV 65

1473

UNCLASSIFIED
Security Classification

�UNCLASSIFIED
Security Classification
1

14.

K EY

LINK A

LINKS

LINK' C

WORDS
ROLE

WT

ROLE

WT

Phorate
0,0-diethyl S-[(ethylthio)methyl] phosphorodithioate
Organophosphorus Insecticides
Plants
Insecticide Residues
Insecticide Metabolism

UNCLASSIFIED
Security Classification

ROL E

W T

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5707">
              <text>016</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5709">
              <text>0172</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5712">
              <text>Series II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5703">
                <text>Kotchmar, George S., Jr.</text>
              </elementText>
              <elementText elementTextId="5704">
                <text>Billy C. Wolverton</text>
              </elementText>
              <elementText elementTextId="5705">
                <text>Elizabeth E. Boothe</text>
              </elementText>
              <elementText elementTextId="5706">
                <text>Sandra M. Lefstad</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5708">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Flame, Incendiary, and Explosives Division, Air Force Armament Laboratory, Eglin AFB, Florida</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5710">
                <text>1971-02-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5711">
                <text>The Metabolism of High Concentrations of the Organophosphorus Insecticide Phorate Applied Foliarly to Selected Plant Species</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5713">
                <text>pesticide testing</text>
              </elementText>
              <elementText elementTextId="5714">
                <text>pesticide toxicology</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="1250" public="1" featured="0">
    <fileContainer>
      <file fileId="1134">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/355890c6af5da1f145114408fa767656.pdf</src>
        <authentication>b1c89d4bddbc724805f64a142582eca8</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63083">
                    <text>Item ID Number: 00101
Author
Corporate Author

Simmon, Vincent F.
Stanford Research Institute, Menlo Park, California

Report/Article TltlB Evaluation of Seleclod Pesticides as Chemical Mutagens 'In Vitro' and 'In Vivo'
Studies

Journal/Book Title
Year

™n

Month/Day

Ma

v

Color
Number of Images

252

DOSCriptOn NOtBS

Conlracl No. 68-01 -2458; EPA-600/1 -77-028

Friday, Doccrnbcr 08, 2000

Pago 101 of 106

�S immon , V . F . ,
1977
F.va-luation oC selected pesticides as chemical
mutagcns 'In vito' and 'In vivo1 studies

I Technical Information Service

•-

*-

*"*"^it" "'^

"^^ ^* "Iff™1* ™1*

PL268&amp;4Z _

Evaluation of Selected Pesticides as
Chemical AAutagens 'In vitro' and
'In vivo' Studies
a
.-

'

. •

_

-

. . _ . . _ .

1.

Stanford.Research Institute, Menlo Park, Calif
•

-

-

•

-

-

-

r.

•

-

c
z

.: - '
I "-- -

Prepared for

Health Effects Research Lab, Research Triangle Park, N C
May 77

AEROM EDICAL LIBRARY

APR 21 1980
DOCUMENT'S

�:(:C!(,MiCAL REPOR1 •. A
1 ,:-asc read Instructions on the reverse be}u.'f completing)
i REPORT NO
J:PA-600/1-77-028
4. T I T L E AND S U B T I T L E

5 REPORT DATE

May 197/

EVALUATION OK SELECTED PESTICIDES AS CHEMICAL MUTAGENS
In Vitro and In Vivo Studies

6. PERFORMING ORGANIZATION CODE

B. PtHFORMING ORGANIZATION RfPOHT NO.

7 AUTMOR(S)

Vincent F. Silicon, Ann D. Mitchell and Ted A. .Torgenson

LSU-3493
iO-'pROGHAM ELEMENT NO".

9&gt;EFirORMlNG ORGANIZATION NAME AND ADDRESS

Stanford Research Institute
Menlo Park, California 94025

1EA615
TTCONtH'AflT^eHANi^NO. *

68-01-2458
12. SPONSORING AUKNCY NAME AND ADDRESS

13. TYPE OF REPORT AND PERIOD COVERED

HeaJth Effects Research Laboratory - RTF, NC
Office of Research and Development
U.S. Environmental Protection Agency
Research Triangle Park, N.C, 27711
iSTs u P PL'EMFNTARYIVIOTES" ""

[^"ABSTRACT

"
"

"

14. SPONSORING AGENCY CODE
600/1.1

~

Twenty pesticides being reviewed as part of the EPA Substitute Chemical Program
were studied for mutagenic activity by several _Ln vitro and in vivo test procedures.
The pesticides reviewed were: monocrotophos, bromacil,, ca^codyllc acicf, captan,
chlorpyrifos, dinoseb, DSMA, fenthion, folpet, azinphos-methyl, malathion, methomyl,
monuron^ MSMA, parathion, parathion-methyl, quintozene (PCNB), phorate, simazine,
and trtfluralin.
Ten of the twenty compounds were evaluated in_vivp by the mouse dominant lethal
test. All twenty compounds were tested in vitro. None of the ten compounds tested
in the mouse produced a dominant lethal response. Ten of the twenty compounds were
mutagenic in one or more, in vitro assays. Two were mutagenic in all of the in vitro
assays: captan and folpet.

KEY WORDS AND DOCUMENT ANALYSIS

7.

b.lDENTIFIERS/OPEN ENDED TERMS

DESCRIPTORS

pesticides
in vivo analysis
in vitro analysis
Diutagtms

COS AT I Held/Group

06 F
06 T

19. SECURITY CLASS (This Keportl

19. DISTRIBUTION S T A T E M E N T

21. NO.

__UNCLAS^IFIED

RELEASE TO PUBLIC

20. SECURITY CLASS (Thispage)
REPRODUCED EV

EPA Form 2220-1 (9-73)

c.

NATIONAL TECHNICAL
INFORMATION SERVICE
U. S. DEPARTMENT OF COMMERCE
SPRINGFIELD, VA. 22161

22. P'RICE

��NOTICE
THIS DOCUMENT HAS BEEN R E P R O D U C E D
F R O M T H E BEST C O P Y F U R N I S H E D U S B Y
THE SPONSORING AGENCY. ALTHOUGH IT
IS R E C O G N I Z E D THAT

CERTAIN

PORTIONS

ARE I L L E G I B L E , IT IS BEING R E L E A S E D
IN THE INTEREST

OF MAKING A V A I L A B L E

AS MUCH I N F O R M A T I O N AS POSSIBLE.

�RESEARCH REPORTING SERIES
Research reports of the Office of Research and Development, U.S. Environmental
Protection Agency, have been grouped intc nine series. These nine broad categories were established to facilitate further development and application of environmental technology Elimination o&lt; traditional grouping was consciously
planned to foster technology transfer and a maximum interface in related fields.
The nine series are:
1.
2.
3.
4.
5.
6.
7
8.
9.

Enviroimenta! Health Effects Research
Environmental Protection Technology
Ecological Research
Environmental Monitoring
Socioeconomic Environmental Studies
Scientific and Technical Assessment Reports (STAR)
Interagency Energy-Environment Research and Development
"Special" Reports
Miscellaneous Reports

This report has been assigned to the ENVIRONMENTAL HEALTH EFFECTS RESEARCH series. This series describes projects and studies relating to the tolerances of man for unneaithful substances or conditions This work is generally
assessed from a medical viewpoint, including physiological or osychological
studies. In addition to toxicology and othe- medical specialities, study areas include biomedical instrumentation and health research techniques utilizing animals — but always with intended application to human health measures.

This document is available to the public through the National Technical information Service, Springfield, Virginia 22161.

�EPA-600/1-77-028
May 1977

EVALUATION OF SELECTED PESTICIDES AS CHEMICAL MUTAGENS
in Vitro and In Vivo Studies

By

Vincent F. Simmon, Ann D. Mitchell, and. Ted. A. Jorgenson
Stanford Research Institute
Menlo Park, California 94025

Contract No. 68-01-2458

Project Officer
Michael D. Waters
Environmental Toxicology Division
Health Effects Research Laboratory
Research Triangle Park, N.C. 27711

U.S. ENVIRONMENTAL PROTECTION AGENCY
OFFICE OF RESEARCH AND DEVELOPMENT
HEALTH EFFECTS RESEARCH LABORATORY
RESEARCH TRIANGLE PARK, N.C. 27711

10.

�DISCLAIMER
This report has been reviewed by the Health Effects Research
Laboratory, U.S. Environmental Protection Agency, and approved for
publication. Approval does not signify that tha contents necessarily
reflect the views and policies of the U.S. Environmental Protection
Agency, nor does mention of trade names or commercial products
constitute endorsement or recommendation for use.

it

�FOREWORD
The. many benefits of our modern, developing, Industrial society are
accompanied by certain hazards. Careful assessment of the relative risk
of pxisting and new man-made environmental hazards is necessary for the
establishment of sound regulatory policy. These regulations serve to
enhance the quality of our environment In order to promote the public
health and welfare and the productive capacity of our Nation's population.
The Health Effects Research Laboratory, Research Triangle Park,
conducts a coordinated environmental health research proBr#:n in toxicology,
epidemiology, and clinical studies using human volunteer Kiibjects. These
studies address problems in air pollution, non-ionizing radiation,
environmental, carcinogenesis and the toxicology of pesticides as well as
other chemical pollutants. The Laboratory develops and revises air quality
criteria documents on pollutants for which national ambient; air quality
standards exist or are proposed, provides the data for registration of new
pesticides or proposed suspension of those already in use, conducts research
on hazardous and toxic materials, and Is preparing the health basis for
non-ionizing radiation standards. Direct support to the regulatory function
of the Agency is provided in the form of expert testimony and preparation of
affidavits as well as expert advice to the Administrator to assure the
adequacy of health care and surveillance of persons having suffered imminent
and substantial endange.rment of their health.
This report describes the testing of a series of twenty technical
grade pesticide chemicals for genotoxic properties by use of a battery
of JLn yjltro and .In vivo methods. The battery includes tests for gene
and chromosomal mutations and primary damage to DNA as measured by
effects on DNA repair recombination. Since DNA is chemically similar in
all species, test results from a variety of cells and organisms are
relevant in assessing the potential genetic hazard of pesticide chemicals
in humans.

John H. Knelson, M.D.
Director,
Health Effects Research Laboratory

\

�ABSTRACT

Twenty pesticides being reviewed as a part of the EPA Substitute
Chemical Program were studied for mutagenic activity by several in vivo
and lii vlcro test procedures. Ten of Che twenty compounds were evaluated
in vivo by the mouse dominant lethal test. All twenty compounds were
tested by the following _in_ vitro procedures:
Unscheduled DNA synthesis (UDS) In human fibroblasts (WI-38 cells); reverse mutation in Salmonella
typhlmur:Lum strains TA1535, TA1537, TA1538, and
TA100 and in Escherlchla.coll. WP2; mitotlc recombination in the yeast Saccharomyces cereylslae D3;
and preferential toxlclty assays In DNA repairproficient and -deficient strains of ]J. coH
(strains VO110 and p3478, respectively) and Bacillus
subtilis (strains H17 and MAS, respectively).
None of the ten compounds tested in the mouse produced a dominant
lethal response.
Ten of the twenty compounds were mutagenic in one or more ^n vitro
assays. Two were mutagenic in all of the in vitro assays: captan and
tolpet. In a heritable translocate on study in mice, under the experimental
procedures employed, captan at 5000 ppm in the diet of male mice for 8
consecutive weeks produced a heritable mutagenic event in F^ generation
male mice.

iv

�CONTENTS

LIST OF TABLES

Hi

SUMMARY

1

TWENTY PESTICIDES EVALUATED BY SRI FOR MUTAGENIC ACTIVITY

3

INTRODUCTION

4

DOMINANT LETHAL TEST IN THE MOUSE

6

General
Experimental

, ,

Animals anil Chemicals
Determination of Acute Toxlclty
Maximum Tolerated Dose Study
Treatment Levels
Administration of the Compounds
Test Groups
Necropsy and Evaluation
Results and Discussion
MAMMALIAN JEN VITRO UNSCHEDULED DNA SYNTHESIS ASSAYS
General
Experimental
Cell Culture
Dilution of Compounds
Controls
UDS Assays
Interpretation of Results
MICROBIOLOGICAL ASSAYS

6
6

6
7
7
7
8
8
9
9
12
12
13
13
13
13
14
15
17

General
17
Experimental
18
Salmonella typhimurlinn Strains TA1535,
~TAi537," TA1538,"and TA100
18
JEscherlchia coll WP2
19
Escherlchla coU W3100/p3478 and
Bacillus 'subtllls H17/M45
20
jjaccharomjrces cerevlslae D3
21
Aroclor 1254-Stlmulated"~MetaboHc Activation System . . . 22
Results and Discussion
22
DISCUSSION

25

REFERENCES

26

APPENDIX A:

Mutageneals Studies of Pesticide Compounds - Mouse
Heritable Translocation Test - Captan

17.1

�TABLES
DOMINANT LETHAL TEST
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

Chi-Square Test of the Fertility Index - Monocrotophos . . . . 28
Average Implants per Pregnant Female - Monocrotophos
29
Average Dead Implants per Pregnant Female - Monocrotophos. . . 30
Chi-Square Test of the Death Index - Monocrotophos
31
Number of Dead Implants per Total Implants - Monocrotophos . . 32
Chi-Square Test of the Fertility Index - Bromacil
33
Average Implants per Pregnant Female - Bromacil
34
Average Dead Implants per Pregnant Female - Bromacil
35
Chi-Square Test of the Death Index - Bromacil
36
Number of Dead Implants per Total Implants - Bromacil
37
Chi-Square Test of the. Fertility Index - Captan
38
Average Implants per Pregnant Female - Captan
39
Average Dead Implants per Pregnant Female - Captan
40
Chi-Square Test of the Death Index - Captan
4i.
Number of Dead Implants per Total Implants - Captan
42
Chi-Square Test of the Fertility Index - Folpet. . .
43
Average Implants per Pregnant Female - Folpet
44
Average Dead Implants per Pregr.ant Female - Folpet
45
Chi-Square Test of the Death Index - Folpet
46
Number of Dead Implants per Total Implants - Folpet
47
Chi-Square Test of the Fertility Index - Azinphos-Methyl . . . 48
Average Implants per Pregnant Female - Azlnphos-Methyl . . . . 49
Average Dead Implants per Pregnant Female - Azinphos-Methyl. . 50
Chi-Square Test of the Death Index - Azinphos-Methyl
51
Number of Dead Implants per Total Implants - Azinphos-Methyl . 52
Chi-Square Test of the Fertility Index - Malathion
T.3
Average Implants per Pregnant Female - Malathion
54
Average Dead Implants per Pregnant Female - Malathion
55
Chl--Square Test of the Death Index - Malathion
56
Number of Dead Implants per Total Implants - Malathion . . . . 57
Chi-Square Teat of the Fertility Index - Parathion
58
Average Implants per Pregnant Female - Parathion
59
Average Dead Implants per Pregnant Female
60
Chi-Square Test of the Death Index - Parathion
61
Number of Dead Implants per Total Implants - Parathion . . . . 62
Chi-Square Tast of the Fertility Index - Parathion-Methyl. . . 63
Average: Implants per Pregnant Female - Parathion-Methyl. . . . 64
Average Dead Implants per Pregnant Female - Parathion-Methyl . 65
Chi-Square Test of the. Death Index - Pp.rathion-Methyl
66
Number of Dead Implants per Total Implants - Parathion-Methyl. 67
Chi-Square Test of the Fertility Index - Quiritozene (PCNB) . . 68
Average Implants per Pregnant Female - Quintozene (PCNB) . . . 69
vi

�43
44
45
46
47
48
49
50

Average Dead Implants per Pregnant: Female Qulntozene (FCWB)
....
Chi™3quare Test, of the Death Index - Quintozene (PCNB). . . .
Number of Dead Implants per Total fmplants Qulntosene (PCND)
Chi-Square Test of the Fertility Index - Phorate
Average Implants per Pregnant E'.--,wile - Phorate
Average Dead Implants per Pregnant Female - Phorate
Chi-Sqisare Test of the Death Index -• Phorate
Number of Dead Implants per Total Implants - Phorate

70
71
72
73
74
75
76
77

UDS ASSAYS
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75

DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation.
DNA Repair Synthesis Assay
DNA Repair Synthesis Assay
Metabolic Activation
DNA Repair Synthesis Assay

of Monocrotophos
of Monocrotophos with
of Bromacil
of Bromacil with
of Cacodyllc Acid
of Cacodyllc Acid with
of Captan
of Captan with
of Chloropyrifos
of Chloropyrifos with
of Dlnoseb
of Dinoseb with
of DSMA
of DSMA with
of Fenthlon
of Fenthiori with
of Folpet
of Folpet with
of Azinphos-Methyl
of Azinphos-Methyl with
of Malathion
of Malathion with
of Methomyl
of Methomyl with
,
of Monuron
vii

78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102

�76
77
78
79
80
81
82
83
84
85
86
87
88
89
90

DNA Repair Synthesis Assay of
Metabolic Activation
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay of
Metabolic Activation. ...
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay of
Metabolic Activation
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay .of
with Metabolic Activation
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay of
with Metabolic Activation
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay of
Metabolic Activation
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay of
Metabolic Activation
DNA Repair Synthesis Assay of
DNA Repair Synthesis Assay of
Metabolic Activation

Monuron with
MSMA
MSMA with
1
Parathion
Parathion with
Parathion-Methy 1
Parathion-Methyl
Qulntozene (PCNB)
Qulntozene (PCNB)
Fhorate
Phorate with
Simazine
Simazine with
Trifluralin
Trifluralin with

103
104
105
106
107
108
109
110
Ill
112
113
114
115
116
117

MICROBIOLOGICAL ASSAYS
91
92
93
94
95
96
9?
98
99
.100
101
102
103

In Vitro Assays with Salmonella ^phjLmurium
118
Results" of Assays with Escerichia coli ~WP2
138
Mlcrobial Inhibition in~Egcerichia coll and
Bacillus subtilis . ... 7~".""..
148
.In Vitro_ Assays with Saccharomyces cerevisiae D3 Monocrotophos
150
In Vitro Assays with Saccharomyces Cjereyisiae D3 "Bromacil
T .." . Y W
"". " ' V
151
In Vitro Assays with .Saccharomyces cerevisiae D3 Cacodylic Acid. . . . . V ."."". ~. .""
T
152
1$. XiS,r,°- Assays with Saccharomyc.es .cereyj.si.ae D3 Captan
153
In Vitro Assays with .Saccharomyces cerevislAe D3 Chloropyrifos
154
_In Vitro Assays with Saiccharoiir/ces £ere\rlsiae D3 Dlnoseb
155
In Vitro Assays with Saccharoniy_ces. cejrwisiae D3 - DMSA . . . 156
In y_it:r&lt;3 Assays with Saccjaromyces cerevisiae D3 Fenthlon
'
157
Iii Vitro Assays with jJaccharoiuyces cereyisiae D3 Folpet
"."." . . " " . " . . .". . 7
158
In Vitro Assays with Saccharomyces. c.ej.evlsi3.?. D^ "Azinphios-Methyl . ."". .* - ". .""".".". ~~~~'~~
159
In y_ltro_ Assays with Sa^cjtonniijrces cerevlslae^ D3 Malathion
".""".""."'. "7"."". ."".' ."".'
160
viii
i

�105
106
^°7
108
109
110
111
112
113
114

Tn Vitrp_ Assays with ^ccharpmyces cer_eyiaiae D3 Methomyl
~.
,
In Vitro Assays with S&amp;ircharqmyces £ereyisiae D3 Moiuiron
,
Jn Vitro Assays- with Sat^charqmjrces cerevlsiae D3 - MSMA . . .
In Vitro Assays with Saccharom^cea cerevlBlae D3 Farathlon
~."".".. . . ." .7
In Vitro Assays with jtaccharomyces cerevlsiae D3 "" Parathlon-Methyl. . .".'. ~.~ .""."'.""." "i ~." "'.
.""
In V_it.ro Assays with jJaccharomyces cerevlgiae D3 Quintozene (PCNB) . . . 7 . . ~
In Vitro Assays with 5a.ccl»arpmyces_ c_ereyl3iae_ D3 " Phorate
T . . . . '." . ".".
"
In Vitro Assays with Saccharomyces cerevisiae_ D3 Simazine
In X*-tr9 Assays with Saccharqmyces cerevirsiae D3 Trifluralin . , , . . " " . . . . " . T " " ' .
" . " " " " " . ' ..'
In Vitro Mutagenf.ais with .Salmouella tyjphlinur_ium. . . . . . .

ix

161
162
163
164
165
166
167
168
169
170

�ACKNOWLEDGMENTS
Stanford Research Institute wishes to thank the EPA project officers
for their guidance and assistance during the course of this project.
Dr. Robert E. McGaughy, Office of Research and Development, Washington,
D.C., was Project Officer from the beginning of the project in June 1974
until July 1975.

Project responsibility then was transferred to

Dr. Ronald L. Baron, Health Effects Research Laboratory, Research
Triangle Park, North Carolina, until January 1976.

At that time,

Dr. Michael D. Waters, now Chief of the Biochemistry Branch in the
Environmental Toxicology Dlvlsi.cn, Health Effects Research Laboratory,
Research Triangle Park, North Carolina, became Project Officer.
Dr. Waters has continued in this project responsibility to the present.

�INTRODUCTION
The Federal Insecticide.. Fungicide, and RodenticJ.de Act designates
Lhe Environmental Protection Agency as the governmental body responsible
for the safety of all pesticides used in the United States. More recently,
the Federal Environmental Pesticide Control Act (PL 92-516) strengthened
EPA's regulatory responRihi.llt.les in the area of pesticides to include,
ttitra- as well as Inter-state commerce.
To be federally registered, a pesticide must h*ve beoii determined
not to be hazardous to health or to the environment when used according
to its labeling restrictions. Thus, relative to new law as well as to
specific directives included in Public Law 9.1-135, 1973, EPA now is conducting a thorough review of rhe implications of using alternate chemicals, including older registered pesticides, for pest control.
Ln the. pesticide review process, EPA emphasizes development of
scientific criteria for evaluating the safety of compounds substituted for
those penticides found to be hazardous.

In addition to reviewing and

evaluating the literature on pesticides and maintaining liaison with
Industry and acadcmia, Che strategy program Includes laboratory studies
to obtain additional data. One of these laboratory programs is directed
toward gathering mutagenesis data on a selected -lumber of compounds.
EPA's program is timely and responsive to one of the recommendations
included in the President's Scientific Advisory Committee Report of
September 1973, Chemlc a_ls_ and Health.

In that document, the Committee

recommended that "Regulatory agencies should take steps to insure that
new scientific data raising the possibility of new or extended hazards
from chemicals in use are subject to careful process of scientific, review
for me.rir. interpretation."
Development of methods for evaluating the rautagenic hazard of chemical compounds has advanced markedly in the last few years.

In contrast

to the undefined empirical tests used a short time ago, procedures now

�available can detect chromosome breaks and other genetic changes caused by
chemical stress. Mutant strains of microorganisms In cell culture and
mammalian flbroblast cells In tissue culture are effective In vitro
systems for .reliable detection of presumptive gene mutations, whereas the
mammalian dominant lethal test is a recognized test for the assessment
of chromosome damage to germinal cells.'
Today many pesticide chemicals in commercial use have not been
investigated adequately for their mutagenlc has:ard. With the public's
increasing concern about possible pollution of our environment by chemicals, the widely used pesticides must be evaluated. In this project,
SRI used test methods that are appropriate for these evaluations and
that are in use by the scientific community.
Under contract to EPA, SRI examined 20 pesticides for mutagenic
activity using a combIntation of in vivo and in vitro mutagenicity assay
systems. The 20 pesticides tested and their sources are listed in the '
following two tables.
The assays used were the dominant lethal test in mice (only
ten compounds); unscheduled DNA synthesis (UDS) in human fibroblasts
(WI-38 cells); reverse mutation in SaJLmojiellji tvj^^miirium strains TA1535,
TA1537, TA1538, and TA100 and in Esch^erlchia coll VF2; mitotic
recombination in the yeast ^Sccharomyjce^ cerevisiae D3; and preferential
toxicity assays in DNA repair-proficient and -deficient strains of IS. coll
(strains W3110 and p3478, respectively) and Bacillus aubtjlls (strains
H17 and M45, respectively.
Based on positive responses in both Tier I (in vitro test) and
Tier II (Droaophila) mutagenic studies, It was recommended that a
heritable trenslocation test (Tier III) la the mouse be conducted

�to further assess the matagenic potential of Captan. The results of
these further studies are reported as Appendix A.
The experimental procedures and results for the mammalian dominant
lethal test, the UDS assay, and the microbiological assays are. described
in the separate sections that follow.

�IS VIVO MC IN VITRO MUTAGENES1S:

SUMMARY DATA FOR E?ft PESTICIDES

Positive Response, +; Negative Response, -

Pesticide

Mouse
Dotiisanc
Lethal*

Salconella
typhJJiuriiaat
(His"1" Reversion)

-HA

+MA

EacSerichia egli WF2
( r '' Reversion)
Ty1

-MA

+MA

Mocccrotophos
bromacil
Cacodylic. Acid
Captan
Chlor?yrlfos
Dnos^S
DbHA
f&lt;jnt!-.ion

foipst
Azlnphos-sechyl
Halathion

Konuron
MSHA
?arathioE
Parachlon-uechyl
Qulntozene (FCNB)
Phorate
Sinazine
Trifluralia

• Only ten pesticides were tested by the dominant lethal procedure.
t See page 170.

T Marginally positive.

Saecharomyces cerevlsiae
(Mitotlc Recombination)

-HA

+MA

Escheriehia coll
(Selative Toxicicy)

Bacillus surtills
(Relative Toxicity)

UDS
(DMA Repair)

-MA

+MA

�TWENTY PESTICIDES EVALUATED 3Y SRI FOR MUTAGENIC ACTIVITY

Common Name*
Monocrouophos
Bromacil
Cacodylic Acid
Cap tar.
Chiorpyrifos
Dinoseb
DSMA
Fenthion
Folpet
Azinphos-methyl
Malathion
Me thorny 1
Monuron
MSMA
Parathion
Par a t h ion-iae t hy 1
Quintozene (PCNB)
Phorate
Simazine
Trifluralin

Tradt Name of
Compound Tested

Manufacturer

Batch or
Lot Number

Batch H,
9-SCL-77
E.I. DuPont de Nemours
T80619/40
Hyvar
Phyton 138
Phytar
Ansul Chemical Company
5X640
Chevron Chemical Conpany
Orthoslde 406
Dow Chemical Company
MM-1 114-1
Dursban
(603-D1)
MM 200554
Dow Chemical Company
PT emerge
Ansul Chemical Company
8100
Ansar
Chemogro
4-15-2026
Bay t ex
Chevron Chemical Company
SX579
Phaltan
Chemogro
411-022S
Guthlon
American Cyanamid Company 40216006.300
Malathion
6602-82
E.I. DuPont de Nemours
Latmate
T-40817-20
E.I. DuPont de Nemours
Telvar
170 H.C.
Ansul Chemical Company
Ansar
Monsanto Chemical Company AD 1236
Niran
Methyl Parathion Monsanto Chemical Company AD 0659
Technical
Olin Mathieson Chemical
Terrachlor
Corporation
American Cyanamid Company MC85
Thimet
FL-740846
Primatol
Ciba-Geigy Chemical Co.
X-26290
Eli Lilly &amp; Company
Treflan

Azodrin-5

Purity (%)

Supplier

55.0

Manufacturer

Shell Chemical Company

95.9
65.6
Technical
98.8

Battelle
Baccelle
Sattelle
Battelle

97.7

Battelle
Battelle
Battelle
Battelle
Battelle
Battelle

80.1
96.0
Technical
Technical
Technical
99.0
97.0
58.4
99.0
80.0
99.0

* Common name as approved by the International Organization for Standardization.

97.7
97.7

Battelle
Battelle
Battelle
Battelle
Battelle
Battelle
Battelle
Battelle
Battelle

�DOMINANT LETHAL TEST IN THE MOUSE
General
In the dominant lethal test, the ten compounds under Investigation
were fed in the diet to proven male breeder mice for 7 weeks. After this
period, each male was mated with two adult virgin females for 7 days;
these females were then replaced by two others for another breeding.
The sequence was continued fof 8 weeks. This procedure emphasizes
possible mutagenic effects on the male sperm, the normal female acting
as a carrier to reveal in her offspring abnormalities that may have
occurred in the male. We evaluated effects by examining the condition
and state of fetal development during the middle to latter stages of
gestation.
Experimental
Animals and Chemicals
Adult ICR/SIM mice from a closed, random-bred colony were used for
the acute toxiclty and maximum tolerated dose determinations as well as
for the dominant lethal assay. These male and! female mice were supplied
by Simonsen Laboratories, Gllroy, California. The males were 3- to
4-raonth-old proven breeders, and the females wore 10- to 12-week-oid
virgin stock.
At the direction of EPA, the Battelle Columbus Laboratories obtained
the pesticides from the manufacturers and subsequently provided SRI with
allquots for the studies reported here.

Each pesticide was a "technical"

grade product (or equivalent) and was provided in sufficient quantity
for us to complete all aspects of the experimental program.

Excess

supplies were refrigerated or frozen, should they be needed fcr future
reference.

�Wo Investigated the solubility of each compound using water,
propylene glycol, polyethylene glycol, corn oil, or carboxymeshylceLlulose to determine the. most appropriate vehicle for administration.
Compounds were administered orally, by gavage for Che acute toxiclty
(LD,-g) determinations, and via the diet Tor the maximum tolerated dose
and dominant letha] studies.
Determination of Acute Toxic ity_
Although acute toxiclty information on .some of the compounds was
available in the literature, we conducted confirmatory tests on all to
obtain an LD

under our Laboratory conditions and for the 1CR/J1F.M

strain of mouse.

If no data were available, we conducted a preliminary

range-finding test, followed by a determination of the oral Lft^Q.
Maximum Tolerated Dose Study
Based on the acute toxicity data and available information from the
literature on dose levels known to cause adverse responses when administered in the diet, several dose, levels were selected and administered in
the diet to adult male mice for 2 weeks.

Treated males then were caged with

two adult virgin females each for 7 days; these females were replaced
by two others weekly for 2 weeks. The females were examined daily for
the presence of vaginal (mating) plugs.

At midterm of pregnancy, the

females were sacrificed and examined for total implants, as well as
for early and late fetal deaths.

For this work, we defined a maximum

tolerated dose as that dietary level which may produce up to a 20%
weight loss, mild but transient clinical signs, no inhibition of breeding
performance, and no mortality.

Thus, these initial studies provided

Information on changes in body weight, acceptability of the diet,
clinical signs, mortality, and breeding performance.
Treatment Levels
For the dominant-lethal study, three dose levels were administered.
The highest was the maximum tolerated dose or 5 g/kg (a maximum level

�agreed on by EPA and SRI), whichever was lower.

The intermediate and

lower dosages were one-half and one-quarter of the highest dose, respectively.
Administration of the Compounds
Each pesticide was fed in the diet to adult male mice for 7 weeks.
An appropriate amount of compound initially was dissolved or suspended
In corn oil; then the compound-oil concentrate was added at a level of 3%
to a finely ground commercial diet of known composition. The use of
corn oil assured even distribution of the compound and prevented stratification of the tost material in an otherwise dry diet.

Diets were pre-

pared at 2-week Intervals and were refrlgeratwd at 4°C until fed to the
animals.

Fresh diet was placed in the. feed containers every other day

to minimize the loss of compound through instability or volatility.

Two reference control groups were included in this project.

One

was run at the beginning of each of the two dominant lethal series, five
pesticides being run concurrently.

In this manner, reference breeding

and implant data were obtained at. two time periods, as was information
on each shipment of research animals.

Males In these groups were fed

a finely ground commercial diet supplemented with corn oil at 3%.
Control groups were treated in the same manner as the compound test
groups.
Two positive control groups were run concurrently wiLth each of the
two series of five pesticide tests.

For these groups, the known mutagen

trlethylenemelamine (TEM) was administered as a single intraperitoneal
inject. Ion of 0.2 mg/kg approximately 2 hours before the first mating.
A commercial pelleted diet was available at all times.
Each control and experimental test group contained 20 adult male
mice.

Af: the end of the 7 -week compound treatment period, each male

was allowed to brer.d with Two virgin females over a period of 7 days.
Femal.es wfico replaced weekly for 8 wpcks.

8

�Females wert sacrificed at midterm of pregnancy.

A completu

necropsy waa performed to determine If an Intercurrent infection was
present; such a condition can induce preimplant&amp;tion loss and early
fetal deaths.

At sacrifice, each female was scored for early fetal

deaths, late fetal deaths, and living fetuses (all of which provide a
LotaL implant score).
The following parameters indicate effects in dominant lethal studies:
Total implants (live Fetuses plus early and late fetal deaths), total
&lt;;.cad (early and late I'tif.al deaths), and dead implants per total Implants.
Total imp]ants and dtad Implants were analyzed for significance by the
t-test.
Th« Jndex of dead implants per total implants was analyzed statistically by the t-test on arcsine- (or angular) transformed data, as
described in Experimental Design (Theory_ and Apjgllcajclon) .
index was computed for each female.

Other parameters analyzed were the

fertility and death indices.

Rcsults and_ Discussion
Single-dose oral acute toxicity data are as follows:

Compound

LD.50

Monocrotophos

17 mg/kg

Bromacil

3.04 g/kg

Captan

&gt; 15 g/kg

Folpet

&gt; 10 g/kg

Azinphos-methyl

15 mg/kg

Malathion

1196 mg/kg

Parathion

This

'

17 mg/kg

I'arathion-methyl

39 mg/'«.g

Qulntozcne (FCNB)

&gt; 10 g/kg

Phorate

6.59 mg/kg

�After evaluating the acute toxicity data and those from subsequent
maximum tolerated dose studies, we selected the following dosage levels
for the dominant lethal studies:

Compound

Treatment Levels
(E/kg_J: Dlet

__

Monocrotophos
Bromacil
Captan
Folpet
Azinphos-methyl
Malathion
Parathion
Parathion-methyl
Quintozene (PCNB)
Phorate

15, 30, 60
1250, 2500, 5000
1250, 2500, 5000
1250, 2500, 5000
20, 40, 80
1250, 2500, 5000
62.5, 125, 250
20, 40, 80
1250, 2500, 5000
5, 10, 20

Throughout the experiment, the biological criteria used to evaluate
mutagenic effects in the mouse showed no consistent responses that could
be attributed to treatment. Although we found occasional statistical
differences between control and compound treated groups, they were random
and did not suggest a time or dose-response effect.
Summary data on the fertility index, implantations per pregnant
female, dead implants per pregnant female, death index, and number of
dead implants per total implants are presented by compound as follows:
Tables 1 through 5, Monocrotophos; Tables &amp; through 10, Bromacil;
Tables 11 through 15, Captan; Tables 16 through 20, Folpet; Tables 21
through 25, Aalnphos-m«thyl; Tables 26 through 30, Malathion; Tables 31
through 35, Parathion; Tables 36 through 40, Parathion-Methyl; Tables 41
through 45, Quintozene (PCNB); and Tables 46 through 50, Phorate.
Two copies of a description of the statistical analysis procedures
used for dominant lethal tests -and computer printouts of the raw data
and the statistical analyses are on file with the current Project Officer,
Dr. Michael D. Waters, Environmental Toxicology Division, Health Effects
Research Laboratory, EPA Environmental Research Center, Research
Park, North Carolina 27711.

10

�The following statistical procedures were used:
Chl-square cest of the fertility index;
Armltage test Cor a linear trend in proportion for the fertility
Index based on dose levels, based on .logarithms of the. dose Levels,
and based on dose levels including the control group;
t-test of the number of implantations in pregnant females;
Regression fits of implantations on dose and log dose and with and
without control group included;
t-test of the (Freeman-Tukey transformed) preimplant.al.ion losses
In pregnant females;
t-test of the number of dead implants;
Chl-square test of the death index;
Arm.itage tost for a linear trend in proportion for the death index,
based on dose levels with and without control group included and based
on logarithms of Che dose levels;
Probit analysis of the proportion of pregnant females with one or
more dead implants;
t-test of the (Freeman-Tukey transformed) number of dead implants
(dead implants/total implants);
Control group analyses of variances for number of pregnant females,
number of implantations per pregnant female, preimplantation loss per
pregnant female, number of dead implants per pregnant female, ratio of
dead implants to total implants per pregnant ferwle; and
t-test of the number of corpora lutea in pregnant females.
Careful review and statistical evaluation of the data show that
folpet, captan, parathion-methyl, parathion, phorate, malathion,
bromacll, monocrotophos, quintozene (PCNB), and azinphos-methyl are
not mutage.nLc in the. mouse by the dominant lethal test.

�MAMMALIAN W VITRO UNSCHEDULED DNA SYNTHESIS ASSAYS

General
Many mutagenic and carcinogenic agents have been shown to induce unscheduled DNA synthesis (UDS) in an ill yitjro tissue culture system of mammalian coll:-;.

UDS is a form of mammalian repair synthesis that involves

at least two processes.

The first is Interaction of the agent with DNA,

resulting in damage of the DNA.

The second, which follows, is incopor-

atton oC micleotldes to repair the DNA.
UDS may be considered a fal-cly universal system because it occurs In
a wide variety oi' mammalian cell types and because it has been observed
in all stages of the- cell cycle (Gg, GI, G?, and M) other than S_, the
normal DNA synthetic phase.?l3

(UDS is not observed during S_-phase be-

cause tin; high level of Incorporation of nucleotides during the scheduled
DNA synthesis obscures the relatively Low level of incorporation of
nucleotide.s during unscheduled DNA synthesis.)
An additional feature of UDS is that It may detect a level of DNA
damage higher than that revealed by examination of chromosomeal aberrations'4 because some DNA repair results in little or no detectable change
in chromosome morphology.

For each compound tested, an in vitro metabolic

activation system should be incorporated for a parallel series of UDS
assays since some compounds may be ineffective in producing DNA damage
unlpss they arc first activated by a microsomal preparation from a mamiiiai.i.-'1 P liv-M homoftenatc.
The- ['DS rystrm we have developed Is unique in that, at the end or
fvich assay, ON.', in axtractt'.d from human diplold flbroblasts (WI-38 cells)
so that, the extent of repair may be expressed per unit of DNA.

We have

found that this. UDS assay system affords sensitivity and precision without sacrificing efficiency or economy.

Under separate contact, NCI

approved our use and validation of this system for the prescreening of
chemical ;arclnogpns.

With the approval of the EPA project officer, we

used this system for testing the* 20 substitute pesticides, with and
wi thou l wo i :ibo 11 c. ac t i va t ion.

�Experimental
Coll Culture
WT-38 cells grown In T-25 tissue culture flasks were used Cor the
UUS assays.

Kepllcdte cultures of chase cells were initiated in Eagle's

Hrisal Medium (BME) containing 10% (v/v) fetal calt serum and aureomycin,
an antibiotic, specific for PPLO*.

For 1 to 2 weeks preceding rlie UDS

assays, the cells were grown in medium containing 0,5% serum.

This pro-

duced contact-Inhibited cells in synchronous cultures in the 01 phase of
the mitotic cycle.

To reduce further the possibility of incorporation

of -'H-TdR by an occasional S-phase cell that might escape the contactinhiblLJon synchrony and thus obscure measurements of UDS, the cultures
2
were prelncubated for 1 hour with 10" M hydroxyurea (HU) before each

assay, and 10""' M HU was iidded during each subsequent step of the assays.
Di 1 u t ion o f Cpmpou nds
Chemicals to be tested were made up immediately before use and were
dJLuted in appropriate solvents (water, echanol, or DMSO), the final
concentration of solvent being one that did not produce a cytDtoxic
effect after repeated testing.

Soniflcation and pH adjustments were

used to ensure maximum solubility or even suspension of the stock solutions of the compounds.

The highest concentration was diluted further

in solvent and then in culture medium to give several log dilutions of
each compound.

All compounds were in apparent solution and within the

physiological pH range when tested, except as otherwise noted in the
tables.
Controls
The positive controls were 4-nitroquinoline-N-oxidc (4NQO), a compound that induces UDS in the absence of a metabolic activation system,
and dimethylnitrosamine (DMN), a compound that induces UDS only with
metabolic activation.

The negative controls were the solvents diluted

in culture medium.
* As, an additional check against the presence of PPLO, which could incorporate tritlated thynddine (3H-TdR) and thus obscure measurements of UDS,
stock cultures were analyzed monthly for the presence of PPLO. The
results of these analyses were consistently negative.
13

�UPS Assays
The contact-inhibited WI-38 cells were incubated at 37°C with log
dilutions of the substitute pesticides and with 1 uCi/ml of 3H-TdR (sp act,
6.7 Ci/nungle) . For testing in the absence of metabolic activation, the
cells were exposed simultaneously to the substitute pesticide and to 3H-TdR
for 3 hours.

For testing with metabolic activation, the cells were exposed

to the substitute pesticide, to 3H-TdR, and to 500 mg/ml of the 9000 x jj
supernatant' fraction of a liver homogenate from adult male. Swiss-Webster
mice, with appropriate cof actors,* for 1 hour; then the cells were incubated with only %-TdR for an additional 4 hours.

The shorter exposure

time for metabolic activation testing was used to preclude cytotoxic effects
of the liver homogenate preparation. Both approaches included a postincorporation incubation with un labeled thymldine. UNA was extracted from the
cells by a modification of the PCA-hydrolysis procedure;5 one aliquot of
the DMA solution was used to measure the DNA content, after reaction with
diphenylamip.e,6 and a second aliquot was used for scintillation counting
measurements of the extent of incorporation of 3H-TdR. Results were expressed as incorporated per unit of DNA and were compared with the background
rate of incorporation.
We have defined ns an acceptable assay one in which the response of
the positive control, compound is predicted, within the 95% confidence
limits, by regressions of average dpm/pg DNA VEJISUS average dpm/ug for
background. The regressions that follow are based on data that we have
acquired in previous testing:
Typti oi; Testing
Without metabolic
activat 1 -n
With M»-cabjllr
activation

____

R*yjT.£?-§lPJ?-+. _________
YI - 696 + 17.45 (X)*
Y, - 263 +

1.83 (X)*

Sample
! • : - -£n).
**£
48
13

Correlation
Coefficient (r)
0.7668
0.9639

*Nicotinamidc, 3.05 mg/ml; glucose-6-phosphate, 16.1 mg/ml;
5.08 mg/ml; NADP, 0.765 mg/mi.
"^Regressions over a range of background dpm/ug DNA of 0 to 450.
*Y! - Average dpm/ug DNA for 10~5 M 4NQO (positive control).
Y^ = AVI rate dpoi/ng DNA for 5 x 10":? M ! M (positive control).
)N
X = Average dpm/ g DNA for background (negative control).

�If the observed avecage level of incorporation for Lh&lt;? po&amp;JtIve ronrr"I
compound is ouCalrle the 95% confidence limits of uhe regression, we
assume that, some variation has occured in the experimental procedutr-.i
and repeat the test.
Interpretation of Results^
In a report to the National Cancer Institute, ' we presented the
results of tests performed without metabolic activation on 40 compounds
of known carcinogenlcity. We have analyzed these results using either
the parametric One-Way Classifiction Analysis of Variance or the nonparametric Rruskal-Wallis One-Way Analysis of Variance, depending on which
was more appropriate.* At f.he 99% confidence limits, all the ultimate
carcinogens significantly elevate the Incorporation of JH-TdR into the
DNA.

The itoncarclnogonic compounds, with one exception, fail to elevate

significantly the incorporation of •'H-TdR at r.hiu level of confidence.
Thus, the 99% confidence Units of these statistical analyses apparently
can be used with reasonable accuracy to predict the biological significance of the response to a chemical.
The number of compounds we have tested with metabolic activation is
insufficient to establish a correlation between statistical significance
and biological significance.

Therefore, we assumed that the 99% confid-

ence levels of the analyses of variance used without metabolic activation
also apply for test'ng with metabolic activation.
Resu1ts_and Discussi on
Tables 51 through 90 present the results of the UDS testing, with
and without metabolic activation, of the 20 substitute pesticides. Tables
51 an) 57, the DNA repair synthesis assays of nonocrotophos, include
detailed summaries of the cell culture and experimental conditions for
these assays. The assays presented In the following tables (53 through
90) were conducted under similar conditions.

In routine testing in the

*If there is reason to believe that tho variances of each of the treatments in a test are equal (I.e., Bartlett's test of the variance is
negative), the parametric analysis is the appropriate one. If the
variances are not equal, the nonparamtitric analysis is the appropriate
one.

�absence of metabolic activation, six samples each are used for five log
concentrations of each test compound and for the negative and positive
controls. However, because of the expense of the metabolic activation
preparations, for all compounds except bromacil we tested three replicate
samples in the presence of metabolic activation and used three concentrations of the rest compound (selected on the basis of the testing without
metabolJc activation).
Based on the criteria for positive responses, we observed significant
Increases in unscheduled DNA synthesis In the absence of metabolic activation afi.er exposure of the cells to only two substitute pesticides, monocrotcphos and parathion.

In the presence of metabolic activation enzymes,

KJgnlv i.cantly increased UOS was detected for five substitute pesticides:
monocrotcphoa, captan, folpet, azinphos-methyl, and monuron.
Co-nr-art-d with those of negative controls, the levels of 3H-TdR incnrpuration were greatly reduced in the absence of metabolic activation at the
highest concentrations tested for captan, folpet, azinphos-methyl, and
mouuron, the same four compounds that induced UDS only in the presence of
metabolic activation. The reduced levels of incorporation may be interpreted as cytotoxlc effects or as inhibition of repair caused by the highest
concentration of the test compounds.

A similar effect was observed in

the presence of mefabollc activation for only one compound, captan, and this
was observed at a higher concentration than had been tested without
metabolic activation.

SLich et al.e have discussed the problem of cyto-

toxlcHiy and possible inhibition of DNA repair systems by some chemicals
and liciv-: &lt;jtr-;ns«d that , whereas such factors may obscure measurements of
UDS, oin.:ii a close relationship exists between concentrations that induce
UDS and

n«ct-.iNat ions thiit are cytotoxic or that inhibit repair.

llcr.ausc of the cy to toxic or Inhibitory effects of the substitute
pesri i.lilt's, ).l should not; hv: assumed without further testing that monocrotophos and parathion would be carcinogenic without metabolic activation
or that the other four substitute pesticides that induced UDS in the
presence of metabolic activation are procarcinogens. The positive UDS
ti&gt;sul£&gt;-, indicate that chnse Filx substitute pesticides should be tested
moi:e iMinnsively, with the testing to Include evaluations of the effects
of cli: s.e •: Jiemiculs In in yfvo Moat's*; j .

�MICROBIOLOGICAL ASSAYS
General
SRI examined twenty pesticides for mutagenicity by in yitjro microbiological assays with Salmonella ty£him_uriuM_ (TA1535, TA1537, TA1538,
TA100), Escherichia coll WP2, repair-deficient: and -proficient strains
of Bacilly_s subtilis and E. coil, and with the yeast Saccharomy_ces
cereylsiae D3. An Axoclor l25&lt;V™3timulated, rat-liver-hoim&gt;gfinate metabolic activation system was included in each procedure, except the relative toxlcity assays, to provide metabolic steps that the bacteria are
either incapable of conducting or that thfy do not carry out under the
assay conditions.

The purpose of this study WAS to determine whether

the compounds elicited a mutagenic response In. microorganisms.
The assay procedure with S_. ^phlinurium has been proven to be 85 to
90% accurate in detecting carcinogens as mutagens, and it has about the
q
same accuracy in identifying chemicals that are not carcinogenic.
The
assay procedure with S. cerevisiae is about 5C% accurate In detecting
carcinogens as agents that increase mltotic recombination.

E, coll WP2

and the microbial sensitivity assay are two additional methods of detecting
tnutagnns.

The combination of these four assay procedures significantly

enhances the probability of detecting potentially hazardous chemicals.

17

�Experimental
Salmonella, typhlmurium Strains TA1535, TA1537^ TA1538. and TA100
The S. ^yphjLmurjLiim strains used at SRI were obtained from Dr. Bruce
Ames of the University of California at Berkeley.10'12 All are histidine
auxotrophs (hls~) by virtue of mutations in the histidine operon.

In

addition to the mutations in the histidine operon, the indicator strains
have mutations in the lipopolysaccharide coat Crfa ) and deletions that
covor a gene lavolvod in the repair of uv damage (uvrB~). The rfa~
mutation makes rhe strains more permeable to large molecules, thereby
increasing their sensitivity to these molecules. The uvr_B~ mutation
decreases repair of some types of chemically damaged DNA and thereby
enhances Hei'ssit Ivity to some aiutagenlc chemicals.

Strain TA1535 is

+

reverted to histidine prototrophy 0»is_ ) by many mutagens that cause basepair substitutions.
t'rameshlft mutagens.

Strains TA1537 and TA1538 are reverted by many
TA1537 is more sensitive than TA1338 to mutation

by some acridine and benzanthracenes, but the difference, is quantitative
rather than qualitative.

TA1GO is derived from TA1535 by the intro-

duction of the R factor plasmld pKMlOl.13

The introduction of this

plasmid, which confers ampleillin resistance to the strain, greatly
enhances the sensitivity of the strain to some base-pair substitution
mutagens. We have shown that mutagens such as benzyl chloride and
2-(2-furyl)-3-(5-nitro-2-furyl) acrylainide (known as AF2) can be detected
in plate -rtssays by TALOO but not by TA1535.

The presence of this plasmid

ill so !r.;jk&lt;vj -."XT'I, T.MOO sensitive to some frameshift mutagens—e.g.,
1CR-191 , ben£o(.i)pyrene, aflatoxin B,, and 7,12~dlmethylbcnz(a) anthracene.
A l l r.!i*' indJrat.or strains arc stored at -80°C. For each experiment,
an inoculum From frnsen stock cultures is grown overnight at 37°C in a
nutrLftnr &gt;•":&lt;'-\i consisting of 1% tryf.tone And 0.5% yeast extract. Afterstationary overnight growth, the cultures are shaken for 3 r.o 4 hours to
ensure, optimal growth. Each culture is checked for sensitivity to
crystal vjul ;t.

Th-; presence of the rfa mutation makes the Indicator

strnLns .'.;*•!.fit. Ivc to this dye, whereas tha parent strain, rfa , is not
senHlt: ivt to the dye. However, the mutation is reversible, leading to

�the accumulation of rtji

cells in the culture.

Therufore. t.b: ,.••)!'

must be tested routinely to ensure their sensitivity to crystal violet.
Each culture, also is tested by specific mutageus known to revert each
tost strain (positive controls).
To a sterile 13 x 100 mm test tube placed in a '43°C heating block,
we add in. the following order:
Assays in agar
(1)

2 ml of 0.621 agar*

( ) 0.1 ml of indicator organisms
2
(3) 0.5 ml of metabolic activation mixture (optional)
(4) Up ro 100 pi oL a solution of the test chemical,*'11
For negative controls, we use steps (1), (2), arid (3) (optional)
and 100 jjl of the solvent used fcr the test chemical .
This mixture is utirred gently and then poured onto minimal agar
plates.i

After the soft agar has set, the plates are incubated at 37°C

for 2 days.

The number of his

revertants (colonies that grow on plates

lacking a sufficient- amount of histldine to support colony formation) are
counted and recorded.

Some of the revertants are routinely tested to

confirm that they are hls_+, require biotin, and are sensitive, to crystal
violet (r_fa~).
Escherichi_a_ col 1 _WP2
The E. coll WP2 (iiyr_A~) used in this project, was given to us
Dr. D. McCalla.

'

by

\ procedure similar to the one used with Salmonella

is used to measure the reversion of WP2 to tryptophan independence.

How-

ever, instead of containing a trace of tryptophan in the top agar, the
minimal agar plates contain 1.25 g of oxoid broth per liter to provide
* 0.6% agar contains 0.05 mM histldine and 0.05 iriM biotin.
t Minimal agar plates consist of 15 g of agar, 20 g of glucose, 0.2 g
of MgSO,.7 H20, 2 g of citric acid monohydrate, 10 g of K2HP04, and
3.5 g of NaHNltyPO^.H;&gt;0 per liter.
**Solvents used as appropriate include: water, dimethyl sulfoxide,
cthanol, and ben/.ene.
19

�Che trace of tryptcphan required for enhancement of any mutagenic effect
of the test chemical.
Alternatively, reversion of the mutated tryptophan gene, WP2
may undergo a forward mutation in a tryptophan tRNA gene to obtain
tryptophan independence.

We do not distinguish experimentally between

the true revert ants and the phenotyplc revertants (although the latter
tend t.i- form smaller colonies).
_H17/_M45
Thi&gt; _:•__. CA.U strains W3110 and p3478 were obtained from Dr. H.
Rosiprikrai-.? . ' Strain p3478 is a polA" derivative of strain W3110. It
carries .! single, revertable mutation in a gene for a DNA polymerase;
" ~t

Gross dn&lt;l Gross
showed that this mutation Ls involved in DNA repair
synltiesj :.' This uiutatlou increases the sensitivity of strain p3478 to
chemicals that lead to alterations (damage) of the DNA. Therefore, we
ran assay for chemicals that damage DNA by comparing the relative sensitivity of the two strains (p3478 and W3110) to the test chemical.
The IJ. subtilijs strains HI 7 and M45 were obtained from Dr. Kada.

18

Strain H17 (rec+) is derived from H17 but is deficient in the genetic
recombination mechanism necessary to repair DNA damage.

Cells deficient

in r.hJs repair mechanism are killed more oasily by chemical mutagens
than arc wild-type cells (rec+).

If the chemical is toxic to rec~ cells,

b:H at the same concentration is not toxic to rec_+ cells, the chemical
;;V(. 'ftt-1 v i s a i:;utap.en.
fiv.i--- •l-iT*- from frozen stocks are grown overnight in nutrient broth*
:it '&lt;•"&lt; .,:'•; .•.'irtViog. V&lt;: ?. ml of nutrient broth containing 0.6% agar
1s Tidod r'. i mi ot the Lest culture. The suspension is mixed and poured
cnL--i .1 1 '.'. , containing nutr i.&lt;.=ni. broth and 2% agar.
After the soft agar has solidified, a sterile filter disc impregnated with the test chemical is placed in the center of the plate. The
r:hve.--; •, : .- abated at 37°C for 15 hours, and the width of the zone of

* Trypr•.-'!»•, 1%, and 0,5% yeast extract, supplemented with 5 jig of
tlij-'tii v-v's:1 to pruvent selection of t:liy+ revcrtants.
20

�!-oxLcir.y or Inhibition of growth is then measured. We usually must test
several concentrations of chemical to detect accurately differences Ln
i:he zones '••£ growth inhibition because higher initial concentrations load
to steep concentration gradients that may reduce the differences in
growth inhibition of the two strains.
The positive control for this assay is 1 nil. of l-phenyl-3,3-dimethyltriazene placed on the disc. A zone of approximately 40-ram width is
observed (52 and 61 mm, respectively).
of chloramphenlcol placed on a disc.

An additional control is 30 pg
Equal zones of inhibition are

oxpected in all four strains (approximately 30 mm) since the toxlcity of
this chemical does not depend on a mechanism that leads to i)NA damage.
All assays are performed at least three times.
Saccharomyces cereyisiae D3
The yeast 3. cerevlsiae D3 is a dip]old heterozygous for a mutation
^n an adenine-metabolizing enzymes.*' Cells homozygous for this mutation
produce a red dye when grown on medium containing adenine.

Adenine-

vcquiring homozygotes can be generated from the heterozygotes by mitotic
recombination.
nation.

Many mutagens increase the frequency of mitotic recombi-

Mitotic recombination is Indicated by the development of

colonies with red pigmentation, and the degree of conversion to this
pigmentad colony indicates the mutagenlcity of a compound or its
on
metabolite.
The Saccharomyces test strain from the liquid nitrogen is grown overnight .it 30°C with aeration in 1.0% tryptone and 0.5% yeast extract.
The cells are washed twJce In 0.067M P04 buffer (pH 7.4) and resuspended
In the same buffer at a concentration of 10

cells/ml.

The _ln vitro yeast mitotic recombination assay in suspension consists of 5 x 10 washed, stationary-phase yeast cells in 1 ml of 0.067M
I'O^ buffer (pH 7.4) and 50 rag/ml of'the test chemical (or a fraction of
the concentration required to give 50% killing)..
Incubated at 30° for 4 hours.

The suspension is

After incubation., the sample is diluted

serially in sterile saline and plated on tryptone-yeast-agar plates.
21

�Plates of a 10~^ dilution are incubated for 2 days at 30°C, followed by
2 days at 4°C to enhance the development of the. red pigment indicative
oh" adenine-negative homozygosity. To detect red colonies or red sectors,
we scan l.lie plates with a dissecting microscope at 10 x magnification.
Plates of a 10

dilution are incubated for 2 days at 30°C for determi-

nation of the total number of colony-forming units.
The in Vitro yeast Itotic recombination assay in suspension with
metabolic activation is conducted as above with the addition of the. metabolic activation system to the incubation mixture.
ArocLor 125/t-Stimulated Metabolic_Actiyation System
Some' •.•arcinoganic mutagens (e.g., dlmethylnitrosamine) are inactive
unless they are converted to their active form by being metabolized.
Ames et a I. ,21 hav? coderib«d the metabolic, activation systems we use.
Adult mnle mice are given a single 500-mg/kg intraperltoneal injection
of A poiychlorinated biphenyl (Aroclor 1254).^ Four days after the
injection, the animals' food is removed. On the fifth day, the mice
are killed.
The liver are removed aseptically and placed in prewelghed, sterile
glass beakers.

The organ weight, is determined, and all subsequent

operations to th« metabolic, activation step are conducted in an ice
bath,

[he organ is washed in an equal volume of cold, sterile 0.15 M

KC1 (I snl/g of wet. organ), minced with sterile surgical scissors in three
VO'MSK.' • ' O.l.S K.C1, and homogenized with a Potter-Elvehjem apparatus.
'fie h'jirn-v'-.i.it? Is centrifuged for 10 minutes at 9000 x £, and the. superi: ii .'.is;, i

; in .-"TfJ .ir.d stored J.n liquid nitrogen. To the postmito-

ciu-niuia.k .jMp.v^nii'.f ate added MgCl2» KC1, glucose-6-phosphate, TPN, and
(•odium oV'?spi!jr.e {pH 7,4).
Results _and_ Dtscussion
A.i i " 1 o«&lt; ;&gt;i&gt;3! icides submitted to SRI for examination were tested
at icj.--: (.hi&gt;:c times in tho microbiological assays.
1

Hiifz'.ed ^"iii *. are an average cf those experiments.
22

The results pre-

�T.'ib1'. 11 i&gt; •-•.•;ii;.

!K i r s i i l i 1 ; uf

ag;ir with Snlmonol la _tyj»li1Lniui"iuin.

• •&gt;

i . :. n i u g i v , 1 .i.^-.-

v.i

In this liisridlne reverse •:•'.• .; t l o i

assay system, two pesl:icides—rnptan and folpct

were hu.'tiig:-nii-.

I'oi

oach chemical, we observed an increase in the number ot his'-'.:! ine independent revertants on strains TA1535 and TA100 but not on Jiir.iiny.
TA98, TA1537, or TA1538.

These results suggest that these u«&gt;st •:: ld&lt;?.-.

can alkyJate DNA, causing mutations of the base-pair substitution type.
This conclusion is consistent wiLh Llie rjiitagbnic activity of these
compounds in assays with E. coli WP2 (Table 9?), which is sensitive no
base-pair substitution mutagons.

Although liver homogcnate activation

was not required for mutagcnic activity, the mut.igenic activity was
enhanced somwhnt with activation .it some doses.

A toxic effect:

(reduction of the: number of mutants) wt;.i observed at 'doses of 100 pg
ot" each compound.
Table 92 presents I he results of jssiiys with E. roli WP2.
Essentially, thi 1 results were i d e n t i c a l to (.hose- obtained with J&gt;.
fyp!.1H!!ui:'iU!!: TA1515 ,-md TAIOO; «-aptan and Tolpnt were mutagenic,
but. none of the other pesticides was mutagenic.
Table 93 piesents the results oE the assays for microbial inhibition
in repair-deficient arid-proficient strains of _B. .su_b_tj_li_s and K. .cpj.i.
Folpet, captan, chloropyrifos, and dinoseb all gave toxic zones that
were larger on the repair-deficient strains than on the repair-proficLent
strains, indicating a mutagenic response.

Toxic chemicals that do not

act by damaging DNA (e.g., chlorampheiiico]) should give equivalent zones
of toxicity.

However, many if not all nutagens damage DNA and, if the

damage is not repaired, can result in cell death.

Thus, a given

ciinreiitration of mut.agon may be toxic for a repair deficient strain
but not for a str.iin the effectively it-pairs its DNA.
Tables 94 through 1 1 3 present the results of the assays fur m i t o t i r
recombination ir Saccharomyras ccrevisiae D3.

A p o s i t i v e - response in

t h i s assay IK ind iru tc-d by an increase- of more llian three-fold in the
.'ib'.olute number of mitoM'c reroiisbi runts per m i l l i l i t c r a.s w e l l as in
lhi&gt; relative nunibi-r of i n i l o l i c re&lt; oi:ib iiicint s per 10

survivors.

l-'olpei.

�captan, monocrotophos, cacodylic acid, and azinphos-methyl increased
mitotic recombination significantly and are considered positive by
these procedures. Methyl parathion gave a marginally positive response.
Our results indicate that 7 of the 20 pesticides examined give
positive responses in one or more of the four microbiological assay
ps o...••'J'srea.

Although a mutagenic response in a microorganisms does

r-i-'.na that a chemical is a mutagen in humans, the combination of
four separate assay system greatly enhances the probability of detecting
PO'-M Maily h&amp;zardous chemicals.

Folpet and captan are mutagenic in

:&gt;i •. : ou, assay procedures. Chloropyrifos and dinosftb are positive in
U: I'.'crobial sensitivity. Monocrotophos, cacodylic. acid, and azinphos3&gt;s-••••,••!. ;tre pofiitlve in the yeast assays.

�DISCUSSION

Of the 20 pesticides tested for mutagenic activity, 9 were clearly
mutagonic in one or morr i.n vitro assays.

Of these. 9, 2 ware mutagenic

in all the in vitro assays, but none of them produced a dominant, lethal
response in the mouse.

In the Salmonella assays., these chemicals caused

base-pair substitution mutations but not fraine.shi.ft mutations.

The

absence of activity in the dominant lethal assay may be due r.o a lack
of sensitivity of the mouse to these types of compounds; for example,
N-methyl-N'-nitro-N-nitrosoguanidine and other alkylating agent*: that
cause base-pair substitution mutations do not all cause dominant lethality.
Anotho.r explanation for the absence of activity may be flint these pesticides did not reach the gonadal tissues In sufficient amounts to cause a
mutagenic event.

None of the other 6 pesticides was mutagenic in all

the in vitro assays.
The combination of assays used in this program is one means of
identifying those pesticides that may present a rautagenic health hazard.
Those that show positive responses in several experimental systems
should be evaluated more, thoroughly before they are substituted for
ocher pesticides already considered as a risk to the environment.

Also

apparent is that no one assay system is uniquely capable of detecting
the spectrum of mutagenic events that different chemical, structures may
cause.

25

�REFERENCES
1. W. T. Federer. Experimental Design (Theory and Application). The
M,i. Vi! ii:ui Company, 1955.
2.

b. .„.; -«i•J',evlc acid L. Tolraach. Response of synchronized populations
of "sieLn. cells to ultraviolet Irradiation at selected stages of the
generation cycle. Radiat. Res. 32, 327 (1967).

7

.

f&lt;. T.. W,' -s .mssen and R. B. Painter. Radiation-stimulated DNA
iils in cultured mammalian cells. J. Cell Blol. 29, 11 (1966).

'- ,

il.
Stich and B. A. Lalshes. DNA repair and chemical carcinogens.
Ii&gt; |fat Sobtology Annual. H. L. loachim (ecL), Apple ton-CenturyCroris, NP-W York, 1973, pp. 341-376.

5.

K.. £lgjo, H. Hennings, D. Michael, and S. H. Yuspa. Natural
synchrony of newborn mouse epidermal cells in vitro. J. Invest.
Derm. 66, 292-296 ( 1 6 )
.96.

6. K. Burton. A study of the conditions and mechanism of the
dipheny.lamJ.ne reaction for the coloriinetric estimation of deoxgrlbonucleic acid. Biochem. J. 62_, 3.1.5-323 (1956).
7. A. D. Mitchell.
Unscheduled DNA
National. Cancer
LSU-2735 (April

Potential Prescreens for Chemical Carcinogens:
Synthesis, Task 2. Final report prepared for
Institute under Contract N01/CP-33394, SRI Project
1976).

8. H. F. Scich. D. Kleser, R.H.C. San, and B. A. Laishes. The Use of
ONA i-op/iir in the identification of carcinogens, precarcinogens,
in j •• strnet rLssue. Jjs Canadian Cancer Conference: Proceedings of
•-!.: .•.-•'! •"a"..i:.iian Cancer Conference, Vol. 10. P. E. Scholefleld
•v«j.y. Jinlvqrsity of 1'oronto Presss, Toronto, Canada, 1973, pp. 83-110.
. :!&lt;•«'. :••"., 5. f,hoi. v. Yamasaki, and B. N. Ames. Detection of
;.ai.&lt;- .',H^.-,:N-:-, ,!•&gt; nutagffjs in the Sa^lmorKilla taicroaome test: Assay of
.iOO ,-.f.vcii..,-ils. Pro,. N.-iir. Ac..id~." ScT/"uSA" 7_2, 5135-5139.
10.

B. N. Amcs, I'., G. Curney, J. A. Miller, arid H. Bartsch. Carcinogens
as frameshlft mutagens: Metabolites and derivatives of 2-acetylaminofluorene and other aromatic araine carcinogens. Proc. Nat. Acad.
Scl. USA 69, 3128-3132 (1972).

IS..

Si. • • AMKS., F . D . L«e, and W. E. Durston. An improved bacterial
'•-":( .-; v •. t t-iii for thu detection and c. JLossif ication of oiutagens and
..ir.-'..,Tv,»ons. Proc. Nat. Acad. Sci, 'JPA 7_0, 782-786 (1973).
26
i

�12.

R. N. Aro«-is, F.. W, Ours ton, K. Yamasaki, and P. !. I.PP. O., .--. IP--.;, n
)
are mutagGiis: A simple test system combining llvor homogenous
for activation and bacteria for detection. Proc. Nat. Acad. Sri.
USA 7Ci, 2281-2285 (1.973).

.13.

J. Mcl'-ann, N. E. Spingarn, J. Koburi, and B, N. Au.es. Thi* deJi.'.r? Ion
of carcinogens as muthgens: Bacterial tester strains with R fp.ctor
plasmids. Proc. Nat. Acad. Sci. USA 72, 979-983 (197.5).

14.

B. A. Bridges. Simple, bacterial systems for detecting mut.agenJc
agents. Lab. Pract. 21, 413-416 (1972).

15.

D. R. McCalla and D. Voutsinos.
Mutation Res. 26_, 3-16 (1974).

16.

M. D. Anderson, E. E. Slater, and H. S. Rosenkranz. Rapid detection
of mutageus and carcinogens. Cancer Res. Tl, 970-973 (1971).

17.

J. Gross and M. Gross. Genetic analysis of an E. coll strain with
a mutation affecting; DMA polymerase. Nature 22i, 1166-1168 (1969).

18.

T. Kada. MntagenLclty testing of chemical? in microbial systems.
New Methods In Environ. Chem. Toxicology 127-133 (November 1973).

19.

F. K. Zimmermann anr. R. Schwaicr. Induction of mitotic gene conversion with nitrous acid, l-methyl-3-nItro-l-nitrosoguanldine and
other alkylatJng agents in Saccharomy_ces cereyisiae. Mol. Gen.
Genet. UK), 63-69 (1967). "

20.

U. J. Rrusick and V. W. Mayer. New developments in mutagenicity
screening techniques with yeast. Environ. Health Perspectives ^,
83-96 (1973).

21.

I.. D. Kier, E. Yamasaki, and B. N. Ames. Detection of mutagenic
activity in cigarette smoke condensat.es. Proc. Nat. Acad. Scl.
USA 7_l_, 4159-4163 (1974).

On mutagenlcity of nitrofurans.

22. fl. N. Ames. J. McCann, and E. Yamasaki. Methods for Detecting
Cnri-i.iogens and Mutngcn.s with the £Salmone : lla/MaminaL lan-Microsome
Mutagenicity Test. Mut. Res. TJL... 34"7~364 ~(1975).

27

�TRST OF THE FEBTILITY INDEX - MOKOCftOTC.'HO?.
.1 DEGREE OF FREEDOM

i--. a

V?.«ICLE CONTROL

ft N
P»5 MTO

PERT.
INDEX

O5S3

N
N
Pftii MYO

1?

74-10

iFERT.

:*OEx

CriliQ

N
if
PR6 HTO

30

MG/KG

iFCST.
2NDEX

KG/KG

TFM

ChiSO

n
PHi

*t

iFcBT.
CHIS3

h
ft
PRG MTO

FERT.
INDEX CHISG

MULTIPLE TNEA7MIENT

I

28

ill

.70

0.05

23

40

,57

.7
6

16

40

.45

4.14

.a

40

.40

*,!l«

29

40

.72

0.30

2

24

.C

.65

O.Cfl

Ji

•0

.?
7

.98

20

49

.0
6

1.28

16

40

5*0

4,&amp;6 *

27

39

.9
6

.03

3

23

4S

.?
5

0.36

3C

40

.75

19

«C

.*T

.45

22

40

.5
5

0.30

32

40

.ec

3.7?
.6
0

00

«

3?

40

.67

0.00

2S

40
39

40

.5
5

.4
8

IS

4fi

.38

6.07*

2?

40

.7
6

.5
8

4.79*:

25

40

.63

0.00

?1

40

.5?

.20

30

40

.5
7

1.42

.03

23

40

.7
5

.8
0

25

38

.6
6

0.00

27

36

.71

.24

!8
.l

21

40

.52

4.91*

26

38

.4
7

.07

27

36

."&gt;

.02

20 40

.50

2'7S

24

38

.3
6

.4
2

26

36

.?
7

• 02

.3
6

i

£4

«Q

.60

C.Ofl

33

6

?»

38

.63

C.93

2?

*0

.7
6

7

30

38

.11

0.00

25

40

.3
6

9

27

38

.71

0*00

23

40

.0
7

*
I

SIGNIFICANT AT P LT 0.05
INCREASED ABOVE COHTSOL

2.01
.&amp;»

• 02

22

�Table 2
AVERAGE IMPLANTS PER PREGNANT FEMALE - SONOCROTOPHOS

WEEK

CONTROL

74-10

15

HO/KG

7*-10

30

MG/KG

74-10

60

.2 MS/KG

TEH

MG/KG

M ULTIPLE TREA TKENT

1

28-11.39

249/

2.08
31.3

189/

18-10.50

ISO/

2
16-11 . 5

316/

29-10.90

2
to

319/
303/

26.11.65

332/

31-10.71

242/

20-12.10

ISO/

2
16-11 . 5

*93/

27-13.85

3

24S/

23.10.65

356/

30-11.87

239/

19-12.58 "I

267/

2£-12.14 *1

34a/

52.I8.97

4

309/

27.11.44

314/

2.25
51.6

274/

2 . 2 45
21.

le,6/

15-11 .0?

266/

2 . 9.35*
7

5

2T4/

24.11.42

372/

33.11.27

270/

25.10.33

248/

2!«1S .81

e

302/

24-12.58

327/

27-12.11

275,

23-11.96

25S/

25*10 .2'J

7

346/

30-11.53

285/

25.11.40

25S/

2l&gt;12. 14

316/

8

292X

27-10.81

313/

28.11.18

228/

20-11.40

291/

•
••
I

SIGNIFICANT AT P LT
SIGNIFICANT AT P LT
INCREASED ABOVE CONTROL

0.05
0.01

3S4/

30-11.8?

2V3/

27.10.11**

2
28-11 . 9

306/

27-J1.33

24-12 .12

322/

26.12.3f&gt;**!

*"

�Table 3
AVERAGE DEAD IMPLANTS PER PREGNANT FEMALE - rtQNOCROTOPHPS

MCEK

?*-10

CONTROL

15

M6/K9

74-10

30

MO/KG

74-10

60

.3 M6/K6

TEW

r

MUIL.TIPLE TftEATHENl

1

S3/

28*

.6
4

2B/

23"

2

9X

26*

.31

3X

31*

.10 *D

3

9X

23*

.39

;6X

30*

.53

4

2X

27*

.?
0

?X

25*

.28 *

5

ilX

24*

.«*

22X

33*

.?
6

1.22

lex

18*

.6
5

iOX

16*

.3
6

62X

29* 2.14"

1GX

20*

.50

2X

16*

.13

77X

27» 2. 8 '
5*

19*

.7
*

9X

22*

.!
*

87X

32*

27"
.2

26X

22* 1.16*

9X

15*

.0*
6*

11X

27*

.41*

\il

25*

.8
4

*X

2l«

.3
4

?2X

30*

,73

25*

,4*
2*D

9'
,

6

2iX

24*

.35

\6X

2T*

.9
5

14X

23*

• 61

6X

17X

27*

.3
6

7

30/

30* 1.00

\\f

25*

.*
4

4/

21*

.19

ex 28*

.9
2

IIX

27*

.41

a

19X

27*

24X

28*

.6
8

7X

20*

,35

9X

24.

.8
3

ii/

2S-

,2
*

•
••
D

.70

SISNIFICANT AT P LT 0.05
SIGNIFICANT AT P LT 0.01
DECREASED BELCM CONTROL

�Table 4
CHI-SQUAR2 TEST OF THE DEATH 1SDES - MONOCROT3PHOS
1 OEGRSS 07 KSEEDOM
•EcK

VEHICLE CONTROL

N
N
*i)I PRO

DEATH
CMIS3

74-10

N
N
SCI PWG

IS

MS/KG

DEATH
I NOES

74-10

N

H
"KG

CKISO

30

MG/KG

DEATH
INDEX

CHiSS

00

MG/KG

N
. 1 .S
0
'O

DEATH
C ,. 5
r
s

we I

fi

OEATM

MULTIPLE TREATftEN T

11

1

10

28

.6
3

0.00

2

7

26

.7
2

0.00

3

9

23

.9
3

0.00

11

4

2

27

.0?

o.oo

7

23

.8
4

.35

7

18

.39

.01

6

,6

.39

.04

25

?9

.So

13.27 **

3 31

.10

1.84

7

20

.35

,07

2

16

.13

.52

26

e.7

.6
9

24.26 «

30

.It

.01

7

19

.37

.03

6

2?

.27

.28

25

32

.79

?.C5 *
.

25

.6
2

2.54

11

22

.50

*

IS

.6C

11.21 **

a

2~

.10

3.6?

12

25

.8
4

.21

3

2:

.33

.of

10

30

.33

,CO

23

.8
4

.52

5

25

• 2G

7.48

10

27"

.37

2.36

7

28

.25

.02

9 27

.33

»GT

a

2,

.33

.27

26

.36

.03

9.20**

5

t

24

.33

0*00

11

33

.33

.00

6

15

24

.63

0.00

13

2T

.8
4

.6
5

11

.?
2

0.00

8

25

.32

.02

4

21

.19

.9
0

.4
4

0.00

IS

28

.4
5

.17

7

20

.5
3

.12

7
8

**

a 30
12

27

SIGNIFICA.NT AT ? LT 0.01

10

�Table 5
SWttSH OF DEAD IMPLANTS PER TOTAL DfPLAKTS - MONOCS01X)?HCS

•CEK

CONTROL

?4-10

15

we/US

?4-i3

30

KG/KG

?*.- SO

40

«fe/SG

TEN

.2 MG/KG

*H.(VTIPtE TREATMENT

1

13/ 319-

,0«

2

?•&lt; 303*

.03

3

&lt;?/ 245*

.04

M/ £49" .11

5/ 332«
! / 356*
&amp;

,6i
.04

10/ 1B9*

.OS.

10/ 160*

.6
0

*&gt;2/ 316*

.20**

10/ 24S«

. 4
0

2/ 180*

.01

77/ 293*

.26**

9/ 267*

.03

B7/ 348*

.25**

ll/ 266*

.04*

9/ 239*

.0*

.02

2 . 274.
6'

.09**

9/ 166*

.05**

.04

ze/ 372* .e«

12/ 2?o*

.04

9/ 246*

.04

2?/ 356*

.6
0

21/ 3C2*

.07

16/ 327*

.OS

14/ 2T5*

.ns

6/ 2S5»

.0?**D

IT/ 273=

.6
0

^

3.0 / 3*6*

.09

ll/ 285=

.04

4/ 255*

.02

a/

316*

.03

ll/ 306*

.04

B

14/ 292*

,'
0

24/ 313*

.6
0

T/ &lt;2B*

.03

9/ 29S&gt;

.03

ll/ 322-

.03

4

2/ 309.-

5

i*./ 274«

6

*
••
D

7/ 314.

. Oi

SIGNIFICANT AT P LT 0,05
SIGNIFICANT AT P LT O.C1
DECREASED BELOW CONTROL

�Taole 6
CHI-SW.-AHE TEST OF THE FERTILITY IKDEX - BROMAC1L
1 DEGREE OF FREEDOM

VEHICLE CONTROL
N

N

PERT.

PRG MTO INDEX

CHI SO

74=06

N
N
PRG MTO

1230 HG/KG
PERT.
INDEX

CMISO

7.-06
N
N
PRG MTC

2500
PERT.
INDEX

r»-Gi

CHiiG

5303 Mli/KG

N
N
PRG MTD

PERT.
IHOEX

CHIS9

KG/KG

TEM
K,
N
PRG KTQ

PERT.
FNCKX

CMISO

MULTIPLE TREATMENT

1

26

40

.70

0.00

21

40

.2
5

1.90

23

40

.57

.87

29

40

.2
7

0.00

29

40

.72

o.co

2

26

40

.5
6

0.00

24

40

.to

.OS

26

38

.8
6

.01

23

40

.63

0.00

27

39

,9
6

.03

3

2.3

40

.57

0.00

29

40

.72

1.37

19

38

.50

.19

25

40

.63

.05

32

40

.SO

3.78

40

.3
6

.05

22

38

.8
5

.!
4

23

40

.70

0.00

27

•0

.6?

.6
0

20
.9

.8
5

1.4?

4

27

40

.67

0.00

25

S

24

40

.0
6

0.00

31

40

.7
7

22

38

.00

27

40

.7
6

.2
2

30

40

.5
7

6

24

38

.63

0.00

31

40

.77

1.30

25

38

.6
6

0.00

27

40

.7
6

.03

27

38

.71

.2*

7

30

38

.79

0.00

29

40

.72

.16

22

38

.8
5

2.98

29

40

,72

.16

27

36

.75

.02

8

27

38

.71

0.00

213

39

.72

.03

24

38

.63

27

*C

.67

.01

26

36

.7?

.02

.24

�Table 7
AVERAGE IMPLANTS PEH PHEGHJUfT FEMALE -

CONTROL

74-S6

74-06

Z500 HG/K6

74-06

5000 MS/KG

TEH

MO/KG

MULTIPLE TREATMENT
i

?,!&lt;¥/

28• 11
.39

235,"

21-1 i. I,

2T8/ 23.12.09

32B/

29.11.31

316/

29.10.90

*

C-Ci-.-

6
26
.11 . 5

253'

24BJ0.54

264/

26.10 . 2
9

304/

25.12.16

293/

2.08
71.5

3

24S/

23.10 . 5
6

33SX

29.il.5S

22S/

*
19.1 i . 4

319/

2 . 2 /6**I
51.

348/

32.10.87

4

30*-'

4
27-11 . 4

2?Q/

25.11*60

2&amp;8/

22=12.18

34 6/

28-12.36

266/

87- 9.85 *

*

S7*/

S«-11 .42

3$\/

31*11.65

26 I/

22*11 .d6

523/

27-21.96

356/

30*11.67

.-.

.10 a/

5
24.12 . 8

363/

31" 11. Sf

294/

7
25-11 . 6

276/

27«10.30**

273/

2?-10.11 **

7

34S/

30.11 ,53

35&amp;/

29.12.24

2S3/

22.11 .50

357/

2«i.U.31

306/

27.11.33

3

292/

27«10.61

318X

28.11.36

5
277/ 24.11 . 4

307/

27-11.37

322/

26*12.38 **I

• S I G N I F I C A N T AT P LT 0.05
** SIGNIFICANT AT P LT 0.01
I
INCREASED A30VZ CONTROL

�Table 8
AVERAGE DEAD IMPLANTS PEH PREGNANT FEMALE - BROMACIL

*EEK

CONTROL

74-06

1250 MG/KG

74-06

2500 *S/ivG

74-06

5000 MS/KG

TEH

.2

MG/KG

MULTIPLE TRE* TMENT

1

28=

.46

8/

21 =

.38

10X

23=

.43

17/

29=

.9
5

62/

29=

2.14**

2

e/

26=

.31

12/

24=

.0
5

a/

26=

.31

5/

25=

.20

77/

27=

2 8 *
. S .

3
Ln

13/

9/

23=

.39

6/

29=

.21

12/

19=

.63

10/

25=

.40

87/

32=

2,72**

4

2/

27=

.07

7/

25=

.28

16/

22=

. 3 *
7 *

15/

29«

. *
5 *

1 I/

27=

.41*

5

ll/

24 =

.6
4

12/

31 =

.9
3

15/

22=

.8
6

B/

27=

.30

22/

36=

.3
7

6

2i/

24=

.8
8

7/

31 =

.23 **D

16/

25=

.*
6

21/

27"

.78

17/

27»

.63

7

30/

30 = 1.00

ll/

29=

.3
3

14/

22=

.4
6

14/

29=

.8
4

ll/

27=

.41

8

19/

2.
7

15/

28-

.4
5

8/

2.
4

.33

9/

27=

.3
3

ll/

26=

.42

.TO

•
S I G N I F I C A N T AT P LT 0 . 0 5
*» S I G N I F I C A N T AT P LT C . C !
D
DECREASED BELOW CONTROL

�Table 9
CHI-SQf*RE TEST OF THE DEVTH INDEX - BROMAC !I.
1 DEGREE OF FfiEEDOM

VEHICLE CQKT90L

N
N
«DT PSKi

OEATh
INDEX

CHISd

74-Ofc
N
fc
aJl PRG

7»-06

1250 MS/KG
DEATH
INDEX

CMisa

N

N

25CQ HG/KG

DEATH

WDI PRG INDEX CHI so

*.-06

5000 MQ/KG

H
N
DEATH
riDI PRG INDEX

CHIS3

.2 MG/KG

7EM

h
N
«DJ[ PHG

DEATH
INDEX

CHISg

MULTIPLE TREATMENT
1

10

28

.6
3

0,00

7

21

.33

.2
0

7

23

.30

.01

2

7

26

«S7

0.00

10

24

.42

.4
6

a

26

.31

3

9

23

.39

0.00

»

29

.£1

1.32

9

19

.47

.us

*

2

27

.07

O.CC

6

2S

• 24

I.b2

11

22

.50

9.20**

5

5

S*

,38

O'OO

12

31

.9
3

.4
0

12

22

.5
5

. 4
7

9.00

14

29

.8
4

.48

25

29

.6
8

13.27**

.96

24.26**

5

25

.20

.06

26

27

6

25

.2«

.?
6

25

32

,-&gt;B

7.05**

14

28

.so 10. a**

a

27

.30

3.Q7

8

27

.30

10

30

.33

.00

10

sf

7

2-16

9 27

.33

.07

26

.38

.03

.09

b

15

24

.3
6

o.oo

5

31

• 16

10.65**D

13

25

.52

.21

10

27

.37

2.J6

7

8

30

.7
2

0.00

7

29

.4
2

.01

10

22

.5
4

1.2*

12

29

.41

.64

8

12 27

.4
4

o.oe

11

28

.9
3

.01

7 24

.9
2

.70

7 27

.26

1.30

**
D

SIGNIFICANT AT F LT C.01
DECREASED EELOW CONTROL

10

«3

�Table 10
NUMBER OF DEAD IMPLANTS PER TOTAL IMPLANTS

• EEK

74-06

CONTROL

5000 MG/K5

TEM

.2 «G/R5

MULTIPLE TREATMENT

1

13/ 319=

2
3
i
'

8/ 3039/ 245*

4

2/ 309,

a/

.0.
2*

77/ 293-

.6.
2*

10/ 319-

.03

87/ 3iiis.

.25** .

15/ 34e&gt;

,04«*

ll/ 266-

.04*

323-

.02

?£/ 35*=

.06

.05

21,' 278 =

.OS

1 I/ ?73 =

.06

.06

! / 357*
*

.34

K/ 306-

.04

9/ 307-

.03

! / 32?*
!

.03

5/ 304 =

.02*0

12/ 225-

.05

7/ 290.

.02

16/ 268-

,06**

.03

is/

.)
16

.02 **D

16/ 294*
14/ 253*

.03

.3
0

.5
0

.04

6/ 335.

.01

ll/ 274.

.04

12/ 361 =

6

2l/ 302=

.07

7/ 368*

7

30/ 346*

.9
0

ll/ 355*

.03

a

19/ 292*

.07

IS/

3ia-

.5
0

SIGNIFICANT AT P LT
SIGNIFICANT AT P !_T
DECREASED BELOW CONTROL

62/ 316.

.02

17/ 323-

.)
13

.03

5

*
•«
D

. OS

.04

284-

235-

12/ 253-

.4
0

0.05
0,0!

10/ 278-

a/

a/

261-

277-

a/

�Table 1).
CHI-S41MKE TEST OF THE FERTILITY INDEX - C'IP'SA.S
1 CEGREE OF FREEDOM

VEHICLE C'J.',TS3i.
*
N
P3C 1TO

FES',
INOCS

ChlSi.

MG/Ki

7*-0?

«=as -'••vo INDEX

CilSO

i-u/'Ki.-

?*-62

S
N
PHG MTU

! tH 1a
F

IMOEX

Ch;S3

7«-oe
N
u
PR G "ilD

fc

PERT.
INDE?

CHI SO

t.

F£RT.

PBG MTO

IMDCX

CHISQ

HULTIPUE TREATMENT

oo

1

2J

*Q

»57

o,OC

34

40

.as

6.10*1

31

40

.7
7

2.?9

29

40

.72

1.37

29

40

.7?

1.37

2

a7

39

,&amp;&lt;5

i.OO

30

40

.75

.10

36

40

.0
9

4.07*!

30

40

.75

.10

27

39

.9
6

.6
0

3

2*

»0

.5
6

0.03

23

*C

.s-*

.21

3U

40

.5
7

.54

31

40

.77

.8
9

32

41

.89

1.57

*

2?

to

«S7

;-.''C

31

3«

.2
8

1.35

33

40

.2
6

l.*7

32

»0

.80

i.os

27

*0

.7
6

.6
0

i

?&lt;*

*0

»''?

O.CO

26

3S

.6
6

.02

30

40

.5
7

o.oo

26

38

.9
6

.2
0

30

40

.
M

0.00

*&gt;

2*

40

»7g

0.0-3

27

.]
7

.91

34

40

.as

1.20

30

38

.79

.16

27

M

.71

.01

.71

.01

30

40

.5
7

0*00

S*

38

.8
6

.32

27

36

.5
7

.00

38

.7]

v*3

2*

36

.?
7

.6
2

'
S

*
I

i"?
1J

*0
*0

7

.?
.60

O.CO
0.00

SICNIFICAKT AT ?LT O.C3
INCREASED ABOVE CONTROL

27
31

3«

39
35

.7
8

.6
2

34

40

.9
8

-09

27

�Table 12
AVERAGE IMPLANTS PER PREGNANT FEMALE - C4PTAN

sit*.

CONTROL

7&lt;.-Cc

12--0 M S / K G

74-02

MG/K&amp;

2500

HG/KG

TEH

MULTIPLE TREATMENT
i

25'
6.

23*11.52

3B7/

3«=11.3B

339/

31 = 10. &lt;,*

310/

29=10.69

3S6/

29=:0.9C

2

305/

27=11.30

3?6/

30=10.93

375X

36=10. *2

3*2/

30=: l.*0

293/

27«1C.H5

3

268/

26=10. 11

2S2/

23=10.96

313/

30=10.4.3

3*5 /

31=11.13

34A/

32=10. «7

*

?RB/

?7=10.67

32»/

31=10. *5

3S9/

33= lO"*"

333/

32=10. *1

2fci&gt;'

27= 9 8
. 5

5

33»/

29=11. S2

2fi2/

26=: 0.65

348/

30=11.b O

298/

26= 11. * A

35is/

30=11.87

6

323/

29=11. !
•

312/

27=11.56

361/

34=10.h2

3*0/

30=11.33

273/

27=10.11

30=10.97

3G9/

26=11. AA

30n/

27*11.33

3»»11.^

301/

27=11.15

322/

26=12.38

7

3?3/

29=11.!*

30V/

27=11.**

329/

r

3= If

32=11.*!

3B2&gt;

33 = 11.S&gt;»

383/

• SIGNIFICANT A7 P LT 0.05
«• SIGNIFICANT AT P L7 0 . 0 1

�Table 13
AVERAGE OS*D IUPLAWTS FER PREGNANT FEMALE -

«fct.K

T + -02

CONTROL

2500 MG/XG

7,-Cc

533C -li/tt-i

Ifrt

«WLT£f&gt;LE TREATMENT
19/

31-

.fcl

15.'

2i*

^2

M, 24« 2.14 **

.0
5

J7/

36-

.&lt;•?

!»/

30*

,*7

77/

27s 2.85 *•

.70

16/

30-

.53

15/

31-

.8
4

67/

32« 2.72 »*

12/

31ft .39

]S/

33s

.5
*

ll/

32«

.3*

ll/

27,

• »1

?*/

26= .92

9/

30s

.30

ll/

26-

.42

?2/

30s

.73

.4,3

21'

34*

.t&gt;2

18.'

3C*

.60

i?/

27-

•63

27 =

-.Si

14/

30=

.*7

a/ 2*= .31

ll/

27-

.41

33=

.35

!/
!

3s
4

.32

7/

27=

il/

26-

i

23*

. ?5

2
**
O

«/

:\S

27s

.*!

Is/

30 =

3

io/

26s

,*2

16/

23-

*

;&amp;/

2T-

. =9

5

i5/

24-

. '2
.

t

9/

?^s

,^&gt;

13/

J'l

?

1

Ji.

2&lt;!s

.72

IS./

d

n/

32s

,»l

12/

17,'

• SIONIFICAKT AV P LT O.OS
•• EISNIFICftNT AT P LT 0.01

3» = .50

.26

.42

�Table 14
CHI-SQUARE TEST 0? Thl DEATH IM3EX - CAPTAK
1 DEGREE OF FREEDOM

VEHICLE CONTROL

N
UDI

N

DEATH

PRG INDEX

CHISQ

74-02
N
N
»DI PRG

12SO HO/K6
DEATH
INDEX

CHISQ

74-02

N
N
tfDI PRG

?50C MG/KQ
DEATH

INDEX CHISQ

74-02

N
N
yOI PRG

5000 MS/KG
DEATH
INOE«

.? KG/KG

N
PRG

CHlSa

N

SEAT*.
INDEX

CHISC

MULTIPLE TREATMENT

1

a

23

.5
3

0.00

10

34

,9
2

.2
0

12

31

.39

.00

12

29

.41

.4
0

25

29

.«*

IS.**"

2

9

27

.33

0.00

8

30

.7
2

.07

12

36

.33

.07

!C

30

,33

,OS

26

27

.*
9

20.79"

3

•0

24

.8
3

•0.00

12

23

.2
5

.6
4

11

30

.37

.32

13

31

,*?

.00

25

32

&lt;78

7.85"

4

11

27

.41

0.00

9

31

.6
2

.6
5

7

33

.21

:.as

6

32

.25

1.02

8

27

. 3&lt;3

.32

.38

.6
0

7

30

.23

.37

li

26

.42

.00

10

30

.33

,G1

.03

15

34

.44

lag!}

!
0

30

.33

.0*

1C

27

.37

.23

.0]

^

26

.27

.71

4

27

.33

.12

.19

5

27

.19

1.15

10

24

.38

.03

5
fc

11

29

.*
3

0.00

10

26

•-2*

n.on

9

27

.33
.4
4

.00

11

30

.37

• 24

.9
3

9

34

.26

8

29

7

12

29

.!
*

0.00

12

27

8

11

32

• 34

0.00

a

33

**

SIGNIFICANT AV PLT O.Oi

�Table !5
NUMBER Of DEAD IMPLANTS PER TOTAL IHPLASTS - C*PT'.&gt;.

74-02

C3NTROL

2500 MS/KG

74-02

n S«C/X3

TE'M

.?

MULTIPLE TREATMENT
;

.03

IT/ 367*

.3*

19/ 3 9
3.

,6
0

15/ 310*

.CS

**/ 316=

.20**

£
*•-

d/ 2&amp;5«
11.' 315s

.Ofc

iS/ 326s

.05

IT/ 375-

.5
0

14/ 34?&gt;

.04

77/ 293*

.iff*

2

Si/ 26Gn

.06

IS/ 25?B

.06

!«./ 313*

.US

! / 3*55

.0*

87/ 3 8
4.

.25**

-'

ib/ 2AAc

. &amp;'•

IS/ 359.

•0*

ll/ 333"

.03

ll/ 266=

,04

5

IS/ 33*3

.3*

9/ 348=

.03

11,' 29»=

.0*

22/ 356 =

.06

16/ 3*3=

.05

17/ 273.-:

.6
0

fsi

12'* 3£» =
2»/ 28?-

.04
.39

b

•&gt;/ 323s

,ft3

i3- 312=

.0*

21/ 3*1.

7

2i/ 323»

.Ci7

! / 3Q9=
5

.5
0

I*/

329.

.11*

a/ 305.

,C3

1 S .-' 30&amp;.

.04

-

!.' -•}«!=
'.

.03

j2' 382=

.03

ll/ 383.

.03

7/ 30i=

.Og

ll/ 322"

.03

•
SIGNIFICANT AT P LT 0.05
•* SlSNieiCANT AT P LT 0 . 0 1

.06*

�Table 16
CH1-SQUAR2 TEST OF THE FERTILITY INDEX - FOLFZT
1 DEGREE OF FHSEDOM

• EEK

VEHICLE C O N T R O L

N
N
PRG MTD

PERT.
INDEX

CMISU

74-03
N
N
PHIi MTJ

1250 MG/K6
(•tRT.
INDEX

CHIaQ

74-03
h
N
PRG MTU

2500 H6/KI.
FE.RT.
INDtX

CHIiO

74-OJ
N
N
HRii MTU

SOO'j Mto/KG

TEN

F£RT.
INDtJt

CrilSQ

h
w
PRG HTD

fEKT.
INDEX

CHI Si

Ul
MULTIPLE TREATMENT

1

23

40

.57

0.00

&lt;J7

4Q

.67

.»e

29

40

.72

1.J7

3\j.

4U

,T5

£.01

&lt;&gt;&lt;»

«&gt;J

.7?

1.37

2

27

39

.9
6

0.00

2U

40

.70

.03

23

40

.37

,fe

3S&gt;

«C

.8
8

£.99

27

39

.9
6

.6
0

3

26

40

.5
6

0.00

i-'b

40

.63

O.UO

31

4U

.77

.SIB

32

tLi

.60

1.57

32

40

,60

1.57

4

27

40

.7
6

0.00

30

40

.5
7

.tf*

18

40

.5
4

3.£5

30

40

.75

.24

jfr

no

.6?

.0=

Q.OO

26

40

.65

.&lt;!3

33

4Q

.8
3

j9)
.!

30

40

.75

0.00

O.OC

id

4o

.7s

U.OO

^ 36

•7i

.01

.72

U.OO

JO

4Q

.75

40

.2
7

0.00

3U

4g

.75

O.UO

28

4u

• 7o

29

40

.72

0.00

28

40

.70

0.00

27

4Q

.67

. 0*

31

32

40

.BO

U.OO

e~&gt;

40

.67

1.03

29

40

= ?2

, JS

j'J

5

29

6

29

7

a

40

4Q

.77

.Q7

27

jo

.75

.30

4Q

,"
j

.07

?t

J6

.?2

-2B

�17
IMPLANTS PEB PREC-NAST FEMALE

74-03

CONTROL

1

Xt-js

23*ilnb?

JOB/

2 7 x &gt; l . «l

J24X

-

j&gt;i&gt;00 Kfi/Kb

29*11.1?

. ZHG/.V.;

32flX

30*10,93

316X

29*10.90

£

:i?5/

27x11.36

JO-/

2a*10.Bb

267/

23»ll.i7

393X

3!i»lS.14

293/

27x10.35

3

fat/

26x10.31

2Ti/

2bxl0.tt4

33«/

31x10. 11

327/

32x10.22

348/

32.10.87

4

28Ui'

2?BH'» A ''

29V/

30* 9.97

18J/

l«»i'J.l7

J20/

30*10«b7

26fc/

27* SUSS

%

33*/

29*11. Si

333/

3U*il.l9

31a/

26«12.&lt;i3

3&lt;*9/

iS)ill,*0

35a/

30*11.87

i

323/

2V&gt;il.i*

33&lt;r/

3J=ilt13

294/

2b«10.30

J12/

28=11,14

273/

27x10.11

7

323/

24*11.14

30 f /

2Hai3.V6

311/

27*11.32

3b6/

3&lt;cll.4b

306/

27il!.33

322'

26«12.38

15

3fel/

32*11.*!

30 i''

• SIGKIFICAMT AT P LT O.Oi
•« SIGNIFICANT AT V LT U.01

27*il.l5

34!&gt;X

1

2 ** 11.^9

J46X

X

30 11.53

�Table 16
AVERAGE DEAD IMPLANTS PER PREGN»T FLSIALE - POPPET

CONT3CL

7*-OJ

12!&gt;0 KG/KG

74.03

2*33 MS/ISO

7&lt;t-93

5000

MULTIPLt TKtATMtNT

1

8/

23.

.35

It)/

27*

.37

25/

29.

• a*

13/

2

ll/

27.

.!
*

lb/

2Us

.4
6

20/

23*

.87*

3

16/

2.
6

.2
6

U/

25, .52

19/

31.

.01

4

it/

2 .
7

.9
5

16/

30s

.b.3

a/ 18.

b

15/

29,

.2
5

IS/

30=

,40

9/

6

«/

29,

.31

}7/

3o»

.b?

7

21/

2.
9

.72

!&lt;;/

28.

.41

ll/

27.

8

13/

32 =

• S I G N I F I C A N T AT P LT O.C5
•• S I G N I F I C A N T AT P LT 0.01
0
DECREASED BELOW CONTROL

30»

.43

2i/

3&amp;»

.60

T7/

27. 2,05**

ll/

32«

.34

87/

32. 2.72**

.4
4

7/

30-

26«

.JS

io/

35.

. **&gt;

22/

?Ca

.73

10/

2.
8

.67

i3/

£«•

.*
•

!.
»'

jTa

.63

.43

10/

27»

.37

le/ 3i&gt; 08

H/

27*

.*1

.41

20/

29.

.9
0

13/

ll/

26«

.42

30«

c c3*D

.43

62/

29" i.14**

:i/ z?a .*i

�Table 19
CH!-Si3TARB TEST OF THE DEATH INDEX - FOLPET
1 DECREE OF FREiDOK

74-03

¥E*!Cl.i CONT^l-L

N
N
• 01 i

1DEATH
INDEX

-41SU

ft
N
»Ul PhG

iL)E«TH

!NOEK

CnliiU

N
N
«01 ORb

2500

7»-Q3

*&lt;t/f\i

DEATH
iNUtX

N

*&gt;

5000 Mfa/Ati
IDEATH

IN-JtK

CHi^Q

CHlSU

TEH

M
N
»l): f&gt;nG

ULATn
INDEX

CHtSU

"ULTIPUE TMtATMENT

I

e

23

.35

0.00

a

27

.30

.ul

13

29

.6
4

.&lt;•»

10

30

.33

.03

25

£1

.6
6

12.49**

3S

.43

.5
3

26

&lt;7

.6
9

20.79*.
7.85**

e
.3

9

27

.33

S.i-0

13

*S

.»a

.Si

12

23

.2
6

i.iS

1=

10

26

.8
3

0.00

V

&lt;!&lt;9

.6
3

,«1

4

31

.29

.22

d

32

,2i

.67

2b

Je

.78

4

I:

27

.41

O.i'O

11

20

.3?

,UO

7

la

.39

,iiJ

7

30

.23

1.27

a

j-7

.3G

.32

5

11

29

•38

0.50

10

39

• 33

ic

35

.34

:'.-U

10

JO

..
31

.01

6

0

29

•28

u*cs

11

30

.37

.«2

il

26

.39

.43

V

28

•32

.01

10

l7

.37

.22

7

12

29

.41

000

6

&lt;;B

.29

.S&gt;4

4

27

.3
3

.12

13

31

.42

.05

t

ft

.33

.12

c*

.8
3

.00

a

*•

11

32

•34

0.00

SIGSIFTCAHT AT PLT 0.01

4 2r

.33

&gt;t«l

'4
0

»

16

26

29

.Ji

.5
5

.'
«

1.H9

11

30

OT

.01

10

�Table 20
NUMBER OF OEAO IMPLANTS PER TOTAL IMPLA.STS - FOLPET

fettK

7*-03

CONTROL

1250 M6/KG

7«-03

/4-U3

5000 M u / r G

,2MG/«b

Ttl

MULTIPLE TREATMENT
1

a/ 265*

.03

10/ JOB-

.03

»/ 324*

. J8

i3/ 328 • .04

62/ 316-

.20**

2

ll/ 305*

.4
0

le/ 304*

.06

20/ 257-

.06*

21/ 390 • .05

77/ 293*

. 6 *K
2

3

16/ 268.

.06

1J/ 271.

.05

I1*/ 33*«

,U6

ll/ 327 • .03

87/ 3 8
.*

.25 t*

*

16/ 288*

.0*

J6/ 29V=

,Q5

5
6

e/

1H3-

,y»

7/ 320-

.02

ll/ 266*

• C4

.04

Z£f 356*

.36

.04

n/

£73*

.06

.0*

lit 333*

.04

9/ 318-

.03

16/ 399 *

«/ 323 = .03

I?/ J3»=

.05

4
16/ ^ .

.ub

i3/ 3i2

15/ 334-

E

7

21/ 323*

.0?

li/ 307.

.04

10/ 311-

.03

IS/ 356*

.05

M/ 306&gt;

.0*

a

13/ 381*

.03

ll/ 301- .04

20/ 345-

,U6

13/ 346*

.4
0

ll/ 322-

.03

•
••

S I G N I F I C A N T AT P LT 8.C5
S I G N I F I C A N T AT H LT 0.01

�Table 21
ikl-SQUABE fSST OF THE FERTILITY INDEX - AZINPBO:--fETFYi.
1 DEGREE OF FREEDOM

HS/K6

*E"SCLt

*
*
PRO * !
T)

PERT.
IWE*

•lisa

P*3 »T()

i ••*?.£* c«isa

T4-09

f4
N
PR6 MTD

MS/KG

PERT ,
CHISQ
INDEX

74-09

H
M
PRO MTO

BC

KG./HG

PERT.
1MJEX

CnlSQ

Kl
PR6

N

PERT.
CHISQ

MULTIPLE TREATMENT

^

1

?8 43

.70

C-,09

34

?6 40

.5
6

c.eo

29

oo
2
J

S3

40

.57

3.00

33

40

•as
.2
7

40

.2
8

28

.23

40

.70

.06

27

40

.67

0.00

29

40

.72

0.00

27

40

.7
6

0,00

27

40

.7
6

0.00

27

39

.9
6

.03

.72

1.37

24

3*

.63

.OS

32

40

,SS

3,72

21

36

.8
5

.35

27

40

.7
6

.6
0

.02

30

40

.75

1.42

27

J«

• 7i

.24

• »M*I 29

40

*

2?

»0

.7
6

5.00

30

42

.75

.24

29

40

.72

.06

5

2*

*0

.60

o.co

2*

*0

.72

.9
8

26

49

.5
6

.05

20

34

.53

6

2*

33

.3
6

3.00

JO

40

.5
7

.79

27

40

.7
6

• 03

28

34

.82

7

3?,

i8

• 79

0.00

27

40

.7
6

.6
7

25

40

.3
6

1.81

24

34

.71

.30

27

36

.75

.02

8

27

J5

.71

0.00

26

40

.5
6

«n

26

40

.5
6

.11

22

34

.5
6

.10

25

36

.72

.02

*
I

SIGNIFICANT AT F LT D-lr.
INCREASED ABOVE CONTROL

2.41

�Table 22
AVERAGE IMPLANTS PZR PREGNANT FEMALE - A7IN7HOS-METHYL

CONTROL

74.09

20

MG/KG

74-09
MULTIPLE

»C

74»0&lt;5

80

MG/KG

MS/KG

TREATMENT

1

319/

28*11.39

375/

34.11 .03

300X

28*10 ,71

306/

27.11 .33

31*/

29.iC.90

2

303/

26*11.65

335/

29.11 . 5
5

312/

2r«n .56

310/

e7.il .*3

293/

2V. 10. (55

3

?45/

23.10.65

379/

33.11 . 8
*

338X

29.11 . 6
6

272/

2«.l!.33

348X

32.10.87

*

309/

27.11.44

367/

30.12 . 3
2

369/

2 . 2 7 * !
9 1 . 2 *

247/

21.1! .76

?66/

27. 9 8 *
.5

5

?74/

24-11.42

33?/

29*11 . 2
6

310/

26*11 .92

228/

20=11 .40

35S/

30»11.S7

t,

302/

24*12.Sa

345/

33*1 i .50*

2?6/

2 . 10. 2
?
2"

323/

2a-H • S**

27"&gt;/

27*10.11 **

T

346/

30*11.53

288/

27.10.67

273X

2S«11 .12

262/

24.10 .42

30&lt;S/

27.11.3J

8

292X

27.10.81

306/

26.11 .
"

293/

26.11 .27

2SO/

22.11 .3*

322/

26.S2.3a **I

•
SIGNIFICANT AT P LT O.OS
•• SIGNIFICANT AT P LT 0.0!
I INCREASED ABOVE CONTROL

�Table 23
AVERAGE L'EAD 1MPIANTS PER FSEuNAtT =EMALE -

£0

CONTROL

"lu/Ms

74-3?

K6/".G

40

.? Mr,'KG

MULTIPLE TREATMENT

1

!3/

26-

.46

13/

3-.«

,36

3*/

23« 1.21 *

19/

J7-

.•JO

«/

29" 2.1* **

2

&lt;3'

26"

.31

16/

2%»

.5
5

15/

?T«

19/

?7,

,?0*«

T7/

2T« 2.85**

e/

ll/

24&gt;

.6
4

8T/

32. 2.72**

T/

2i»

.33*

!/
!

27"

.41 *

3

•»A

23.

.35

31X

3 .
3

.4
9

4

?/

27*

.0'-'

2i/

30*

.TO**

5

ll/

24-

.4fc

IS/

29*

.52

t

£i/

24m

,63

15.'

3C-»

,33**D

T

3C.'

30* I.GJ

8/

S7s«

.30

e/

3

'*"
,.

27.

13/

26-

,60

ia/

.TO

* SIGMFICAhT AT P Lf 5.05
•' SIGNIFICANT AT P LT 9.01
D
DECREASED BELCH CONTROL

31 /

2.
9

.56
.20

29" l.oT «*

6/

2e,"

.23

ll/

20=

.5
5

22/

3ft-

.73

IT/

27«

.3
6

9/

2fia

,32«. E

IT/

27.

.3
6

2 . .32
5

19/

2.
*

.79

li/

27.

.41

8/

£2i

.36

11.'

26*

.".2

2b.

.e
j

�Table I-.
CHI-SQUARE TEST OF THE DEATH INDEX - AZINPHOS-METHY'..
1 DEGREE OF FREEDOM

VEHICLE CONTROL

MEEK

M
s
hDI PRO

DEATH
INDEX

CMisa

74-09
N
N
WOI PRG

20

74-09

HO/KG

DEATH
INDEX

CHI SO

N
N
tfOI PRG

40

MG/K6

DEATfi
INOEX

74-09

HO

NO/KG

.2

K
N
.01 PRG

OEUTH
INOEx

N
PRO

DE*Th
INDEX

11

27

.41

.01

25

29

.flfi

13.27**

26

27

N

CKiSO

CMISQ

C*iSG

MULTIPLE TREATMENT
1
£

10

2B

.6
3

0.00

12

34

.5
3

.05

14

28

.27

0.00

11

29

.6
3

. 4
3

3

27

.0
3

.01

12

27

.4
*

1.09

,9ft

24.26*"

16

33

.8
4

.18

5

29

.17

2.11

a

24

.33

.01

25

32

.78

7.05**

14

29

.6
4

9.53**

7

21

.33

3.65

a

27

,30

3.07

6

26

.3
2

.*
6

7

20

.35

.02

10

30

.33

.00

9

it

.33

3.25

£

28

.9
2

10

27

,37

2.36

.6
0

7

25

.8
2

,0*

iO

24

.*2

.6
7

9

27

.33

.07

.03

a

26

.31

.5
S

6

22

.36

.8
0

1G

26

,3fl

.03

2

7

26

3

9

23

.9
3

0.00

4

2

27

.07

0.00

13

30

.3
*

5

9

24

.8
3

0.00

13

29

.»5

6

15

2*

.3
6

0.00

a

30

.7
2

.27

0.00

7

27

.6
2

.*»

0.00

10

7

8

30

a

12

27

*
**
D

SIGNIFICANT AT P LT 0.05
SIGNIFICANT AT P LT 0.01
DECREASED SELOV CONTROL

26

.8
3

7.70**
.07

5.61 **D

.0
5

.6
6

4.73 *D

�Table 25
TCMBER OF DEAD IMPLANTS PER TOTAL IMPLANTS - AZIXPH.Oi-y.r.THl;L.

«££*

?*-S9

CCfeSQOL

7*-09

20

74-09

KG/KG

60

MULTIPLE TREATMENT

IS/ 31Q"

,0*

13/ 3TS.

.03

34/ 300»

.11

la/ 306"

.36

62/ 316«

.20"

S

1,' 303-

.03

ii/ 335,

.OS

IS/ 312-

.OS

19/ 310*

.06

?7/ 293«

.26**

3

*/ 2*5.

.0*

31/ 379S

.8
0

.02

ll/ 272s

.0*

67/ 348a

. 5
2 "

4

iV 339*

.01

2 I/ 367s

.36 "

.03*

ll/ 266&gt;

.04*

S

11 / 2?»«

.0*

IS/ 337»

.0*

.OS

22/ 356m

.06

6

21/ 302«

.07

\0/ 3*5»

.33 **3

.03**S

17/ 873a

.06

7

30 / 3*fes

8

l$/ £92»

S0&lt;»
7

.O

6/ 2ACSic

.03

13' 306=

. 0*

•
••

SIGNIFICANT AT *&gt; LT O.U5
SIGNIFICANT AT P LT 0.51

I)

DgCKFA.-3! BELOH COKTROL

a/

336*

31X 369*

. 8
0 "

?/ 2*7«

.02

ll/ 22Ea

.6
0

9/ 323«

8/ 2 8
7.

.03

19/ 262:

.07

ll/ 306=

.04

IO/ 293-

.3
0

6/ J5o»

.03

ll/ 322«

-03

6/ 3iO»

IT/ 276.

�Table 26
CHI-SQUARE TEST OF THE FERTILITY INDEX - MALATHION
i DEGREE OF FREEDOM

V E H I C L E CONTROL

N
P»3

N

FERT.

NTo INDEX

CHISQ

74.07

N
N
PRG MTD

1250 MG/KS
FERT,
INDEX

CM I SCI

74-07

N
N
PRG MTD

2500 KG/K6
FERT.
IN3EX

CM 1 56

74-07

5003 MG/KG

N
N
PRG MTD

FERT,

INDEX

CM I SO

MG/KG

TEM

N
PRG MTO

FERT,
INDEX

CHISU

MULTIPLE TREATMENT

40

.5
6

.06

29

40

.72

0.08

29

40

,7?

o,c*

24

40

.0
6

,05

31

39

.79

1.40

27

y*

.1
6

.03

.00

24

40

.0
6

o.oa

33

40

.32

4.82*1

32

40

oflO

3.72

.6
6

.01

22

38

.8
5

.41

*
'

40

.67

.06

27

40

.?
6

.6
0

36

.8
5

.01

22

36

.61

• 01

34

*0

.5
8

S.08*I

30

40

.5
7

1.42

36

.8
7

19

34

.6
5

.15

35

40

.38

5.02*1

27

38

.71

.4
2

32

40

,80

.03

27

36

.75

.92

37

40

.92

4.72*1

2*

36

.?
7

.2
0

0.00

31

40

.77

.6
2

,65

0.00

30

40

.75

.4
5

4C

.57

0.00

23

38

.61

27

40

.7
6

0.00

25

38

5

24

40

.C
6

G.OC

21

6

24

38

.3
6

0.00

28

1

28

2

26

40

3

23

4

40

7

30

38

s

27

36

**
I

.8
7

.9
7
.71

0.00

30

36

0.00

30

36

SIGNIFICANT AT P LT 0.05
INCREASED ABOV3 CONTROL

1.26

26

.3
8

.03

19

34

.6
5

3.39

.3
8

.6
9

16

34

.47

3.36

�T » D l e 27
A.^HAftE IMPLANTS PER PREGNANT FSMALi

CONTROL

74-Q?

12SO

74-07

2SOO MS/&gt;6

530S MG/KS

!£•(

H'JLTIPLE TREATMENT
iit,'
2

JliJ/

3
*"

28*11.39

e-S/

*

3l^/

29^10.90

3:^ii.*s

293S

27.10.85

33.12.18 *I

348/

3.08
21.7

27.11.11

266/

27. 9.85*

2.10
21.5

366 / 34.ll.jS

3So/

30.11.87

1 . 11.89
9

391/

35-^.17 •*

2T3/

27.10.11"

19.18.37*1

352/

32.il. C3

3I56/

27all.33

16.11.69

?;,3
397 / 3 . 0 7

32 ?
/

?6.12.3B**l

31--IU16

26'
9.

2.16
61.5

363/

3C»O2.10

267/

24.11.12

356/

23.J0.65

291/

23.12.22 *T

305/

2»«12.71-I

402/

359v

£7.11.44

304/

25.12,16

256 /

22=11.6*

300/

5

£7&lt;i.'

2«.11,*£

23G/

91x11,33

2*3/

n

JC-3^

2»«12.5«

J1S/

2A&lt;£S.3&amp;*

226/

f

3*o/

3.153
01..

337'

30.il. 23

23S/

S

£9^/

2.06
71.i

323'

30»:0,T7

187/

* SlGNiFICANT AT P LT 0.05
•• SISKIF1CANT AT f LT 0.01
I IKCiLASED ABOVE COMTBOL

26.11.46

32 1/

36'
4,

£4.11.07

�Tahl*- 28
AVERAGE 3E*D IMPLANTS PER PREGNANT FEMALE - MAHTHIOS

CONTROL

74-07

125i&gt; MS/KG

7*-C7

2500 CS/KG

7»-07

5000 MGXKG

TEM

.?

MULTIPLE TREATMENT
2.
6

.31

13/

23*

.45

«f/

29= 2.14*'

2.
*

.&amp;
*

11X

31*

.35

77X

2?^ 2.65"

.61

e/
nx
l*x

24*

,58

I4X

33.

.?
*

87X

32* 2.72**

.6
5"

8X

22*

.36*

7X

2.
7

.6
2

!1X

27a

.*i*

ax

22-

.36

ex

34*

.2*

22X

3C=

.73

19* 1.05

23X

35*

.6
6

l^X

27=

.63

1

13/

28*

.6
4

lex

31.

.8
5

2

8/

26*

.31

12/

30.

.0
*

3

9X

23*

14X

23*
2.
5

J4X

2«*

.6
*

*/

21X

24*

.8
8

21X

28*

.5
7

20X

7

3,
0'

39* i.CS

lax

30*

.33

6/

19*

.32

i5/

32=

.«7

iiX

27.

.!
*

a

19X

27.

)9X

30s

.63

7X

16.

.**

32X

37.

.6
8

11X

26&lt;

.*2

2X

5

it/

6

27.

.39
.07

A

.70

SIGNIFICANT AT P LT 0.05
SIGNIFICANT AT P LT 0.01

21. .19

�Ti-ble 29
CHI-SQUARE TEST OF THE DEATH INDEX - HALATHIOli
1 DEGREE OF FREEDOM

7i-07

VErtlCLE CONT*0-_
N
N
dtl »RG

OEAT*
INCil

H

N

0£»TH

^ftc- £sie)i c*&gt;ise

C.iiStJ

74-07

-250 KG/KG
N

N

SDI p»e

5300

2500 KG/KG
i
INDEX

N
P«S

h
CrU5G

Ml

m

IMCES

CM ISO

DEATH
INOEX

CHISO

MULTIPLE TREATMENT
•

1C-

28

.(
3i

(i.OO

13

31

.42

.05

T

26

.27

.16

JO

29

.34

.03

25

29

.6
8

13.27 "

30

.27

.8
0

9

24

.6
3

.5
2

a

31

.6
2

.4
0

26

27

.6
9

24.26 **

11

24

.6
4

.03

9

33

.27

.41

25

32

.7fl

7.05 •*

£

7

iS

.7
8

3.03

a

3

9

23

.39

S.OO

7

23

,30

,1G

»

^

3'f

,C&gt;

P. 06

10

25

.40

6.04*

3

22

.3
S

1.24

5

2'

.19

.6
6

e

27

.30

3.07

=

9

2*

.3
,9

9. CO

3

Si

.14

2.01

6

22

.27

.18

7

34

.21

1.36

10

30

.33

.0
0

2*

.2
6

0,00

11

£8

.30

1.93

6

19

.32

Z.41

16

35

,«6

l.Oi

10

27

.3?

27

,
"

.07

26

.38

.03

t&gt;
'

8

•
**

i%

9
ji

30
27

.2?

.*&lt;&gt;

5.80

T

0. CO

1*

SICHIFICAXT AT P LT fi.05
SICSIFICAXT AT f LI 0.01

30
30

,Z3
.47

0. 90

.01

4 19

.21

.vil

12

se

.3
3

.:
*

a

/

.44

,C7

16

37

.43

.33

10

16

2.36

�T a b l e 30
KUIIBER OF DEAD IMPLANTS PER TOTAL IMPLANTS - KALATHIOS

?*-07

5000 MG/KG

MULTIPLE TREATMENT

1

13/ 319.

.4
0

18/ 346,

.05

3/ 298*

.93

13/ 321*

.04

62/ 316.

.20"

2

e/

303*

.03

12/ 363*

.03

ll/ 267=

.4
0

ll/ 356«

.3
0

?7/ £93,

. 6
2 "

3

9/ 2*5.

.0*

14/ 281.

.5
0

I*/ 305.

.05

!*/ *02«

.03

37/ 3 8
4 .

.25**

4

2/ 309.

.01

• I*/ 304.

.OS"

256 . .03

7/ 300*

.02

ll/ 266,

.0»*

5

ll/ 27*.

.0*

*/ 236=

.02*0

,03

8/ 386*

.02

22/ 3 6
5 ,

.6
0

6

21/ 302.

.07

21/ 31B&gt;

,07

. 9
0

23/ 391-

.6
0

' 7 273,
,/

.06

7

30/ 3*6.

,09

10/ 337.

.03

&amp;/

25
3.

.03

IS/ 352,

.04

ll/ 306,

.04

3

19/ 292.

.07

19/ 323.

.6
0

7/ 187*

.0*

32/ 397*

.08

ll/ 322.

.03

Ln

•
SIGNIFICANT AT P LT 0.05
•• SIGNIFICANT AT P LT 0.01
D

DECREASED BELOW CONTROL

e/
a/

2 3
* .

20/ 226*

�Table 31
CHI-S«?.i*aE T-iSY OF THE FERTILITY INDEX l DECRSE OF ?iu£.£.XHi

*EEK

N
id
•I: "TO
''

74-01

a.2.5 MQ/Kn

VEHICLE

*£RT.
INGES

Crfisa

h

N

FERY&gt;

PRS HTO !*OE* CHI so

N

N

125). MS/KG
FERT.

?4-01
H

PRO NTO INDEX CHisa

230. Mt/KCi

N
MTO

FEfi?.
CnlSJ

Hi
N
PMG MIR

FEHT.
: MDF. x CHISO

CO

MULTIPLE TREATMENT
?3

«0

.57

C.OC

2S

40

.63

.05

27

40

.AT

»*e

22

40

.55

u.OG

i:4

*0

.?
7

i.37

£

?7

i9

.6%

3£

40

.an

.7i

23

40

.57

.72

23

•a

.57

.72

27

jS

.*&lt;»

.6
0

J

26

40

.6%

£3

tO

.i.7

,ci

20

40

.50

1.29

76

40

.65

.OSs

32

*3

.HP

1.57

«

27

»0

.67

o.co
B.OO
e.oo

25

40

.63

.05

23

40

.7
5

.8
4

aa

40

.70

0.90

27

«0

.•
'7

.06

5

S&lt;&gt;

40

.72

O.flS

25

40

.63

.51

25

40

.63

.SI

30

40

,75

0.00

30

«1

.7S

0.00

6

2*

40

,72

».co
s.os

26

40

.70

0.10

23

40

.7
8

1.3.'

32

40

.ao

.2S

2F

J'»

.71

.01

&gt;9

4n

.•??

.0*

21

4G

.52

2.61

2*

40

,7*

.6
0

c~&gt;

36

.*
7

t.OI

33

49

.»2

t.ta

?&lt;»

40

.72

.28

30

»0

,*S

,0?

if6

36

.7?

.no
.?(&gt;

'
•

it
32

44
41

.?
7
.9
8

�T a b l e 3?
AVEKWE IMPLANTS PER PHSGNANT FEMALE - PA3ATHION

MEEK

CONTROL

74-01

62.5 MG/KO

7*-01

125. M 5 / « 6

74-C1

250, M&lt;;/KI;

TF«

MULTIPLE THEATNfcNT

1

23-11.52

266/

25=10 . *
6

3!*/

27-11 .63

22*/

23=10 .IS*

316/

29=10.90

2
tr

265/
305/

27x11.30

337/

32=10 . 3
5

250/

23-10 ,H7

23d/

3
23--1C . 5

291/

27-50. BS

26-10.31

25 7 / 23=11 .17

2«6/

20-12 .30 **I

277/

26=10 . 5
6

3»8/

3iT=iO.S7

3

S68/

VD

4

298X

27-10.67

277/

25-11 . 8
0

253X

23-11 .UO

311/

2S=M .11

266X

27= W.85

5

33»X

29=11.52

299X

25=11 . 6
«

285/

26-11 . 0
4

339/

3
30=11 . 0

35*i/

33=11.87

6

323/

29-11.14

322/

28=11 . 0
5

259/

23-11 .it,

331/

32-10 .3*

27?/

27-10.11

7

323/

29-11. !•»

322/

29=11 .10

236/

21*11 . *
2

339/

29-11 . 9
6

30&lt;i/

27-11.33

3.
3o = ll . ?

33?/

26=:2. 3«

8

9

••
I

38l/

32-11.91

393/

S I G N I F I C A N T AT P LT 0.05
S I G N I F I C A N T AT P LT 0.01
INCREASED ABOVE CONTROL

33-11 .91

336/

29=11 .&lt;&gt;9

35.5X

�Table 33
AVERAGE DEAD IMPLANTS PER PREQ1AMT FEMALE - FAKATHIIW

WEEK

CONTROL

74-Cl

fe2.S

US/KG

74-01

12*&gt;. MG/KG

74-01

250. «G/Ku

TEM

.2 «G/*C,

HW.TIPLE TREATMENT

1

G.'

23=

.35

IS/

25-

.72

ll/

2

ll/

2T-

.*!

!«/

32«

.44

3

it..'

26*

.62

7/

23-

.30

10/

4

16/

£7-

.9
5

9/

25s

.36

5/

S

!«/

29»

.53

IV

?5«

S52

&amp;

9/

2.
9

.31

1G/

2 . .36
6

7

2i/

29«

.72

35/

29«

a

IS/

32-

.41

13/

• SIGNIFICANT AT P LT 9.OS
&lt;• SIONIFICANT »T P LT 0.01
D DECREASED BELOW CONTROL

33*

10/

27»
2320-

.41

8/

.3
4

IT/

.50

e/

.36

6?/

29- iJ.!4**

23-

.74

77/

27* 2.85**

2b-

.31

B7/

32- 2.72**

ll/

27-

22-

42/

28= 1.50

14/

232.
5

.20
2*

.6
5

22/

2.
3

.39

303?=

.37

*/

ll/
I*/

.»4

21- 1.10

22/

29-

6/

3C«

.52

23/

.9
3

9/

2&lt;».

.31

.41

.73

17/

30?T,

.63

, 7e

ll/

27=

.41

.20

I)/

?*•=

. 2
4

�X,

Table 34
Cni-SQCAKE ITST ,r-F THE DEATH INDEX - PARATHlON
1 DEGREE OF FREEDOM

VEHICLE CONTROL

WEEK

N
N
HOI PRO

DEATH
INDEX

CHISB

74-01

N
N
MDI PRG

62.5 MS/KG

DEATH
INDEX

CHISO

7*-01

N
N
WDI P«5

?*-01

125.

DEATH
INDEX

CMISQ

250.

N
&gt;i
HEATH
• l!l PRO INDEX

.?

ChlSJ

K
N
"Di P«S

DEATH
INDEX

CHISU

MULTIPLE TREATMENT

1

8

23

.5
3

0.00

6

25

.4
2

.5
2

9

27

.33

.4
0

5

22

.23

.32

25

24

.»&lt;•&gt;

12.49**

2

9 27

.33

0.00

11

32

.34

.04

B

23

.5
3

. 4
0

7

23

.30

.01

26

27

.9ft

20.7V**

7ft

7.8*3 **

3

10

26

.8
3

0.00

7

23

.30

.08

8

20

.0
4

. 4
0

7

?6

.27

.3-5

JS

3&lt;»

4

4

11

27

.41

0.00

a

25

.32

.13

4

23

.17

2.^1

10

2B

.36

.01

*

tl

.33

.32

25

29

.8
3

0.00

7

25

.8
2

.23

9

.6
3

.02

8

30

.27

.42

10

30

.11

.01

6

8

29

.8
2

0.00

9

28

.32

.01

7

23

• 30

01

10

32

.31

.00

10

27

.37

.22

7

12

29

.41

0.00

12

29

.41

.07

12

21

.7
5

.6
6

il

29

.38

0.00

9

2?

•n

.12

8

11

32

.34

0.00

11

33

.3
3

.1)3

9 29

.31

.uu

5

30

.17

1.70

10

^fi

.ia

.nc

5

11

** SIGNIFICANT AT PLT 0.01

�Table 33
3F OEAD IMPLANTS PER TOTAL IMPLANTS - PWlTHION

74-ui

CONTBOL

74-0\

fc2.i

125. MG/KG

250.

.?

MULTIPLE TREATMENT

1

S/ 265*

.03

IB' £66*

.07

ll/ 314«

.04

e/ 22*=

.04

fc?/ 316=

.20**

! / 337=
4

.04

10/ 250*

.04

i7/ 23flr

.07

77/ 293=

.**
2.*

10/ 24fc.

.4
0

B/ ?77«

.03

97/ 34fl,

. 5
2 "

42/ 311«

.1*

ll/ 266s

.4
0

.6
3

Z
v

: s &gt;• 305* .04

3

16/ ?68x

.06

7/

257.

.03

ID/ 28Bs

.06

*/ 277,

.03

5/

253.

. 02*D

e

S5/ 334.

.04

13/ 299*

.C4

14/ 2S5»

.ns

Jl/ 339=

.03

2?/ 356s

•-

*' 323s

.03

lu/ 322-

.03

9/ 2 ^
5 *

.03

I*/ 331=

.*
0

IT/ 273=

.6
0

7

l\/ 323«

.07

15/ 322=

.5
0

23/ 236*

.10

22/ 33&lt;»

.06

I!/ 30»i =

.04

e

1 . 3313'

.03

13' 393*

.03

9/ 336&gt;

.3
0

6/ 355&lt;

.21
0*!

ll/ 322=

.03

*
••
0

SIGNIFICANT AT P LT 0.95
SIGNIFICANT AT P «.? 0.01
DECREASED SEUM COPT&amp;OL

�T a b l e 35
CHl-SQCAEUi TEST OF THE FERTILITY INDEX - PARATH ION-METHYL
1 3EGREE OF FREEDOM

VEHICLE CONTROL

-EEK

M
N
PRG MTU

PERT.
INDEX

CHISU

7»-OS

PNG MTO

20

H6/KG

FtRT.
INDEX

CNIbU

74-06

N
N
PRG MTU'

»0

nb/Kb

PERT.
INDEX

CHISU

74-Ci*;

N
N
Prtfc KTD

80

Mlj/Ku

TEW

N
i\
PKG M f D

PERT,
INCEX

CHI SO

.2
'

1.37

29

iNOt*

CH1SC*

40

.72

1.37

39

MULTIPLE TREATMENT

1

2

23
27

3

26

4

27

40

.57

0.00

29

40

.72

1.J7

24

40

.60

0.00

29

40

.9
6

0.00

33

40

.82

!.&lt;*

23

40

.57

,7«?

29

40

.72

.01

27

.9
6

.6
0

40

.5
6

0.00

30

40

.5
7

.4
3

32

40

.0
0

1.57

28

40

.70

.6
0

32

40

.80

1.57

40

.7
6

0.00

Jo

40

.5
9

26

37

.70

.00

£6

39

.67

.03

27

vu

.o7

.06

7

39

e.,&lt;i**i

5

29

4Q

.2
7

0.00

.»2

»0

.0
8

.£8

2*

*0

.6Q

&gt;b9

3j

4Q

.75

B.CO

30

-»J

• *

0.00

6

29

40

.2
7

0.00

33

40

.2
S

.5
6

30

40

.75

O'bO

2»

4C

.0
6

.9
3

£T

36

.71

.01

7

29

40

.72

0.00

36

40

.0
9

2.VS

32

40

.0
8

.c8

13

40

.2
8

.5
6

27

it,

.75

.00

.5
8

.09

36

.72

.28

6

**
I

32

40

.0
6

0.00

SIGNIFICANT AT P LT 0.0!
INCREASED ABOVE CONTROL

32

*0

.0
8

.6
0

35

40

.8
6

.7
3

34

40

26

�Table 37
AVEHAGE ISSPLASTS PER PREGNANT FEMALE - PAEATHION-iffill:«J.

• ifcK

21)

CONTROL

74-05

w.iLTIPLE

40

MG/KG

Tt-O'S

80

.2 MG/K3

TRfcATHENT

i

£6S/

23*11.52

30i/

29-10,46*

26a/

24.11.1?

303/

29.10.45*

316/

29=10.90

&lt;J

33'
0.

27.11.3C

3»T/

3.05
31.2

241/

2 . 0 »8
31.

323/

29.11.14

293/

27=10.85

30s]0.20

3

(

38'
6.

26*10.31

306/

331/

32.10. J4

297/

28.10.61

348/

32.10.87

-F

266/

27« 9 8
.5

*

29S/

27*10,67

41?.'

38«1«S9

27S/

26-10.58

2Bi/

26-10. Bl

5

334/

29.11.52

39V

32*12.16

30C/

Z4.12.3U

36B/

30^12.27

35&amp;/

30=11.87
27.10.11

6

323/

!

323 /

U

381/

*
••

29*11.14
2 . 1 1«
91.
32.11,41

366/
»0)/
347/

SIGNIFICANT *T P LT 0.05
SIGNIFICANT AT P LT 0,01

334/

30-11.13

279/

24*11.62

273/

36.11.14

357/

32*11.16

349/

33.12.09

306/

27.11.33

32.10.d4*

407/

3 . 1 63
S1.

402/

34*11.62

322/

26*12.38

33*11.39

�Table 33
AVERAGE DEAD IMPLASTS PER PREGNAitT rcMALE - PARATHrON-METHYi.

74-Ob

CONTKOL

20

HG/Kli

74-05

»0

Mb/Kb

74-09

80

Mb/KG

TtM

MULTIPLE TREATMENT

1

8/

23*
27.

.35

9,

29-

.31
.JO

.!
*

10/

33=

2.
6

.62

8/

30.

.27 *D

16/

27-

.9
5

lb/

3tl =

5

IS/

29*

.52

23/

a

•*/

2V.

.oi

7

21/

2.
9

e

13/

32*

2

ll/

3

16/

4

8/

24= 1.U4 *

23- . Jb

16/

.55

62/

2&lt;i= i | «
.*

.31

77/

27 = 2.65**

2ea 1.21

S7/

32. 2.72**

9/

26=

.35

ll/

27=

•41

12/

30*

.40

22/

30*

.73

.?&lt;&gt;

17/

27=

.3
6

9/

29=
2&lt;»»

22/

32-

.bS

.7
4

b/

26=

. i« *D

32.

.72

IT/

£4=

.rl

20/

33=

.bl

:o.-' 30=

.'
.i

.72

7/

36.

.19 -3

ll/

32.

.34

lex

33*

.48

ll/

?7x

.41

.41

ll/

32=

.4
3

18/

35=

.31

12/

34-

.35

ll/

26=

.42

Cn

*
••
D

25/

SIGNIFICANT AT P LT 0.05
SIGNIFICANT AT P LT 0.01
DECREASED BELOW CONTROL

34/

fe/ 24=

�Table 39

TEST OF THE DEATH INDEX - PABATHION-METHYL

•itrt&lt;. OLE

ai.f.1.

N
N
KOI PRO

CONTROL

DEATH
IMOEX

CM ISC

74-05
ft N
*0i PRO

20

KG/KG

C-£ATrt

CM I in

74-Ob
N
h
• 1 PR6
0

HG/Ku

40
DEATH
iNDtX

7&lt;t-05
*

H

SO

YE*

« «/!«-,

ft

N

DCdlf

CrUaG

CnlSU

.? M G /KG

•ci P«G

UtAT*
INDEX

CHI 51*

NULTIPLE TREATMENT
1

$

23

.5
3

C.09

t&gt;

£9

.S
2

.07

12

24

50

.8
5

9

29

.31

.30

25

29

.6
8

1 . 9
2 4 "

2

5

27

.3
3

0.00

9 33

.?
2

.5
0

b

23

26

.6
0

0

29

.28

.03

26

47

.6
9

20.79**

a 33

3

10

26

.8
3

0.5C

.27

..
4'

14

32

»»

.02

V

&lt;B

.*&lt;&gt;

.64

25

J2

.8
7

7.85**

&lt;•

11

27

.41

f,03

14

38

.37

.00

5

26

19

1.98

I

26

.27

.0
6

6

d7

.38

.32

*

il

29

.8
3

0.00

11

32

.4
3

,1)0

10

24

42

.00

10

30

.33

.01

1C

30

.33

.01

a 2*

.28

0»00

11

33

.3
3

.5
0

6

30

27

.05

6

24

.5
2

• 01

10

£7

.37

.22

•41

0.00

6

36

•H

3. '
4

B

32

25

1.18

13

33

.39

• 01

•i

27

.23

.12

.4
3

0,00

&lt;*

32

.2*

.JO

7

35

2u

1.10

&amp;

34

.24

.9
4

1C

36

.6
3

.00

6
7

; 2

a

li

•*

C?

32

SIGNIFICAST iT f LT 0.01

�T a b l e 40
NUM3E3 OF DEAD [MPLANTS PER TOT^L IMFLWTS - PAH A T H I OS-METHYL

«ttK

CONTROL.

74-05

20

NG/KG

74-05

«0

KG/KG

74-0 =

ItM

80

,Z

MULTIPLE TREATMENT

1
2
N

B/ 265s
ll/ 305s

.03

9/ 301 =

.0*

10/ 347.

e/

306.

.03

6
25/ , 8 =

.3V*

id/ 303=

.05

62/ 3lt&gt;=

.20**

.03

B/ 241s

.U3

9/ 323,

.33

77/ 293»

.2&amp;*»

.03

22/ 331.

.a7

34/ 297s

.11

8?/ 343.

.5*
2.

9/ 281=

.03

!&gt;/ 266=

.04

3

16/ 266s

.06

4

16/ 288=

.6
0

18/ 417=

.04

5/ 275=

5

IS/ 334&gt;

.04

23/ 389=

.06

17/ 300"

.06

12/ 3fc8=

.03

22/ 356=

»C6

6

9/ 323=

.03

20/ 366=

.05

10/ 334 =

.03

6/ 279=

.02

17/ 2'3»

.06

7

21/ 323=

.07

7/ 401 =

.02*D

ll/ 357=

.03

16/ 399s

.04

ll/ 306s

.34

0

13/ 381=

.03

ll/ 347 =

.03

18/ 407 =

•&lt;J4

12/ 402=

.03

11 / 322=

-03

J

*
•*
D

SIGNIFICANT AT P LT 0.05
SIGNIFICANT AT P LT 0.01
DECREASED BELOW CONTROL

«u2*D

�Table 41
CHL-SQL'ARE TEST O? THE FERTILITY INDEX - QUISTOZ1&amp;E. (PCKS)
1 DEGREE OF FREEDOM

:c5C MS.'XG

•tf.ti

*

»«

FEBT.

P3G ffj

INDEX

CMIS3

N
M
PAS HTQ

IKOfc*

CHtSa

7*-0»

N
PSS

N

MTO

2500 MG/KG

FERT.
INDEX CHISO

?&lt;t-oe
H
N
PRO MTO

soco

"M;

TEM

N
CrllSQ

Mfi/KG

N

PflG MTO

fEBT.
SHOP*

c*'.sa

MULTIPLE TREATMENT

g
,

oc

i

2 i
f

4
0

. 0
7

.72

0.00

29

( . j
l - l

34

.62

.CO

40

.75

.6
0

31

40

.77

.6
2

29

*0

.?
7

0.00

22

40

.5
5

.7
4

26

40

.5
6

.5
0

27

39

.9
6

.03

30

2

?6

40

. 65

3

23

»3

.57

O.OC

25

38

.6
6

.27

26

38

,8
6

,58

24

40

.72

1.37

32

40

.0
8

3.72

»

f

43

.67

0.60

33

33

.87

3.09

30

40

.75

.2*

28

4C

.0
7

0.09

27

*0

.7
6

.6
0

5

24

40

.60

0.00

19

39

.50

.4*

28

40

.0
7

.9
4

33

40

.2
8

3.91*1

30

*Q

.5
7

1.42

6

2c

38

.63

0.00

33

38

.61

0.00

2
6

40

.5
6

.00

36

40

.90

6-47*1

27

38

.71

.4
2

7

*u

38

.79

0.03

27

38

.71

.26

27

40

.7
6

.8
7

28

40

.0
7

.2
4

27

36

.5
7

.02

31

40

36

.72

.02

e

I

27

33

.71

C , 00

40

21

A. 00

SIGHIFICAHT AT F LT 0.05
INCREASED ABOVE COMTSDL

JO

3n

.T9

.8
2

.7
7

.IS

30

40

.5
7

.02

26

�T a b l f -,2
AVERAGK LMPLAOTS HER PREGSAST FEMALE - JUIYTOZESE (FCNE)

CONTROL

74-OH

1350 MS/KG

74-08

2500

74-08

SOOC riu/KG

TEW

MULTIPLE TREATMENT
349/

29*12.03

338/

30 = 11. ,?7

361/

6
31 = 11 . 5

316/

29=10.90

303/

26=11.65

222X

21=10.57

235/

22=10.68

2S9/

26= 9 .96*

293/

27.10.65

3

?*S/

23=10.65

296/

25=11.64

326/

26=12. -54 «*I

353 /

29=12 .17*1

34B/

32-10-87

4

309/

27=11.44

392/

33=11.88

349/

30=11.63

317/

28*11 .32

266X

27= 9.05*

5

27«/

24=11.42

214/

19=11. 26

342/

28=12. &lt;?1

376/

33.11 . 9
3

356/

30=11,87

6

302/

24S12.S8

267/

23=11.«,!

291/

26=11.19 **

»00/

36=11 .

273/

27=10.11 **

306/

27«11.33

322/

26»12.36"I

1

28:11.39

2

\o

319/

7
8

346/
292/

30=11.53
27=10. 81

26//
3S4/

• S I G N I F I C A N T AT P LT 0.05
«• S I G N I F I C A N T 4T P LT 0.01
I
INCREASED ABOVE CONTROL

i:-

2T«10.63*

292/

27=10. «1

30£/

28=10 .79

30=11.80

336/

31=10. H4

333/

30 = 11 .10

�Table ii
DEAD IMPLANTS PER P5EGSANT FEMALE - qiiIHIt.-7.ESz ...-Ys

"&lt;G/K&amp;

74-08

2500 M6/K6

.2 Mfi/KG

TTM

7»-Os

MULTIPLE TREATMENT

31"

.35

62/

?&lt;»* 2.1* **

fr/ 26»

.23

77/

2 . 2. 85 **
7

29»

.52

87/

32» 2.72 **

10/

2e=

.36*

ll/

27«

.41 *

.75

lb/

33=

.5
4

2?/

3.
0

= 71

26=

.35 **D

16/

36s

.44*0

I?/

2.
7

.3
6

!/
&amp;

27=

.&lt;-,&lt;)

?0/

28»

.71

ll/

27*

.41

10/

31=

.32

)3/

30:

.43

ll/

26*

.2
4

i

13/

28*

,*6

ll/

2S&gt;

.38

12/

30=

. tO

2

5/

S6r

.31

:a/

21 =

.5V

15/

22=

.8
6

9/

23*

.39

25=

.52

7/

26=

.gl

15/

^

2/

27*

.07

15/

33»

. 5 *
4 *

7/

30=

.&lt;-3

5

ll/

».
.

.6
4

111/

19.

.53

ai/

28=

S

SI/

24s

.88

9/

»

JO/

30* 1.00

1 1/

27s

.!
*

a

5&lt;&gt;/

?T"

i?/

30 =

.S7

ll/

3

^
0

*
••
D

.70

ti/ 23=

SIGNIFICANT AT i» LT 0.05
SIGNIFICANT AT P LT 0.01
DECREASED BELCH COXTROL

^35*0

�Tail? ii
CHI-SQ'JARE TEST OF THE DEATH INDEX - QUIST'W.RN* (PCN3)
1 DECJREE OF Frl

VEHICLF CONTROL

U&amp;E.K

N

•ni

N
PRG

DEATH
INDEX

CHISO

74-06

N
N
• DI PKG

1250 MG/KG
DEATH
INDEX

CHISO

74-03
N
N
WOI PR'J

74-oa

2SOO MG/KO
DEATH
INDEX

sooo

. 3 Mr,/KG

N
PHG

N

CiIbQ

flEATh
INDEX

CnlSU

N

N

•DI PKG

DEATH

INPF*

CHJSO

MULTIPLE TREATMENT

1

10

28

.3*

0.00

7

29

.24

.44

10

30

.33

.01

•*

31

.2^

.07

25

^4

.8*

13.27 **

2

7

26

.27

0.00

10

21

.4B

1.35

9

22

.!
*

.51

2

26

.08

2.15

26

£T

.9ft

24.26**

3

q

23

.9
3

0.00

11

25

.44

.00

6

26

.3
2

.82

11

29

.38

.04

25

32

."«

7.05**

4

2

27

.07

0.00

12

33

.36

5.44 *

6

3«

.20

.97

7

28

.25

i.96

«

27

.3"

3.07

28

.6
4

.1*

13

33

.39

.02

10

JO

.31

.00

8 26

.31

3.B6*D

12

36

.33

3.84*D

10

£7

.•*7

2.34

27

.2
5

2.01

10

28

.36

.21

9

£7

.IS

.07

9 31

.9
2

.89

12

30

.40

.00

2ft

.33

.03

5

9

24

.3fl

0.00

9

19

.47

6

15

24

.63

0.00

6

23

.26

7

8

30

.27

0.00

10

27

.37

.31

a

12

27

.4
4

0.00

13

30

.43

.03

*
**
D

SIGNIFICANT AT P LT 0.05
SIGNIFICANT AT P LT 0.01
DECREASED BELOW CONTROL

.12

4.91 *D

13

14

10

�Table 45
.Tfflat; OF DEAD IMPLANTS PER TOTAL IMPLANTS - QUINTiSZiiN?

,.'£ f.«.

74-08

1250

COKTROL

2500 MG/KQ

74-88

,2 MG/SG

TF-

5000

MULTIPLE TREATMENT

1

!3/ 319-

.04

ll/ 3*9=

.03

12/ 33»&gt;

2

»/ 303-

.03

1 . 222=
2'

.OS

IS/ 235.

3

9/ 245-

.04

13' 296-

.4
0

7/ 326=

4

2/ 309-

.01

IS/ 392-

.04**

7/ 349«

.03

t,gf 316*
1

.20**

6/ 259-

.02

77/ 293=

.26**

• 1 2 »D
)

15/ 353-

.04

B7/ 34«-

.*
2*

.02

10/ 317-

.03*

ll/ 266*

.4
0*

.6
0

16/ 376s

.4
0

22/ 3^6*

.Oft

.03 *D

16/ 400-

.*
0

IT/ ?73=

.6
0

.6
0

ll/ 2?»»

.04

10/ 214-

b

SI/ 302-

.07

fl/26?-

7

30,' 3 «6-

.09

ll/ 287-

.04

16/ 292*

.05

20/ 302=

.07

ll/ 306 =

.04

.0?

I*/ 354 =

.5
0

10/ 33«&gt;

•03

13/ 333=

.04

ll/ 322-

• 03

a

I?/ 2?2

•
SIGNIFICANT AT P LT 0.0«&gt;
•* S I G N I F I C A N T AT ° LT 0.01
D
DECREASED BELOW COHTXOL

.02*0

21/ 342=

ll/ 361-

S

e

.OS

.4
0

9/ 291 =

�Table 46
CHI-SQUARE TEST OF THE FERTILITY INDEX - PHOBATE
1 DEGREE OF FREEDOM

• EEK

VEHICLE. CONtHUL
N
N
PRO HTO

FF.RT.
INDEX

CHISU

74-04

K
N
PKb MTU

MG/Mi

•&gt;

FtUT.
INDEX

CHI SO

74-u*

N
N
PHG MTU

10

Mb/Kb

FEBT.
INDEX

CnlbQ

MO/KG

20
N
N
PHG MTO

PERT.
IfcDE.lt

CHISU

N
PHli H F U

fEKT.
INDEX

CHISU

U)

MULTIPLE THEATNENT

1

23

40

.57

0.00

2J

40

.57

.US.

21

40

.52

.t&gt;5

.
4

40

.0
6

o.oo

29

40

.72

1.37

2

27

39

.9
6

0.00

30

40

.75

.10

2J

40

.i&gt;7

.72

29

40

.72

.01

27

J*

,(r,9

.Ob

3

26

40

.5
6

0.00

2b

40

.65

.US

24

40

.60

.liS

31

40

,77

."«

32

40

.0
8

1.57

4

27

40

.7
6

0.00

26

40

.65

0. 00

26

40

.65

O.UO

32

40

.0
8

l.OJ

27

40

.*"

.06

.72

0.00

#&gt;

40

.3
6

.»
!!

27

40

.7
6

.6
0

31

40

.77

.07

30

40

.75

25

40

40

.5
6

.3
4

33

40

.2
8

.S
6

21

3*

.71

27

Jb

.75

.01'

20

JO

.72

.21*

b

29

40

b

29

40

.72

O.OU

.3
6

.31

26

7

29

40

.72

0.00

30

40

.75

O.UO

29

40

.72

.06

Ji

40

.0
8

B

32

40

.9
8

0.00

26

40

.65

l.»7

29

40

.72

«&lt;B

30

40

.75

1.95
.07

0.00
.01

�Table 47
AVBRAGE IMPLANTS PER PREGNANT FEMALE - PHOIiAT2

7«-0*

CCK'SOL

10

NO/Rti

.2

TtM

7»-0«

MULTIPLE TRLATHtNT

1

?65/

5
23-11 . 2

2* I/

23»i0.te*

221/

24-11 .21

316/

29-10.90

30i/

27-11 .30

326/

30*10.37

2SS/

10 .52*
212 .11 . 9
3
0

269/

i

3U7/

29-10 . 9
5

293/

27-10.05

3

268/

2 . .31
6 10

29«/

26-11.50*1

257/

2 .10 .71
*

34i/

31-li .03

3«B/

32=10.87

*

6
288/ 27.10. 7

2S&gt;1/

26-11.19

277/

353/

32-11 .03

266 / 27- 9 8
.5

S

J3*/

2 .ii .52
*

2?B/

2b=S1.12

31Z/

10 6
26- . 5
27.il eb6

6

j2
)V

2 . .1*
9 11

305/

7

32j/

29.11 .1*

J36/

B

.»Bi/

32- il .91

jib/

AT P I.T 0.05
** SJG'v^ICANT AT f LT C.C1
1 IHCBEASED ABOVE CONTROL

25.12.20*1
30.11.20
2.:.2
6'21

295/
3l?/
33b/

3
26- li . 5

369/ 31-11 .90

356/

30-11.87

384/ 33.11 .79

273/

27.10.11
27.11.33
26-12.3B

10 . 3
*

»07/

35-11 . 3
6

306/

.5
6

J24/

30*10 .do*

32^/

**-

29- 11

�Table 48
AVERAGE DEAD IMPLANTS PER PREGNANT FEMALE - PHORATE

MG/KG

CONTROL

r&lt;t-Ut

10

Mti/nG

f»-0»

20

Mb/Kb

.2

FtM

MuLTIfLE THEATHfcNT

1

a/

23*

.35

9/

23"

.39

10/

21*

.*H

3/

2**

.13

6?/

29= 2.1* **

2

ll/

27*

,»1

lt&gt;/

30*

.53

«/

23*

.U

17/

29*

.9
5

77/

27» 2.85 **

3

16/

26*

.62

1J/

26*

.50

U/

24*

.SO

IS/

31s

.B
*

87/

32- 2.72 **

*

16/

27s,

.59

15/

26s

.SB

26/

26s l.DO

12/

32*

.6
3

ll/

27=

.41

3

IS/

29s

.52

13/

25s

.S2

ll/

27*

13/

31*

,»2

22/

30*

.73

6

9/

29s

.31

13/

25s

.52

7/

26*

.27

7/

33*

.21

30*

.43

2i/

29*

.76

7/

35*

26*

.38

26/

29.

.90

ll/

33*

7

21/

29*

.72

U/

8

13/

32s

,»1

10/

•
••
D

S I G N I F I C A N T AT f LT 0.05
S I 6 N I F I C A H T AT P LT 0.01
DECREASED BELOW CONTROL

.!
*

.37

17/

27s

.63

IS/

27*

.41

ll/

26*

.4?

�Table 49
CHI-SQl'ARE TEST OF THE DEATH INDEX - PHORA7E
1 DECREE OF FREOXtt

i?Et*

^i.'ilCLE CONTntn.
N
N
»DI Pkb

QEATrt
INOex

V«. ~%K

5

MCi/Kb

f.

PMC

CH;Sw

SftDEx

CHIiU

74-U*
N
N
• 01 PR6

10

HG/Ku

0£ATH
1NUEX

T

-.;»

20

N

N

CH1SU

N

OE4TM
iHliCa

.?. HG/KG

TEM

W&lt;!/KB

"

N

CniSu

UEATH
INDEX

CHI SO

HOUTlPLt TREATMENT

25

&lt;:.-&gt;

.86

12.49 **

.37

26

^7

.96

20.7***

.32

.04

25

32

.78

7.b5**

34

.34

.05

8

^7

.30

.32

1

a

23

.35

w.OO

d

23

.J5

.10

7

21

.33

.US

2

24

.00

3.45

2

9

27

.33

U.tO

13

30

,»3

,«!S

2

23

.09

3.07

13

2V

.45

3

10

«

.33

3.00

T

s!fe

.27

.JS

U

£4

.50

.,49

10

31

4

11

27

.*k

a. 00

11

26

.42

.03

IS)

2b

.5tt

.»2

11

1

5

il

2&lt;s

.38

I . CO

Id

25

.48

,£2

7

2T

.26

.46

11

31

,3S

.01

10

JO

.33

.01

6

0

2S

.28

0.00

10

25

* 40

.46

7

26

.27

.Ob

7

33

.21

.00

10

&lt;*7

.37

.22

7

12

&lt;!9

.41

IJ.CO

S

30

.30

.41

15

29

.52

,*B

»

3*

.!«

4.66*D

9

e?

.33

.12

b,UO

4

26

,35

.07

14

29

.48

.71

a

30

1C

ft,

.38

.00

a

*
**
D

ii

3£

.3*

SIGNIFICANT AT F Lt 0 0
. 5
SIGNIFICANT AT P LT 0 0
. 1
DECREASED BELOW CONTROL

.27

.19

�T a b l p 50
NUMBER OF DEAD IMPLANTS PER TOTAL IMPLANTS - PRORATE

• EEK

MG/Ku

CONTROL

/4-0*

74-04

10

20

Mb/Ho

MG/KQ

ICM

MULTIPLE. TRtATMtNT
.01 *D

62/ 316=

.20 **

17/ 307 =

.06

77/ 293=

. 6 **
2

.)
15

IS/ 341 =

.04

67/ 348 =

.25 **

26/ &lt;iT7«

PU 9

12/ 3S&gt;3=

.03

ll/ 266=

.0*

.05

ll/ 312=

.04

13/ 369=

.04

Z2/ 356=

.06

13/ 3ub =

.0*

7/ 29j=

,o2

7. 1-9=
.'

.02

)7/

77.1=

.6
0

.07

13/ 336=

.04

i'i./ 317=

.'
0

7/ 407 =

.02*0

ll/ 306=

.4
0

.3
0

10/ 31b=

.03

26/ 33b=

. l)B

ll/ 324=

.03

ll/ 322=

.03

.04

10/ 221=

.U=

3/ * , .
.*

lb/ 32b=

.05

4/ 2b5=

.0^

.Ob

13/ 299=

.04

12/ 257=

16/ 288=

.06

lb/ 291 =

.OS

S

IS/ 334=

.04

13/ 278=

6

9/ 323 =

.03

7

21/ 323=

8

13/ 361*

1

8/ 265 =

.3
0

2

ll/ 305»

.04

3

6.
16/ 2 8

4

•
••
D

9/ 241=

SIGNIFICANT AT P UT 0.05
SIGNIFICANT AT P UT 0.01
DECREASED BELOW CONTROL

�Table 51
DMA REPAIR SYNTHESIS ASSAY OF Monocrotophos
(dpm/u« DNA)
4NQO (M)

Monocrotophos (M)

Sample 1

_£_.
tt
65

io-7

io-6

io-8

IO"4

lO-3

46

31

54

70

64

1354

46

46

86

1273

10-5

2

35

42

3

39

39

25

40

36

69

1306

4

34

34

25

40

40

51

975

5

30

26

53

64

64

972

6

20
32

-f
38

46
_.t
32

37
50

92
71

1135

—f
47

1169

SD

7

7

10

7

14

15

168

SE

6

3

5

3

&amp;

6

69

Mean

9*

Sample deleted from calculations because of low DNA value.
Only five samples used.

Cell culture and exporiosontal condj.t_ions
T-25 flask cultures of passage 24 WI-38 cells were initiated in medium containing iO% serum. The medium was replaced with medium containing 0.5%
sarv.m on day 5 following initiation and subsequently on days 11 and 15.
Tho assay was conducted on day 22.
Hyriroxyurea (10~*M) preincubation = 1 hour.
Compound exposure time = 3 hours.
3
li~TdR added with compound.
3
H-TdR incorporation = 1 uCl/ml (S.A. ==6.7 Ci/mmole), 3 hours.
Postincorporation incubation = medium containing TdR, 3/4 hour.
Cells were removed with IN NaOH. 1 minute, 70°C.
DNA was oxtfflcted by the PCA-hydrolysls procedure and measured following
reaction with dtphenylamlne.
S«j;aUvu control and compounci solvent -~- 0.5% EtCH.

78

�Table 52
DMA REPAIR SYNTHESIS ASSAY OF Monocrotophoa
WITH METABOLIC ACTIVATION
(dpm/ng DMA)

_Monocrotop_ho8_ OjO

DMN (M)

0_

10-^

10-J

j°Jll_.

Sample 1

55

67

43

87

206

2

54

66

48

84

220

3

52

43

52

82

223

54

59

48

84

216

2

14

4

2

9

1

8

2

1

5

Mean

SD
S

E

5 X 10"'

Cell £ulture_and experimental conditions
T-25 flask cultures of passage 24 WI--38 cells were initiated in medium
containing 10&lt;jfe serum. The medium was replaced with medium containing 0.5% serum on day 4 following initiation and subsequently on
day 10. The assay was conducted on day 16.
Hydroxyurea (10~2M) preincubation - 1 hour.
Compound exposure time = 1 hour, with the 9,000 g fraction of a mouse
liver homogenaie.
3
H-TdR added with compound.
3
H-TdR incorporation = 1 p,Ci/ml (S.A. =6.7 Ci/mraole), 4 hours.
Post.incorporation incubation = medium containing TdR, &amp; hour.
Cells were removed with IN NaOH, 10 minutes, 22°C.
DNA was extracted by the PCA-hydrolysis procedure and measured following reaction with diphenylamine.
Negative control and compound solvent = 0.5^ EtOH.

79

�Table 53
DNA REPAIR SYNTHESIS TESTING
OF BROMACIL
(dpm/ug DNA)
Broroacll (M)

_4NOO_(M)
--

J&gt;*.

IP"7

10~6

10"5

ID-'*1"

10-3t

195
153
212
230

207

201

148

129

212

215
121

248
178
179
231

144
152
204
144

137

200
165
28
12

Sample
!

2
3
4
5
6

Mean
SD
SE

217
298
218
48
19

156
187
182
251
199
32
13

218
184
220
193
38
15

240
178
209
34
14

Negative control and compound solvent =0.5% DMSO.
Slight precipitate observed at 10~3 M and 10™1* M

80

2670
2850

107

2688
2702

80

2438

74
87
50
20

2662
2668

105

134
55

�Table 54
DNA REPAIR SYNTHESIS ASSAY OF BROMACIL
WITH METABOLIC ACTIVATION
(dpm/pg DNA)

Bromacll (M)

DMN (M)

0

10~7

10-6

10-5

10-*

ID'3

113
102
141

191
112
174

91

102

120

161

400

117
110

102

110

178

397

102

149

131

158

189

82

91

135

218

152

104

167

136

170

96

126
190

145

165

100

119

165
141

SD

41

30

13

37

23

SE

17

12

5

15

9

185
141
133
155
24
10

5 X 10"2

Sample
1
2
3

6
Mean

* vample lost.

81

*
529
645
448
484
105
50

�Table 55
DNA REPAIR SYNTHESIS ASSAY
OF CAOODYLIC ACID
DNA)

Cacodylic Acid (If)

4NQO (H)

o*

io-7

io-3

10-s

io-4

1 . at
0

Sample 1

61

41

47

_-*

31

36

1891

2

31

48

27

-_*

27

19

1681

3

32

59

25

63

30

45

2418

4

L8

32

68

29

19

2245

5

25

39

38
__*

23

22

38

1430

35

22

__*

29

28

36

2275

Mean

34

40

34

46

28

32

1990

SD

15

13

10

23

3

11

387

SE

6

5

5

11

1

4

158

6

Negative control and compound solvent =0.5^ DMSO.
t Slight lowering of pH at 10~3 M.
4' Sample lost.

82

10-6

�Table 56

DMA REPAIR SYNTHESIS ASSAY OF CAOODYL1C ACID
WITH METABOLIC ACTIVATION
ONA)
Cacodylic Acid (M)

DMNjM)

0*

io-5

10- «

io-3

Sample 1

44

25

21

29

381

2

30

33

22

25

384

3

23

39

28

21

339

Mean

33

32

24

25

368

SD

11

7

4

4

25

SE

6

4

2

2

15

Negative control and compound solvent =0.5$ EtGH.

83

5 X 10~2

�Table 57
DMA REPAIR SYNTHESIS ASSAY OF CAFFAN
DMA)

Gaptan (M)
8

io-

4MQO(M)

fl

--12LL

io-

10~

5

10-"

IP"5

Sample l

37

43

41

74

81

8

924

2

64

58

53

60

81

6

947

3

76

50

68

52

57

7

1106

4

76

60

73

37

51

5

801

5

63

61

56

50

72

5

760

6

66

44

66

82

65

6

884

Mean

64

51

59

59

68

6

904

SD

14

8

12

16

12

1

122

SE

6

3

5

7

5

Negative control and compound solvent = 0.5$ DN5O.

0.4

50

�Table 58

DNA REPAIR SYNTHESIS ASSAY OF CAPTAN
WITH METABOLIC ACTIVATION
DNA)
)_
io~5

10-*

5**)l.l*?i
io-3

5 x io-a

Sample 1

30

53

89

7

i

2

40
__t

50

73

5

323

48

71

5

384

35

50

77

6

353

SD

7

2

9

1

43

SE

5

1

5

0.6

31

3

Mean

Negative control and compound solvent =0.5$ DMSO,
Sample lost.

85

�Table 59
DNA REPAIR SYNTHESIS ASSAY OF CHLOROPYRIFOS
(dpm/,ig/DNA)

Chloropyrifos

4NQO (M)

io-5

JL

_10-7_

115

2801"

282*

2

1

143 "

129

93

110

67

3

98

102

84

60

&lt;t

72

95

64

110
_„*

52

—*
68

5

97

89

99

98

64

37

1208

6

78

- 98

85

86

79

49

1209

Mean

92

103

85

101

64

66

1339

SO

17

15

13

11

9

31

220

SE

7

7

6

5

4

15

98

Sample i

10-6

TO-5

KM

__*

6.1

HT3
109
__*

Negative control and compound solvent = 0.5^ DMSO.
Sample deleted from calculations because of low DNA value.
Sample loKt.

1337

—*
1721
1220

�Table 6G
DNA REPAIR SYNTHESIS ASSAY OF CHLOHOPYRIFOS
WITH METABOLIC ACTIVATION
DNA)

DMN (M)

Chloropyrifos (M)
10-

10-4

10-"

5 X 10~2

Sample 1

72

79

70

52

355

2

75

65

75

71

349

3

55

67

63

79

384

Mean

67

70

69

67

363

SD

10

8

6

14

18

SE

6

5

4

8

11

Negative control and compound solvent =0.5$ DMSO.

87

�Table 61
DEN REPAIR SYNTHESIS ASSAY
OF DINOSEB
(dpm/^g DNA)

Dinoseb (M)

4NQO (M)

_°:

.10-'

115

101

67

103

106

2

143*

101

68

100

100

3

96

112

54

116

79

1721

4

72

61

58

62

66

1220

5

97

57

63

60

67

1208

6

78

58

73

60

76

1209

Mean

92

82

64

84

82

1339

SO

17

26

7

25

17

220

SE

7

11

3

10

7

98

Sample 1

_L2I±

'

!
•

11

••
•

_iP±+

Negative control and compound solvent = 0.5$ DMSO.
Suggestion of precipitate at 10-" M.
Sample deleted from calculations because of low 'DMA value.
§ Sample lost.

88

HlL.
1337
__ §

�Table 62
DMA REPAIR SYNTHESIS ASSAY OF DINQSEB
WITH METABOLIC ACTIVATION
(dpm/pg MA)

-

«M»._.n«,

0*

Dinoseb (M)

,

J. _v 1 *
. .

w-

_ _ __ .

10-5

10~"

10-3

DMNjM)
5 X 10-a

Sample 1

72

93

76

71

355

2

75

81

80

64

349

3

55

51

58

89

384

Mean

67

75

71

74

363

SD

10

22

12

13

18

SE

6

12

7

8

11

Negative control and compound solvent =0,5$ DMSO.

89

�Table 63
DNA REPAIR SYNTHESIS ASSAY OF DSMA
(dpm/&gt;g DNA)

DSMA

j&gt;!

(M)

io-7

ig-g

1Q-S

10- y

io-3

Samp Le I

67

51

79

86

100

62

2

58

54

67

64

155

49

3

44

36

99

64

35

58

4

55

36

400*

45

44

59

5

79

62

74

53

55

68

6

105

32

75

107

89

69

Moan

68

45

79

70

80

61

SD

22

12

12

23

45

7

SE

9

5

5

9

18

3

Negative control and compound solvent = H2O.
Sample deleted from calculations because of low DNA value.

90

�Table 64
DNA REPAIR SYNTHESIS ASSAY OF DSMA
HTITH METABOLIC ACTIVATION
(dPm/|ig DNA)

DSMA

DMN__(M)

(M)

io-5

10 -&lt;

10-3

5 X 10"

Sample 1

44

28

25

38

381

2

30

36

29

36

384

3

23

21

32

28

339

Mean

33

29

29

34

368

SO

11

8

4

5

25

SE

6

4

2

3

15

Negative control and compound solvent - 0.5$ EtOH.

91

�Table 65

DNA REPAIR SYNTHESIS ASSAY
OF FENTHJON
(dprn/u-g DMA)

',
L

Fenthion (M

0*
Sample 1

89

2
3

43
107

4

10-6

10-5

4NQO (M)

10-j

10~3t

io-s

65
105

154

37

64

2983

337*

34

67

2272

83

85

40

36

2552

62

46

54

63

63

4059

5

61

34

102

31

44

1728

6

94

51

44

—§

33

1893

Moan

76

64

88

41

51

2583

SO

24

26

44

13

15

857

SE

10

11

18

5

6

350

•a
Negative control and compound solvent ~ 0.5$ EtOH.
Precipitate observed at 10"3 M.

' Sample deleted from calculations because of low DNA value.
§ Sample lost.

92

�Table «6

DNA REPAIR SYNTHESIS ASSAY OF FENTHIOH
WITH METABOLIC ACTIVATION
DNA)
Fenthion J.M)

_0?.

SSLUtiL

10-JL

10~ *

10

~JL

5 X 10~a

Sample 1

55

54

30

51

206

2

54

50

46

64

220

3

52

42

64

63

223

54

48

57

60

216

SD

2

6

10

7

9

SE

1

4

6

4

5

Mean

Negative control and compound solvent - O.S^t EtOH.

93

�Table 67
DM REPAIR SYNTHESIS ASSAY OF FOLPET
DNA)

Folpet (M)

4NQO(M)

*
Sample 1

37

43

63

45

82

29

924

2

64

58

62

54

58

25

947

3

76

91

108

52

92

31

1106

4

76

83

91

92

65

26

801

5

63

107

72

70

85

31

760

o

66

60

84

104

107

29

884

Mean

64

73

80

71

82

28

904

SO

14

24

18

25

18

2

122

SE

6

10

7

10

7

1

50

*

Negative control and compound solvent =0.5% DM80.

94

�Table 63
DNA REPAIR SYNTHESIS ASSAY OF FOLPET
WITH METABOLIC ACTIVATION
(dpm/yg DNA)
DMN JM^

_F°lP_et ($
0*

1 0~"

ID--

ID'3

5 X 10~2

30

49

49

—_ T

40
__t

54

63
82

40

323

58

384

35

52

49

353

SD

7

9

43

SE

5

3
2

98
81
18
10

5

31

Sample 1
2
3

Mean

54

Negative control and compound solvent
Sample lost.

95

m

0.5% DMSO

�Table 69
DNA REPAIR SYNTHESIS ASSAY
OF AZINPHOS-METHYL
DNA)
Azinophos-raethyl (M)

JL!

1^
2

10-"

102

145

99

99

.115

3

77

4

4NQO (M)

io-5

10- «

12±

264*

51

55

804

103

99

105*

39

924

96

71

82

55

33

629

97

125

100
__§

80

85

34

856

5

85

93

79

57

97

761

6

111

n

72

56

68

35

897

95

108

89

79

63

49

822

12

25

16

15

14

25

87

5

10

7

7

6

10

36

Sample 1

Mean
SD
SE

10- *

Negative control and compound solvent - 0.5% DMSO.
t Precipitate observed at .10"3 M.
t Sample delated from calculations because of low DNA value.
5 Sample lost.

96

�Table 70
DNA REPAIR SYNTHESIS ASSAY
OF AZINPHOS-METHYL WITH METABOLIC ACTIVATION
(dpm/yg DNA)
E&gt;MN (H^
_0_*

-!E1

-.19.7.1

JLSZi

5__x_ur_*
--1"

Sample 1

30

70

75

42

2

40

66

65

55

323

—f
35

78

41

54

384

71

60

50

353

SO

7

6

18

8

43

SE

5

3

10

4

31

3

Mean

itNegative control and compound solvent =0.5^ DMSO.
Sample lost.

97

�Table 71
DNA REPAIR SYNTHESIS ASSAY OF MALATHION
(dpm/pg DNA)
Mala thion (M)

4NQO (M)

_o*.

10-

lOTi

10-5

10-"

1C!

110

128
124

SE

6

9
4

29
12

90
126
67
113
91
156
107
31
13

33

130
116
127
143
128

144
78
74
119
132
127
112

SD

123
125
106
100
114
138
118
14

Sample
1
2
3
A
5
6

Mean

111
86
133
116
110
111
15
6

* Negative control and compound solvent • 0.5% EtOH.

98

34
23
44
39
40
35
7
3

1943
1626
1538
1264
1737
1651
1626
225
92

�Table 72
DNA REPAIR SYNTHESIS ASSAY OF MALATHION
WITH METABOLIC ACTIVATION
(dpm/jig-HJNA)
Halathion

(H)

7o-r

DHN (Mj_

0*

io-5

Sample 1

55

48

46

38

206

2

54

49

52

48

220

3

52

62

55

223

54

51

37
41

5

6

9

3

4

5

Mean
SD

2

53
8

SE

1

5

1 0™

*

Negative control and compound solvent =0.5^ EtOH.

99

5 X IO-2

216

�Table 73

DNA REPAIR SYNTHESIS ASSAY
OF METHOMYL
DNA)
Methomyl (M)
0*

io-7

Sample 1

135

2

133

3

165

—f
100

4

72

S
6

io-«

10~s

4MJO (M)

io-«

ID'3

10"6

116

117

126

88

1442

133

108

116

69

1544

129

97

122

69

1518

98

97

115

109

69

1385

104

85

103

109

70

1423

103

95

93

116
139

130

61

118

94

112

118

71

SD

32

6

17

115
14

f
—
1462

9

9

67

SE

13

3

7

6

4

4

30

Mean

95

Negative control and compound solvent =0.5^ DMSO.
Sample lost.

LOO

�Table 7-\
DNA REPAIR SYNTHESIS ASSAY OF METHOMYL
WITH METABOLIC ACTIVATION
DNA)

Methpmyl (M)

DMN(M)

0*

10-°

1C-4

ID'3

Sample 1

44

26

22

24

381

2

30

25

20

25

384

3

23

22

26

30

339

Mean

33

25

23

26

368

SO

11

2

3

3

25

SE

6

1

2

2

15

ft
Negative control and compound solvent - 0.5$ EtOH.

101

5 X 10-a

�Table 75
DMA REPAIR SYNTHESIS ASSAY
OF MDNUUON
DMA)

Monuron (M)
_°!

Sample 1

135

2

133

3

165

4

io-7
113
__*

io-6

4NQO (M)

io-5

10-'

86

97

83

48

1442

93

88

72

47

1544

10-3'

^ » ^ W
« * H

89

77

81

46

1518

72

129
__*

83

75

82

49

1385

5

104

118

92

77

84

45

6

103

131

110

109

85

38

1423
_J

118

123

92

87

81

46

1462

32

8

9

14

5

4

67

13

4

4

6

2

1

30

Mean
3D
SE

Negative control and compound solvent -'• 0.5% DMSO.
Precipitate observed at 10"3 M.
t Sample lost.

102 ,

�Table 76

DNA REPAIR SYNTHESIS ASSAY OF MONURON
WITH METABOLIC ACTIVATION
DNA)
Monuron (ll)

.£

10-"

10- «_.

_12I',.

5 x 10~a

-t

Sample J.

30

78

81

74

2

40

88

68

74

323

3

~r
'

92

63

88

384

35

86

71

79

353

SD

7

7

9

8

43

SE

5

4

5

5

31

Mean

w
Negative control and compound solvent =0.5^ DHSO.
Sample lost.

103

�Table 77
DNA REPAIR SYNTHESIS ASSAY OF MSMA
(dpm/jig UNA)

MSMA &lt;

k

4NQO (M)

01 )

10-8

10-4

io-3

10-"

108

60

68

902

84

93

53

93
52

39

1241

44

114

68

61

66

61

1380

4

55

1

235 "

50

63

66

67

990

5

79

75

75

48

60

1087

8

105

53

66
__*

50

59

75

971

Mean

68

73

77

60

64

62

1095

SD

22

29

23

9

16

12

182

SE

9

13

9

4

7

5

74

0*

10-'

Sample 1
2

67

38

58

3

10-"

Negative control and compound solvent = H20.
Sample deleted from calculations because of low DNA value.
Sample lost.

104

�Table 78
DNA REPAIR SYNTHESIS ASSAY OF MSMA
WITH METABOLIC ACTIVATION
(dpm/^g DNA)

MSMA (M)

-.0!

DMN (M)

JL°:L

10~5

io-3

JLJLlfiL1.

Sample 1

44

27

21

32

381

2

30

25

35

25

384

3

23

21

34

24

339

Mean

33

24

30

27

368

SD

11

3

8

4

25

SE

6

2

5

3

15

•ii-

Negative control and compound solvent =0.5^ EtOH.

105

�Table 79
DNA REPAIR SYNTHESIS ASSAY
OF PARATHION
(dpm/pg DNA)

_Q^

Sample
1
2
3
4
5
6
Mean
SD
SE

iQlL

Parathlon (M)
IP"6
10-5

123

127

151

221

125
106
100
114
138
118
14
6

129
135
124
137
145
133
7
3

155
135
200
160
210
169
29
12

129
157
137
155
126
154
35
14

4NQO (M)
IP"5

io±

10-

102
94

90
104
93
116
102

1626
1538
1264
1737

93
100
10
4

1651
1626
225
92

83
72
93
71
86
13
5

* Negative control and compound solvent - 0.5% EtOH.

106

3

1943

�Table 80
DNA REPAIR SYNTHESIS ASSAY OF PARATHION
WITH METABOLIC ACTIVATION
DNA)

Parathion £M)

DMN (H)

0*

10-s

10- «

10-3

Sample 1

44

33

42

20

381

2

30

33

32

23

384

3

23

35

30

30

339

Mean

33

34

35

24

368

SD

11

1

6

5

25

SE

6

1

4

3

15

Negative control and compound solvent -0.5% EtOH.

107

5 x 10- *

�Table 81
DNA REPAIR SYNTHESIS ASSAY
OF PARATHION-METHYL
DNA)

Parathion-Methyl (M)

.
£

4NQO (M)

10-7

10~8

10~B

10~4

10~3 t

10~5

Sample 1

36

36

33

34

44

40

2

34

38

32

.55

44

23

411*
781

3

8G

49

28

31

53

28

782

4

94

56

27

52

41

29

858

5

53

49

35

43

40

29

1296

6

112*

46

41

44

27

,1103

Mean

61

.6
4

33

85
50

44

,2
.8

964

SO

28

8

5

20

.5

6

227

SE

13

3

2

8

2

3

102

T,*

Negative control and compound solvent = 0.5% EtOH.
Precipitate observed at 10~3 M.
* Sample deleted from calculations because of low DNA value.

108

�Table 32
DNA REPAIR SYNTHESIS ASSAY OF PARATHION-METHYL
WITH METABOLIC ACTIVATION
DNA)

Parathion-Methyl (M)
•M-

DMN (M)

0

10-

10-*

10"" "^

Sample 1

55

44

65

51

206

2

54

54

52

48

220

3

52

57

37

45

223

54

52

51

48

216

SD

2

6

14

3

9

SE

1

4

8

2

5

Mean

Negative control and compound solvent =0.5$ EtOH.

109

5 X 10~a

�Table 83
DNA REPAIR SYNTHESIS ASSAY OF QUINTOZENE (PCNB)

DNA)
PCNB (M)

j£
Sample 1
2

61

3

32

4

18

5

25

6

35

31

Mean

34

SD

15

SE

6

JO"7

io-«

IP-6

10-*

35
43

33

21

27

23

22

21

18

37

44
30

31

23

18

19

30

16

18

21

38
20

27

32

22

27

20

39

20

27

35
9
4

27

23

20

26

5

8

4

6

2

3

2

3

Negative control and compound solvent =0.5$ DM90.
Precipitate observed at 10~3 M.

110

. 10"3

�Table 84
DNA REPAIR SYNTHESIS ASSAY OF QUINTOZENE (PCNB)
WITH METABOLIC ACTIVATION
DNA)

10

5 X 10

Sample 1
2

72

75

95

106

355

75

79

71

72

349

3

55

84

73

49

364

Mean

67

79

80

76

363

3D

10

5

13

29

18

SE

6

3

8

17

11

Negative control and compound solvent = 0.5% DHSO.

Ill

�Table 85

DNA REPAIR SYNTHESIS ASSAY OF PHORATE

DMA)
. Phorate

(M)

io-3t

1'
0"

27

56

411*

17

50

45

781

22

42

55

782

26

107
_.§

43

43

50

858

53

40

44

52

37

61

1295

112*

56

26

77

39

59

1103

Mean

61

43

52

39

40

55

964

SD

28

13

32

23

8

6

227

SE

13

5

14

9

3

2

102

0*

1

36

58

38

25

2

34

45

44

3

86

31

4

94

5
6

Sample

10-7

J£±

1Q-8

J£±

Jf.

Negative control and compound solvent = 0.5^ EtCH.
Precipitate observed at 10"3 M.
* Sample deleted from calculations because of low DNA. value.
§ Sample lost.

112

�Table 86
DNA REPAIR SYNTHESIS ASSAY OF PHOKATE
WITH METABOLIC ACTIVATION
DNA)
Phoraice. (ll)

DMN (M)

_wrf_

5 X 10-'

J&gt;!

_™L*

Sample 1

55

45

43

37

206

2

54

59

41

35

220

3

52

63

39

38

223

54

55

41

37

216

2

10

2

1.4

9

1

6

1

08
.

5

Mean
SD
SE

-12™

Negative control and compound solvent =0.5^ EtCH.

113

�Table 87
DNA REPAIR SYNTHESIS ASSAY
OF SIMAZItiE
(dptn/ug DHUO

Slmazlne (M)

4NQO (M)

_ai
Sample
1
2
3
4
5
6
Mean
SD
SE

io-7

IP"6

10"5

iEi

IP"3

10"5

195
153
212
230
217
298
218
48
19

165
91
131
138
152
113
132
27
11

151
171
152
146
179
213
169
25
10

195
190
312
290
237
305
255
55
22

177
193
253
281
166
161
205
50
20

369
208
233
165
205
t

2670
2850
2688
2702
2435
2662
2668
134
55

* Media control and compound solvent » 0.5% DMSO.
t Sample lost.

114-

236
78
32

�Table 38
DNA REPAIR SYNTHESIS ASSAY OF SIMAZINE
WITH METABOLIC ACTIVATION

g MA)
Slmazlne __(M)
5 X 10"*

Sample 1

72

57

64

59

355

2

75

58

60

58

349

3

55

64

61

76

384

Mean

67

60

62

64

333

SD

10

4

2

10

18

SE

6

2

1

6

11

Negative control and compound solvent = 0.5^&gt; DHSO.

115

�Table 89
DMA REPAIR SYNTHESIS ASSAY
OF TRIFLURALIN
DHA)

Trlfluralin (M)

4NQO (M)

0*

io-7

10-e

io-»

io-«

10-'

10- •

Sample 1

56

42

53

51

71

639

2

68

29

26
_J'

152*

97

123

3

51

78

48

68

158*

112

570

4

45

51

76

89

78

83

894

5

50

47

79

97

56

80

663

6

29

41

59

57

43

53

986

Mean

50

48

58

73

62

87

812

SD

13

17

22

19

28

26

222

SE

5

7

10

9

12

11

91

Negative control and compound solvent =0.5$ EtCH.
Sample lost.
Sample deleted from calculations because of low DMA value.

116

1125

�Table 90
DNA REPAIR SYNTHESIS ASSAY OF TRIFLURALIN
WITH METABOLIC ACTIVATION
DNA)

Trifluralin (M)
0*

DMN (M)

10-'

10-*

10-'

5 X 10~a

Sample 1
2

72

67

79

51

355

75

58

55

74

61
.._t

349

3

64
79

Mean

67

66

74

56

363

SD

10

8

9

7

18

SE

6

5

5

5

11

*

Negative control and compound solvent =0.5% DM30.
Sample lost.

117

384

�Table 91
IN VITRO ASSAYS WITH SALMONELLA TYPHIMURIUM

Compound

Metabolic
Activation

yg Compound
Added/Plate

95
113

Negative control

+
Positive control, 4-o-tolylazo-l-toluidine
v-

oo

Mofioerotephos

—
+
_
—
+
+
+
+
+
+
+

Average Number of
Histidine-Positive Revertants /Plate
TA1538
TA100
TA1537
TA1535

25
25
1
5
10
50
100
500
1000

1
5
10
50
100
500
1000

13
13

8
10

7
10

87
101
93
107
97
95
126

9
22
14
23
13
17
14

10
9
9
7
11
10
10

6
183
11
10
13
10
9
7
6

101
89
75
79
71
78
113

16
20
16
14
16
19
18

14
13
12
10
15
9
10

12
12
11
10
11
15
10
o
n
o
ft
o
•o

�Table 91 (continued)

Compound

Metabolic
Activation

pig Compound
Added/Pla te

Negative control
Positive controls
p-Propiolactone
AF-2
2-Anthramlne

Bromacll

^
.

Average Number of
Histidine-Positive Revertants/Plate
TA1537
TA1538
TA100
TA1535
145
154

+
-

+
+
+
+
+
+
+

50 p,l
0.05
50

22
25

25
24

16
30

756
372
63
338

50
1
5
10
50
100
500
1000

120
129
123
117
16
3
10
4
101

23
17
31
29
40
30
14

24
13
22
16
18
15
6

26
14
13
15
1
9
15
11

1
5
1
0
5
0
1
0
0
500
1000

118
131
157
136
138
145
162

35
28
33
26
30
21
8

21
1
6
21
14
12
20
5

16
20
19
13
15
20
16

�Table 91 (continued)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Cacodylic Acid

Average Number, of
Histidine-Positive Revertants/Plate
TA100
TA1537.
TA1535
TA1538

56
72

15
14

12
9

7
15

15
15
15
10
11
11
8
14
15
12
11
15
14
13

10
150
5
11
8
8
9
9
8
18
8
18
12
19
15
13

25
25

1
5
10
50
100
500
1000

48
42
42
39
43
44
44

1
5
10
50
100
500
1000

69
53
64
50
64
54
59

17
15
12
18
22
15
16
17
15
16
15
18
21
14

S?
n

a
^j
p™

HO

fr

£

�Table 91 (continued)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Captan

Average Number of
Histidine-Positive Revertants/Plate
TA1537
TA100
TA1535
TA1538

72
98
2
2

18
14

7
3

8
25

2
5
0
0
0
0
2
2
2
0
0
1

7
14
16
26
6
22

3
100
211
532
822
820
720

1
5
10
15
25
50

Killing

1
5
10
15
25
50

141
210
285
340
330
704

29
80
76
104
SO
Killing

20
60
113
55
71
143

19
22
26
21
46
44

•o
ft

�Table 91 (continued)

Compound

Metabolic
Activation

lig Compound
Added/Plate

Negative control

Average Number of
.
Histidine-Positive Revertants/Plate
TA100
TA1535
TA1537
TA153S

92
80

18
14

12
16

16
16

Positive control, 4-o-tolylazo-o-toluidine
Chloropyrifos

5
10
50
100
500
1000

66
92
65
SB
67
87
79

20
22
14
26
20
17
13

12
15
21
15
17
18
20

15
168
22
28
24
25
22
17
22

1
5
10
50
100
500
1000

67
71
87
77
77
72
77

11
9
11
16
11
13
14

15
15
15
18
14
14
11

14
16
20
13
16
30
22

1

3
M
O
O

O
CD

�Table 91 (continued)

Compound

Metabolic
Activation

Vi g Compound
Added/Plate

97
30

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Dinoseb

ro

Average Number of
Histidine-Positive Revertants/Plate
TA1537
TA1538
TA100
TA.1535

15
15

12
16

25
25

1
5
10
50
100
500
1000
1
5

10
50
100
500
1000

21
17
•

69
59
57
67
82
91

12
12
17
17
12
7

Killing

Killing

79
82
94
83
87
104
Killing

13
14
12
14
13
12
Killing

21
16
18
1.7
16
17
Killing

19
18
17
15
17
10
Killing

15

168
15
14
20
17
15
19
Killing

15
14
15
17
14
7
Killing

CD

s-

�Table 91 (continued)

Metabolic
Activation

yg Compound
Added/Plate

56
72

Negative control
Positive control, 4-c-tolylazo-o-teluidine
DSMA

Average Number of
- *Histidine-Positive Revertants/Plate
TA1538
TA100
TA1537
TA1535

15
14

7
15

12
9
.

25
25

10
250

1
5
10
50
100
500
1000

50
56
51
66
71
53
43

12
10
20
15
16
13
12

7
10
10
11
7
12
7

4
5
3
8
8
7
9

1
5
10
50
100
500
1000

54
85
50
55
50
60
53

22
7
16
17
13
15
14

8
8

8
15
3
5
7
10
8

11
9
5
2

o

(A

�Table 91 (continued)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Azinphos-methyl

Average Number of
Histidine-Positive Revertants/Plate
TA100
TA1535
TA1537
TA1538

101
102

26
26

6
3

25
25

13
24
13
78

1
5
10
50
100
500
1000

66
74
74
73
75
107
104

39
22
23
30
49
30
31

1
5
10
50
100
500
1000

76
69
68
81
65
84
119

23
23
24
22
24

:io
24

4
3
2
3
4
2
3
1
2
3
3
2
0
0

10
11
9
11
10
10
13
20
25
28
21
19
24
23

o

CD

�Table 91 (continued)

Compound

Metabolic
Activation

pg Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-taluidine
Fenthion

Average Numb en of ;. ^c, -Histidine-Positive Revertants/Plate
TA1537
TA1538
TA100
TA1535

94
80

36
20

10
9

12
12
15
168

25
25

1
5
10
50
100
500
1000

64
97
105
112
100
107
90

31
34
32
36
38
42
32

8
11
15
15
16
10
6

13
17
12
14
14
14
12

1
5
10
50
100
500
1000

114
97
81
90
98
86
89

15
17
9
16
14
22
20

10
12
9
12
7
8
10

12
10
17
21
13
10
15
(D
3

O

�Table 91 (continued)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Average 'Number of
Histidine-Positlve Revertants/Plate
TA100
TA1537
TA1535
TA153S

72
93

Negative control
Positive control, 4-o-tolylazo-o-toluidine

1
5
10
25

3
7

25
25

Folpet

19
15

50
100
500
10GO
1
5
10
25
50
100
500
1000

127
150
244
300
550
286

20
35
39
48
111
110

Killing
Killing

Killing
Killing

112
173
241
420
720
532

20
51
79
70
218
216

Killing
Killing

Killing
Killing

7
0
1
0
2
0
0
0
2
1
5
6
10
3
0
0

8
20
6
183
5
8
11
14
7
2
Killing
Killing

30
26
35
36
45
48
Killing
Silling

•&lt;B

�Table 91 (continued)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Negative control

39
92

Positive control, 4-e-tolylazo-o-tol.uidine

OS

1
5
10

10
10

8
10

25
25

Malathion
IsJ

Average Number of
Hiscidine-Positive Revertants/Plate
TA1537
TA100
TA1535
TA1538

7
7
6
183

500
1000

54
48
85
99
81
82
61

8
7
7
8
7
12
10

11
12
10
6
7
5
7

3
3
5
7
5
7
4

1
5
10
50
100
500
1000

65
61
99
92
75
90
66

5
6
9
8
9

6
8
7
7
6
12
10

9
5
4
6
5
4
4

50
100

a

7

gf

h0)
ft

HO

a

�Table 91 (continued)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Methomyl
N&gt;
vO

Average Number of
Kistidine-Positive Revertants/Plate
TA1538
TA100
TA1537
TA1535

128
149

18
14

33
20

1
5
10
50
100
500
1000

123
112
98
109
110
119
105

28
35
28
27
34
23
24

1
5
10
50
100
500
1000

145
115
125
129
132
133
122

19
20
16
18
21
17
13
12
10
12
10
13
10
14

17
22
17
206
14
10
18
14
24
26
21

18
18
21
19
20
20
24

15
15
13
20
19
18
14

25
25

�Table 91 (continued)

Compound

Metabolic
Activation

Mg Compound
Added/Plate

Negative control
Positive control, 4-o-colylazo-o-toluidine
Monuron
UJ

o

Average Number of
Hisiidine-Positive Revertants/Plate
TA100
TA1535
TA153V
TA1538

128
149

17
12

17
15

25
25

17
22

6
177

1
5
10
50
100
500
1000

126
. 98
108
122
114
122
125

.15
24
17
19
19
20
22

15
12
12
11
15
18
14

1
5
10
50
100
500
1000

125
142
119
116
108
104
123

10
13
17
15
15
15
11

15
15
13
19
16
15
15

19
18
22
21
29
29
19
21
15
18
21
19
12
17

1
o

9

�Table 91 (continued)

Compound

Metabolic
Activation

li g Compound
Added/Plate

56
72

Negative control
Positive control,
MSMA

Average Number of
Histidine-Positive Revertants/Plate
TA100
TA1537
TA1538
TA1535

4-o-tolylazo-o-toluidine

15
14

12
9

7
15
10
250

25
25

1
5
10
50
100
500
1000

79
69
62
52
41
53
48

1
5
10
50
100
500
1000

79
64
65
67
53
66
68

15
15
14
17
15
17
13
11
15
7
7
12
14
10

7
13
11
11
12
8
12

6
4
6
6
7
5
5

11
8
10
14
8
7.
10

10
10
9
7
8
8
10

�Table 91 (continued)

Compound

Metabolic
Activation

pg Compound
Added/Plate

Negative control
Positive control, 4-o-toIylazo-o-toluidine
Parathior

Average Number of
Histidine~Fositive Revertants/Plate
TAiOO
TA1537
TA1535
TA1538

95
114

19
21

6
13

25
25

1
5
10
50
100
500
1000
1
5
10
50

100
500
1000

94
138
85
98
87
110
107
56
75
69
76
88
105
103

12
12
13
13
15
1314
11
16
14
14
17
15
12

7
7
4
4
4
4
3
12
7
5
6
7
8
6

6
7

6
177
8
7
7
8
6
8
13
15
15
19
8
5
9
12
(B

rt

HO

�Table 91 (continued)

Compound

Metabolic
Activation

ug Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Phorate

Average Number of
Histidine-Positive Revertants/Plate
TA100
TA1535
TA1537
TA1538

96
118

15
17

8
11

25
25

1
5
10
50
100
500
1000

70
65
85
65
72
70
58

17
15
17
17
11
14
14

i
5
10
50
100
500
1000

101
103
79
89
79
59
70

14
11
13
15
15
16
19

8
8
7
5
7
6
7
11
8
10
9
6
6
8

8
11
6
177
16
11
11
8
9
6
9
15
10
12
11
7
11
5

I

�Table 91 (continued)

Compound

Metabolic
Activation

wg Compound
Added/Plate

Negative control
Positive control"-," 4-o-tolylazo-o-toluldine
Siaazine

.&amp;&gt;

Average Number *of'
Histidine-Positive Revertants/PlaLe
TA1537
TA1538
TA100
TA1535

98
106

10
7

8
8

83
72
73
87
85
71
6S
84
90
82
S3
87
89
120

7
5
7
7
8
3
4

15
10
20
10
12
7
11

25
26
22
266
22
20
20
22
17
25
22

9
4
8
9
8
4
2

11
11
16
9
11
16
10

22
22
15
14
15
15
18

25
25

1
5
10
50
100
500
1000
1
5
10
50
100
500
1000

(
4

H-

�Table 91 (concluded)

Compound

Metabolic
Activation

yg Compound
Added/Plate

Negative control
Positive control, 4-o-tolylazo-o-toluidine
Trifluralln

Average Number of
Histidiae-Positive Revertants./Plate
TA1537
TAiOO
TA153S
TA1535

96
80

15
15

17
20

14
8

18
24
29
23
25
22
18

15
168
15
14
14
16
15
11
15

13
16
18
14
16
13
15

9
9
14
13
15
11
10

25
25

1
5
10
50
100
500
1000
1
5
10
50
100
500
1000

73
81
74
93
86
76
95
72
80
78
90
81
79
81

11
12
16
19
18
18
13
10
13
14
15
8
12
12

l-l
p&gt;

�Table 92
RESULTS OF ASSAYS WITH ESCHERICHIA COLI WP2

Compound

Metabolic
Activation

Negative control

.
-f-

Positive control,
AF-2

+
-

yg of Compound
Added per Plate

Moncrotopbos

- •

+
+
+
+
+
+
Bromacil

—
B

—
B

.
.

^
—

+
+
+
+
+
+

0.05
0.05

1
10
50
100
500
1000

i
10
50
100
500
1000

1
10
50
10
0
500
1000
1
10
50
100
500
1000

Average Number o± Tryptophan
Positive Revertants per Plate

68
73
204
220
89
83
76
77
61
70
90
88
76
73
75
95
65
74
71
70
70
67 71
73
66
70
70
71

�Table 92 (continued)

Compound
Cacodylic Acid

Metabolic
Activation
-

+

+
+
+

1
10
50
100
500
1000
1

Average Number of TryptophanPositive Revertants per Plate
m
102
89
82
91
85
95

+
-

+
+

+
+
+
+

10
50
100
500
1000
j
5
10
15
25

381
733
1358
1755

50

+

Captan

yg of Compound
Added per Plate

76
79
89
81
85

2600

1
5
10
15
25
50

89
182
423
699
955
1712

124

�Table 92 (continued)

of TryptophanMetabolic
Activation

of Compound
per Plate^

Dindseb

1
10
50
100
500
1000

57
57
49
71
52
42

1
10
50
100
500
1000

Chloropyrifos

60
73
53
49
61
49

1
10
50
100
500
1000

64
73
5fr
55
44Toxic

1
10
50
100
500
1000

73
69
63
65
49
Toxic

�Table 92 (continued)

Compound

Metabolic
Activation

DSMA

Average Number of TryptophanPositive Revertants per Plate

1
10
50
100
500
1000
+
+
+
+
+
•i-

Fenthion

Mg of Compound
Added per Plate

86
81
67
68
68
71

1
10
50
100
500
1000

69
62
67
73
81
79

1
10
50
100
500
1000

59
63
62
56
70
71

1
10
50
100
500
1000

64
50
67
64
64
81

�Table 92 (continued)

Compound

Folpefc

Metabolic
Activation

-^g of Compound
Added per Plate

1
5
10
25
50
100

Azinpbos-methj'l

1
5
10
25
50
100
1
10
50
100
500
1000

1
10
50
100
500
1000

Average Humber'Wf "1'ryp^lbphanPositive Reveftantfl "per Plate

65
162
170
424
720
1260

74
167
202
900
16SO
1880

92
87
83
89
68
88
83
74
87
86
73
79

�Table 92 (continued)

Halathion

Methomyl

Metabolic
Activation

wg of Compound
Added per'Plate

-

1
10
50
100
500
1000

62
54
60
60
54
48

+
+
+
+
+
+

Compound

1
10
50
100
500
1000

58
50
55
59
75
64

-

1
10
50
100
500
1000

61
76
83
57
68
71

+
+
+
+
+
+

1
10
50
100
500
1000

70
81
78
83
63
74

.

Average Number of TryptophanPositive Revertants per Plate

�Table 92 (continued)

Compound

Metabolic
Activation

pg of Compound
Added per'Plate

Average Number of TryptophanPositive Revertants per Plate

Momuron

-

1
10
50
100
500
1000

72
68
57
63
65
63

MSMA

+
+
+
+
+
+
-

1
10
50
100
500
1000
i
10
50
100
500
1000

60
59
47
71
50
61
55
64
57
76
60
63

+
+
+
+
+
+

1
10
50
100
500
1000

55
71
73
71
61
72

�Table 92 (continued)

Compound
Parathion

Metabolic
Activation

]jg of Compound
Added per Plate

1

Average Number of TryptophanPositive Revertants per Plate

10
50
100
500
1000
1
10
50
100
500
1000

Parathion-methyl

71
64
66
70
64
64
69
53
76
57
72
66

1
10
50
100
500
1000
1
10
50
100
500
1000

53
56
60
68
63
52
64
83
60
65
53
71

�Table 92 (continued)

Compound

Metabolic
Activation

Average-Number of TryptophaaPositive Revertantsv.per Plate

1
10
50
100
500
1000

Qulntozene (PCNB)

+
+

•s+
Phorate

ug of Compound
Added per Plate

70
60
57
62

1
10
50
100
500
1000

78
67
54
57
59
62

1
10
50
100
500
1000

63
64
65
49
71
60

1
10
50
100
500
1000

78
86
83
73
90
70

54

:-s

�Table 92 (concluded)

Compound
Simazine

Metabolic
Activation

pg of Compound
Added per Plate

1

Average Number of TryptophanPositive Revertauls per Plate

10
50
100
500
1000

1
10
50
ICO
SCO
1000
Trifluralin

55
51
73
54
54
53
64
66
72
56
71
83

1
10
50
100
500
1000

75
73
81
86
69
60

1
10
50
100
500
1000

58
63
63
65
70
70

�Table 93
MICROBIAL INHIBITION IN ESGHERICHIA COLT AND BACILLUS SUBTILIS

Diameter of Zone of Inhibition (mm)
• ...

\

•

Compound

TCg of Compound
Added to Disc

E. coli

W3110

p3478

B. subtilis
HI 7
m45

Positive control,
"i-plieiiyl-3,-.'
diiriethyitriazene

1.0

37

52

40

61

Negative control,
chlcracsphenacol

0.03

34.5

34

32

31

Monocrotophos

1

6 .

6

6

6

Bromacil

1.0

6.5

6.5

6.5

6.5

Cacodyiic acid

I

6

6

6

6

Cap tar.

0.1

6.5

11

9

19

Chloropyfif os

2.5

6

10

6

11

Dinoseb

1

10

17

8.5

11

DMSA

1

6

6

6

6

Fenthion

1

6

6

6

6

Folpet

0.1

6.5

6.5

7.5

Azinphos-methyl

1

6

6

6

CD

10

6

�Table 93 (concluded)

Diameter of Zone of Inhibition (mm)
Compound

mg of Compound
Added to Disc

E. coli
p3478
W3110

B. subtilis
H17
m4 5

Malathion

1

6

6

6

6

Me thorny 1

1

6

6

6

6

Monuron

1

6

6

6

6

MSHA

1

6

6

5

6

Parathion

1

6

6

6

6

Parathion-methyl

1

6

6

6

6

Qulntozene (PCNB)

1

6

6

6

6

Phorate

1

6

6

6

6

Simazins

1

6

6

6

6

Trifluralin

1

6

6

S

6

�Table 94
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - SwSiOCRCTCPEOS

Metabolic
Compound

Percent
Concentration
(w/v or v/v)

Mitotic Recombinants
Survivors
per 105
Cells/ml
per ml
Percent of
3
7
Control ,. . (x 10- ) Survivors
(x 10- )

EXPERIMENT 1

5.7

100

4.5

7.9

5.8

100

4.5

7.8

0.1

5.8

102

1,650

2,845

0.1

46
.

79

1,435

3,120

5

5.7

10O

44

77.2

5

47
.

81.

30

63.8

91
.

100

8

8.8

86
.

100

9.5

5

6.3

69

26

41.2

5

48
.

56

40

83.3

Negative control

Positive control

1,2,3,4-Diepoxybutane
Monocrotophos

EXPERIMENT 2
Negative control

Uonocrotophos

11.0

�Table 95

IN VITRO ASSAYS WITH SACCHAROHYCE3 CEREVISIAE 03 - BROHACIL

Compound

Metabolic
Activation

Percent
Survivors
Percent of
Concentration Cells/ml
(w/v or v/v) (x 10 •&gt;)
Control

Mi t otic Recombinants
per I0a
per ml
fx 10 3) Survivors

EXPER1HHJT 1

4.8

Negative control

4.7

Positive control
1,2,3.4-Dlepoxybutane

100
100

3
3

71
74
104
94
104
92

745
683

3.4
3.5

005
.0
0.01
0.05
01
.0
05
.0

50
.
4.5
5.0

005
.0
0.01
00
.5
0.10
05
.0

Bromacil

0.04
0.04

4.4
3.9
4.3
3.8
2.4

94
83
91
81
51

5

4.5
4.2
00
.4
00
.4
00
.5
01
.0
0.25

4.4
2.0

42

3
2
3
1
1

6.3
6.4
2191
1951

6.0
4.4
6.0
2.3
10.0

3
1

11.4
7.7
7.0
2.6

3

12.5

10
0
10
0

5

11.1

3

7.1

4.5
4.2

100
10
0

80
7
653

5.7
54
.
5.5
49
.

126
120
122
108

7
5
5
1

4 .9
47
.
48
.
4.9

117
112
114
117

4
5
6
1

3

EXPERIMENT 2
Negative control
Positive control

1,2,3,4-Dlepoxybutane
Bromacil

0.50
0.05

01
.0
0.25
05
.0

1933
1555
12.3
9.3
9.1
20
.

8. 2
10. 6

12.5
2.0

�Table 96
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - CACODYLIC ACID

Compound

Metabolic
Activation

. Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10~7 )
Control

Mitottic Recombioants
per 10a
per ml
3
(x ID' ) Survivors

EXPERIMENT 1

Negative control
;

74
.

7.5

7.7

10
0

5

5

5.6

76

20

35.7

5

6.3

82

11

17.5

7.1

100

3.5

49
.

6.5

100

3

4.6

5

15.5

217

1,187

766

5

17.5

270

1,159

662

+

Cacodylic acid
so

10O

+

10.1

6.5

EXPERIMENT 2

Negative control
+
Cacodylic acid

+

�Table 97
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - CAPTAN

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
Control
(x 10-7)

Mitotic Recombinar.ts
per 105
per ml
3
(x lO" ) Survivors

EXPERIMENT 1
Negative control

7.1

100

3.5

49
.

6,5

100

3.0

4.6

0.003

60
.

84

205

342

0.0
03

9.1

140

145

159

7.5

100

1.5

2.0

60
.

10
0

4

67
.

10

37

481

85

58

114

+

Captan

+
Wl

EXPERIMENT 2

_
Negative control

+
Captan

003
.0

+

0. 0
03

.7
7
5.1

�Table y8
IN VITRO ASSAYS WITH SAGCHAROMYCES CEREVISIAE D3 - CHLOROPYRIFOS

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Mitotic Recorabinants
Survivors
Cells/ml
,per 10s .„
Percent of
per ml
7
•*
(x 10~ )
Control ",,(* 10 -.».) ^urviVorssf

EXPERIMENT 1
7.5

100

1.5

2.0

6.0

100

4

6.7

5

7.7

103

7

9.1

5

8.0

133

10

12.5

6.3

100

1.5

2.4

7.4

10O

3.5

4.7

0.1

3.8

60

1,045

2,750

0.1

5.2

70

903

1,737

5

7.9

125

3

5

7.4

100

10

Negative control
+

ChloropyrifoB
+

•-J--

EXPERIMENT 2

Negative control
+

Positive control,
1,2,3, 4-diepoxybutane

+

Chloropyrifos
+

3.8

13.5

�Table 99
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - DINOSE3

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10-7)
Control

Mitotic Recombinants
per ml
per 10s
(x 10-') Survivors

EXPERIMENT 1

-

6.3

100

1.5

2.4

+

7.4

100

3,5

4.7

0.1

3.8

60

1,045

2,750

0.1

5.2

70

903

1,737

0.2

62
.

98

9

14.5

0.2

40
.

54

1

2.5

0.3

Negative control

.
3

5

5

0.3

2.4

32

5

5.5

100

2.5

4.5

5.2

100

2.0

3.8

0.1

4.4

80

3

68
.

0.1

40
.

77

4

10.0

02
.

4.1

75

8

19.5

0.2

4.3

83

8

18.6

Positive control,
1, 2 ,3 ,4-diepoxybutane

+
in
in

Dinoseb

+

+

167

20.8

EXPERIMENT 2

_
Negative control

+
Dinoseb

+

+

�Table 100
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - DSMA

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
Control
(x 10-')

Mitotic Recombinan,£s
5
per ml
per 10 (x 10j3) Survivors:

EXPERIMENT 1
Negative control

7.4

100

7.5

10.1

7.7

100

5

6.5

4.5

1.1

15

0

4.5

5.2

68

0

7.1

100

3.5

4.9

6.5

100

3

4.6

5

4.7

66

3

6.4

5

3.4

52

7

+

DSHA
+
Ul

a-.
EXPERIMENT 2
_

Negative control
+

DSMA
+

20.6

!

�Table 101
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - FENTHION

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10"7)
Control

Mitotic Recombinants
oer ml
per 105
3
(x 10- ) Survivors

EXPERIMENT 1
Negative control

6.3

100

1.5

2.4

7,4

100

3.5

4.7

0.1

3.8

60

0.1

5.2

70

903

5

6.6

105

9

5

7.5

101

5

6.7

7.5

100

1.5

2.0

6.0

100

4

6.7

5

7.S

104

4

5.1

5

7.1

118

6

8.5

+
Positive control,
1 , 2 , 3 , 4-d iepoxybutane
Ul

•vj

+

Fentbicn

+

1,045

2,750
1,737
13.6

EXPERIMENT 2
Negative control

+
Fenthion

+

�Table 102
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - FOLPET

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Percent of
Cells/ml
Control
(x 10-7)

^MJ-.totic Rjgcombinants
|
"* ' per ml * "~p~e*" 10s .
U io-3) Survivors

EXPERIMENT 1

_
7.5

100

1.5

2.0

60
.

100

4

67
.

003
.0

40
.

53

119

298

0 .0
03

3.8

63

65

171

6.3

100

1.5

2.3

74
.

100

3.5

47
.

0 .0
03

9.5

151

89

94

0 .0
03

9.1

123

82

90

Negative control

+
Folpet

+

EXPERIMENT 2

_
Negative control

+
Folpet

+

�Table 103
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 -AZINPHOS-METHYL

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Percent of
Cells/ml
Control
(x 1 " )
0'

Mitotic Recombinants
per ID5
per ml
3
(x 10- } Survivors

EXPERIMENT 1

_
5.7

100

4.5

7.9

5.8

100

4.5

78
.

0.1

5.8

102

0.1

46
.

4.5
4.5

Negative control
+

Positive control
1,2,3,4-Diepoxybutane

+

79

1,435

3,120

5.3

93

15

28.3

5.8

100

15

25.9

100

8

8.8

8.6

100

S.5

5

Azinphos-methyl

2,845

S.I

+

1,650

5.7

63

68

119.3

5

6.2

72

80

129

EXPERIMENT 2

_

Negative control
-i-

Azinphos-methyl
+

11.0

�Table 104
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - MALATHION

Compound

Metabolic
Activation

Percent
Concentration
(w/v or -v/v)

Survivors
Cells/mi
Percent of
Control
(x 10~7 )

Mi tot ic Recorabinants
per 10s
per ml
3
(x 10- ) Survivors

EXPERIMENT 1

Negative control
• . -. . i \ --. • * •. •
Positive control,
1 , 2., 3 , 4-diepoxy butane
o*
o

5.7

100

4.5

7.9

5.8

10
0

4.5

78
.

0.1

5.8

102

1,65O

2,845

0.1

4.6

79

1,435

3,120

5

7.8

137

11

14.1

5

6.3

109

7

11.1

9.1

100

8

8.8

8.6

100

9.5

5

8.1

89

13

16.0

5

7.6

88

8

10.5

+

+

Malathion
+

EXPERIMENT 2

Negative control
+

Malathion
+

11.0

�Table 105
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - METHOMYL

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10-7)
Control

Mitotic Recombinants
per 10s
per ml
3
(x 10- ) Survivors

EXPERIMENT 1

6.6
5.8

100
100

0.1
0.1

1.8

27

266

1,478

1.5

29

184

1,227

2.0

5.0

76

4

2.0

2.7

50

0

3.0

Positive control,
1,2,3, 4-diepoxybutane

+

Negative control

3.7

56

8

21.6

3.0

4.1

76

6

14.6

5.5

100

2.5

4.5

5.2

100

2.0

3.8

3

4.7

85

15

31.9

3

4.4

85

10

22.7

+

Methomyl

+

+

4.5
2.5

6.8
4.6

80
.

EXPERIMENT 2
_

Negative control

+
Methomyl

+

�Table 106
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - MONURON

Compound

Metabolic
Activation

Percent
Concentration
(v/v or v/v)

Survivors
Cells/ml
Percent of
Control
(x 10~7)

Mitotic Recorabinants
per 105
per ml
Survivors
. (x 10-»)

EXPERIMENT i

66
.

100

45
.

68
.

5.4

100

2.5

4.6

0.1

1.8

27

266

148
,7

0.1

1.5

29

184

1,227

5

3.5

53

3

8.6

5

3.8

70

1

2.6

5.5

100

2.5

4,5

5.2

10
0

2.0

3.8

5

6.9

125

2

2.9

5

6.2

119

9

14.5

Negative control

+
Positive control,
1,2,3, 4-diepoxybutane

+

Monuron

+

EXPERIMENT 2
Negative control

+
Monuron

+

�Table 107
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - MSMA

Compound

Metabolic
Activation

Percent
Concentration
&gt;/v or v/v)

Survivors
Cells/ml
Percent of
(x 10~7)
Control

Mitotic Recombinants
per ml
per 105
3
(x 10- ) Survivors

EXPERIMENT 1
Negative control

7.4

100

7.5

7.7

100

5

6.5

5

4,3

58

1

2.3

5

5.4

70

3

5.6

7.1

100

3.5

4.9

6.5

100

3

4.6

5

4.9

69

10.2

20.8

5

5.8

89

10.4

17.9

+
MSMA
-f-

10.1

EXPERIMENT 2
Negative control

+
MSMA

+

�Table 108
IK VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - PARATHION

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Percent of
Cells/ml
Control
(x 10-')

Mitotic Recombinants
per 10s
per ml
3
(x 10- ) Survivors

EXPERIMENT 1

_

Negative control

5.7

Positive control,
1 , 2 , 3 , 4-diepoxybutane

4.5

7.9

5.8

+

100
100

4.5

7.8

2,845
3,120

1,650

46
.

79

1,435

6.5

3

4.6

5

5.8

114
100

5

8.6

100

8

88
.

8.6

100

9.5

5

••!

102

9.1

Parathion

5.8

5

+

0.1
0.1

8.8

96

4

4.5

5

8.2

95

5

6.1

EXPERIMENT 2

_

Negative control
+

Parathion
+

11.0

�Table 109
IN_ VITRO ASSAYS WITH SACCHAROMYCES rEREVISLAE D3 - PARATHION-METHYL

Compound

Metabolic
Activation

Percent
Concentration
{w/v or v/v)

Survivors
Cells/ml
Percent of
Control
(x 10-7)

Mitotic Reconibinants
per ml
per 10s
3
Survivors
(x ID' )

EXPERIMENT 1

Negative control

5.7

100

4.5

7.S

5.8

100

4.5

7.8

0.1

5.8

102

1,650

2,845

0.1

46
.

79

1,435

3,120

5

7.7

135

16

20.8

5

5.4

93

15

27.8

-

91
.

100

8

S.8

+

8.6

100

9,5

5

7,4

81

19

25.7

5

7.2

84

25

34.7

+

Positive control,
1,2,3, 4-diepoxybutane

+

Parathion-methyl
+

EXPERIMENT 2

Negative control

Parathion-methyl
+

11.0

�Table 110
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - QUINTOZENE (PCNB)
\—
f

Compound

Metabolic
Activation

Percent
Concentration
'',w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10-7)
Control

Mitotic Recombinants
per ml
per 105
3
(x 10- ) Survivors

EXPERIMENT 1

_
5.7

100

4.5

7.9

5&amp;
.

100

4.5

7.8

0 .1

5.8

102

1,650

2,845

0.1

4.8

79

1,435

3,120

2

3.7

65

3

8.1

2

4.2

72

4

9.5

9.1

100

8

8.8

8.6

100

9.5

1

58
.

64

4

69
.

1

7.0

81

7

10.0

2

68
.

75

3

44
.

2

7.5

87

10

13.3

Negative control
+

Positive control,
1,2,3, 4-diepoxybutane

+

Quintozeue (PCNB)

+

EXPERIMENT 2
Negative control

+

Quintozene (PCNB)

+

+

11.0

�Table 111
IK VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - PHOKATE

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10~7)
Control

Mitotic Recombinants
per ml
per 10s
(x ID'3 } Survivors

EXPERIMENT 1

9.1

100

8

8.8

100

3.5

11.0

5

8.7

96

9

10.3

5

7.5

87

3

40
.

5.7

100

4.5

7.S

5.8

100

4.5

7.8

5

7.5

132

4

5.3

5

7.2

124

7

9.7

Negative control

-!-

Phorate
+

8.8

EXPERIMENT 2
Negative control

+
Phorate

+

�Table 112
_IS VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - SIMAZINE

Comoound

Metabolic
Activation

Percent
Concentration
: w/v or v/v)

Survivors
Cells/ml
Percent of
Control
(x 10~7 )

Mitotic Recombinants
per ml
per 10
3
(x 10" ) Survivors

EXPERIMENT 1

_
66
.

100

4.5

6.8

5.4

100

2.5

46
.

0.1

1.8

27

266

1,478

0.1

1.5

29

184

1,227

5

3.8

58

3

7.9

5

2.0

37

1

5.0

5.5

100

2.5

4.5

5.2

100

2

3.8

5

7.0

127

7

10.0

5

7.0

135

4

5.7

Negative control
;

Positive control,
1 , 2,3,4-diepoxybutane

+

+

Siraasine

+

EXPERIMENT 2

_
Negative control
+

Simazlne

+

�Table 113
IN VITRO ASSAYS WITH SACCHAROMYCES CEREVISIAE D3 - TRIFLURALIN

Compound

Metabolic
Activation

Percent
Concentration
(w/v or v/v)

Survivors
Cells/ml
Percent of
(x 10"7 )
Control

Mitotic Hecombinants
per 10*
per ml
(x 10-3) Survivors

EXPERIMENT 1
Negative control

7.5

100

1.5

2.0

6.0

100

4

6.7

5

8.4

112

5

5.9

5

6.0

100

2

3.3

6,3

100

1.5

2.4

7.4

100

3.5

4.7

0.1

3.8

60

1,045

2,750

0.1

5.2

70

903

1,737

5

8.7

138

7

80
.

5

8.4

114

3

3.6

+
Trifluralin

+

EXPERIMENT 2

VO

Negative control

+
Positive control,
1,2,3, 4-diepoxybutane

+
Trifluralin

+

�Table 114
III VITRO MUTAGENESIS WITH SAIMONELIA TYPHIMURIUM
SUMMARY DATA FOR EPA PESTICIDES
Positive Response, +; Negative Response, -

Pesticide
Hottocrotophos
BroAacll
Cucodylic Acid
Captaa

ESMA

Fen tb Ion
Folpet

Malathlon
Methonyl

MS4A
Parathloa

Parathlon-Bsethyl
tpilntozene (PQtB)
Phorate
Slaazine
Trlfluralln

TA100
- Metabolic + Metabolic
Activation Activation

TA1535
- Metabolic + Metabolic
Activation Activation

TA1S37
- Metabolic + Metabolic
Activation Activation

TA1538
- Metabolic + Metabolic
Activation Activation

�APPENDIX

A

MUTAGENEST.S STUDIES OF PESTICIDE COMPOUNDS
MOUSE HERITABLE TRANSLOCATION TEST
CAPTAN

171

�SUMMARY
SRI conducted a heritable translocation study of Captan in mice to
investigate whether heritable mutagenic events occur when the compound
is ingested repeatedly over an extended period.
For 8 weeks, adult male mice were administered Captan in their diet;
60 mice received 2500 ppm, and 61 received 5000 ppm. A control group
of 60 adult male mice received an untreated diet during this time.
A positive control group containing 66 adult male mice was treated as
a control group for 4 weeks and then received the known mutagen triethylenemelamine (TEM) Jn the drinking water for 4 weeks. After
treatment, all males were bred with two virgin females each to produce
an F generation, the males of which were raised to maturity. Selected
(200 per group) F males were bred to three virgin females each, and
presumptive translocates were rebred to three additional females each.
A third breeding was conducted with selected nonbreeder and/or presumptive males.
Evaluation of the data on fertility, breeding, and litter size
distribution for F. and F generations does not suggest the presence
of translocation heterozygotes in control or Captan-treated male mice.
Data on dead implants and rebreeding did, however, suggest the presence
of translocation heterozygotus in the group treated with 5000 ppm Captan.
Meiotic cell preparations of the testcs of the presumptive males
were evaluated cytogenetically.

Normal meiotlc chromosomes were found

in the following numbers of F males derived from the. group specified:
8 of 8 controls, 8 of 8 from the 2500 ppm Captan group, 8 from the
5000 ppm Captan group, and 2 of 2 from the 5000 ppm Captan-treated group
derived from traumatized F

females. Five of 5 TEM-treated F males

and i. of 8 from the. 5000 ppm Captan-treated males showed reciprocal
translocations.

172

�The results of this study show that under the experimental procedures
employed, Captan at. 5000 ppm In the diet of male mice for 8 consecutive
weeks can produce a heritable mutagenic event in F generation male mice.

173

�'

INTRODUCTION

The EPA is reviewing and evaluating the health hazard of pesticides
and of substitute candidate, pesticides according to available data.
Additionally, the Agency is obtaining supplemental laboratory data.
The objective is to enable the EPA to select those chemicals that are
minimally hazardous when used according to labeling restrictions.

SRI

is participating in this Substitute Chemical Program by investigating
the mutagenic potential of selected materials by in vitro and in vivo
procedures.
Captan has been shown to respond in a positive manner in Salmonella
typhimurium, Escherichia coll WP2, Saccharomyces cerevisiae, J£. coll
(relative toxicity), Bacillus subtilis, WI-38 unscheduled DNA synthesis
(UDS) with metabolic activation, and Drosophlla melanogaster experiments.
It was not positive in a mouse dominant-lethal test. Based on positive
responses in both Tier I (in vitro test) and Tier II (Drosophila)
mutagenic studies, It was recommended that a heritable translocation
test (Tier III) in the mouse be conducted to further assess thie mutagenic
potential of Captan.
In this study, young adult male JCR/SIM mice from a closed, randombred colony were administered Captan in the diet for 8 weeks. After
treatment, each male was mated to two virgin females to produce an F
generation, the males of which were raised to maturity and bred to three
virgin females each.

Pregnant females were evaluated against pre-

determined selection criteria for Identification of suspect F.J males,
which were rebred and evaluated again.

Presumptive F.. males were

examined cytogenetically.
Through this procedure, a heritable mutagenic response can be
detected. Potential mutagenic effects were Identified by examination
of fetuses during the middle to later stages of gestation.

174

Cytogenetic

�examinations were made of meiotic cell preparations of the testes from
suspect males for confirmation of findings obtained front the breeding
studios.
Reported here are the results of the heritable translocatlon
study of Captan.

175

�MOUSE HERITABLE TRANSLOCAT10N TEST

Human populations frequently are exposed to man-made chemicals,
often at barely detectable levels, for extended periods.

To evaluate

the genetic hazards of such chemicals, a prudent approach is to study
them In mammalian systems so as to maximize detection of a mutagcnlc
response.

The study reported here was such an investigation of Captan

for its potential to produce heritable genetic defects.
Chemical induction of chromosomal aberrations in the mouse is a
valuable and Important experimental aid in understanding the many
genetic defects due to chromosomal anomalies in humans. To date,
mammalian evaluations of chemically induced chromosomal aberrations
have been attempted with the dominant-lethal test and cytogenetic studies
of somatic and germinal cells. Although these procedures can provide
useful information, they do hot measure heritable genetic effects, the
most important mutagenlc occurrences ttiat are permanent and transmissible.
A need exists for a method to reliably identify compounds that cause
heritable chromosomal aberrations in mammalian systems.

The mouse

translocatlon procedure appears to be such a system.
A well-defined translocation test will demonstrate the fertility
of an F male population derived from F males created with a tost agent.
Confirmation of a nonbreeder, sterile, or partially sterile response,
can be obtained by cytological examination of the germ cells from suspected
males.

Sterility and partial sterility are closely correlated with the

induction of translocation heterozygotes.
The procedure used in conducting this translocatlon test was based
on experimental techniques described by Leonard and DeKmidt,1 Cattanach
et al.,'1 Falconer et al.,J and Generoso.4

We modified this approach,

in consultation with government and industry scientists actively
engaged In mutagenesls research.
176

�Materials and Methods
Animals
Male and female ICR/S1M mice were purchased from Simonsen Laboratories,
Cilroy, California.

The FQ males were 8 to 10 weeks old. The females

used in the breeding phases were 10- to 12-week-old virgin stock.
Chemical_ Supply
A supply of Captan sufficient for all aspects of the experimental
program was received from Battelle CoJumbus Laboratory and F.PA-RTP.
Lot number SX-640, Chevron Chemical Company, was used for all treatment
periods. The excess material has been placed in storage in case it is
needed for future reference.
Dosage Selection and Compound Administration
SRI and EPA staff selected the two dosage levels of Captan Lo
be used in this experimental program.

For 8 weeks, Captan was fed in

the diet at 2500 and 5000 ppm.
An appropriate amount of Captan was dissolved and/or suspended in
corn oil. Then the compound-oil concentrate was added at a level of
3% to a finely ground commercial diet (Purina) of known composition.
The use of corn oil assured even distribution of Captan and prevented
its stratification in an otherwise dry diet. Diets prepared at 2-week
intervals were refrigerated at 4°C until fv&gt;d to the animals. The diet
was replaced in the feed containers twice weekly to minimize the
possibility of compound loss. Body weights and food consumption were
recorded weekly during the 8-week exposure period.
Reference Control
Males in the reference control group were fed the Purina diet with
only corn oil added at a level of 3%. These mice were treated In the
same manner as those in the compound test groups. Body weights were
recorded weekly, as was food consumption.
177

�Positive Control
For the positive control group, the known mutagen triethylenemelamlne
(TEM) was administered in the drinking water at 0.32 ing/liter for 2 weeks
and then at '0.124 mg/liter for 2 weeks. TEM treatment was initiated after
the males had been on the control diet for 4 weeks. Body weights and
food consumption were recorded weekly.

TEM is one of the chemical

mutagens that have the demonstrated effect of inducing translocations in
the F progeny of F_ treated males.
Genetic Tests
After 8 weeks of treatment, the males in each treatment group were
mated to two adult virgin females each, After 1 week, each female was
housed individually and allowed to deliver its litter. The F males
were discarded.

All litters were raisod to weaning age, at which time

the females were discarded. The F males were raised to maturity. At
maturity (10 to 12 weeks of age) , 200 I*' males from each experimental
group were selected randomly and housed individually.
Three adult virgin females were housed with each F male for the
first breeding.
plugs.

They were examined daily for the presence of vaginal

These females were sacrificed 14 days after mating, and a

uterine analysis was performed for determination of the number of total,
live, and dead implants.

Males bred to females that produced litters

fitting our criteria for presumptive classification as sterile, partially
sterile, or nonbreeder were rebred to three new virgin females each.
The same evaluation was made for the second breeding.
Our criteria for presumptive classification of a male as "partially
sterile," "sterile," or "nonbreeder" are:
• ^Partia 1J_y_ S, t er II e^jto 1 e
each

must have 9 or fewer

live implants, with at least I. having h or fewer live implants.
- _If^only_ 2^f_3._fema.JLjes_ .are pregnant, both must have 9 or
fewer live Implants, with 1 having 6 or fewer live implants.
178

�. . L £ . . . ? e ? : ? ? l . l ' ? gl-- : &gt;
i . l - ? - .S J . , _ 5 J I . . I a n ! .
6 or fewer live implants.

tnis

female must have

• "Sterile" Male
- None of 3 females pregnant—previously identified by presence
of vaginal plug.
• "Nonbreeder" Male
- None of 3 females pregnant—not previously identified by
presence of vaginal plug.
Any F, male that did not fit one of these descriptions waa
considered "normal" and was discarded. For each F male in the control
and compound-treated groups suspected of being a translocate or nonbreeder
after 2 or 3 breedings, a cytogenetic evaluation was made of meiotic cell
preparations of its testes. Five males from the positive control group
were also subjected to cytogenetic evaluation.
I]yaluat^ipn_qf Breeding n_ata
F I males were identified as sterile, partially sterile, or nonbreeders by the methods outlined above.

Individual data were totaled

to give the number of observed (presumptive) translocaticns per treatment
group, using a data base of 600 to 800 females per group.

Also, for an

accurate review of such findings, the F breeding and litter data were
thoroughly evaluated. The various measured evaluated included percentage
of pregnancies, average litter size, average number of males and females,
average number of males with females having zero to five or more dead
Implants, average number of females having zero to five or more dead
Implants, percentage of females with plugs, and percentage of pregnancies
with and without plugs.
Meic tic_.Cell Cytogenetic Studies
Cytogenetic examinations were made of the testes of 31 F mice, with
the two testes from each mouse being examined separately.

179

The procedures

�used for the cytogenetic preparations arc as follows.

C0« was used

to sacrifice the mice. The testes Were removed, weighed, and placed In
an Isotonlc solution of 2.2% sodium citrate. The tunica of each testls
was punctured to release the tubules, which were then rolled on a glass
plate to release the cell contents into the isotonic solution.

The

resulting cell suspension was centrifuged at 800 rpm for 5 minutes; the
supernatant was removed, and each pellet of cells was resuspended in
5 ml of 1% sodium citrate hypotonic and held at room temperature for
15 minutes.

The cells were centrifuged again at 800 rpm for 5 minutes

and the supernatant was discarded.

The cells were then treated with

Carney's fixative (3 parts methyl alcohol and 1 part glacial acetic,
acid) to give a total volume of 5 ml, and. immediately centrifuged again
at 800 rpm for 5 minutes.

This procedure was performed twice,

Then

the cells, suspended In an appropriate amount of fixative, were dropped
onto clean, wet microscope slides and allowed to air-dry. The slides
were stained with 2% buffered Ciemsa for 5 minutes.

Coverslips were

attached with Permount. The slides were coded to preclude bias on the
part of the scorers.

180

�RESULTS AND DISCUSSION

Table 1 presents the average body weights for mice In the various
groups. The body weights of the control, TEM, and 2500 ppm Captan
group were within normal limits and comparable throughout the experiment.
The 5000 ppm Captan-treated group showed a depressed body weight for
5 weeks before demonstrating a recovery trend during Weeks 6 to 8.
This body weight depression appeared to be due to the inability of the
male mice to acclimate to such a high level of compound in their diet.
Table 2 summarizes the average food consumption by treatment group.
Both Captan-treated groups (2500 and 5000 ppm) showed a lower average
weekly food intake than did the control arid TEM-treated groups.
During the week immediately following (..he 1-week F

generation

rating, one animal rack holding some females that had been mated with
the mice given 5000 ppm Captan was accidentally tipped and some cages
were sptiled onto the fllor, resulting in our inability to identify
which males had been mated with these females. There were, however,
sufficient numbers of F, generation males from those females that were
not traumatized to allow us to randomly select 200 F males for use in
subsequent F generation breedings.

In addition, we held all females

that had been traumatized by the tipping of the rack and maintained
them throughout the remainder of the study is a separate group.

From

this separate group we selected 50 F males (at least one. per female
retained) for use in the F generation breedings and evaluations.
F

Generation
Information on the breeding performance, litter size, sex distribu-

tion, and clinical effects of the Ffi generation should be Included in
the evaluation of translocation data, because it may provide valuable
reference data.
181

�Table 3 .summarizes the breeding .mcl Litter performance of the F
generation.

NQ adverse effects were observed in the control and 2500

ppm Captan groups.

The two 5000 ppm Captan groups showed a reduced

pregnancy ratej the rate for the traumatized females was 29% below that
of the controls.

Litter sizes for the 5000 ppm groups were slightly

below control values. As expected, the TEM group had a reduced pregnancy
rate and a litter size 47% below the control level.
Table 4 presents litter-size distributions of live young from the
F

generation mating. Although the distribution patterns for the control

and Captan-treated animals were within normal ranges for our strain of
mouse, there was evident a definite pattern of decreasing litter size
and increasing variance and standard deviations between the different
experimental groups.

As exnected, the TEM-treated animals showed the

classic shift toward smaller Jitters.

Figure ] graphically presents

the data on the F- generation litter-size distribution.
J_i Generation
Table 5 summarizes breeding data from the first mating of the F
generation male mice.

In the females mated with TEM nales and with

males from the 5000 ppm Captan group of traumatized F_ mothers, there
were 10% fewer females with mating plugs, and an increased percentage
of nonpregnant females in comparison with control values; also, these
two male groups had an increased percentage of males with no pregnant
females.

Results from males in the 2500 and 5000 ppm Captan groups

were within normal limits for this strain of mouse and comparable with
t

values from control males.
Litter-size distributions of live Implants derived from the first
mating of F I generation males are presented in Table 6. Responses of
control and Captan groups were within normal limits and readily
comparable. The TEM group showed approximately a 13% reduction in
litter size. Mean litter sizes were 11.72 for the control group,
U.73 for tin1 2500 ppm Captan group, 11,56 for the 5000 ppm Captan
group, 11.88 for the 5000 ppm (traumatized F

182.

female) group, and

�10.24 for the TEM-treatcd group. The data on the F generation littersize distribution are. presented graphically in Figure 2.
Tables 7 and 8 summarize the data on dead implants per F, male
.and dead implants per femaLe, respectively. The 2500 and 5000 ppm
Captan groups showed a slight increase in total dead Implants for both
males and females at the 4, 5, and &gt;5 levels when compared with controls.
TEM animals showed significant increases in dead implants for both males
and females.
Table 9 summarizes the breeding results by treatment of those FI
males classified as presumptive sterile, partially sterile, or nonbreeders after three breedings.

Table 10 identifies these F males

individually by number and treatment.
Details of the breeding and rebreeding data for presumptive F
males are presented in Table 11.

In the reference co:itrol group, 24

of the 200 males were considered as presumptive translocates. When
rebred, 12 males remained in this classification. A third mating of
selected questionable and/or nonbreeder males reduced the number of
presumptive males to eight:

1 nonbreeder, 1 presumptive sterile, and

6 partially sterile (3 of which were questionable partially sterile).
For the TEM group, 83 of 200 F males were identified as presumptive
mutants after the first breeding.

When rebred, 53 still met the original

criteria. A third breeding reduced this number to 49; 4 continued to
be nonbreeders, 14 were presumptive sterile, and 31 were partially sterile
(6 of which were questionable partially sterile).
In the 2500 ppm Captan group, 30 of 200 F males were identified
as presumptive mutants after the first breeding. When rebred, 11
still met the criteria:

5 were nonbreeders, 1 was a presumptive

sterile, and 2 were partially sterile (1 cf which was questionable
partially sterile).
The 5000 ppm Captan group also had 30 of 200 F^ males identified
as presumptive mutants after the first breeding. The second mating
reduced this number to 9. After a third breeding, 8 males still met the

183

�original criteria:

2 were nonbreeders, 1 was a presumptive sterile,

and 5 were partially sterile.
For the group of F. males derived from traumatized F

females

and males treated with 5000 ppm Captan, 12 of 50 FI males were identified
as presumptive mutants after the first making. A second breeding
reduced this number to 4 and a third breeding further reduced to 2 the
number of F males that still met the original criteria; both were
partially sterile, with one of them being questionable partially sterile.
The data on the F. and F.. generation.?' fertility, breeding, and

litter-size distribution'as well as the data on the F generation's
dead implants and rebreeding show that Captan tends to induce doserelated effects on the reproductive performance of male mice.

The data

also suggest the presence of translocation heterozygotes in the 5000 ppm
Captan group.
Review of the data on dead implants, breeding, and rebreedlng for
the F- generation of the TEM-treated group showed, as expected, the
potential for the presence of translocation heterozygotes in 24.5%
of the FI males.
Cytogenetic Studies
Table 12 presents the findings from the cytogenetic evaluation of
meiotic cell preparations from F males in the Captan groups characterized
as nonbreeder, presumptive sterile, or partially sterile.

Also, eight

control males and 5 of 49 TEM males were evaluated.
v,

Whenever possible, 25 spermatocytes per testls were scored.

The

slides were decoded only after all scoring was completed. The results
are summarized as follows:
• All eight males examined In the control group were cytogenetically normal.
• The five TEM males all showed positive reciprocal translocations.
• All eight males in the 2500 ppm Captan group were cytogenetically normal.
• Seven males in the 5000 ppm Captan group were cytogenetically
normal; however, the eighth male (No. 657) showed as a
positive reciprocal translocation.
184

�• The two males examined In the 5000 ppm Captan group derived
from traumatized F iemales were cytogenetically normal.
Discussion
Increased use of the translocatlon procedure has revealed that a
meaningful relationship exists between the Incidence of dead Implants
in F matings and the occurrence of a heritable translocatlon event.
Previous experiments at SRI and at Oak Ridge National Laboratories have
demonstrated this correlation. The following paragraphs discuss
occurrences of dead implants in this study.
When females had a total implant count of less than six or when
all their implants were identified as dead, we generally considered
thin to be a result of first breeding or of some factor other than
compound treatment (such as background IncJ-denc.c) and excluded those
females from this evaluation. Tables 13 through 17 present the total,
dead, and live implantation data for suspect translocates of the control,
the TEM group, and the three Captan groups.
The control group (Table 13) showed a normal implant distribution,
with the exception of one F male (No. 122) for whom the number of
implants was high.

In the TEM group (Table 14), the expected Increase

in dead implants and the resultant decrease in live implants occurred,
although the numbers of tot.al implants were generally normal. This
pattern occurred during all breeding periods.
The 2500 ppm Captan group (Table 15) contained seven males in
the first breeding with females having high dead implant counts but
normal live litter size, according to the criteria. Also, 3 males
showed high dead implant counts during the first breeding, with live
implant counts fitting the criteria for partially sterile males. This
Increase in dead implant occurrence was not repeated in subsequent
breeding, and all FI males were classified as normal after the breeding
phases.

185

�(1 •'&lt;
-I I*-}

Five FI males in the 5000 ppm Captan group (Table 16) showed an
increase in dead Implants during the first breeding. In the rebreeding
of these males, only male No. 657 continued to show the increase in
dead implants and the resultant decrease in live implants. All other
FI males in this group had a normal distribution of dead and live
implants for all breedings.
Table 17 presents the implant data for F. males derived from
traumatized females in the 5000 ppm Capcan group. With the exception
of an occasional female showing an increase in dead implants, the
distribution of total, dead, and live Implants was normal.
The numbers of total implantations were generally within normal
limits for all experimental groups in all breedings.

186

�REFERENCES
1. A. Leonard and G. H. DeKmidt. Mutation Res. 9, 127 (1970).
2. B. M. Cattanach, C. E. Pollard, and T. H. Isaacson. Mutation
Res. J&gt;, 297 (1968).
3. D. S. Falconer, D. M. Slizynskl, and C. Auerbach.
81 (1952).

J. Genet. 51,

4. W. M. Generoao. Proc. Second Annual Environmental Mutagcn Soc.,
p. 9 (March 1971).

187

�Table 1
AVERAGE BODY WEIGHTS IN GRAMS FOR MICE RECEIVING
VARIOUS LEVELS OF CAPTAK IN THEIR DIETS

Week of
Test
Initial

1
2
3
4

5
6
7
8

Control

TEM

Dietary Levels
of Captan
Cppm diet)
2500
5000

33.8
32.5
33.7
34.8
34.6
34.8
37.3
37.7
39.2

33.4

33.8

33.6

32.9

33.3

31.8

34.6

33.7

31.4

35.4

34.4

32.1

35.8

34.4

31.4

35.9

36.0

33.0

38.1

37.5

35.3

38.9

39.3

35.8

39.8

38.9

36.9

188

�Table ?.
AVERAGE FOOD CONSUMPTION FOR MICE RECEIVING
VARIOUS LEVELS OF CAPTAN IN THEIR DIETS
(Grama of Food Consumed/Mouse/Day)

Week of
Test

1
2
3
4
5
6
7
8

TEM

Control

Dietary Levels
of Captan
(ppm diet)
2500
MOO

4.01

4.05

3.74

3.25

4.82

5.00

4.72

4.38

4.91

5.08

4.90

4.40

5.28

5.33

4.45

5.08

5.55

4.95
5.44

5.36

5.56

4.95

4.75

5.81

6.14

5.63

5.27

5,55

5.74

5.13

4.83

189

4.95

�Table 3
TRANSLOCATION STUDY OF CAPTAN
F0 GENERATION MICE
SUMMARY OF BREEDING AND LITTER DATA

Parameter

Control

TEM

2500 ppm

5 0 ppm
00

5 0 ppma
00

60

66

60

31

30

120

132

119

61

59

Number pregnant

93

77

91

38

33

Percent pregnant

77.5

58.3

76.5

62.3

55.9

8

5

13.3

16.1

11.68

Number of FQ males
Number of F

females

Number of nonbreeder males

8

19

Percent nonbreeders
vO

o

13.3

Average live litter size

12.30

6.55

12.16

5.84

3.26

5.68

Average number of males weaned/litter

28.8

6.29

—
-11.33
5.25

Group of females accidentally tipped off rack following 1 week of mating with 5000 ppm-treated
mates. These traumatized females, and their offspring, most of which could not be identified
back to a particular FQ male, were considered as a separate group for the remainder of the
study.

�Table 4
TRANSLOCATION STUDY OF CAPTAN
MOUSE LITTER-SIZE DISTRIBUTION OF LIVE YOUNG
DERIVED FROM F GENERATION ADULTS

2500

Captan
(ppm diet).
_5000.

jooof

1

0

0

0

0

2

0

I

0

3

0

3

0

0

0

4

0

8

0

1

5

0

10

0
1

0

0

6

0

15

2

1

1

7
8

I

0

0

1

2

12
8

0

0

9

9

8

3
3

1

3

10

6

2

8

6

3

11

8

7

18

9
24

5

12

3
1

8

5

13

22

0

20

9

8

14

18

1

10

6

1

15

6

0

6

1

3

16

3

0

3

0

0

17

0

0

2

0

0

18

0

0

0

0

0

Mean (p,)

12.30

6.55

12.16

11.68

11.33

3.89

5.84

4.97

5.73

6.09

1.97

2.42

2.23

2.39

2.47

Litter
__Si*£__

Control

1

0

2

Variance
(o3)
Standard
Deviation
()
a

TEM

Traumatized FQ females.

191

�24

\

I
.— •in

I

I

I

I

I

I

I

I

I

i TO- Control

22
___«,.. 2600 pprn Captan
—»' • — • « 6000 ppm-Ceptan
« • 6000 ppm Captan

20

(Traumatized Females)

18

16

ui

12

10

/ ,&gt;\

.•""••' -l5^
8

10

12

14

LIT TEH SIZE

FIGURE. 1

LITTER SIZE DISTRIBUTION FO GENERATION

192

16

IB

�Table 5
TRANSLOCATION STUDY OF CAPTAN
FL GENERATION MICE
SUMMARY OF BREEDING DATA- -FIRST BREEDING

Parameter
Number of Fl males
Number of females
Number of mating plugs
Percent mating plugs
Number pregnant
Percent pregnant
Number pregnant with plug
Percent pregnant with plug
Number pregnant without plug
Percent pregnant without plug
Number not pregnant
Percent not pregnant
Number not pregnant with plug
Percent not pregnant with plug
Males with no pregnant females
Percent males with no pregnant females

a

Traumatized Fo females.

Control
200
600
450
75
492
82
434
88
58
12
108
18
16
15
13
6.5

TEM

2500

200
600
376
63
383
64
326
85
57
15
217
36
50
23
39
19.5

200
600
442
74
472
79
419
89
53
11
128
21
23
18
14
7.0

Captar. (ppm)
5000
jQOOa
200
600
439
73
477
80
413
87
64
13
123
20
26
21
9
4.5

50
150
95
63
112
75
94
84
18
16
38
25
1
3
7
14.0

�Table 6
TRANSLOCATION STUDY OF CAPTAN
MOUSE LITTER SIZE DISTRIBUTION OF LIVE YOUNG
DERIVED FROM FI GENERATION ADULTS--FIRST BREEDING
Litter
Size

1
2
3
4
5
6
7
8
9
10
11
12
13 .
14
15
16
17
18
19
20

Control

TEM

2500

5
4
2
4
5
8
• 7
14
35
37
73
80

4

4
0
5
6
4

89
&gt;. 72
32
16
7
1
0
0

9
12
.; ,

17

'•'•' - 2 1
11
8
17
25
31
53
61
52
27
21
8
1
1
1
0

5
6
13
35
40
77
75
87
54
36
14
7
2
0
1

Captan (ppm)
5000a
5000
3

0

3

0

1
5

0
1

6

1

8

4

11

3

19

4

17

2

53

16

77

14

85
93

0
0

15
17
14
13
5
1
0
0
0

55
19
11

7
3

Mean (JA)

11.72

10.24

11.73

11.56

11.88

Variance
Co*)
Standard
Deviation

8.13

13.59

8.68

7.40

7.20

2.85

3.69

2.95

2.72

2.68

(CO

traumatized Fo females.
19A

�120

Con 11 ol

110 —

TEM

2500 mm
GOOO ppm Capinn

100 —

5000 ppm Capinn
(Ti,ium,ili/rd Females)

in —

1. ..I._!...L.J....L10

12

LITTEfl SIZE

FIGURE 2

LITTER SIZE DISTRIBUTION F, GENERATION

195

— FIRST MATING

�Table 7
TRANSLOCATION STUDY OF CAPTAN
SUMMARY OF DEAD IMP!ANTS PER Fl MALE
Number of Males
with Females Having

Cap tan Copm)
5000
5000a

Control

TEM

2500

0 Dead implants

68

37

69

49

20

1 Dead implant

54

36

44

68

11

2 Dead implants
3 Dead implants

30
18

25
16

31
13

36
18

7
2

4 Dead implants

8

9

18

9

0

5 Dead implants

2

6

4

3

2

&gt; 5 Dead implants

7

32

7

8

1

Traumatized FQ females.

196

�Table 8
TRANSLCX;ATION STUDY OF CAPTAN
SUMMARY OF DEAD IMPLANTS PER FEMALF.

Number of Dead
Implants/Female

Control

TEM

2500

0

320

182

295

28^

79

1

109

83

113

23

2

39

35

37

130
41

3

18

16

16

9

0

4

11

7

11

2

3
o

0

5

3
0

0

&gt; 5

3

45

2

8

1

492

383

472

477

112

Total Pregnant
Females

Traumatized Fo female.

197

Cap tan (ppjn)
„
5000
j&gt;QO.pJ

9

�Table 9
TRANSLOCATION STUDY OF CAPTAN
SUMMARY OF PRESUMPTIVE TRANSLOCATION T MALES AFTER THREE BREEDINGS

Control
Total num&amp;er of FI males

TEM

2500

200

200

200

Number o f nonbree.der males
Number o f presumptive sterile males
Number of partially sterile males
VO

00

Traumatized Fo females

Captan
5000

1
1
6(3?)

4
14
31(6?)

200
5

5000a
50

2

1

1

2(1?)

5

0
0
2(1?)

�Table 10
TRANSLOCATION STUDY OF CAPTAN
INDIVIDUAL IDENTIFICATION OF PRESUMPTIVE
AFTER THREE BREEDINGS

MALES

Partially
Sterile

Presumptive
Sterile

Nonbreeder

Contro L

16?
65
122?
164?
189
190

72

220

TEM

215
216
232
235?
238
245
262
264
269
280
281
290
292
299?
300
314
315
327?
344
345
350
359
360?
361
371
375
376
388
390
399?
400?

202
231
251
256
268
273
288
317
321
326
339
343
369
389

220
241
391
396

Treatment

(Continued)
199

�Table 10
(Concluded)

Treatment

Partially
Sterile

Presumptive
Sterile

Captan
2500 ppm

480?
526

474

449
479
496
523
583

Captan
5000 ppm

635
657
760
779
780

736

634
733

Captan
5000 ppma

805
837?

^Traumatized Fo females.

200

Nonbreeder

�Table 11
TRANSLOCATION STUDY OF CAPTAN
BREEDING AND REBREEDING SUMMARY OF PRESUMPTIVE

MALES

(Live Implants Only)

Treatment
Control

Male
No.
11
16
1.7
24
39
43
50
59
65
67
72
86
102
122
129
139
144
152
164
179
189
190
192
200

First Breeding
(3 Females)
.**

202
215
216
220
226
227
228
229
230

1.3

6

(15)*
-

(LI)
9
4
0
4
6
3
0
1
7
-

Totals
TEM

Third
Breeding
(3 Females)

Second Breeding
13 Females)

_
0
7
0
.2
9
1
/t

(14)
-

.
6
5
(ID
13
9
0
6
-

_

0*
0
12
10
3
14
0

11
11
9
6
11
_

(12)

1

5
7
~
10
8
0
0

12
13

-

9
7
14
9
10
10
0

0
.4
(9)
0
-

0
(9)
2
9
-

0
7
12
12
14
14
11

0
U
2
4
12
14
10

11

11
-

12
_
2
.
16
14

_

12

12

4
-

14
13
(9)
0
0

0
0

1
1

0
1

-

12

2 '4

0
0
7
.

11

12
1.0

8
0
._

4

-

8
11
13
-

(Continued)

"0" indicates a plug was observed for a female that was not pregnant.

**
•-" indicates a plug was not detected and the female was not pregnant.

t,, ( ) indicates all implants were in early stages of development and impossible
"
to determine if they were live or dead upon gross observation.

201

�Table 11
(Continued)

Treatment
TEM

First Breeding
(3 Females)
Females)

Wo,
231
232
233
235
237
2218
239
241
244
245
251
253
254
256
258
262
264
267
268
269
270
273
280
281
283
286
288
290
292
294
299
300
302
314
315
317
318
321
322

**

.

0*
3
8
5
3

4

1

7
9
0

6
8
1

_

_

_

©
0
3
4
0
0
2
3
_
0
9
©
9
0
5
6
8
8
6
9
0
0
4
0
9

0
0
10
8
5
_

Third
Breeding
(3 Females)

Second Breeding
(3 Females)
Femalea)

1
0
5
_

7
6
9

2
8

0
5
3
(18) t
(15)
3
0
4
0
-

0
4
0
9
0
0
3
(Continued)

0
8
11
7
10
1
13

0
2
15
7
10
2
-

0
5
6
13
14
©"
-

10
1
0
14
13
13
5
©
13

13
0
0
11
14
0
4
5
©

11
3
0
11
5
9
12
_

6
8
0
8
4
14

7

8
1
0

0
7
3
10
9
8
13
2
0
0
9
0
11

0
5
3
12
4
5
12
1
0
0
4
0
11

-

.
5
2
-

10

0
0
8
11
9
2
15
4
0
11
.-

"0" indicates a plug was observed for &amp; female that was not pregnant.
"-" indicates a plug was not detected and the female was not pregnant.
"( ) indicates all implants were in early stages of development and impossible
"
to determine if they were live or dead upon gross observation.
"®" indicates female was pregnant but had no live implants.

202

�Table 11
(Continued)

Male

First Breeding
Q Females)

Treatment
TEM

326
327
333
334
339
343
344
34e,
346
349
350
355
356
359
360
361
363
367
369
371
372
375
376
381
382
385
387
388
389
390
391
396
397
399
400

Totals

**

0
0

6

-

.*
0
0
10

(10) t
0

1
12

4
9
(15)
4
5
0
4
(16)
3
5
(13)
9
.
3

0
5
4
)
4
4
.6
..
..
0
(11)
5
4

4

3

-

4
2

0
0
5
4
12
10

8
9
-

()
6
0

13
11
7
2
3
12
4
5
10
5
1
11
10
15
3

5

-.
6

(^
F

0
0
4
4
11
8
0
0
3
©
7
14
5
.
5
9
0
12

12

11

10

0
0
5
3
10
I
(15)
7
()
P
11
5
7
1
.

3

7
4

3

5

3

11
5
4

0
2
5

0
4
2

-

5
2

„
0
5
(12)
2

()
9

-

_

0
0
3
6
-

Third
Breeding

Second Breeding
13 Females)}

(14)
(ID
1.1
12

53

83

49

(Continued)

"0" Indicates a plug was observed for a female that was not pregnant.
** ,
'-" Indicates a plug was not detected and Che female was not pregnant.
"( ) indicates all Implants were in early stages of development and impossible
"
to determine if they were live or dead upon gross observation.
" ( ) " indicates female was pregnant but had no live implants.
?

203

�Table 11
(Continued)

n

Treatment
Captan
2500 ppm

Captan
5000 ppm

Male
No.

430
432
436
449
450
451
452
455
461
469
472
474
479
480
484
489
496
518
523
526
528
546
561
568
569
582
583
585
588
590
Totals
601
604
620
622
626
627
634
635

First Breeding
(3 Females)
.*
*
b
4
(17)'
_
_
9
5

Third
Breeding
(3 Females^

Second Breeding
(3 Females)

—

"

9
8

12
11
_
11

8
10
_
12

12
12
13

10
0
13
10
13
0
0

13
0
11
12
11
.
11
_
0
11
_
11

13
10
13
11
9
11
10
_
-

5
.
11
13
13
11

0
_
.
8
10
7
13
12

—

0*
7
9
8

(3)
4
11
7
0
8
-

9
8

7
8
.
8
-

1
0
10

14

10

10
-

9
.

-

11
6
.
_
-

0
14
12
.
3
()
9

10
0
30
(U)
9
.
8
-

(1)
.
.
(13)
.
12
(12)
9

()
8
9
()
9
8
-

.

(13)
11
_
9

_
0
0
14
9
11
8
12
9
0
11
9
9
0
(12)
10
-

11
0
10
12
12
6

&lt;B

8
12
_
14
_
13

9
15

13
11

U

14
(P1
-

(Continued)

**

"0" Indicates a plug was observed for a female that was not pregnant.
"-" Indicates a plug was not detected and the female was not pregnant.
"( ) indicates all Implants were in early stages of development and Impossible
"
to determine If they were live or dead upon gross observation.
" ? " Indicates female was pregnant but bad no live implants.
()

204

�Table 11
(Concluded)

Treatment

Captan
5000 ppra

Fl
(tale
No.

638
646
653
657
660
668
671
672
679
722
732
733
734
736
743
760
761
765
767
769
779
780

First Breeding
(3 Females)
10
10
0*
2
0
.

6
4
0
7
9
9
10
8
2
4

805
806
815
816
817
818
822
823
837
84L
846
847

(13)f
5
10
.

0
-

5
10
0
0

1

6
1
8
_
6
8
(15)
8
(12)
1

5

10
11
14
2
14
9
14

6
10
5
(14)

Totals

9
(10)
6
-

12
13
13
1
9
12
11
12

11
9
10
4
12
12
14
3
12

12
11

12

14
1
5
12
12
12
0
0

10
0
13
11
13
13
4
2

30

Totals
Captan
5000 ppm

6
-**

Third
Breeding

Second Breeding
J 3 FemaJjBs)

10
0
11
9
12
10

-

4

9

7
(11)
-

.
12
13
9
7
11
6
13
7
13
10
10

14
11
0

8
10
12
10

2
10
10
.
12
-

11

2

13

10

12

12

12
14

4

12

Traumatized ?o females.
"0" indicates a plug was observed for ;
**

"-" indicates a plug was not detected and the female was not pregnant.
"( ) indicates all implants were in early stages of development and impossible
"
to determine if they were live or dead upon gross observation.

205

�Table 12
TRANSLOCATION STUDY OF CAPTAN
CYTOGENETIC EVALUATION OF FI MALE MICE

Fl

Testes
Weight (ma)

16

64.6

265

Partially sterile
(questionable)

Normal

58.5
38.8
68.0
48.7

307
237
232
289

Nonbreeder
Partially sterile

Normal
Normal
Normal
Normal

164

Control

Body
Weight (g)

17
65
72
122

Treatment

Male
No.

Classification-Based
Upon Breeding Data

55.8

314

Partially sterile

Presumptive sterile

Partially sterile

Cytogenetic Classification

(questionable)
N&gt;
o

Normal

(questionable)

TEM

Captan
2500 ppm

189
190
232
262
290
345
361

49.6
47.5

245
222

Partially sterile
Partially sterile

Normal
Normal

54.6
41.4
62.6
54.1
50.4

276
243
222
294
278

Partially
Partially
Partially
Partially
Partially

Positive reciprocal translocation
Positive reciprocal translocation
Positive reciprocal translocation
Positive reciprocal translocation
Positive reciprocal translocation

449
474
479
480

60.2
56.5
65.1
58.7

256
175
287
307

Nonbreeder
Presumptive sterile
Nonbreeder

496
523
526
583

60.9
50.7
54.1
50.7

242
348
295
297

sterile
sterile
sterile
sterile
sterile

Partially sterile

Normal
Normal
Normal
Normal

(questionable)
Nonbreeder
Nonbreeder
Partially sterile
Nonbreeder

Normal
Normal
Normal
Normal

�Table 12
(Concluded)

Male
No.

Body
Weight (g)

Testes
Weight (mg)

Classification-Based
Upon Breeding Data

Capcan
5000 ppm

634
635
657
733
736
760
779
780

57.1
56.0
61.0
62.2
57.9
55.9
54.8
53.0

299
312
231
256
256
298
224
295

Nonbreeder
Partially sterile
Partially sterile
Nonbreeder
Presumptive sterile
Partially sterile
Partially sterile
Partially sterile

Normal
Normal
Positive reciprocal translocation
Normal
Normal
Normal
Normal
Normal

Captan
5000 ppma

805
837

70.0
56.9

268
303

Partially sterile
Partially sterile
(questionable)

Normal
Normal

Treatment

ro
o

Traumatized Fn females.

Cytogenetic Classification

�Table 13
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F. MALES

local
F Male Female
Dead
Live
Number Number ^plantations Implantations Implantations
First
breeding

11

16

1
2
3
1
2

.*
*
-

-

24

39

43

50

59

65

67

72

86

102

122

-.v

3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2

(13)t
.
.
-

3

17

13

•
?
.
••
.
.
-

.
(13)
.
-

9
0
.

9*
0
.
4
B
7

0
0
.
0

i
1

4
7
6

0

0

-

4
0
5
.
-

Nonbreeder
Partially sterile
(questionable)

Nonbreeder

Nonbreeder

0

5
0
5
.
.
.
••
(11)
If,

Initial Clas sj.ficatloi

Normal

Nonbreeder

Partially sterile

Presumptive sterile

u

1
0

0
.

-

.
.

.
7
10
2
0

.
(11)
6
2
13

Partially sterile

Nonbreeder

Nonbreeder

Nonbreeder
Partially sterile
(questionable)

Normal

"0" indicates a plug was obgtfrVod for a f e m a l e t h a t u.is not pregnant.
"-" indii:ar.?s a piu); was not dt-tuctb'd and Che female uis not p r e g n a n t .
"()" indicates all Implants vrere in e a r l y stages of development, aric! thus d i f f i c u l t to
determine if they were live or dene! upon gross 'observation.

208

�Table 13 (Continued)
I'RANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F, MA1JES

F Male Female
Total
Number Number lmp_l anjt ationa
First
breeding
(concl.)

129

139

IV*

152

16/t

179

189

190

192

1
2
3
1
2
3
I
2
3
1
2
3
1
2
3
I
2
3
1
2
3
!
2
1
I
2

_ ..Contrpljjroujg
Dead
Live
Implant a_ti on s Imp lantBliona

**
-

.

-

.
-

7
12
9
-

-

4

3
0
.
..
-

0*
1
0

0

1

0

It

0
0

0

6

0

7

0

?

-

-

.

-

2

3

200

(L4) +

-

3
1

-

-

.
.
3
9
9
.
.
0
1
0
1
It
6
7
(14)
-

-

Initial Claaslficatio
Nonbreeder

Nonbreeder

Nonbreeder

Partially sterile

Nonbreedei

Nonbreeder

Partially sterile

Partially sterile
Partially sterile
(questionable)

Nonbreeder

Final Classification
Second

11

breeding
16

I
2
3
1
2

17

3
1
2
3

13
9

(15)
-

0

1
•;

-

-

-

-

-

13
H

(15)
-

Normal

Rebred

Rebred

h

b

"0" Indicates a plug was observed for a female Ihut was not pregnnnt.
"-" iinlic.ii.es .1 plug was ni&lt;t delected and the fern .Tic was not pregnnnt.
" ) incllc.itps .ill implants wrrc in cnrlv stages of development, and thus difficult to
("
determine if Llicv were l i v e or dead upon gross observation.
See t h i r d b r e e d i n g f o r f i n a l i - L a s s if t e a t ion .

209

NOT REPRODUCIBLE

�Table 13 (Continued)
TRANSLATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE T

F Male Female
Total
Number Number Implantations
Second
breeding
(cont.)

24

39
43

50

59

65

67

72

66

102

122

129

1
2

3
I
2
3
I
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

139

I

144

2
3
i
2
3

MALES

Control Croup
Live
Dead
Implantations Implantations

0*
12
tafr

0
12
11
12
10
12
3
6
2
15
11
0
.
(12) +

0
1
0
.
0
0
0
0
3
0
0
0

1
0

0
-

-

?
-

-

-

10

1
1

6
16
14
14

2
.
15
••

9
10

0
7
7
8
1
0
0

0
11
•
0
12
11
12
10
9
3
6
2
14
11
-

Final Classification
Normal

Rebred

Rebred

h

K

Normal

Normal

Partially sterile

Normal

0
-

(12)
9
5
16
7
7
4

14
9
10

Rebred

b

Rebred

b

Normal

Normal

Rebred

b

Normal

Normal

"0" indicates a plug was observed for a female tluit was not pregnant.
;(

"-" Indicates a plug wns not detected and the female was not pregnant.
" ) indicates all implants were in early stages of development, and thus difficult to
("
determine 11 they were live or dead upon gross observation.
See third breeding for final classification.

210

�Table 13 (Continued)
TRANSLOCATION STUDY OF C APT AM
IMPLANTAIION SUMMARY OF PRESUMPTIVE F MALES

_
._..._
F, "Male" Female " "ToTaL™
Dead
Live
Numhe r Number Lni£].ant_a,tlon8_ IniE.lantatJ.ons. lEJRL™!:8.1-!??.! -_F.
Second
breeding
(cone] .)

152

164

179

169

190

192

200

Third

16

breeding

17

39

43

72

1
2
3
1
2
3
1
2
3
1
2
1
1
2
3
1
2
3
1
2
3
1
2
1
2
3
1
2
3
1
2
3
1

11
8
14
_*•«
(9)t
11
-

1

10

0
1
.

13

?
1
-

()
9
10
-

0*

0

0
0

0

1
0
0
13
12
13
..
_

.
12

12
11
10
-

0
0
0
0

I
1

-

0
-

.
_

.

0

1

0

0

.

-

-

e

.
.

0
0
0

Normal

Rebred

Normal

Retired

1
0
0
12
11
13
.
_
12
11
11
10
-

Rebred

Normal

Normal

Partially sterile
(questionable)

Nonbreeder

Normal

Normal

Presumptive sterile

86

3
1
2
3

-

-

14
14
5

2
2
1

12
12
4

Normal

"0" Indicates J plug was observed for a female tliac wjs not pregnant.
"-" indicates a plug was not decocted and the female was not pregnant.
" ) indicates all implants were in early stages of development, and thus difficult to
("
determine 1C they were live or dead upon gross observation.
'SRC rhird breeding for final classification.

211

�Table 13 (Concluded)
TRANSUOCAXION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F

HALES

Control Croup
Dead
Live
F. Male Female
Total
Number Number 1Implantations Implantations Implantations
Third
breeding
(concl.)

129

164

189

190

1
2
3
1
2
3
1
2
3
1
2
3

14
**
.
•
0*
1
0

1

1

"0" indicates a plug vas observed

0
.
.
0
0
0
0
0

14
.
.
•

0
1
0

1
1

for a female that was not pregnant.

"-" indicates a plug was not detected and the female was not pregnant.

212

Final Classification
Normal
Partial ly sterile
(questionable)

Partially sterile

Partially sterile

�Table 14
THANSLOCATION STUDY OF CAPTAN
TMPLANFATION SUMMARY OF PRESUMPTIVE F, MALES

__ __TEM Oroujs
Total
Dead
Live
F. Male female
Number Number jjpg 1 an tail on s. Implantations .lmp.1 ant a
First
breeding

202

215

216

220

226

227

228

229

230

231

232

233

I
2
3
1
2
3
1
2
3
1
2
3
I
7.
3
1
2
3
I
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2

2J5

3
1
2

217

3
1
2
3

0*
0
0
kit

-

.
(9)*
.
0

11
II
-

()
9
-

8
0
10
.
0

0
0
0
.
..
7
.
.
0

7
9
-

7

1

0

1

-

0

-

-

-

-

12
9

9
5
9
-

10
.
-

-

15
11
11

7
4
5

b

0
3

12

12

0
0
Q
.
()
9
.
..
.0
4
2
.
()
9
7
0
9
.
.
0
3
4
I
-

PisaumptLve sterile

Nonbreedcr
Partially sterile
(questionable)

Nonbr eerie r

Nonbrceder

Partially sterile
Partially sterile
(questionable)

Normal

Nor.breeder

Presumptive sterile
P a r t i a l l y sterile

Nonbreeder

e
7

Partially s t e r i l e

6
5
9
6

P.irtlally sterile

"0" lndic«ti* r &lt; ••' pl"K w.is observed [or n fcmalr tli.u was not prepnant.
i. •/:

"-" ind itiitr i .1 pliiR u,tq nol di-rortrd and Lhc C entitle w,is not pregnant.

"()" i n d i c a t e s ,1.1 i m p l . m l s uorr in e a r l y stnges ol d e v e l o p m e n t , and thus d i f f i c u l t to
i l c t c n n i n c i f t h e y were 1 L v o or dead upon gross o b s e r v a t i o n ,

213

�Table 14 (ContInucd)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRKSUMPTIVE F. MALES

F, Male Female
Number Number
First
breeding
(cont.J

238

239

241

244

245

251

253

254

256

258

262

264

267

266

269

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
I
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

Total
Implantations
14
0*
9
.*
*

.
.
6
0
4
0
0
0
12
12
6
0
0

TEM Group
Dead
Live
Implantations Implantations
11
0
8
.
.
.
.
.
6
0
1

3
0
I
.
.
_

0
0
0
9
2
2
0
0

Initial Classification

0

-

-

12
12
15
8
8
.

10
4
10

5

3
.

-

.
-

-

-

Nonbreeder

_

Nonbrcedcr

.
-

Nonbreeder

0

0

1

0

0
3
10
4
0
-

Partially sterile

Presumptive sterile

Normal

Partially sterile

Presumptive sterile

0

2
0
5
3
5
.
_
.
.
.

"0" indicates a plug wan observed for a female t;&lt;at WAS not pregnant.
t-

"-" indicates a plug was not detected and the fe.ua le was not pregnant.

214

Partially sterile

Presumptive sterile

Partially sterile

P rtially sterile

Nonbreeder

Nonbreeder

Nonbreeder

�Table 14 (Continued)
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F, MALES

TEM_Groi;ji
Total
F, Male Female
Number Number Implantations

First
breeding
(cont.)

270

273

280

7.81

283

286

288

290

292

294

299

300

302

314

1
2
3
I
2
3
1
2
3
1
2
3
I
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

0*
.*
*
-

13
1?
.1
4
12
12
11
9
.

-

0
0

0
9
14
11
14
10
0

8
(18)t
11
11
9
(15)
11
.
.
-

Dead
Implantations

0
4

5
1
4
6
3
2
1
.
0
0
0
4
9
7
8
7
0
0
9

2

3
3
1
2
.
-

Live
Implantations Initial Classification

0
.
9
7
2
0
6
9
&lt;!
8
..
0
0
0
5
5
4
6
3
0
8
(18)
9
8
6
(15)
9
.
-

Presumptive sterile

Nonbreeder

Partially sterile

Partially acerUe

Normal

Nonbreeder

Presumptive sterile

Partially sterile

Partially sterile
Partially sterile
(questionable)

Normal
Partially sterile
(questionable)

Normal

Nonbreeder

"0" Indicates a plug was observed for a female that wan not pregnant.
"-" Indicates a plug was not detected and the female was not pregnant.
"()" Indicates all Implants were In early stages of development, and thus d i f f i c u l t to
determine If they were live or dead upon gross observation.

215

�Table 14 (Continued)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F. MALES

TEM Group

F. Male Female
Number Number
First
breeding
(cont.)

315

317

318

321

322

326

327

333

334

339

343

344

345

34fi

34S

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
I
2
3
1
2
3
1
2

3

Total
Dead
Live
Implantations Implantations Implantations Initial Classification
0*
3
0

0
0
0
0
5
9
10
0
0
1
.
0

-

-

0
3
0
0
4
4
3
0
0
9
.
.
.
0
-

0

0

0

-

5
-

6
.
-

0
.*
*
9
13
13
0
0
10
.
.
0

11

.

-

0

0
0
0
10
12
14
10
10

.
&lt;!'-) +

0

0
0
0
7
7
8
6
5
.
.
7

Partially sterile

Presumptive sterile

Partially sterile

Presumptive sterile

Normal

Nonbreeder

Presumptive sterile

Partially sterile

Nonbreeder

0
-

Presumptive sterile

0
0
0

Presumptive sterile

3
r
j
-

Tart tally sterile

6
4
5
.
-

Partially sterile

Nonbreeder
Partially gtcrllo

(quest lonable)

. (12)

"0" indicates a
wns observed Cor a female rli.it was not pregnant.
""'',.,,
'
• • i •% . i - &lt; : . . . »
.
.
'-" indicates a phiR was not Jctp.ct.ed and the female was not. prcgndht .
"()" indicates all implants nere in e a r l y stapes of development, and thus d i f f i c u l t to
determine if they were live or dead upon gross observation.

216

�Table 14 (Continued)
TRANS I/ICATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE I'

F "Male
_Njumb;" r
Flvst
breeding
(cont.)

Fema ' c
Number

rc'tdl
Im£lantat lona

350

I
2
3

TKM Grou P
IV ad
Live
Impi.int.'itloiis Imp Ian t u t lone

12
11
H
_.h,

355

356

359

360

36L

363

36 /

369

371

MALES

Initial Classification

P a r t i a l l y sterile

.
-

.
-

Nunbreeder

.
-

I
2
3

4
3
2

-

1
2
3

8
8
6

.
-

-

Nonbrceder

ft
8
8

9
/i
8

P.irl t a l l y 3 t « r l IP

r,

1
2
3

12
16

1
2
3

(l'j) +
-

•]
•
-

1
2
3

12
14
11

8
10
2

4
&lt;i
9

1
2
3

9
-

4
-

s
-

I'artUilly sterile

i
2
3

.
-

.
-

.
-

Nonbreudur

I
2
3

()'•''
-

0
-

-

(15)
-

-

P a r t i a l l y start If
(rjur.it ioriahle)

P.u-tially sterile

0

-

Presumptive s t e r i l e

-

/,

I
2
3

LO
13
-

6
7
-

372

1
2
3

(16)
-

•&gt;
-

375

1
2
3

14
..
-

11
.
-

3
-

P,irti.al Iv s i e r i l e

1
„!
3

11
0
10

6
0

Part i.illy s t e r i Lr

'•

5
0
6

1

-

.

-

17(&gt;

381

6
-

(16)
-

P a r t i a l l y sterile.
P a r t i a l l y sterile
(questionable)

Nonbret'iler

"0" i n d i c a t e s a p l » t r ft-1.

-

w

"'! ohsi-r^cil FIT ,1 ( r m a l c t h a t w j s n o i prf-|;iianL .

i nil 11.'Hi", ;i p l u j &gt; , was not d i ' l i ' C tod nnd the

f o i i ' i l c was not p r e g n . i n t .

j

"()" Lii(ltc,ii.cs a l l Linplniun u r r o in ''.'ii-lv 'itajies cl dcvi loju'it'il , &lt;uid thus d i f f i c u l t
d c i i ' r m i n o i l i h o v won 1 1 i v o IT .lead upon BIMSS n l i s o r v i i l i n n .

2.1.7

to

�Table 14 (Continued)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F

MALES

TEM Group

F. Male Female
Number Number
First
breeding
(concl .
)

382

.
38$

387

(13) +
(11)
_**

1
2
3
1

9
6
()
6
.
.
14
9
0*
.
11
12
14
.
.

3
1
2

3B9

390

391

396

397

399

400

Implantations

1
2
3

2

388

Total

3
1
2
3
I
2
3
I
2
3
1
2
3
I
2
3
1
2
3
1
2
3

.
(14)
11
9
(ID

12
9
(12)

Dead
Implantations

Live
Implantations

7
7
0
1

(13)
(ID
9
5
()
6

7

5
0
..
-

.
3
4
0
-

7

3
5
.
.

Partially sterile
(questionable)

Partially sterile

4

9
8
.
-

Initial Classification

11

.
?
6
5
7

10
7
7

-

Nonbrecder

Partially sterile

Nonbrecder

Partially sterile

Nonbrceder

Nonbrceder
Partially sterile
(questionable)

(14)

5

4
(ID
2
2

Partially sterile
(questionable)
Partially sterile
(questionable)

(12)

Final Classification
Second
breeding

202

2li

I
2
3
1
2

0
0
0
11
1

0
0
0
4
5

0
0
0

Presumptive sterile

7

4

Partially sterile

3

"0" indicates a plug was observed for a female chat was not pregnant .
*
"-" indicates a plug was not detected an;! the female wns not p
"(}" indicates; all implants were In early stages of development, and thus difficult to
determine if they were live or dead upon gross observation.

218

�Table 14 (Continued)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F. MALES
TKM[..Group
F. Male

Number
Second
'iroedlng
'.cont.)

216

220

226

227

228

220

230

231

232

Female
Number

I
2
1
L

2
1
I
2
3
1
2
J
1
2
3
L
2
3
1
2
3
1
2
3
1
7.

233

235

237

?18

239

3
1
2
3
1
2
3
I
2
3
1
2
3
1
2
3
1

Tot nl

Imj)1 an tat Ions

Imp lantatlons

.*
*
.
14

5
12
11

a
i/i

12

12
15
14
13
11
10
0*
0
0
17
12

15
11
15
7
11
13

.
-

2
3
0
7
0
0

0

1
I

0
0
0

0

0
0
0
9
10
10
0

I
1

Live
implantations
ImpJLanta

-

4

Normal

a
14
12
11

Normal

14
14

Normal

n
11
10
-

8
2

5
11
15
6

1
2
0

.
-

3

-

7
13

Normal

Normal

Norm.il

Partially sterile

13
-

Normal

-

Rebred

"0" I n d i c a t e s a p l u j ^ was observed for n f o m a l c that was nor p r e g n a n t .
"-" i n d i c a t e s a p l u g was not d e t e i t c ' d and clip female was not pregnant.

219

Partially sterile

7

,'.

Si'e clii.nl breeding for f i n a l c l a s s i f L e a l ion.

Presumptive sterile

0

8
10
13
0
.
.
-

Normal

0

0

9
12
13
-

Rebrodb

Normal

LU
10
14

n

Rebred

12
2
12

11
14
14

14

Final Classification

.

4
(&gt;
I
1
4
1

2

241

Dead

�Table 14 (Continued)
TRANSLATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F.

MALES

TEH droop

Totnl
F. Male Female
Number Number Implantations
Second
breeding
(cont.)

244

245

251

253

254

1
2
3
I
2
3
1
2
3
1
2
3
1
2

256

258

262

264

267

268

269

270

273

280

3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
I
2
3
1
2
3
1
2
3
I
2
3
1
2
3

Dead
Implantation

Ltve
Implantations

12
13
11
1
0*
7
0
0
G
16
11
.*
*

2
0
0
0
0
4
0
0
0
2
1

10
13
11
1
0
3
0
0
0
14
11

13
14
11
.
13
0
B
12
10
9
11
12
14
I
14
_

0
0
0
-

13
L4
11
13
0
-

..
6
7
-

8
0

11
11
10

0
0

3
8
5
9
6
3
1
L

2
_
.
0

0
0
-

-

0
-

5
4
5
0
5
9
13
0
12
_

6
7
B
-

-

-

3
3
5

8
B
5

"-" Indicates .1 plug was not detected and the female was not pregnant.
Sec t h u d breeding fci f i n a l classi.ficdti.ori.

220

Normal

Partially sterile

Presumptive sterile

Normal

Normal

b

Rebred

Normal

Partially sterile

Partially sterile

Normal
Rebredb

Partially

Rebred

0

"0" I n d i c a t e s a plug was observed Tor a fe.uale Lli.-it was nut pregnant..
:&gt;

Final Classification

Rebred

sterile

b

b

Partially sterile

�T a b l e 14 (Continued)
TPANSLCCATION STUDY OF (.A.PTAN
IMPLANI'ATrON SUMMARY OF PRESUMPTIVE F, MALES

JNk'T.bs.1.
•Second
breeding
(cont .
)

281

(in1???!?..!?.

1

1.

3
1
2

Total
i3lP':anJ:1tA(-nilc

T.KM_Gruup
Dead
Live
!mP'j?,n.Ln..!LLPnl?. .-!S.P.!-Ji1?.a!:-^yP..5.

11
I?
10

7
11

8

4
1
2

Final C.lagsIficatton

Partially sterile

14

3

14
0*
.**

286

1

.

.

..

-

-

-

28S

2
3
1

0
0
0

0

0

0
0

0
0

6
3
0

7
5
0

(i
11

3
3

3
1
0
1
5
8
1

8
10

2H3

2
290

292

294

3
1
'f.
1
1
"I
3
;.
2

:i

299

;
2

300

:i
1

302

2
3
1
2

314

315

:&gt;
i
i
3
1
2

317

3
i

11
H
0
9
14
11
11
12
12
1/4

321

Retired

Presumptive sterile

Partial ly sterile

P-ITI islly sterile

No rma I

9

5
4
10

8

Partially sterile

5

(questionable)

0
1
0

13

7
12
1?

5
11

Part tally sterl le

8

2
I
4

0
0
0

0
0
0

f)
0
0

Partially storlle

n

0
0

0
0

=,
b
2

9
4
11

0
0

0
i)
-

13

q
12
13

n
15

\

14
9

1
2
3

12
11

Normal

No rma 1

0

2
1

0
-

4
9

12
12

L

318

0
0
-

n
0

n
-

-

2
12
15

"0" I n d i c a t e s a plup. was observed for n female thai w.ii, not p r e g n a n t .
r.-*
"-" indicates i plug uda nut doii'clod and thr female wns not
Si.'u third breeding for f i n a l classification.

221

pregnant.

Normal

Presumptive .sterile

Normal

Presumptive sterile

�Table 14 ( C o n t i n u e d )
TRANSLOCATION STUDY OF C APT AN
IMPLANTATION SUMMARY OF PRESUMPTIVE F,

MALES

TEH Group
F, Male

Nurtb'er
Second
breeding
(cent.)

322

326

327

333

334

339

343

344

345

346

Female
Number

Total
Im plantations

Dead
Implantations

1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
I
2
3
I
2
3
1

11
11
_**

0
0
0
-

2

349

3
1
2

350

3
1
2

355

3
I
2

356

3
1
2
3

0*
-

Live
Imp Ian tat ion a Final Classification
11
11
0
0
(10)

Normal

Presumptive sterile

13
(10)t
12
0
-

13
•)
-

0

0
0
0

Presumptive sterile

0

0
0
0

0
0

Presumptive sterile

0

2
0
-

0

0

0

0

0

0

10

5

10

6
6
2
8
I
0
1
-

11

6
1?
4
12
12

10
11
1?

a

0
3

2

0
10

8
0
9

n
0
-

0
0
-

IL
.
(1^)

0
.
•&gt;

b
Rcbred

10
0

No rnifl 1

.
-

Uebrecl

n

-

0
5
4

Partially sterile

5
4

4
3
12
11
-

Partially aterile

Normal

10

8
10
0
0
I
11
0

Normal

Partially sterile

Normal

-

11
.

Normal

(15)

"0" Indicates a plug was observed for a female that was nor pregnant.
*i -

indicates a plug was not detected and the female was not pregnant.

"()" indicates all implants ucrc in early stages of development, and thus difficult, to
determine if they were live or dead upon gross observation.

Sue third breeding for final c lassification.

222

�Table 14 (Continued)
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE f }

I'EM C r o u p
Dea.l
Live
Implantations
Implantations

F, Mali?
Number

Second
breeding
(cont .)

Female
Number

Total
Implantations

359

1
2
3

LO
9
16

1
2
3

10
13
_**

1
2
3

13
13
8
I/.
K

10

10

360

361

363

367

369

371

372

375

376

381

3H2

J65

387

3KH

"0"

I
2
3
1
2
3
1
2
3

3
6
9
8
13
-

Partially

(questionable)

2
0
-

12
14
-

Norma 1

f&gt;
6
0

11
11

.
-

4
5
11

Normal

10
11
14

1
2
3

11
9
-

1
0
-

1
2
3

5
11
1
l,
11

0

4
0
-

3
0
0

0*
-

sterile

Partially sterile

8

-3

1
2
3

1
2
3

7
3
7
2
0

Final Class.If Icatlc

3
7
0

*)
6
9

1
2
3

MALES

-

-

5
5
5
10
9
5
7
1
1
11
0
-

Partially sterile

Robred '

Partially sterile

Normal

Partially sterile

Partially sterile

Normal

1
2

-

-

-

-

"

Rcbrrd

1
2
3

10
17.
7

0
0
0

10
12
7

Normal

1
2
3

I'j
12
b

0

15
-

Normal

1
2
J

9
3
R

i;&gt;

intl i rates &lt;i |il"R uas observed for

3
3
4

a [(.male Lli.-u VMS not pregnant.

-.•

"-" IndicaiTb n plui' war. not ilererred and the female* was not pregnant.
Sec tlilnl brucilinK for f i n a l *. l a s s i fi c a t i o n .

223

b

Partial ly sterile

�Table 16 ( C o n t i n u e d )
TRANSLOCAIION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRF.SUMPTIVE F

MALES

TEM Group

F Male Female
Number Number
Second
breeding
(concl.)

389

1
2

390

391

396

397

399

400

3
I
2
3
1
2
1
2
3
1
2
3
I
2
3
1
2
3

256

1
2
3
I
2
3
1
2
3
1

268

Third
breeding

2
3
l

216

220

241

Total
Imp lao tat ions

bead
Implantations

.*
*

14
12
12
•
.
11
0*
0

11
7
9
•

Live
Implantations Final Classification

2
5
3
~

273

b

Partially sterile

Rebred

b

.
0
0
0
9
3
0
5
8
1

.
11

Pebrcdb

0

Normal

0
5
2
4

Partially sterile
(questionable)

4
5
2

Partially sterile
(questionable)

4
.
.
.

Partially sterile

.

5
.
.
-

-

-

-

0

0

0

14

7
4

9
13
3
9
.
-

(questionable)

Nonhrecder

Nonbreeder

Presumptive sterile

2
270

Rebred

**r

Presumptive sterile

1
2

9
-

0
-

9
-

1
2

.

.

„

-

-

-

Normal

Presumptive sterile

3

"0" Indicates a plug was observed Cor a fomale tliir was no I pregnant.
t;

"-" indicoLes a plug was nor. detected and the fc'in.i'.c was not pregnant .
Set- third breeding for final classification.

224

�Table 14 (Concluded)
TRANSLOCATION STUDY OF CATTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F

MAIES

TEM Croup

F. Male
Number
Third
breeding
(cone I.)

Ftfma IE
Number

286

1
2
3
1
2
3
1

327

334

2

369

3
1
2

332

389

391

1

2
J
1
2
1
1
2

396

3
I
2

3

Total
Iro plantations

11
.*
*
11
(9) t
-

L'ead
Jjnplantnt ion.j

I
10
•i
-

Live
il.1Pla.n.?flI_'-5n,?. Final Class if icat Ion

10
1
(9)
-

14
12
.
-

2
0
.
-

12
12
.
-

11
10
-

0
f)
0

0

-

.-

-

-

-

•
.

-

-

-

-

.

.

-

-

-

Partially sterile
(questionable)

11

0*

Normal

-

10
-

Normal

Fresumpt ! v sterile

Normal

Presumptive sterile

Nonbrccdcr

Nonbreeder

"0" indicates a plug was observed for a femulc that was not pregnant.
"-" Indicates a plug was not detected and the Ecmalc was not pregnant.
" ) indicates all implants were In early stages of development, and tl'-us difficult to
("
determine if they were I Ive or dead upon gross ibsrrvation.

225

�Table 15
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F L MALES

F. Ma,le Female
Number Number
First
breeding

430

432"

436

1
2
3
1
2
3
1
2

449

450

451

452

455

461

469

472

474

479

3
1
2
3
I
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
I
2
3
1
2
3
1
2

480

464

3
1
2
3
I
2
3

Total
Implantations

2500 ppm Group
Dead
Live
Implantations Implantations

.*
*
-

.
-

4

4

(17)t
9
14
7
11
.

9

0*
5
14
11
0
-

10
12

13
.
.
,
_

9
11

12
.
.
.
(3)
f)
11
16
11

9
5
2
3
.
-

4
(17)
9
9
5
8
.
.

4

0
1

0

7
0
9
10
10
.

Nonbreeder
Partially sterile
(questionable)

Partially sterile

Nonbreeder

14

4

Initial Classification

0

0
1
2
3
..
..
1
1
'3
-

.
.

No nn a 1

Norm.! I

Normal

Nonbreeder

Nonbreeder

Nonbreeder

8
10

Normal

9
.
.
-

7
0
•

(3)
0
-

7
2
0

14
11

Nonbrecjdef

Nonbreeder

Partially sterile

4
Normal

"0" indicates a plug was observed for a female that was not pregnant.
:•

-

indicates a plug was not detected and the female was not pregnant.

"O" Indicates all Implants were l.i early stages of development, and thus difficult to
dutprmine if they were live or dead upon gross observation.

226

�Table 15 (Continued)
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F. MALES

F, Male Female
_Nfunibe_r_ Number
Firs I
breeding
(concl .)

489

1
2
3

496

1
i

518

3
I

523

3
I

2

2

526

3
1
2
1

528

546

561

1

2
3
1
2
3
1
2

568

3
1
2

569

582

583

585

588

590

3
1
2
3
I
2
3
1
2
3
1
2
3
1
2
1
I
2
3

Total
Dead
I.«!]p..l_ant_at_i._ons. Implantations

)4
13
8
.*
*

.
.
-

3
1
2
.
.
.
-

Live
Initial Classification
11
12
6

Normal

-

Nonbreeder

-

Nonbres-der

-

Nonbi'p.edei

7

7
4
(l)t

0
1
•
)

3
(I)

0*
-

0

0

-

.

.
.
.

-

-

L2
()
9
(13)
.

4

8
()
9

..
.
-

-

-

.

-

9
I
.

.
-

-

-

10
11

1

15
(12)
11

0
9

-

1

3
.
i
3
0
0

Partially sterile

Presumptive sterile

Nonbreeder

Nonbreeder
Partially sterile
(questionable)

(13)

.
.
9
10
12
-

Nonbreeder

Nonbreeder

Nonbreedur

Normal
Partially sterile
(questionable)

(12)

8
0

Normal

9

"0" indicates &lt;n pluK was observed for a female chat van not pregnant.
*
- indicates a plug was not decoded and the Eemjlc wus not pregnant.
4-

" ) indicates all implants were in early stages of development, and thus difficult Lo
("
determine I f they were l l v r or deaf I upon Rrosa observation.

227

�Table 15 (Continued)
TRANSLOCAT10N STUDY OF C APT AN
IMPLANTATION SUMMARY OF PRESUMPTIVE F MALES

F, Male Female
Number Number
Second
breeding

430

432

436

449

450

1
2
3
1
2
3
1
2
3
1
2
3
1
2

451

452

455

4f.l

469

3
1
2
3
1
2
3
1
2
3
1
2
3
1
2

472

474

3
I
2
3
I
2

479

480

3
1
2
3
1
2
3

Total
Implantations

2500 ppm Group
Live
Dead
Implantations Implantations Final Classification

12

e

14
12
11
13
12
12
13
.*
*

11
13
14
0*
0
11
14
11
13
10
12
12
13
11
11
.
.
12
0
12
11
0
(13)t
8

I

12
8
12
11
10
12
11
12
13
.10
13
13
0
0
10

L
0
0
0
0
1

13
11
13
10
12
11

0
0

13
11
9
..
11

0
0
2
1
1
1
1
0
0
1
0

1

0
0

2
.
.
I

!

0
11
10

0

-

Normal

Normal

Retired

0

1

t

Normal

Norm ill

Normal

Normal

Normal

0

Normal

Rcbred

-

b

Normal

0

-

Normal

Rcbred

b

b

-

(1J)
9

Rcbred

b

"0" indicates a plug was observed for a female that was not pregnant.

.-*

-

indicates a plug was not detected and the female VMS not pregnant.

"()" Indicates a l l implants were in early stages of development, and thus difficult to
determine If they were live or dead upon press observation.
Sec third breeding for final classification.

228

�Table 15 (Continued)
TRANS LOCATION STUDY OF C APT AN
IMPLANTATION SUMMARY OF PRESUMPTIVE F, MALES

? 5.QP.. PJ"P .

F, M a l e
jluinbot
Second
breeding

Fundlc
Number

48'.

1
2
3

n

1
2
3

9
13
14

( con t . )
489

496

518

523

526

528

546

561

568

569

582

•&gt;B1

505

588

I
2
3
1
2
3
1
2
3

1'Otlll

Tmplan in t tons.

Dcnd
ImjjJ an t a t. limn

Live
Imp ) an ta tlcna

0
0
2

11
0
12

Normal

0

9
11
14

No rma 1

0*
14

'i
0
-

.**
.
-

.

-

Kchrcd

n

15
.
.
.
-

I
2
3

No nn a 1

-

0
r

1
2
3

0
11
IJ

-

n
•

1
2
3

&gt;

0
0

0

0

•j

b

Rcbred

b

b

0
14
-

Normal

-

Rob red

-

i
.
.
-

-

Rcbred

1
2
3

11
11
H

2
0
0

9
11
8

Normal

1
2
3

11
-

n
-

11
-

0

10

in

Normal

1
2
3

7

0

7

!')

2
&gt;

13
8

1
?
3

-

-

-

Rrbri'd

I
2
3

12
11
13

0

12
13
13

Normal

1
2
11

&lt;)
-

0
-

9
-

Rehriid

r&gt;

(1

0

-

"0" indicate."-, a p l " H was observed 1'or a Crm.ilc 111,11 u is ncl p r r K M ' U i L :.-v&lt;

v

Rebred"

0
0
0

0
11

1
2
3

.
-

Final C l a o s i f l c

"-" i n d i c a t e s a plug was noi d e l e c t e d and die f o n m l e \im nol p r e g n a n t .
hire r h i r i l b r e a d i n g for f i n . ' j l c l a s s i f L c u c i o n .

229

Normal

b

b

�Table 13 (Concluded)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F

MALES

2500 ppm Croup

F, Male Female
Number Number
Second
breeding
(concl.)

590

Third
breeding

449

474

479

480

1
2
3
1
2
3
I
2
3
1
2
3
1
2

496

523

526

546

561

583

588

3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

Total
Dead
Implantations Implantations
0*
13
12

.*
*

.
10
.
••
.
2
I
0
9
13
15
11
-

0
2
0
.
,
.
B
.
.
0
0

0
0
0

0
0

-

-

-

12
.

-

-

1

Live
Implantations Final Classification

0
11
12
.
.

Nonbreeder

-

Presumptive sterile

2
-

Nonbreeder

.
2
I
0
9
13
15
11
11
-

"0" indicates a plug was observed for n fcmnU* chat was not pregnant.
ft

"-" (nilicat.es .1 p l u g was not detected and the fur.ialo was not pregnant.

230

Normal

Pdrtially sterile
(questionable)

Nonbreeder

Nonbreeder

Partially sterile

Normal

Normal

Nonbreeder

Normal

�T a b l e 16
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F

F^ Male" Female
Number Number
First

601

breeding

604

620

622

1
2
3
1
2
3
1
2
3
1
2

626

3
I
2
3

627

634

635

1

2
3
1
?
3
1
2
3

638

1

2
3

646

653

657

660

1

2
3
1
2
3
1
2
3
1
2

668

3
1
2

3

Total
Implantations
.*
*
( 1 I) +
(8)
7
11
14
H
.
-

CM
.
9
11
R
.
••
10
6
6

12
-

5000 ppin Grou P_
Dead

Live
IseJ.SPiat.lonS. Jj)J tial Classification

.
9

7
0
2
•i
0
'!
_
-

0
)
8
8

.
-

.

Partially sterile
(questionable)

Normal

Normal
Partially sterile
(questionable)

Nonbreeder

Normal

R
.

-

0
0

0
2
-

Nonbreeder

Nonbrocder

10

6

0*

0

?
-

9

7
8
7

0
11
H
7

.
(H)
(8)
7
9
')
8
-.
.
-

1
3
0
-

(13)
13
8

MALES

0
1
0
.
1

6

Normal

10

0
(13)
-

Normal
Partially sterile
(questionable)

2

5
1
0
10

Partially sterile

Normal

H
.
-

Partially sterile

6

"0" i n d i c a t e s a plug was observed for a female t l u t u.-is not p r e g n a n t .
V:

"-" indir.-itcs a plug was not detected an&lt;i rhc female uas not pregnant.

t
'(
)

i.ndical.es all Implants were in early stcigrs of development, and tbus difficult to
determine if chpy were live or dead upon gross observation.

231

�Table 16 (Continued)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE Fj MALES

F. Male Female
Number Number
First
breeding
(cont .
)

671

672

679

722

732

733

734

736

743

700

7ft 1

765

767

I
2
3
1
2
3
1
2
3
1
2
3
I
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2

Total
Implantations
.*
*
.

6
0*
12
.
4
.
.
-.
0
-

(15)t
8
5
9
12
12
11
-

5000 ppm Group
Dead
Live
Implantations Implantations
_
..
.
6
0
0
0
8
4
.
.
4
0
.
.
.
.
0
0
t
(15)
1
7
5
0
8
1
9
3
.
9
3
1
10
-

1

8
(12)

8
•t

Nonbreeder

Nonbreeder

Partially sterile

Nonbreeder

Partially sterile

Nonbreeder

Nonbreeder

Nonbrseder

Partially sterile
(questionable)

Partinlly sterile

Normal

Normal

10

-

2
3

769

2

3

12
..
-

Initial Classification

8
(1?)

Normal

Partially sterile
(questionable)

"0" indicates a plug was observed for a female thnr was not pregnant .
"-" indicates a plug was not detected and tlic female was not pret-nanL.
" ) indicates all implants wen1 In early stages of devulopmont, and thus difficult to
("
determine if thoy were live or dead upon Rro.i.9 obsctvation.

232

�T a b l e 16
TRANSLOCATION STUDY OF CAP! AN
IMPLANTATION SUMMARY OF PRF.SUMPTIVE F ] MAJ,ES

F" Male
_Numher_
First
breeding
i.concl .)

'Female
fjumbfii:

779

1
2
3

780

I
2
3

_ __5000_ ppni G r c u p
Tor.al
Dead
Live
I m p l a r t a t iona Imp Ian tat iona .Implantations

2

0

1

0

4
1

0
0
0

n*

2
0
1

4
1

;_
I n i t i a l Classlilcatic

P a r t i a l l y sterile

P a r t i a l l y sterile

Final C l a s s i f i c a t i o n
Second
breed ing

601

604

620

622

626

627

634

635

&lt;&gt;38

'&gt;46

M3

1
2.
3

I
2
J

n

1
0

11
0

Normal

10

0
0
I

9
10
1'.

Normal

12

1
2
3
1
2

10

1
2
3

(12) t
12

1
2
3
I
2
3

13

1
2
3
I
2
1
2
J
1
2
J

0

1

Normal

0
0

0
12

Normal

0

(12)
12

Normal

1

10
6
0

No rma 1

-

0
I

9

Rebred

"

-

1

1

0

Rebred

10
12
11

0
0
0

10
12
11

Nonndl

11

0
0

1

Norm al

10

1I
13
9

n

0
0
0

14
13
10

b

Normal

n

10

"0" i n d i r a r c s a p l n p w.is obsorvod for J f e m a l e I b a i was n o t p r e g n a n t .
!•

"-" i n d i i . i t , " ; .1 p l u R was n n t d o t c c t r d find tliv f c m . i l r wds IIOL p r e g n a n t .

*

" ( ) " i n d i r d t o - j . i l l i m p K n U i wc'rr i n p . i r l y s t a p e s oC i l l v c l o p m c n L , .mil t h u s d i f f i c u l t
i l j l v r m l n c L f Liu1)1 were l i v e nr dcjd upon i&gt;ross n ' . ) ? o r v a t ion.
Sec r'.urd h r c c d i n n f;n l n u l c \ .i.-&gt;s i f ic.ii ion .

233

to

�Table 16 ( C o n t i n u e d )
TRANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF PRESUMPTIVE F , MALES

F. ,Mj»lc
Number
Second
breeding
(cont .
)

Female
Number

Total
Implantations

657

1
2
3
1
?
3
I
2
3
1
2
3
1
2
3
1

5000 pp&lt;n Group _
Dead
Live
Implantations Imp! an t a t lo n 9 Final Classlf Lcat ion

7
9
5
14
10
12
9
13
13
14
11
-**

.660

668

671

672

679

2

722

732

733

734

736

7'3
,

760

761

765

3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
'3

5

2
1

8
1

4

0
1
0

14
9
12

Normal

0

9
12
12

Normal

1
1

0
0

.

-

-

U»

0

7
12
'
'

0
0

14
11
-

-

-

-

14
7
12
3
-

12

0

-

-

Normal

Normal

12

-

Partially sterile

1

-

-

-

0
0

11
12
_

-

Normal

Rebred

Normal

-

Re b red

11
12
_

.

-

-

-

14
10
11

0
0

10

1

0*

0
0

1
0

0

0

5
14
1.2

0

0
5
13
11
12
11
9

1
!
3
0
0

13
11
9

h

Normal

LO

"0" indicates a pliifl was observed for a female that was not pregnant.
"-" indicates n plug was not di'toclcd and rhu female was inn. pregnant.

234

Rebred

14

.1
Soc 1'iird breeding for final classi Cication.

1)

Normal

-

1

b

Partially sterile

Normal

No nn LI 1

�T.ihlo 10 ( C o n e l u l l e d )
IKANSLOCATION STUDY OF CAFTAN
IMPLANTATION SUMMARY OF I'RESUtlPTIVE F

MALES

SpOOjpm
F Male;
Number
Second
brcudlnK
(cone I .)

767

?r,9

Total
female
Numbc r Implant actions
1
?
3
I

1
2

0*
4

2
0
0
ll
0
0
0
0

1

0
2
I

0
0
1

.
-

.
1
.
0

2

)
771

/HO

2

3
Tlur.1
breeding

634

I
2
3

635

722

•'33

1

2
3
1
2
3
1
2
3

736

Dead
Implantations I.

1
2

3

14
13
12
12
13
10

13
.
..
-

0

12
13
12

Normal

12
13
10

Normal

0
4

P a r t i a l l y s«ti&gt;rilt!

Nonbrccder

1'artlally sterile
12

-

-

"0" indicates ti plug was observed for a female thai was not pregnant.
I:

"-" indicates a plup, was not detected and the female was not pregnant.

235

Partially sterile

Norma 1

Nonbrecdcr

Presumptive sterile

�Table 17
fRANS LOCATION STUDY OF C APT AN
IMPLANTATION SUMMARY OF PRESUMPTIVE F

F Male Female
Number Number
First
breeding

805

806

815

816

8L7

Total
Implantations

I
2
3
1
2
3
I
2
3
1
2
3
1
2

818

822

823

837

3
I
2
3
1
?
3
1
2
3
I
2
3

841

84(&gt;

847

1
2

5000 pp.n Group
Dead
Live
Implantations Implantations

**
.
6
9
7
-

.
0
0

.
.
6
9

0

-

(10)t
(U)
.

•J

-

-

10

-

0

.

.

-

.
.

-

-

-

.
-

0

5
-

-

1

(14)
-

•;

-

Nonbrceder

Nonbreeder

Partially sterile

Partially sterile.
(questionable)

10

'.'

0

.
-

-

(10)
(U)
.
.
-

6
.

-

Initial Classification

7

1
2
3

2
3

MALES

-

-

6
.
5
(14)
-

Nonbreed?r

Normal

Nonbrceder

Nonbreeder

Nonbreoder

Nonbreeder

Partially sterile
Partially sterile
(questionable)

-

Final C l a s a i f i c a t l o n
Second
breed! n i&gt;.

H05

Bebred

' i n d i c . u o s t [V.umiiLl/.c'd F., f e m a l e s .
,v

,v-\

t

"0" i n d i c a t e s &lt;i pl'ip, was observed tor a Ornate t l u L was not.

"-" indic.'ilc's ,1 plug was n''t detected jnd rht; fomnlc was nol procnjnt.
"()" indicate 1 . 1 ; J l l i m p l a n t s wcro in r j r l y suigos o f d e v e l o p m e n t , and thus d i f f i c u l t t o
d e t e r m i n e if they were l i v e or dead upon gross o b s e r v a t i o n .

'Sue I ' . i i r d brci-dinp, f o r f i n j l

classification.

236

�T a b l e 17 ( C o n t i n u e d )
TRANSLATION STUDY OF CAPI AN
IMPLANTATION SUMMARY OF PRESUMPTIVE F MALES
_

_ _ .5000' ._|jpm (-rpu[)_
_ _
Dead
Total
Live
rmg lap tat ions Implant a t :um:j Implantations Final C l a s s i f i c a t i o n

F. Male
Niinibe r
Second
brooding
(concl.)

Female
Number

806

1
2
3

13
14
10

1
0
0

12
14
10

Normal

1
2
')

I'l
11
13

1
0
3

IJ
11
10

Normal

I
2

i;

*

Normal

I
2
3

11
n*
n

4
0
-

7
0
••

Kobr«-d h

0
0

11

811

816

817

818

822

823

837

841

846

847

1
2
3

805

817

B22

8
1)

2

n

1

0

Normal

12
6

1
2

b

1
2
3

n
-

1
2
1

8

1

-

-

-

I1)

2
0
-

13
10
-

Normal

0
0
0

10
12
12

Noniia 1

1

10
10
14

Normal

I
2
3
1
2

3
1
2
3

Third
b reed inn

**

1
2

Kobred''

in
in
12
12

;i
in
1/1

.
n

0

-

0
0
„

Retired

_

1'artially sterile

-

2
7

1I
2
11

Normal

in
i?
i?

Normal

1J

n

1
2
3

10
12
12

0

I n d i c ' i i l c s tr.jum.it izcd F

_'

Normal

-

I
2
3

4

13
-

n

0

Inn.ili";.

"0" i n d i c a t e s ,1 I ' l n p was n b s c i v e d lor a Connie f i a r vjni MOL prep.n.ini.
"-" i n d i c a t e s n pluj; was not d i ' l p c t r d .irnl the female u;is mil p r e g n a n t .
Sot t h i r d breeding for l i n j l c la-ii if i r a t i o n .

237

�Table 17 (Concluded)
TRANSLOCATION STUDY OF CAPTAN
IMPLANTATION SUMMARY OF PKESUMPTIVF, f} MALTS

F. Male Female
Number Number
Third
breeding
(concl.)

837

1
2
3

Total
Implantations
-**
-

5000a ppm Uroup
Dend
Live
Implantations Implantatlona
-

-

'Indicates traumntizod F. females.
'-" indicates a p l u g was nol. detected and the female was not pregnant.

238

Final Classification
Normnl

�a

a:
a.

V ,-

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5105">
              <text>012</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5107">
              <text>0101</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="5110">
              <text>Series II</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5102">
                <text>Simmon, Vincent F.</text>
              </elementText>
              <elementText elementTextId="5103">
                <text>Ann D. Mitchell</text>
              </elementText>
              <elementText elementTextId="5104">
                <text>Ted A. Jorgenson</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5106">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;Stanford Research Institute, Menlo Park, California</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5108">
                <text>1977-05-01</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5109">
                <text>Evaluation of Selected Pesticides as Chemical Mutagens 'In Vitro' and 'In Vivo' Studies</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="5111">
                <text>animal testing</text>
              </elementText>
              <elementText elementTextId="5112">
                <text>pesticide testing</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
  <item itemId="1233" public="1" featured="0">
    <fileContainer>
      <file fileId="1117">
        <src>https://www.nal.usda.gov/exhibits/speccoll/files/original/8dd45d44d672ef1c545bc2019d64ceab.pdf</src>
        <authentication>dbb36089c3a06149ea2ff579fb93a3a3</authentication>
        <elementSetContainer>
          <elementSet elementSetId="4">
            <name>PDF Text</name>
            <description/>
            <elementContainer>
              <element elementId="60">
                <name>Text</name>
                <description/>
                <elementTextContainer>
                  <elementText elementTextId="63066">
                    <text>Item ID Number:
Author
Corporate Author

00054
Boush, G.M.
University of Wisconsin, Department of Entomology,
Madison, Wisconsin
Pesticide Degradation By Marine Algae

Journal/Book Title
Year

1975

Month/Day

A ril

Color

W

Number of linages

23

DeSCrlptOU Notes

Contract N00014-67-A-01 28-0023, Task No. NR 306-061

P '

Friday, November 17, 2000

Page 54 of 57

�Boush,G.M., et al
1975
Pesticides Degradation by Marine Algae
.AD A 008 275

AD-A008 275

PESTICIDE DEGRADATION BY M A R I N E ALGAE
G. M. Boush, et al
Wisconsin University

P r e p a r e df o r :
Office of Naval Research
1 April 1975

DISTRIBUTED BY:

Hiflimi TttfciHtil hififiiititi ftftfrt
V. 1 BEMRTMENT if C8MMERCE

�118104

10

Off lev of Haval Research
Contract H0001U-67-A-0128-0023

00

o
o

Task Ho. HB 306-061
PHIAL REPORT

Pesticide Degradation by Marine Algae
by

G. N. Bousb and F. Matsumura
University of Wisconsin
Department of Entomology
Madison, Wisconsin 53706
April 1, 1975
Reproduction in whole or in part is permitted for any purpose of the
United States Government
Approved for public release: distribution unlimited

This research was supported in part by the Office of Haval Research,
Haval Biology Program, under Contract Ho. H0001U-67-A-0128-OO23, HR 306-061.
Reproduced by

NATIONAL TECHNICAL
INFORMATION SERVICE
US (topulnmt ol Comn««
Sprl.gfM&lt;l. VA. 2JI51

�DOCUMENT CONTROL DATA - R I D
l*ll&gt; i &lt;im«l w *nl*n4 wh*r&lt; lh» •rmtmll ttffrl

/« «•/««»&lt;«•«)

I*. RIPORT f C C U R I T V CLASSIFICATION

I. ORIGINATING A C T I V I T Y

Department of Entomology
University of Wlseouln
Madison, Wisconsin 93706
1. HtPMT TITL«

Pesticide Degradation by Marine Algae
4. DC«CRIPTIV« NOTCt (Tyf» 01 np*r« and

Final report
»- »0 TMOMMI rFinf HMwTiiMffi Mail. lm»l MM)

George M. Boush and Fumio Matsumura
• - RCPOMT OATC

If. TOTAL NO. OF FAOU

7». NO. Of KCFI

April 1, 197?

0

M. eONTHACT ON CHANT NO

». PHOJ.CT NO. H
B

HOOO1H-OY-A"0120-0023

M. OMIOINATOITl KCPOHT NUMBCHI*)

306-061

M&gt;. OTHCM HKPOMT NOIII (Any oHm Itwmbfn timt muy b* ••

10. DISTMIC JTION STATKMCNT

Standard Distribution List
II. SUPPlCMCMTAItV NOTt*

12. SPONSORING M I L I T A R Y A C T I V I T Y

Office of Naval Research

Rone
I

AStTRACT

Various algae species are tested for their susceptibilities towards chlorinated
hydrocarbon insecticides. Deildrin, which is the most frequently found pesticidal
contasdnant in the 1)8, and its analogs were found to inhibit the growth of certain of
algae species. Anacystis nidulans in particular showed narked susceptibility to endrin
dieldrin, ketoendrln sad photodieldrin. This species was also susceptible towards
dieldrin metabolites such as metabolite F and 0. Among DDT metabolites DDD (TDE) was
found to be the most toxic material) followed by DDE, DDT and FW-152. It has not been
mown that DDT should be more toxic to algae. In terms of acute toxiclty phenylmercuri
acetate was by far the most alglcidal agent among all pesticidal chemicals tested.
This pesticide is toxic to both A. nidulans and A. quadruplicatum at the concentration
of 1 ppb.
Algae, along with other plankton, are known to bioaccumulate pesticides and thereby play a vital role in the process of food-chain accumulation of these micropollutants
Oar studies indicate that the rates of pick-up of pesticides are very rapid. To study
the feasibility of constructing a model ecosystem we used algae as a key food chain organism. By this way we could demonstrate that TCDD, the most toxic contaminant of 2,
&gt;-T does not really accumulate in the aquatic organisms as compared to DDT.
Algae as a whole are not very active in degrading pesticidal chemicals in vivo.
They were found to play, however, a key role in the process of environmental alteration
of pesticidal residues. The way they participate in such processes was found to be
through aynerglstlc actions on photochemical reactions. Algal products, when tested
in the form of aqueous extract from dead algal cells, were found to be excellent photosensitizers for DDT and mexacarbate degradation by the sun-light f«ini»-i&gt;t.»rt «»n i«miO

00.^.1473
S/N 0102^)14^600

(PAGE t )

PLATE NO. 21BJ6
Security CUmlTic«tion

PWCB SUBJECT TO CHANGE

�Ill
LINN A

• HIV ••no*

•OLB

*T

•»t

oblarlmtrt hydrocarbon*
ioMMllua quadrupliotiai
•icrcfcial tegxmtetion
DDT

up-tak* t&gt;ceuul»tlon
food elmini
teniflAl realdue*
TCDD

•otel •eocystmu

i

X

i

•

DD
(PAGE 2)

&lt; BACK »

LIMN e

LIMN- •
N«Ll

Security CU»ific«tlofi

tt«LI

•T

�,UA«*

/v/
TABLE CT COITOrTS
Page

or RESEARCH ACCOMPLISHED - r

-

i

I. - Effect* of pesticide* on plankton - — . . — . — . 1
.
II. - Effect* of degradation products . . — . — . . 2
.
.
..
III. &gt; Effects of pesticide •icro-contaainaats
-— - 6

nm or -nccraiic/u REPORTS
-....17
or ALL PUHLICATICHS ..................i?
MUOR ACCCMPLISBffiHTS - -

16

DOCUMENT caiTROiL DATA - R &amp; D

19

KEY WORDS

. - - - . _ . . .

20

�-1-

SttMAHY OF RESEARCH ACCOMPLISHED

I. Studies relating to the affects of pesticides on plankton.
It has been suggested that the varying resistance of marine phytoplankton to effects of chlorinated hydrocarbons could have far-reaching
effects in terms of phytoplankton population balance. Studies in this
laboratory have also shown varied growth inhibition of planktonic bluegreen algae by chlorinated hydrocarbons. TABLE 1 shows the effects of
aldrin, dieldrin, and endrin on growth rates (generations per 2U hr.)
of Anacystis nidulans (freshwater species) and Agme'nellum quadrupllcatum
(marine species).It is noticeable that generally the marine Isolate is
more tolerant than the freshwater isolate. This may be due to the influence of the growth medium on the insecticide. The toxiclty of a
pesticide in aquatic environments may vary according to the physical
characteristics of water.
Although much variation is noted in the data, the general trend
indicates both algae are tolerant to these insecticides except at concentration* higher than reported in natural waters. Also notable is
the sensitivity of A. nidulana to dieldrin, an isomer of
TABLE 1
Growth Response of Agmenellum quadruplicate* and Anacystis nidulans
to Aldrin*, Dieldrin, and
"""^

ppb

Aldrin
A. q u a d r u - A . 0
pllcatum*5 nidulans

950
U75
95
19
0.2
Control

6.2 * 0.7
7.1 * 0.5
6.6 * 1.2
6.8 * 0.3
6.U * i.o
6.6 * 0.5

Dieldrin
Endrin
A. q u a d r u - A ^
A. q u a d r u - A T
plicatum
nidulans plicatum
nidulans

6.U * O.U 5.8 i 0.9
6.7 * 0.2
6.8 * 0.5
7.1 * O.U
7.2 i 0.3
6.S * O.U

6.0 - 0.8
6.0 - 1.0
6.5 - 0.7
5.3 * 1.2
6.2 i 0.9

3.2*0.8
3.9*1.5
6.9*0.6
7.2*0.9
6.7*1.3
.
6906
.*.

3.5 * 0 9
.
U.8 * 1.5
U.9 * 2.2
5.6 * 1.3
*0.3
6.6 * 0.5

2.2 * 0.7
3.2 * 1.0

6.3 * 0.3
6.6 * O.U
7.0 * 0.5
6.6 * O.U

Concentrations for aldrin 9 0 U55, 91, 18 and 0.2 ppb.
1,
Values reported as number of generations per 2U hours, represents mean of
3 to 5 replicate cultures
Aajaenellum quadrupllcatum (strain FR-6), Anacystic nidulans (strain TX20)
In preliminary experiments the growth response of these two algae
was also tested against phenylaercuric acetate (FHA), an algicide and
fungicide once used extensively in 'Industry. The results are summarized
in TABLE 2.

�-2TABIE 2

Susceptibility of Two Species of Blue-Green Algae
Against Fhenylmercuric Acetate
0.10
A. nidulans
A. quadruplicatum

. 109

Phenylmercuric acetate PPb)
0.75
0.25
0.50
1L.OO
100

109

112to
10
0

8°
7

6*
8
112

1.0
00

0
0

Expressed in % relative growth against controls as 100.
Only 3 of U replicates grew during the experiment.
*? Only 2 of k replicates grew.
Only 3 of 6 replicates grew.
Thus results showed A. nldulans to be affected by as little an 0.50
ppb PMA. At this and higher concentrations growth was irregular and vts
preceded by lag phases. In view of mercury contamination reported in
oceanic environments it was of interest to also consider the toxicity of
FHA to A. quadruplieatum. Duplicate cultures in two experiments yielded
the growth values as compared to controls (TABLE! 2). Thus it is evident
that A. quadruplicatum is more tolerant to FMA than A. nldulans; however,
neither organism showed any growth at 10 ppb IMA.
~~

Much research has shown that in addition to growth, beneficial
activities of microorganisms can be affected by pesticides as well.
Bacteria in soil which convert organic matter to ammonia, and several
herbicides have been seen to influence soil nitrification.
II. Effect of degradation products.
Pesticides, as they may adversely affect microorganisms, involve
not only the parent compound, but the intermediate and terminal residues
of these compounds as well. Recent investigations have pointed out the
potential of certain "terminal" residues to be as Ijxic as the original
pesticides. Data from this laboratory alco support this obeservation.
Anacystis nidulans and Agmenellum quadruplieatum were grown in media
containing microbial degradation products of aldrin, dieldrln, and endrin. The data in TABIE 3 show that A. nldulans continues to be sensitive to photcaldrln and ketoendrin, two metabolites of aldrin and
endrln, respectively. Agmenellum quadruplicatum appears resistant to
both compounds.
However, both organisms show
of dieldrin, as shown in TABI£ U.
formed microbially, photodieldrin
by the action of UV or sunlight.

continued sensitivity to metabolites
While metabolites P and G are only
is also known to form on plant surfaces
Hence, it was of interest to assay the

�-3-

Qrowth Response* of Agmenellum quadruplicatum and Anaeystis nidulans
to effects of Metabolites of Aldrin and Kndrin, toB-i»ll
Photoaldrtn
A. quadruplicatum
A. nidulans

ppb

950
*75
95
19

0.2

Control

Ketoendrin
A. quadrupllcatun
A. nidulans

6.2
6.U
6.5
5.9
6.0
6.6

7.U - O.U
6.8 ± 0.2
7.3 * 0.3
7.1 * 0.8
7.3 * 0.6
6.6 i 0.5

* 1.0
* O.U
* 0.7
;0.7 * 0.6
t 0.5

5.3 -0.8
6.3 * 0.7
6.U 1 0.7
7.0 i 0.6
7.0 i 0.6
6.8 ± O.U

fc.5 * 1.1

3.5 - 0.1
6.0 - 0.8
6.6 ;* 0.2
6.3 - 0.1
6.8 t O.U

Conditions as in 1AHUE 1.

TABLE

Growth Response of Agmenellum quadruplicatum and Anaeystis nidulans
to Metabolites of Dieldrin
Metabolite F
A.
A. quadrunidulans

ppb

950
475
95
19
02
.
Control

5.* I 0.7
5.9 ±0.9

6.1» - 1.2
6 8 - 0.8
.
6.2 ±0.9

3.5
U.8
6.5
7.2
6.7
6.9

*Q.k
±0.3

± 0.5
±0.5
±0.3
±0.6

Metabolite 0
A. quadruA.
plicatum
nidulans

Photodieldrin
A. quadruA.
plicatum
nldulans

M - 1.0 k.Z - l.U
6.U ±0.8 5.9 * 0.6
6.U * 0.9 6.7 * 0.1
6.U i 1.2 6.7 * 0.5
6.5 ± 1.1 6.U ± 0.1
6.2 ±0.9 6.9 * 0.6

5.6 - 1.0
6.9 ±0.5
6.6 ±O.U
6.U ±0.6
7 1 ± 0.2
.

6.2 ± 0.9

u.o Jo.u
5.3
7.2
7.1
71
.
6.9

±0.8
± 0.1

±0.9
±0.8
± 0.6

response of other algal species to photodieldrin. TABUS 5 shows that
of the algae tested, Hostoc sp. and the green alga Chlorella spporensis
appeared only slightly affected by photodieldrin at high concentration,
while A. nidulans was most inhibited. Continued growth of A. nidulans
in successive cultures in medium plus various levels of photodieldrin
did not improve initial growth rates. Other attempts to improve the organisms' tolerance by varying growth conditions and dark incubation intervals were unsuccessful.

�ft.
TABLE 5
Growth Response of Several Blue-Green Algae* to Photodieldrin*»c
Alga*

I
II
III

V

VI*

VII3

Control
2.6 * 0.1 5
0.2
3.5 * 0.2
7.0 * 0.7
- v.i(,\
6.2 * 0.6}?
3.3 * 0.3* '
6 5
- I°- 2 /l!
3.6 * 0.5&lt;6&gt;

0.2 ppb
2.7 *
3.6*
6.7*
6.9*
3 3
7.1 *
"-I""/^
3.7 * 0.7&lt;6&gt;

- ;

19ppb
&gt;..&amp; * 0.2J3J

-

950 ppb

95 PPb

tf\

2.7*
3.6*
7.1 - w.«/_\

SilitjSl I:!!?:!?!
3.5 * 0.5&lt;6&gt;

k'.O *

2.9 * 0.
3.3 * 0.
5i2
3.2
7.1
3.fc

* 0.
* 0.
* 0.
* 0.

* I • Anabaena variabilia; II » Hostoc «p. ; III » Anacyitig nidulana; IV Chlorella •
_^___^
V * Agpenellum quadruplicatua (strain BS-l); VI » Agaenellua quadruplicatum' ( train PR-6J;
VH Coceochloris elabans.
a
All algae tested here are blue-green species, except C soproensis, a gre* *
b
Values reported as number generations per 2k hours. ~
e
Rubbers in parentheses indicate replicate cultures.
d
Indicates marine isolate; others are freshwater isolates.

�-V ' S"*-^ •''
,;;,•'*:tBT*1S, ". '!.-:i,"i £"«?£ i«*3. ':r
E'-f».V&lt;

;&lt;*--;---;; ^m

•BHI |J£J2*g|nlB£gB!|»Dxg ^Sf^^i^HKi^s^i^SiSfff^iHSH9^tMfUffS^HniSSo^3i^^SISKSS^SSS3^S^SSSESS3^Si^

Vjjpirfhi'^H

-5ThHl£ 6
Growth Response of Agnenellum quadrupllc '.turn and
Anacystis nidulans to DDT and its Metabolite** »»

ppb
DDT

A. quadruplicatua

885
442
88
18
0.2

(13)
12)
»0

0.0

5.3
5."»
G.2
6.2
6.7
6.3

* 1.0 6
* 0.9 5
* 0.4 3
± 0.3 ( 4
* 0.4 ( 4
* 0.6 ( 8

791
395
79
8
0.8
0.0

ODD

I 1.1
J 1.3
* 0.6
± 0.4
* 0.6
± 0.7

791
395
79
8
0.8
0.0

DDE

5.1
5.*
6.3
6.5
6.1
6.1

3.4
5.3
6.7
6.8
7.0
6.k

* 0.0 (
* 0.8 (
i 0.1 (
i 0.3 [
* Q.k
* 0.7 1[

6.9 * 0.2 (
6.7 - 0.0 (
7.k * 0.2 [
7.1 * 0.0
7.k * 0.2
6.9 * 0.2

700
350
70
7
0.7

DBA

'

0.0

DBF

6.5 * 0.3

720

6.9
6.6
6.8
6.6
6.9

360
72
7
0.7
0.0
FW 152

( 4)
( 4)
(16)

• 0.3
- 0.1
* Q.k
* 0.1
* 0.2

8

0.8
0.0

5.8 - l.l
5.8 * 0.8
6.5 * 0.6

&lt;f M

"gUSjTaiJl-i-liai

2)c

2c
k
2
2)
2)
6)

4.2 * 0.3
5.3 * 0.3
6.2 t 0.3
6.8 ± 0.3
6.4 * 0.3
7.0 4 0.3 (

j^ C

2)
2)
2)

6.2 * 0.1 2
5.9 * 0.2 2)
6.5 * 0.4 2

2)
3)

6.8 ± 0.0
6.0 ± 0.3

2
2
2
2
2
3)

6.4 t o.l
6.2 i 0.0
6.8 * 0.2
7.1 £ 0.»»
6.6 ± 0.1
6.0 ± 0.3 (

2)

6.8 * O.I* ( 3)
6.6 * 0.3 ( »»)
•AM

«t^«%v^ srn^t**^

•••••ilia ••

5

6.2 * 0.2 4
6.8 J 0.7 4
6.8 t 0.5 16)
5.4 - 2.0
6.5 * 1.5 U
6.5 * 0.4 ( 2)
7.2 * 0.0 ( 2
6.8 * 0.5 ( 7

6.6 i 0.6

i.

6)

o
o

7)

2
2

3
2
2
2
2
2

3)

6.3 i 0.4 2)
7.2 t 0.2 2)
7.4 * 0.2 ( 2)
7.2 ± 0.1 ( 2)

7.«» * 0.2 ( 2
7.0 * 0.3 ( 3

• Values expressed as number of generations/24 hours.
•

16

4.6 * o.O

6.1 - 0.1 4)
6.8 * 0.3 3)
6.6 * 0.* 3)
6.3 * 0.* 4)

821
410
82

A. nidulans

*«w* «MMt1 4 t^+^m

Growth occurred in only one or two of several replicates.

�-6TABUE 6 Incorporates data of several growth-response experiments
of A. quadruplicatum and A. nidulans to DDT and five DDT-analogs. Again,
although much variation occurred, the data show little growth-rate depression of either alga at concentrations below 100 ppb insecticide.
Both species show continued, perhaps greater, sensitivity to the two
analogs DDE and ODD, as well as DDT. However, the more polar compounds
DDA, DBF, and FW 152 apparently have little effect as seen in these
experiments.
III. Microbial uptake and accumulation.
Toxicants, one taken up by primary producers such as marine algae,
can be passed up the food chain to higher trophic levels. In addition,
many toxicants can, depending upon the environmental conditions and
species involved, be accumulated within the cell to levels many-fold
higher than ambient. From the few studies available, accumulation appears to be primarily by inactive surface adsorption. However,
Glooschenko found that dividing marine diatom cells in light accumulated
2
°3Hg longer than did non-dividing cells, thus indicating the possibility
of some active uptake mechanism. The exotic and demanding minor-element nutritional requirements of many organisms would tend to support
active uptake in some instances.
We have found that yeast cells of Rhodotorula gracilis rapidly accumulated yii&gt; of the DDT in a 2-ppm aqueous solution! Likewise, another
yeast, Torulopsis utilis, took up 9^6 of the DDT in 3 minutes.
In TABLE 7, showing the percent radioactivity of the ^C-DDT in
the cellular fraction, the control values showed a random distribution
of DDT between the medium and the cellular fractions, ranging from 21
to 56£. These results were obtained by centrifuging, decanting, and
filtering the aqueous medium, and the distribution of i^C-DDT between
the medium and cellular fractions was determined by liquid scintillation
counting.
In contrast to the erratic control values, the cellular fractions
accumulated DDT at a constant rate over the &lt;X)£ level after 3 minutes.
An extract of R. gracilis was prepared by sonicating the cells
before the additior~of the ^C-DDT. The sonicated pellet was found to
accumulate an average of 96£ of the DDT.
We also attempted to correlate cellular lipid content with the uptake of DDT. Rhodotorula gracilis when grown on a medium rich in carbohydrates and deficient in nitrogen and phosphorus will produce approximately 6o£ lipids, whereas when not deprived of N and P, lipid production
is reduced to approximately UOjt. When cultures were grown under both
circumstances, no differences in DDT pick-up were noted.
It is apparent that the complexities of pesticidal-microbial in-

�-7-

terrelationahips warrants continued study. It has been amply demonstrated that members of the microbial world vary widely in their response to
pesticides and that several factors may influence the toxicity of pesticides. Likewise, the microbial tolerance of pesticides may be affected
by growth conditions, physiological condition of the cells, and various
stress factors which might exist in natural populations (e.g., temperature, limited nutrients, competition). For example, growth experiments
with A. nidulans established separate tolerances of 1% NaCl and 800
ppb DDT (Batterton, Boush and Matsumura, 1972). However, growth of this
alga is severely inhibited in meul^u containing both 1% NaCl and 800
ppb DDT. Figure 1 illustrates relative growth of A. nidulans in various
concentrations of DDT r.nd NaCl. The resulting growth pattern indicates
the combined stresses of NaCl and DDT significantly changes the tolerance of A. nidulans to either substance. However, in similar experiments with test-tube cultures, growth inhibition was contraindicated
when the calcium concentration of the growth medium was increased fivefold.
It is particularly interesting to note the similarities in nearly
all c the uptake-accumulation studies. First, pick-vp of the toxicant
is extremely rapid—varying from a matter of seconds to a few minutes.
And secondly, removal of the toxicant from the medium is quite high—
usually more than 90jt of the total being removed by the cells (dead or
alive), even when ambient levels were many-fold higher than those usually encountered in nature., However, one factor should not be ignored.
Few, if any, studies have included competitive adsorptive substrates.
Might not DDT, for example, readily aifsorb to organic matter, silica,
etc., if available? The apolarity, affinity for lipids, and low water
solubility of virtually all of the persistent insecticides make studies
in aqueous substrates difficult. Of even greater importance, cau we
extrapolate from our work, even to a United degree, to conjecture as
to what occurs in nature?
It is doubtful if we can overstress the important of microbial
accumulation. After more than 25 years of world-wide use and study,
the real threat from persistent pesticides is in their unfortunate
ability to concentrate with food chains. This would not occur were
the toxicants not picked up from low background levels, concentrated in
the cell, and finally, stable for considerable periods of time.
The results shown in Figure 2 indicate the general susceptibilities
of brine shrimp, Artemia salina, to various terminal residues and analogs
of DDT. It can be seen that these analogs, though many of them have
been regarded as non-insecticidal, are indeed toxic to this species.
IV. Effects of chlorinated insecticides on NaCl-tolerance mechanisms.
Since Na+, K -ATPases have been known to serve as the enzyme re-

�-8sponaible for Na+ and K+ exchanging across many biological membranes,
we have decided to study first the effect of DDT on the salinity regulatory mechanism of a blue-green algae (Batterton et al., 1972). The
initial experimental results indicate that the susceptibility of a
blue-green alga, Anacystis nidulans, against DDT varies greatly under
different salt concentrations. At high NaCl concentrations the bluegreen alga becomes extremely sensitive to DDT. It is clear from the
result that this fresh water species loses its NaCl-tolerance capability in the presence of a low level of DDT: the level normally
would not affect the specie. . A spearate experiment in vitro showed
also that DDT was indeed an inhibitor of Na+, X+-ATPases of A. nidulans. blocking all ouabain sensitive ATPase activities. The most important indication that the ATPase is related to the Nad-tolerance
mechanism comes from the in vivo finding that Ca , when added externally to the medium, can antagonize the effects of DDT.
TABLE 7
Percent Radioactivity of lJ*C-DDT in Yeast Cells
Time (minutes )
17.5
32.5

Culture

2.5

7.5

12.5

Control
Torulopsis utilis
Rhodotorula gracilis
Extract-R. gracilis
Protein producing
medium-R. gracilis
Lipid producing
medium-R., gracilis

21
92
97
98

U2
96
98

56
91
97

38
95
98

Average

39
96

97
96

97

96

97

95

98 .

97

In another set of experiments, the brine shrimp, A. salina, was
subjected to various chlorinated hydrocarbon insecticides under different salt concentrations (Figure 10). The results clearly indicate
that the effects of these chlorinated hydrocarbons are strongest at
either extremely low or high salt concentrations. The brine shrimp is
noted for its great capabilities of tolerance on different salt concentrations. It is often found in abundance in inland salt lakes (e.g.,
salt ponds and lakes in Utah) where the salt concentration is so high
that no other organism can survive. The loss of salt tolerance mechanisms for this species by the presence of these insecticides is, therefore, quite a surprising phenomenon.
The examples illustrate only one aspect of pesticidal pollution.
It is important to note, however, that such a finding comes from fundamental knowledge of the chemical interactions with biological materials.

�-9AN'ACYST.'S _N!PULANS

FIGURE 1. Relative growth of Anacystis nidulane in response to
varied DDT and NaCl concentrations. Liquid culture (15 ml) in 60 mm
petri dishes inoculated ( 2 , 0 cells/ml) and incubated 72 hr. under
1000
200 ft-c fluorescent lamps at 37° C. After correction for evaporation
growth was measured as optical density at 660 run. All O.D. values
normalized to 1.0.

«*

0.4 a*

u&gt;

CONCENTRATION

xo
IN

PPM

FIGURE 2. Differential toxicities of DDT analogs and metabolites
on brine shrimp, Artemia salina; 2k hours exposure at 2l*° C.

�" •• ' • &gt; , • • -

.

-10-

It is aJ.so necessary to stress that those stable terminal residues and
contaminants would not have been detected from the environments if not
for the specific knowledge accumulated through basic researches in the
laboratory as to their chemical characteristics and behavior. Factors
involved in the interactions of pesticides with variouii ecosystems are
numerous and complicated, but it certainly is hoped that there are a
number of rate-limiting, key factors that can be analyzed through controlled laboratory experiments.
V. Effects of pesticide micro-contaminants: Model ecosystem
study.
While the problem of pesticidal contamination of the environment
is far from beirg solved, considerable useful information has emerged
from the research efforts made by many scientists in recent years.
First, we now know by experience that the chemicals that cause
environmental problems are the ones which are extremely persistent in
nature, biologically active, and easily concentrated in biological
systems. Compounds which lack any of the above qualifications usually
do not play any significant role in pesoicidal pollution no matter how
acutely toxic they are. The above analysis becomes more important, when
one insiders other aspects of pesticidal pollution. For instance, we
are concerned about only biological effects in considering pollution,
with particular emphasis on the effects on non-target organisms.
In the case of polychlorinated dibenzo-p-dioxins, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the question of bioactivity is indisputable, as it is one of the most toxic compounds known to occur as a
pesticidal impurity. Its chemical stability is also questionable. Thus
the central question of its hazard to the environment must be studied
from the viewpoint of bioconcentration in various ecosystems.
Published data on environmental fate of chlorodibenzo-p-dioxins
are scarce at present. For instance, residues of dioxins were not
found in several aquatic animals at detection limits of 0.01-0.01* pg/g.
In the study reported herein we have made efforts to measure the
degree of bioaccumulatior. of TCDD in relation to well established pesticides by using several model ecosystems. The data are still preliminary,
In that several model ecosystems are still being compared for their relative merits in assessing the actual impact of pesticides in nature.
'The data obtained have been, however, useful in assessing the relative
tendency of a pesticide in comparison with other pesticides.
Materials and Methods—Approximately 100 microbial strains which
have previously shown the ability to degrade persistent pesticides were
screened for their ability to degrade TCDD. Screening was carried out
and the metabolic products were examined by thin-layer chromatography
(TLC) by the method of Matsumura and Boush. The pesticides (0.1 umole
each) were deposited on 1 g of clean sea sand, which was placed on a

*7* TS '*" '''

Urn

*" '1

�-11column of sandy loam type soil. Water was then slowly dropped onto the
surface of the sand at a rate of approximately 2 rnl/hr. The water and
sections of soil were extracted with chloroform. Three groups of invertebrates were used for the pesticide accumulation study: Qatracoda
species, Artemis, salina, and Aedes aegypti larvae, and one fish species
northern brook silverside, Laludesthes sicculus sicculus. Pour pesticides were selected from representative groups of important compounds:
dioxin (TCDD), DDT, /-3HC, and zectran. All compounds were l^-labeled in the benzene rings. Three model ecosystems were used to study
bioaccumulation.
In model I, the pesticides (5 and 10 pmole) dissolved in a solvent
were added directly to water along with the primary food organism,
such as algae and yeast, and this mixture was then added to the aquarium
containing the invertebrate test organisms.
In model II, the pesticides (20 pmole) were deposited on the inner
surface of the glass container by evaporating the solvent to form a
thin film. The primary food organism were grown in the container for
2U hr. and then transferred along with the culture media to the aquarium
contairihg the test invertebrate organism.
In model III, the pesticides (5 and 10 praole) were deposited on 1
g of sand and the solvent evaporated to form a thin film on the surface
of the sand particles. The sand was added to the test aquarium containing invertebrates and/or fish.
In all cases the test organisms were maintained in the aquarium at
room temperature (2U° C), except for the fish cultures which were maintained at 12° C. Test organisms were either homogenized in counting
solution or carbonized (Model 300 Packard Tri-Carb Oxidizer), and the
amount of ^C02 measured. Measurements of the amount of labeled material in the water, primary food organism, and on sand and glass surfaces
were made by extracting with chloroform. All studies were short-term
(k-7 days), in small volume containers (200 ml).
As shown in Table 8, the extent of translocation of TCDD from the
sand to the organic soil layer is extremely small. Virtually no TCDD
was found to leach out from the column. The mobility of TCDD in soil,
therefore, must be considered much less than that of DDT. Thus, the
mode of translocation of TCDD in the environment would be limited to
movement of soil particles or dust-carried dispersion and biological
transfer (but not plant-mediated transfer), particularly in aquatic environments.
As for the microbially mediated degradation of TCDD, our current
survey indicates that such capabilities are rather rare in nature. Approximately 100 microbial strains in which the ability to degrade persistent pesticides has been previously demonstrated were screened for
this purpose. Among them, only five strains showed some ability to de-

�-12-

grade this compound. We ha e not been able to manipulate cultural conditions to increase the rate of degradation of TCDD in any of the microorganisms so far.
In studying the extent of biological transfer of TCDD, three
different model systems were devised. In model system I, pesticides in
acetone were introduced directly into water along with the primary food
organisms. In model system II, pesticides were applied to the inner
surface of a glass container, and the primary food organisms were grown
in the container for 2k hr. and were transferred to the aquarium. In
model III, pesticide-coated sands were placed directly in the aquarium
contairAig the test organisms.
In the model I experiment (Table 9), DDT behaved quite differently
from other pesticides, showing high degrees of affinity to each test
organism, in close agreement with the phenomenon actually observed in
nature. Although this model system is simple and appears to offer a
quick straight-forward answer to the general tendency of pesticidal
accumulation by biological systems, it has one weakness, i.e., that one
is forced to work above the limit of water solubility of some of the
compounds. TCDD for instance was measured at a level 100 times its
water solubility. Also the extent of direct pick-up due to partitioning
and food intake is uncertain. In the model II experiment, where only
the portion of pesticide picked up by the primary food organisms and the
media were introduced into the test aquarium, the levels of total pickup were further reduced in the case of TCDD (but not DDT) (Table 10).
To circumvent the problem of solubility, the model III system was
devised. In this way, only that portion of pesticide that is soluble
should be present in water at any time. The results shown in Table 11
indicate that the rate of TCDD pick-up is extremely low in brine shrimp
and fish under the experimental conditions. Mosquito larvae, which
are bottom feeders, showed a surprising rate of TCDD pick up. The reaction is not at its maximal rate, since further increase in the level
of the pesticide apparently increases the pick up by the larvae. Also
noted is the difference between the bioconcentration pattern in fish as
compared to other invertebrates. y-HHC, in particular, shows high
degree of concentration in fish. To study the effects of food consumption, the same test was repeated in the presence or mosquito larvae.
As expected, the level of TCDD (Table 12) in the fish increased in
the presence of mosquito larvae, which are the best concentrators of TCDD
among the organisms tested. On the other hand, the levels of other
pesticides did not significantly change, indicating that the route through
ingestion of mosquito larvae does not represent the major source of uptake in these pesticides.
It is apparent from these data that the reaction of biological
concentration is greatly influenced by the external conditions and
the design of the experiment, the physical and biological nature of the

�,. ,3t;i,,-*,i[*-i*&gt;»^ ',.', "$&amp;•:•" "'' *?•
., *uf. ; '.Tjr •
.,!«,. . u.

-13organisms, and by chemical characteristics of the pesticides. To facilitate understanding of the role of chemical nature of pesticides in
determining the rate of bioconcentration, a comprehensive list has been
prepared to illustrate their Important properties (Table 13).
It can be seen here that general tendencies of bloaccumulation in
invertebrate species follow closely the trend of the partition coefficients. In model II experiments, however, the valuos for TCDD come
much lower than expected from this rule. Thus it is likely that water
solubility (and solvent solubility) must play an important role where
the initial pick-up is the rate-limiting factor.
It is apparent that species-specific factors play a much more important role than once suspected. For instance, the pattern of bioaccumulation and concentration in fish is quite different from those
in other organisms studies, in that both /"-BUG and zectran snow higher
degrees of affinity than DDT and TCDD, respectively. Although the
data are not sufficient to permit a definite conclusion, they suggest
the possibility that water-soluble pesticides tend to accumulate in fish.
TABLE 8
Vertical translocation of pesticides from sand to organic soil.a
Pa s t ic ide c on tent, *
DDT13

Top sand
0-0.5 cm
0.5-1.0 cm
1.0-1.5 cm
1.5-2.0 cm
2.0-2.5 cm
Water
1st
2nd
3rd

eluatec
50 ml
50 ml
50 ml

Zectran"

90. Ul
7.32
1.0U
0.50
0.26
0.18

65.01
30.75
3.51
0.55
0.26

0.19

0.07
0.06
0.08
0.05
0.06
0.06

0.12
0.08

0.06
0.0*1.
0.02

1*9. U
17.6
29.1

0.09

10 x 1.5 cm glass column
Pesticide introduced: 0.1 jamole each (33-8
for DDT, and 22.2 ;ig for Zectran)
Water eluted per day, 50 ml

for dioxin, 35.5 ;ig

�-1UTABLE 9
Bloaccutnulation of pesticides by aquatic invertebrates for

model I (pesticides introduced directly into ambient water
with the primary food organisms).
Test
organisms
(primary Pesticide
food)

Original
concentration
in water, ppb

Final concentration found in
test organisms, Concentration
ppb
factor

Paphnia
(algae)

Dioxin
DDT
Zectran

32. **
35.8
22.2

1,592
Ijl»,l6&gt;»
1,969

'•9
123U
89

Ostracod
.Tfalgae )

Dioxin
DDT
Zectran

32. k

7,069
50,771
7,265

218
1U18
327

Brine
shrimp
(yeast)

Dioxin
DDT
/•-BHC
Zectran

35.8
22.2
16.2

If 956
12,336
2,688

17.9
1U.7
11.1

121

689
183
1U

155

TABIE 10

BJ©concentration of pesticides by aquatic invertebrates for model II
(primary food organisms allowed to pick up pesticide from glass surface and
then given to the test organisms).
Test
organism
(primary
food)

Pestici-ie

Original amount,
jig (theoretical
concentration,
ppb)

Daphnia
(algae)

Dioxin
DDT
Zectran

6.U8 (162)
3.58 (179)
2.22 (111)

Ostra :od
(algae)

Dioxin
DDT
Zectran

6.U8 (162)
3.58 (179)
2.22 (111)

of the test.

Final concentration
found, ppb
Water
Test
aquarium organisms

O.U

22.9
15.1
2.6
50.8

H:.&lt;,

879
U3.123
37,l»99

279
36,391
6,177

Concentration
factor*

2,198
1,883
2,U88

107
716
1U2

�TABI£ 11

Bioconcentration of pesticides by aquatic organisms for model III (pesticides introduced into system
in the form of rp-iuues on sand).
Amount of
pesticide

Concentration found, ppb
Test
Water
(including food)
organisms

Test
organism

Pesticide

Brine shrimp

Dioxin
DDT
V-BHC
Zectran

1.62
1.79
1.47
1.11

0.1
0.5
5.2
5-0

Dioxin

1.62

O.U5
2.1+0
0.85
1.40

Mosquito larvae

PC

DDT
/-3HC

Zectran

3.24
1.79

3.58
1.47
2.9k
1.11
2.22

Fish (silverside)

Dioxin
DDT
y^-SHC
Zectran

1.62

1.79
1.47
1.11

6.6
13.1
5.45
10.8
0
2.1

1.8
4.7

157

Concentration
factor

1,570

3,092
495
89

6,184
95
18

" 4,150

0

9,222
5,000
16,765
21,571
220
221
0

89

8

2
458
2,904

*?•

218

12,000
14,250
30,200
1,450

2,900

213

—.

1,613

U5

w*

�-16'CABLK 12
Two-step bioconcentrution of pesticide by mosquito larvae, and
northern brook silverside (model III).

Pesticide

1.62

Dioxin
DDT
/•-BHC
Zectran

Water
(including
Hood)

1.3
1.1

1.79
l.U?
1.11

1.9
5

Concentration
factor
Mosquito Fish
larvae

3,700
17,900
690
0

Amount of
pesticide
jig

Concentration
found, ppb
Mosquito Fish
larvae

2.8U6
16,273

708

337
1080
76

383
0

5^
306
600
15

TABIB 13
Physiocochemical characteristics of dioxin
in comparison with other insecticides.
Water
solubility

Solvent solubility
Water solubility

0.2
1.2
100
10

ioio
1

Dioxin
DDT
Zectran
/•-BHC
5

ppb
ppb
ppm
ppm

Partition
coefficient
(vs. hexane)

106

10 *
105

100
,0*
1000
0,0
100*
1,700

Benzene
solubility,
g/10Q g
O.OU7
80
80 -

Estimates

The data indicate that TCDD is not likely to accumuhte in as
many biological systems as DDT. This is likely because of TCDD's low
solubility in water and lipids as well as its low partition coefficient
in lipids. Since microbial degradation is not expected to be a rcajor
factor, the predominant mode of elimination of this compound in the
environment is photodecopposition by sunlight.
VI.

Degradation of pesticides by algae.

Three salt water algae, Porphyridium sp., lAinaliella tertiolecta,
ard Coccochloris elabans strain Di, were selected and studied for their
ability to degrade a number of environmentally important pesticides
(2,U-D, 2,U,5-T, mexacarbate, and DDT) and a pesticide contaminant

�-17(tetrachlorodihcnzo d i n x i n ) . Pure algae cultures were grown on a
dci'initlve raedla under laboratory c o n d i t i o n s . The compounds were
studied under the following conditions: (l) growing al|,ao undor 2't
hour light, (2) heat killed algae under 2'* hour light, (3) growing
algae undor total dark (standard mrdia amended w i t h glucose) and
('0 controls (the medium alone but no algae) under ?.h hour light. The
above studies were conducted for 7 days.
Three co-npomids, 2,U-D, 2,U,5-T and TODD were reslstent to breakdown under those conditions. Mexn.carba.te, and DDT were readily broken
down. Although inexaoarbatc was defended in the presence of light alone,
in the presence of algae ( l i v i n g and d e a d ) , over '(0$ of the compound
was converted to water soluble materials not fo^nd in controls. These
compounds became solvent exl.ractable only after acid hydrolysis. A
chloroform soluble metabolite was also dotcc'-ed v/hich was not found in
c ntro.ls. This material had an Rf (ethyl ether, hexane, othanol;
Y7:?0:3) belween methyl fonaami.do and formamldo mexacarbate derivatives.
Tlie degradation of DDT under the above light conditions seem to
give a small amount of DDA. In the presence of algae (living and dead),
under light conditions, two other compounds were formed. One compound
has tentatively been identified as DDE. The other compound using three
TT£ systems has been identified as DDOH. Due to the fact that dead
algae also forms the metabolites of mexacarbate and DDT it is postulated
that a compound is formed by the algae v/hich causes photo-decomposition.
The identification of the metabolites and the nature of the photosensitizers are proposed for future study.
INDEX OF TECHNICAL REPORTS
1.

No Technical Reports have been issued.
BIBLIOGRAPHY OF ALL PUBLICATIONS

1.

Batterton, J. C . , G. M. Boush and F. Matsuraura. 1972. DDT: Inhibition of sodium chloride tolerance by the blue-green algae
Anaeystis nidulans. Science 176: llUl-llU3.

2. I'atsumura, F. and H. J. Benezet. 1973• Studies on the bioaccumulation and microbial degradation of 2,3,7,8-tetrachlorodibenzop-dloxin. Environ. Health Persp. 5: 253-253.
3.

Boush, G. M.
. Effects of pesticide terminal metabolites on
algae and brine shrimp. (In preparation).

�Mt~

*J

-18M.JOR

Varioi'-. alijue species are tested for i.hclr :iii;;&lt;:opUb1 lities
towards chlorinated hydrocarbon Insecticides. D i o l d r l n , which in the
rnout frequently found pestlcidal contaminant in the Uf5, and Its analogs
were found to Inhibit the growth of certain of algae :;pccles. Anacjfstis nidulans In pai-ticular showed marked susceptibility to endrin,
die.l.drin, ketixrulrin and p h o t o d i e l d r i n . This species was also susceptible towards d l o l d r i n metabolites r.uch as metabolite F and (}.
Among DDT me tab o I. i to s ODD (TDK) was found to be the most toxic material;
followed by DDK, DDT and KW-l'p3. It has not been known that ODD should
be more toxic to algae. In terms of acute toxicity phenylmercuric
acetate was by far the most algicidal agent among all pesticldal chemi c a l s tested. This pesticide is toxic to both A_. nidulans^ and A.
!n,a-lnipj l-.ratvrn at the concentrition of 1 ppb.
Algae, along w i t h other plankton, are known to bioaccumulate
pesticides and thereby play a vital role in the process of food-chain
aoetnaulattnn of these mieruponutants. Our studies indicate that the
rates of pick-up of p o s t i c i i l o s are very rapid. To study the feasibility
of constructing a model censysl&lt;.3i we u;:ed algae as a key food chain or(7xnism. By this way we could dc-nonntrate that 'WJDD, the most toxic
contaminant of 2,'^,5-T does not really accumulate in the aquatic organisms as compared to DDT.
Algae as a whole are not very active in degrading pesticldal
chemicals iji vivo. They were found to play, however, a key role in
the process of environmental alteration of pesticidal residues. The
way they participate in such processes was found to be through synerfjistic actions on photochemical reactions. Algal products, when
tested in the form of aqueous extract from dead algal cells, were
fouiid to be excellent photosensitlsers for DDT and mexacarbate degradation by the sun-light (simulated sun lamp).

�</text>
                  </elementText>
                </elementTextContainer>
              </element>
            </elementContainer>
          </elementSet>
        </elementSetContainer>
      </file>
    </fileContainer>
    <collection collectionId="30">
      <elementSetContainer>
        <elementSet elementSetId="1">
          <name>Dublin Core</name>
          <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
          <elementContainer>
            <element elementId="50">
              <name>Title</name>
              <description>A name given to the resource</description>
              <elementTextContainer>
                <elementText elementTextId="4687">
                  <text>Alvin L. Young Collection on Agent Orange</text>
                </elementText>
              </elementTextContainer>
            </element>
            <element elementId="41">
              <name>Description</name>
              <description>An account of the resource</description>
              <elementTextContainer>
                <elementText elementTextId="49809">
                  <text>&lt;p style="margin-top: -1em; line-height: 1.2em;"&gt;The Alvin L. Young Collection on Agent Orange comprises 120 linear feet and spans the late 1800s to 2005; however, the bulk of the coverage is from the 1960s to the 1980s and there are many undated items. The collection was donated to Special Collections of the National Agricultural Library in 1985 by Dr. Alvin L. Young (1942- ). Dr. Young developed the collection as he conducted extensive research on the military defoliant Agent Orange. The collection is in good condition and includes letters, memoranda, books, reports, press releases, journal and newspaper clippings, field logs and notebooks, newsletters, maps, booklets and pamphlets, photographs, memorabilia, and audiotapes of an interview with Dr. Young.&lt;/p&gt;&#13;
&lt;p&gt;For more about this collection, &lt;a href="/exhibits/speccoll/exhibits/show/alvin-l--young-collection-on-a"&gt;view the Agent Orange Exhibit.&lt;/a&gt;&lt;/p&gt;</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </collection>
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="52">
          <name>Box</name>
          <description>The box containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="4906">
              <text>005</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="53">
          <name>Folder</name>
          <description>The folder containing the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="4908">
              <text>0054</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="54">
          <name>Series</name>
          <description>The series number of the original item.</description>
          <elementTextContainer>
            <elementText elementTextId="4911">
              <text>Series I</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4904">
                <text>Boush, G.M.</text>
              </elementText>
              <elementText elementTextId="4905">
                <text>F. Matsumura</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4907">
                <text>&lt;strong&gt;Corporate Author: &lt;/strong&gt;University of Wisconsin, Department of Entomology, Madison, Wisconsin</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4909">
                <text>April 1 1975</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4910">
                <text>Pesticide Degradation By Marine Algae</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="4912">
                <text>biodegradation</text>
              </elementText>
              <elementText elementTextId="4913">
                <text>dioxin</text>
              </elementText>
              <elementText elementTextId="4914">
                <text>pesticide testing</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </item>
</itemContainer>
